
<html lang="en"     class="pb-page"  data-request-id="8e54b79c-a42a-4ea5-902b-0021329c3e1c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01322;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond" /></meta><meta name="dc.Creator" content="Chien-Huang  Wu" /></meta><meta name="dc.Creator" content="Jen-Shin  Song" /></meta><meta name="dc.Creator" content="Hsuan-Hao  Kuan" /></meta><meta name="dc.Creator" content="Szu-Huei  Wu" /></meta><meta name="dc.Creator" content="Ming-Chen  Chou" /></meta><meta name="dc.Creator" content="Jiing-Jyh  Jan" /></meta><meta name="dc.Creator" content="Lun K.  Tsou" /></meta><meta name="dc.Creator" content="Yi-Yu  Ke" /></meta><meta name="dc.Creator" content="Chiung-Tong  Chen" /></meta><meta name="dc.Creator" content="Kai-Chia  Yeh" /></meta><meta name="dc.Creator" content="Sing-Yi  Wang" /></meta><meta name="dc.Creator" content="Teng-Kuang  Yeh" /></meta><meta name="dc.Creator" content="Chen-Tso  Tseng" /></meta><meta name="dc.Creator" content="Chen-Lung  Huang" /></meta><meta name="dc.Creator" content="Mine-Hsine  Wu" /></meta><meta name="dc.Creator" content="Po-Chu  Kuo" /></meta><meta name="dc.Creator" content="Chia-Jui  Lee" /></meta><meta name="dc.Creator" content="Kak-Shan  Shia" /></meta><meta name="dc.Description" content="The function of the CXCR4/CXCL12 axis accounts for many disease indications, including tissue/nerve regeneration, cancer metastasis, and inflammation. Blocking CXCR4 signaling with its antagonists ..." /></meta><meta name="Description" content="The function of the CXCR4/CXCL12 axis accounts for many disease indications, including tissue/nerve regeneration, cancer metastasis, and inflammation. Blocking CXCR4 signaling with its antagonists ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 27, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01322" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01322" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01322" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01322" /></link>
        
    
    

<title>Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01322" /></meta><meta property="og:title" content="Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0014.jpeg" /></meta><meta property="og:description" content="The function of the CXCR4/CXCL12 axis accounts for many disease indications, including tissue/nerve regeneration, cancer metastasis, and inflammation. Blocking CXCR4 signaling with its antagonists may lead to moving out CXCR4+ cell types from bone marrow to peripheral circulation. We have discovered a novel series of pyrimidine-based CXCR4 antagonists, a representative (i.e., 16) of which was tolerated at a higher dose and showed better HSC-mobilizing ability at the maximal response dose relative to the approved drug 1 (AMD3100), and thus considered a potential drug candidate for PBSCT indication. Docking compound 16 into the X-ray crystal structure of CXCR4 receptor revealed that it adopted a spider-like conformation striding over both major and minor subpockets. This putative binding mode provides a new insight into CXCR4 receptor–ligand interactions for further structural modifications." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01322"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01322">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01322&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01322&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01322&amp;href=/doi/10.1021/acs.jmedchem.7b01322" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 818-833</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01297" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01340" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chien-Huang++Wu">Chien-Huang Wu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jen-Shin++Song">Jen-Shin Song</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsuan-Hao++Kuan">Hsuan-Hao Kuan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Szu-Huei++Wu">Szu-Huei Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Chen++Chou">Ming-Chen Chou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiing-Jyh++Jan">Jiing-Jyh Jan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lun+K.++Tsou">Lun K. Tsou</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1593-5226" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Yu++Ke">Yi-Yu Ke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiung-Tong++Chen">Chiung-Tong Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kai-Chia++Yeh">Kai-Chia Yeh</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sing-Yi++Wang">Sing-Yi Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teng-Kuang++Yeh">Teng-Kuang Yeh</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chen-Tso++Tseng">Chen-Tso Tseng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chen-Lung++Huang">Chen-Lung Huang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mine-Hsine++Wu">Mine-Hsine Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Po-Chu++Kuo">Po-Chu Kuo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chia-Jui++Lee">Chia-Jui Lee</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kak-Shan++Shia">Kak-Shan Shia</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9560-2466" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, R.O.C.</span></div><div class="corresp-info"><strong>*</strong> Telephone: +886-37-246-166 ext. 35709. Fax: +886-37-586-456. E-mail: <a href="/cdn-cgi/l/email-protection#600b1313080901200e0812094e0f12074e1417"><span class="__cf_email__" data-cfemail="600b1313080901200e0812094e0f12074e1417">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01322&amp;href=/doi/10.1021%2Facs.jmedchem.7b01322" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 818–833</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 9, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 September 2017</li><li><span class="item_label"><b>Published</b> online</span>27 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01322" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01322</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D818%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChien-Huang%2BWu%252C%2BJen-Shin%2BSong%252C%2BHsuan-Hao%2BKuan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D3%26contentID%3Dacs.jmedchem.7b01322%26title%3DDevelopment%2Bof%2BStem-Cell-Mobilizing%2BAgents%2BTargeting%2BCXCR4%2BReceptor%2Bfor%2BPeripheral%2BBlood%2BStem%2BCell%2BTransplantation%2Band%2BBeyond%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D833%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01322"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">998</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01322" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chien-Huang&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Jen-Shin&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Hsuan-Hao&quot;,&quot;last_name&quot;:&quot;Kuan&quot;},{&quot;first_name&quot;:&quot;Szu-Huei&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Ming-Chen&quot;,&quot;last_name&quot;:&quot;Chou&quot;},{&quot;first_name&quot;:&quot;Jiing-Jyh&quot;,&quot;last_name&quot;:&quot;Jan&quot;},{&quot;first_name&quot;:&quot;Lun&quot;,&quot;last_name&quot;:&quot;K. Tsou&quot;},{&quot;first_name&quot;:&quot;Yi-Yu&quot;,&quot;last_name&quot;:&quot;Ke&quot;},{&quot;first_name&quot;:&quot;Chiung-Tong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Kai-Chia&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Sing-Yi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Teng-Kuang&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Chen-Tso&quot;,&quot;last_name&quot;:&quot;Tseng&quot;},{&quot;first_name&quot;:&quot;Chen-Lung&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Mine-Hsine&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Po-Chu&quot;,&quot;last_name&quot;:&quot;Kuo&quot;},{&quot;first_name&quot;:&quot;Chia-Jui&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Kak-Shan&quot;,&quot;last_name&quot;:&quot;Shia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;818-833&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01322&quot;},&quot;abstract&quot;:&quot;The function of the CXCR4/CXCL12 axis accounts for many disease indications, including tissue/nerve regeneration, cancer metastasis, and inflammation. Blocking CXCR4 signaling with its antagonists may lead to moving out CXCR4+ cell types from bone marrow to peripheral circulation. We have discovered a novel series of pyrimidine-based CXCR4 antagonists, a representative (i.e., 16) of which was tolerated at a higher dose and showed better HSC-mobilizing ability at the maximal response dose relative to the approved drug 1 (AMD3100), and thus considered a potential drug candidate for PBSCT indication. Docking compound 16 into the X-ray crystal structure of CXCR4 receptor revealed that it adopted a spider-like conformation striding over both major and minor subpockets. This putative binding mode provides a new insight into CXCR4 receptor–ligand interactions for further structural modifications.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01322&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01322" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01322&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01322" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01322&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01322" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01322&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01322&amp;href=/doi/10.1021/acs.jmedchem.7b01322" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01322" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01322" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01322%26sid%3Dliteratum%253Aachs%26pmid%3D29314840%26genre%3Darticle%26aulast%3DWu%26date%3D2018%26atitle%3DDevelopment%2Bof%2BStem-Cell-Mobilizing%2BAgents%2BTargeting%2BCXCR4%2BReceptor%2Bfor%2BPeripheral%2BBlood%2BStem%2BCell%2BTransplantation%2Band%2BBeyond%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D818%26epage%3D833%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The function of the CXCR4/CXCL12 axis accounts for many disease indications, including tissue/nerve regeneration, cancer metastasis, and inflammation. Blocking CXCR4 signaling with its antagonists may lead to moving out CXCR4<sup>+</sup> cell types from bone marrow to peripheral circulation. We have discovered a novel series of pyrimidine-based CXCR4 antagonists, a representative (i.e., <b>16</b>) of which was tolerated at a higher dose and showed better HSC-mobilizing ability at the maximal response dose relative to the approved drug <b>1</b> (AMD3100), and thus considered a potential drug candidate for PBSCT indication. Docking compound <b>16</b> into the X-ray crystal structure of CXCR4 receptor revealed that it adopted a spider-like conformation striding over both major and minor subpockets. This putative binding mode provides a new insight into CXCR4 receptor–ligand interactions for further structural modifications.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The G protein-coupled CXC chemokine receptor 4 (CXCR4) is activated by CXCL12, also known as stromal cell-derived factor-1 or SDF-1, and is constitutively expressed in both CNS and peripheral systems.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> The interaction between CXCL12 and CXCR4 can regulate the trafficking of many different cell types, such as hematopoietic stem cells (HSCs),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> endothelial progenitor cells (EPCs),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and mesenchymal stem cells (MSCs).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Multiple functions have been found along the CXCR4/CXCL12 axis, including the promotion of angiogenesis, metastasis, tumor growth and cancer survival, neurogenesis, immunomodulation, and protective/reparative effects in the lesioned tissues.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Moreover, both chemokine receptors, CXCR4 and CCR5, act as co-receptors in mediating HIV-1 entry. The first-in-class CCR5 antagonist, maraviroc, was approved in 2007 as an anti-HIV drug.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Unfortunately, clinical observation of HIV-infected patients after maraviroc administration resulted in a X4/R5 mixed-tropic viral population with poor prognosis, suggesting that blocking both co-receptors are desirable.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To date, small-molecule CXCR4 antagonists <b>1</b> (AMD3100, Plerixafor, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) and AMD11070 are not being further developed for HIV-1 infection due to lack of overall clinical benefit and hepatotoxicity observed in long-term animal studies, respectively.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> Another advanced CXCR4 blocker KRH-3955, displaying high potency and oral bioavailability in a HIV-1 replication model, is in early clinical development.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Small-Molecule CXCR4 Antagonists with Anti-HIV-1 Activity</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, a significant unmet medical need remains for treatment of AIDS by blocking the CXCR4-utilizing HIV strains. In addition to serving as anti-HIV agents,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> increasing evidence has also strongly supported that CXCR4 specific antagonists could effectively induce functional recovery in various ischemic disease animal models associated with ischemic stroke, acute kidney injury, and myocardial infarction through autologous migration of stem cells out of bone marrow into peripheral circulation.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24 ref25">(20-25)</a> CXCR4 may become a versatile drug target in numerous therapeutic areas, including anti-cancer metastasis<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> and anti-inflammation,<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28-31)</a> as well as tissue repair or nerve regeneration.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A specific CXCR4 antagonist <b>1</b> in combination with the granulocyte colony-stimulating factor (G-CSF; Filgrastim) has been approved by US/FDA in 2008 for use in transplantation in non-Hodgkin’s lymphoma or multiple myeloma patients. It is utilized in a medical procedure called peripheral blood stem cell transplantation (PBSCT) to help cancer patients restore their immune system rapidly after chemo- or radiotherapy.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> More specifically, the procedure consists of an 8-day treatment period, in which patients receive a daily dose of G-CSF for four consecutive days to stimulate stem cell production, and beginning on day 5, a stem cell mobilizer <b>1</b> is co-injected with G-CSF daily for subsequent daily apheresis (days 5–8) until more than 6 × 10<sup>6</sup> CD34<sup>+</sup> cells/kg are harvested.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> More importantly, it was reported that HSCs collected in this manner also showed long-term repopulating capacity, implying that the above PBSCT procedure may replace a traditional surgical operation as a favorable source for adult stem cell transplantation in the future.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Recent encouraging clinical evidence revealed that when patients with acute ischemic stroke were transplanted intra-arterially with autologous CD34<sup>+</sup> stem cells, they all showed significant improvement in functional recovery and reduction in the brain infarct volume in the following six months after treatment.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Though CXCR4 antagonists are structurally diverse as seen in many historical cases,<a onclick="showRef(event, 'ref7 ref22 ref23 ref40'); return false;" href="javascript:void(0);" class="ref ref7 ref22 ref23 ref40">(7, 22, 23, 40)</a> they appear to have a preference for incorporating multiple nitrogen elements in a spider-like skeleton. This structural propensity is presumably due to mimicking highly positively charged natural ligand CXCL12, comprising a sequence of 68 amino acids rich in Lys and Arg residues.<a onclick="showRef(event, 'cit40k'); return false;" href="javascript:void(0);" class="ref cit40k">(40k)</a> In continuation of our long-term studies on CXCR4 antagonists, herein, we wish to report that out of 600 polyamine analogues designed and experimentally realized via docking into the X-ray crystal structure of CXCR4,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> a selective and potent CXCR4 antagonist <b>16</b>, named CX0714 in our in-house library, has been identified as a promising drug candidate for PBSCT and also has potential utility in many other CXCR4-mediated diseases.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Results are presented as follows.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first and only marketed CXCR4 antagonist <b>1</b> is commonly considered toxic and particularly inappropriate for the chronic treatment (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">Supporting Information (SI)</a>, p S64; also see details in ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a>, pp 86–154). Therefore, we set out to identify a new generation of CXCR4-targeted compounds with better safety profiles and HSC mobilization by optimizing a series of quinazoline-core analogues previously designed in our laboratories (e.g., <b>2</b> and <b>3</b>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0015.gif" alt="" id="fx1" /></img></div><div class="NLM_p">We began by simplifying the original quinazoline ring into a pyrimidine unit while maintaining the previously optimized triazole ring linker (e.g., <b>3</b>). As illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> using compound <b>7</b> as a typical example, a general synthetic procedure was implemented to prepare an array of analogues <b>7</b>–<b>13</b>. Starting from 2,4-dichloro-6-methylpyrimidine, C4-substitution with 4-amino-1-benzyl-piperidine was established at room temperature in a chemoselective fashion to produce intermediate <b>4</b> in 62%, which in turn underwent C2-substitution with a <i>N</i>-Boc-protected linker <b>1</b> at elevated temperature (140 °C) in pentanol to afford intermediate <b>5</b> in 63%. Selective hydrogenolysis was carried out under 1 atm of hydrogen with Pd/C as catalyst to give amine <b>6</b> in 92% yield, in which <i>N</i>-Boc was subsequently deprotected under acidic conditions (1 N HCl) to afford desired product <b>7</b> in 95% yield as a hydrochloride salt.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Representative Compound <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-amino-1-benzyl-piperidine, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C to rt, 16 h, 62%; (b) linker <b>1</b>, 1-pentanol, 140 °C, 5 h, 63%; (c) Pd/C (10%), 2-propanol, 60 °C, 16 h, 92%; (d) 1 N HCl in diethyl ether, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 95%.</p></p></figure><div class="NLM_p">As listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, when R<sup>1</sup> is a hydrogen or alkyl group, the corresponding compounds <b>7</b>–<b>10</b> exhibit potent binding affinities (IC<sub>50</sub> = 23–61 nM) toward CXCR4 receptors, suggesting that the pyrimidine unit can replace quinazoline ring as a bioisosteric nucleus. However, as the neutral R<sup>1</sup> group is replaced with either a strong electron-donating (OCH<sub>3</sub>) or electron-withdrawing (CF<sub>3</sub>) group, a dramatic decrease in binding affinities by 10-fold is observed as demonstrated by compounds <b>11</b>–<b>13</b> (IC<sub>50</sub> = 472–859 nM). In addition, an acute toxicity study revealed that all compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> remained toxic, showing a lower maximum tolerated dose (MTD = 10 mg/kg) than that of the positive control <b>1</b> (MTD = 15 mg/kg) following the same subcutaneous (SC) administration in mice.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinity and Acute Toxicity of Polyamines <b>7</b>–<b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MTD (mg/kg)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">23.9 ± 3.0</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">34.1 ± 3.8</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="±">46.8 ± 12.9</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="±">61.1 ± 4.4</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">472.7 ± 136.3</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">708.3 ± 63.7</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">859.7 ± 255.6</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">213.1 ± 26.0</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Determined by 50% inhibition of radioligand [<sup>125</sup>I]CXCL12 binding to hCXCR4-transfected HEK293 membrane; values represent the mean ± SD of at least three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Following SC administration in C57BL/6 mice.</p></div></div></div><div class="NLM_p">Further structural modifications intended for reducing acute toxicity were then attempted by elongating the side arm at C4-position while linker <b>1</b> at C2 remained intact. In fact, the length of linker <b>1</b> has been previously studied in the corresponding bioisosteric quinazoline series as exemplified by compound <b>3</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Linker <b>1</b> with a [1+3+3] methylene unit was considered optimal and engrafted on the current pyrimidine series. According to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, it could be readily prepared using propargylamine as the starting material. Propargylamine was first coupled with benzyl chloroformate to form a Cbz-protected intermediate in a quantitative yield (95%), which was then reacted with 3-azido-propanol via click chemistry under catalysis with Cu(I) to generate triazole alcohol in a regioselective manner in 83%. Triazole alcohol thus formed could further undergo mesylation to afford the corresponding mesylate (90%), which was subsequently substituted with propane-1,3-diamine followed by reductive amination with cyclohexanone and subsequent protection with Boc<sub>2</sub>O to afford a fully <i>N</i>-protected linker <b>1</b> in 43% yield over three steps. Finally, the Cbz protecting group was selectively removed via hydrogenolysis to afford the desired linker <b>1</b> in 93% yield. As illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> using compound <b>16</b> as a typical example, compound <b>7</b> with fixed linker <b>1</b> at C-2 was subjected to further structural modifications via elongating the C-4 substituent by coupling with an array of amino and phosphonic acids to generate compounds <b>16</b>–<b>26</b> in 51–60% yields over three steps. Intermediate <b>6</b> was first coupled with 3-Boc-(2-ethoxy-2-oxoethyl)amino propionic acid under catalysis with EDCI/HOBt to provide compound <b>14</b> in 71% yield, which in turn was subjected to ester hydrolysis under basic conditions to furnish the corresponding acid <b>15</b> in quantitative yield (99%). Compound <b>15</b> was hydrolyzed under acidic conditions to remove <i>N</i>-Boc to afford the desired <b>16</b> in 95% yield as a hydrochloride salt.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of <i>N</i>-Boc-Protected Linker <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzyl chloroformate, K<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O = 1/2, 5 °C to rt, 15 h, 95%; (b) 3-azido-propanol, CuSO<sub>4</sub>, (+) sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, K<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O = 4/1, rt, 15 h, 83%; (c) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C to rt, 15 h, 90%; (d) propane-1,3-diamine, THF, 65 °C, 15 h; (e) cyclohexanone, MeOH, 60 °C, 6 h then NaBH<sub>4</sub>, 5 °C, 1 h; (f) Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 15 h, 43% over three steps; (g) H<sub>2</sub>, Pd/C, 2-propanol, 60 °C, 15 h, 93%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Representative Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-((<i>tert</i>-butoxycarbonyl)(2-ethoxy-2-oxoethyl)amino)propionic acid, EDCI, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 71%; (b) LiOH, THF/H<sub>2</sub>O, rt, 16 h, 99%; (c) 1 N HCl in diethyl ether, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 95%.</p></p></figure><div class="NLM_p">Following a similar synthetic method starting from the same intermediate <b>6</b>, compounds <b>27</b>–<b>32</b> were synthesized as a hydrochloride salt in 50–60% yield over a two-step sequence, involving a typical S<sub>N</sub>2 substitution followed by hydrolysis of the <i>N</i>-Boc protecting group under acidic conditions. As compiled in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, both acute toxicity and structure–activity relationship (SAR) of these compounds are evaluated and elucidated as follows.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinity and Acute Toxicity of Polyamines <b>16</b>–<b>32</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Determined by 50% inhibition of radioligand [<sup>125</sup>I]CXCL12 binding to hCXCR4-transfected HEK293 membrane; values represent the mean ± SD of at least three independent experiments.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Following SC administration in C57BL/6 mice.</p></div></div><div></div></div><div class="NLM_p">In the beginning, compound <b>27</b> with an alkyl group as a R<sup>3</sup> side arm was first synthesized, of which binding affinity (IC<sub>50</sub> = 47.8 ± 9.2 nM) and MTD (10 mg/kg) were found comparable to its parent compound <b>7</b>. When the terminal methyl moiety of <b>27</b> was changed to the cyano group, however, the MTD of the resulting compound <b>28</b> was increased by 2-fold to 20 mg/kg though binding affinity (IC<sub>50</sub> = 72.1 ± 21.1 nM) was slightly decreased. This modest improvement in MTD prompted us to modify the R<sup>3</sup> spacer with more polar terminal groups. Changing the cyano to an amide group resulted in compound <b>29</b> with little enhancement in potency (IC<sub>50</sub> = 25.6 ± 8.2 nM), but acute toxicity was retained (MTD = 20 mg/kg). When the amide group was further changed to the carboxylic functionality, the resulting compounds <b>30</b>–<b>32</b> (IC<sub>50</sub> = 70.4–93.0 nM, MTD = 75–100 mg/kg) showed a sharp increase in MTD though their binding activities decreased by 3-fold relative to parent <b>7</b> (IC<sub>50</sub> = 23.9 ± 3.0 nM, MTD = 10 mg/kg), suggesting that a polar carboxylic group at the terminus of the C-4 substituent could significantly reduce acute toxicity. As such, this functionality is kept constant while other portions of the pharmacophore are varied in further structural modifications. In the meantime, to make the C-4 linker synthetically more variable and practical, two new structural elements including a carbonyl moiety and nitrogen were appropriately incorporated into the linker. As a result, compounds <b>16</b>–<b>19</b> (IC<sub>50</sub> = 34.2–88.5 nM, MTD = 50–100 mg/kg) were then prepared. As demonstrated with <b>16</b> (IC<sub>50</sub> = 34.2 ± 6.1 nM, MTD = 75 mg/kg), the C-4 linker containing [2+1] methylene units appeared optimal in length in terms of potency and acute toxicity. Keeping it as a fixed theme, we slightly altered R<sup>1</sup> and R<sup>2</sup> groups to afford structurally closely related analogues <b>20</b>–<b>24</b> (IC<sub>50</sub> = 71.1–399.3 nM, 50–100 mg/kg). Unfortunately, these modifications led to losing binding affinities by 2- to 10-fold relative to <b>16</b> though their MTD remained at a satisfactory level. Replacing the terminal carboxylic group with its equivalent, phosphonic acid, was also explored; however, the resulting compounds <b>25</b> (IC<sub>50</sub> = 91.6 ± 9.4 nM) and <b>26</b> (IC<sub>50</sub> = 147.1 ± 33.2 nM) showed no improvement in binding affinities though their MTD still maintained at a high level (50–100 mg/kg). The higher MTD seen in this novel series of compounds than bicyclam <b>1</b> is presumably due to the presence of the terminal carboxylic or phosphonic acid, allowing to increase protein binding and decrease distribution (e.g., <b>16</b>, 60–75% vs <b>1</b>, 33–50% in rats). However, the underlying cause remains to be determined. Compound <b>16</b> (IC<sub>50</sub> = 34.2 ± 6.1 nM; MTD = 75 mg/kg, SC) possessing a much stronger binding affinity and higher MTD than the marketed drug <b>1</b> (IC<sub>50</sub> = 213.1 ± 26.0 nM; MTD = 15 mg/kg, SC) was considered a potential drug candidate and elected for various preclinical evaluations as shown below.</div><div class="NLM_p">To examine compound <b>16</b>’s specificity among chemokine family, it was extensively screened against a panel of chemokine receptors in both CCR and CXCR types. As listed in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, compound <b>16</b> exhibited no cross-activity up to 10 μM in cAMP functional assay toward all tested receptors (−11 to 0.5% inhibition) except CXCR4 (73.4% inhibition), indicating that it is a highly selective CXCR4 antagonist (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">SI</a>, pp S10–S21).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selectivity of Compound <b>16</b> against Related Chemokine Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay target</th><th class="colsep0 rowsep0" align="center" char=".">efficacy (%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">assay target</th><th class="colsep0 rowsep0" align="center" char=".">efficacy (%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCR1</td><td class="colsep0 rowsep0" align="char" char=".">–1.2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR1</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCR5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCR6</td><td class="colsep0 rowsep0" align="char" char=".">–2.2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR3</td><td class="colsep0 rowsep0" align="char" char=".">–7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCR7</td><td class="colsep0 rowsep0" align="char" char=".">–4.2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR4</td><td class="colsep0 rowsep0" align="char" char=".">73.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCR10</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR5</td><td class="colsep0 rowsep0" align="char" char=".">–11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XCR1</td><td class="colsep0 rowsep0" align="char" char=".">–2.8</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">CXCR6</td><td class="colsep0 rowsep0" align="char" char=".">–3.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Percentage inhibition was determined in GPCR cAMP assay at a concentration of 10 μM; very weak inhibition (∼0.5–11%) was observed for all tested chemokine receptors except CXCR4 (73.4%).</p></div></div></div><div class="NLM_p">Subsequently, the chemotaxis assay was conducted to evaluate compound <b>16</b>’s role in cellular migration of CXCR4<sup>+</sup> cells. As indicated in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, CXCL12-induced movement of CCRF-CEM cells, a human cell line highly expressed with CXCR4, was efficiently blocked at a very low concentration (EC<sub>50</sub> = 13.7 ± 3.8 nM). Compound <b>16</b> was also subjected to the cytotoxicity assay against Detroit 551 (human normal skin fibroblast cells) with a CC<sub>50</sub> value of more than 100 μM. Taken together, above <i>in vitro</i> studies suggest that compound <b>16</b> is a highly selective CXCR4 antagonist and tolerated up to high doses in mice.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CXCL12-induced chemotaxis assay was conducted for compound <b>16</b>. Data were collected from three independent experiments and represent the mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For comparison purposes, pharmacokinetic studies on both control <b>1</b> and <b>16</b> were carried out simultaneously prior to <i>in vivo</i> studies, results of which were summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Accordingly, compound <b>16</b>’s blood exposure (AUC = 13515 ng/mL·h) and <i>C</i><sub>max</sub> (16 400 ng/mL) are almost 2 times as high as those of drug <b>1</b> (AUC = 7152 ng/mL·h; <i>C</i><sub>max</sub> = 6200 ng/mL).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Studies of Control <b>1</b> and Compound <b>16</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>(0–4 h)</sub> (ng/mL·h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="±">6200 ± 394</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">7152 ± 135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="±">16400 ± 2858</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">13515 ± 1618</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values indicate mean ± SD (<i>n</i> = 3) following SC in C57BL/6 mice.</p></div></div></div><div class="NLM_p">Meanwhile, from the mechanistic point of view, CXCR4 antagonists are supposed to be eliminated timely when stem cells circulating in peripheral blood are collected. Thus, compound <b>16</b> with <i>T</i><sub>1/2</sub> = 30 min, presumably due to phase II metabolism by kidney, apparently meets with this pharmacokinetic requirement for PBSCT indication. To determine its maximal response dose, compound <b>16</b> was administered subcutaneously at an escalating dose of 1, 6, 20, 35, and 50 mg/kg, respectively, in 8- to 10-week-old C57BL/6 male mice. As a result, a dose dependent curve of the number of CXCR4<sup>+</sup> stem cells was observed via the flow cytometry analysis as illustrated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CXCR4<sup>+</sup> cells were analyzed by flow cytometry. The blood samples containing mobilized CXCR4<sup>+</sup> stem cells were collected from C57BL/6 mice and measured by flow cytometry at a time point of 2 h after SC injection with indicated concentrations of compound <b>16</b>. Data represent the mean ± SEM (<i>n</i> = 3 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05 and **<i>p</i> < 0.01 between control and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A 3-fold (<i>p</i> < 0.01) increase in CXCR4<sup>+</sup> stem cells was observed at a dose of 35 mg/kg, tentatively assigned as a maximal response dose, as compared to vehicle. Since its minimal effect dose (MED) occurred at 6 mg/kg, thus, the therapeutic window was determined as MTD/MED = 12.5. More than the maximal response dose resulted in a significant decrease in the number of CXCR4<sup>+</sup> stem cells as observed at a dose of 50 mg/kg (<i>p</i> < 0.05). We are particularly interested in CD34<sup>+</sup> and CD133<sup>+</sup> as well as VEGFR2<sup>+</sup> and VEGFR2<sup>+</sup>Sca-1<sup>+</sup> cell types; the former (CD34<sup>+</sup> and CD133<sup>+</sup>) are widely recognized as biomarkers for HSCs,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> and the latter are for EPCs.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> Thus, double staining experiments (e.g., CXCR4<sup>+</sup>/CD34<sup>+</sup>) were further performed and results were analyzed as follows. A maximal response dose of positive control <b>1</b> (6 mg/kg) and test compound <b>16</b> (35 mg/kg) was given via SC injection, respectively, to evaluate their ceiling effects on moving out HSCs and EPCs stem cells.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> As displayed in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, treatment with compound <b>16</b> alone did exhibit greater ability than marketed drug <b>1</b> as well as vehicle by about 2- and 7-fold, respectively, to move out HSCs and EPCs into the peripheral circulation. Following the clinical protocol of positive control <b>1</b>, however, compound <b>16</b> in combination with G-CSF was further examined to evaluate its combination effects on moving out HSCs. Since the experiment is critical for determining whether <b>16</b> is qualified as a drug candidate for PBSCT, instead of the primary assay using flow cytometry, a more accurate but time-consuming CFU assay was then conducted to analyze HSC counts between dosing with <b>1</b>+GCSF and <b>16</b>+GCSF.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Double staining analysis by flow cytometry. (A) CXCR4<sup>+</sup>CD34<sup>+</sup> cells, (B) CXCR4<sup>+</sup>CD133<sup>+</sup> cells, (C) CXCR4<sup>+</sup>VEGFR2<sup>+</sup> cells, and (D) VEGFR2<sup>+</sup>Sca-1<sup>+</sup> cells. The blood samples were collected from C57BL/6 mice and measured by flow cytometry at a time point of 2 h after SC injection of compound <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg) at the maximal response dose. Data represent the mean ± SEM (<i>n</i> = 3 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 between control and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Peripheral blood mononuclear cells (PBMCs) were first isolated from blood samples and incubated for 10–14 days until CFU-GM (colony-forming unit-granulocyte/monocyte) colonies could be clearly formed and unambiguously counted under an inverted microscope. In general, the aggregate equal to or more than 50 cells is recorded as a colony. As can be seen in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, the number of CFU-GM colonies provided by <b>16</b>+GCSF was significantly increased by 1.6-fold relative to <b>1</b>+GCSF, interestingly which was in good agreement with the CD34<sup>+</sup> and CD133<sup>+</sup> cell population ratio (1.7:1) obtained by flow cytometry as illustrated in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A,B. Also emphasized is the fact that the number of HSCs, as demonstrated by CFU-GM colonies, was dramatically increased by roughly 5.3-fold in the combination regimen compared to control using G-CSF alone.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> efficacy comparison in colony-forming assay. C57BL/6 male mice were treated with G-CSF (100 μg/kg) daily for 4 consecutive days by SC injection. On day 5, G-CSF (100 μg/kg) in combination with <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg) was given, respectively. The heparinized blood samples containing mobilized stem cells were collected 2 h after SC administration, and then peripheral blood mononuclear cells (PBMCs) were isolated and cultured for CFU-GM colony-forming assay. Data represent the mean ± SEM with 8–12 mice per group. Statistical analysis was performed by <i>t</i> test: ***<i>p</i> < 0.001 between control (G-CSF alone) and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>16</b> was also subjected to 68 off-target standard assays (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">SI</a>, pp S2–S9). Accordingly, besides calcium channel N-type and muscarinic M2 sodium channel with 73% and 70% inhibition at 10 μM, respectively, compound <b>16</b> showed low binding and inhibitory activity toward other 66 off-targets (<50% inhibition at 10 μM). In addition, no hERG liability was observed for compound <b>16</b> at a concentration up to 100 μM in the patch-clamp assay (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">SI</a>, pp S25–S35). Effects of compound <b>16</b> on six human liver microsomal CYP enzymes, including 1A2, 2C9, 2C19, 2D6, 2E1, and 3A4, were also investigated and results showed that IC<sub>50</sub> values against above CYP enzymes were all greater than 100 μM, implying that drug–drug interactions caused by co-administration with compound <b>16</b> are not likely to be a major issue. In addition to moving out HSCs and EPCs mentioned above, many CXCR4<sup>+</sup> mature immune cells such as white blood cells (WBCs), also referred to as leukocytes, could be released by CXCR4 antagonists <b>1</b> and <b>16</b> as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vivo</i> efficacy comparison in WBC mobilization. The blood samples containing mobilized white blood cells were collected from C57BL/6 mice and analyzed for (A) total white blood cells, (B) neutrophils, (C) lymphocytes, and (D) monocytes at a time point of 2 h after SC injection with compound <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg). Data represent the mean ± SEM (<i>n</i> = 5 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 between the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, WBCs are composed of neutrophils, eosinophils, basophils, lymphocytes, and monocytes.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> As can be seen in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B–D, compound <b>16</b> can mobilize out neutrophils, lymphocytes, and monocytes, which are mainly responsible for anti-infection, activating immunity and engulfing antigens in the living system, in cell counts higher than drug <b>1</b> by 30–50%, and more than control by 2- to 4-fold, again verifying that it is a versatile CXCR4-targeted agent.</div><div class="NLM_p">To further support compound <b>16</b> as a suitable drug candidate, its non-GLP 14-day repeated dose toxicology study (SD rats, 50 mg/kg/day, SC) has been carried out, results of which revealed that all major organs, including liver, kidney, lung, heart, etc., are normal in size, weight and color as compared to those in vehicle. As well, blood sample analysis also showed that no significance difference was observed in both hematological and biochemical data between vehicle and experimental rats (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">SI</a>, pp S65–S67). Since structurally compound <b>16</b> is a polyamine and highly suspected to be metabolized by kidney as seen with compound <b>1</b>,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> an acute histology study on kidney was also performed. Consequently, no specific histological difference was found in renal tissue between the control and experimental groups at a dose up to 100 mg/kg as analyzed by photomicrographs illustrated in Figures S1 and S2 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">SI</a>, pp S68–S69).</div><div class="NLM_p">To better understand the SAR of this newly developed series, computational docking studies were extensively undertaken during the course of development. As typified by <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, molecular docking of <b>16</b> to the X-ray structure of CXCR4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS">4RWS</a>) displayed that secondary amino and carboxylic groups of <b>16</b> could form hydrogen-bonding/polar interactions with Asn33, Asn37, Asp97, His203, Gly207, and Tyr256 (cyan) constituting the major subpocket, and the terminal cyclohexyl ring was anchored at the minor subpocket surrounded by a series of hydrophobic residues Trp94, Trp102, Val112, His113, Tyr116, and Cys186 (yellow). This putative binding mode, crossing both major and minor binding pockets, could be further highlighted via superimposing the above simulating complex structure on both X-ray co-crystal structures IT1t/<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ODU">3ODU</a> and CVX15/<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0">3OE0</a>. As illustrated in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, it clearly demonstrates that different from the cyclic peptide CVX15 (pink) interacting with the major subpocket and small molecule IT1t (green) with the minor subpocket, compound <b>16</b> (orange) assumes a stretching-out conformation to occupy both major and minor subpockets simultaneously.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This spider-like putative binding mode seems to interact favorably with the open and negatively charged CXCR4 receptor, and provides a new insight into CXCR4 receptor–ligand interactions, whereby more effective CXCR4 antagonists with improved oral bioavailability might be developed in the future.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking compound <b>16</b> (orange) to the CXCR4 crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS">4RWS</a>) after 20 ns of MD simulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>16</b> (orange) is assumed to occupy both major and minor subpockets displayed with a pink (CVX15) and green (IT1t) surface field.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Though currently autologous adult stem cell transplantation is the only therapeutic utility for CXCR4-targeted agents (e.g., <b>1</b>), CXCR4 might become an important drug target in light of its versatile mechanistic pathways.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We have discovered a novel series of pyrimidine-based CXCR4 antagonists, the representative (i.e., <b>16</b>) of which apparently exhibited a higher MTD dose and better HSC/EPC-mobilizing ability at the maximal response dose than drug <b>1</b> in mice following SC administration, suggesting that compound <b>16</b> could serve as a promising drug candidate for PBSCT and other disease indications. In addition, inspired with the putative binding mode of this novel series of compounds, further structural modifications will be carried out to generate a second generation of CXCR4 antagonists with potential enhancement in safety profiles and oral bioavailability.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div class="NLM_p">Unless otherwise stated, all materials used were commercially available and used as supplied. Reactions requiring anhydrous conditions were performed in flame-dried glassware and cooled under an argon or nitrogen atmosphere. Unless otherwise stated, reactions were carried out under argon or nitrogen and monitored by analytical thin layer chromatography performed on glass-backed plates (5 × 10 cm) precoated with silica gel 60 F254 as supplied by Merck. Visualization of the resulting chromatograms was performed by looking under an ultraviolet lamp (λ = 254 nm) followed by dipping in an ethanol solution of vanillin (5% w/v) containing sulfuric acid (3% v/v) or phosphomolybdic acid (2.5% w/v) and charring with a heat gun. Flash chromatography was used routinely for purification and separation of product mixtures using silica gel 60 of 230–400 mesh size as supplied by Merck. Eluent systems are given in volume/volume concentrations. Melting points were determined using a KRUSS KIP1N melting point meter. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian Mercury-300 (300 MHz) and a Varian Mercury-400 (400 MHz). Chloroform-d, methanol-d4 or deuterium oxide-d2 was used as the solvent and TMS (δ 0.00 ppm) as an internal standard. Chemical shift values are reported in ppm relative to the TMS in delta (δ) units. Multiplicities are recorded as s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), dd (doublet of doublets), dt (doublet of triplets), and m (multiplet). Coupling constants (<i>J</i>) are expressed in hertz. Electrospray mass spectra (ESMS) were recorded as <i>m</i>/<i>z</i> values using an Agilent 1100 MSD mass spectrometer. All test compounds displayed more than 95% purity as determined by an Agilent 1100 series HPLC system using a C18 column (Thermo Golden, 4.6 mm × 250 mm). The gradient system for HPLC separation was composed of MeOH (mobile phase A) and H<sub>2</sub>O solution containing 0.1% trifluoroacetic acid (mobile phase B). The starting flow rate was 0.5 mL/min and the injection volume was 10 μL. During first 2 min the percentage of phase A was 10%. At 6 min, the percentage of phase A was increased to 50%. At 16 min, the percentage of phase A was increased to 90% over 9 min. The system was operated at 25 °C. Peaks were detected at 254 nm. IUPAC nomenclature of compounds was determined with ACD/Name Pro software. All novel compounds reported here were screened for PAINS using KNIME: PAINS-Indigo (module) software, and results showed that no PAINS liability was detected for them.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (1-Benzyl-piperidin-4-yl)-(2-chloro-6-methyl-pyrimidin-4-yl)-amine (<b>4</b>)</h4><div class="NLM_p last">A solution of 2,4-dichloro-6-methylpyrimidine (1.00 g, 6.1 mmol), 1-benzyl-piperidin-4-ylamine (1.20 g, 6.3 mmol), and TEA (0.92 g, 9.1 mmol) in THF (72 mL) under an atmosphere of nitrogen was stirred at 25 °C for 15 h and then quenched with aqueous NH<sub>4</sub>Cl. The resulting mixture was extracted with ethyl acetate. The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue thus obtained was purified by flash chromatography on silica gel with <i>n</i>-hexane/ethyl acetate (1:1) to give compound <b>4</b> (1.20 g, 62%) as sticky oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.35–7.21 (m, 5H), 6.05 (s, 1H), 3.62 (m, 1H), 3.52 (s, 2H), 2.82 (m, 2H), 2.32 (s, 3H), 2.19 (m, 2H), 1.98 (m, 2H), 1.55 (m, 2H). ESMS <i>m</i>/<i>z</i>: 317.5 (M+1).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> [3-(4-{[4-(1-Benzyl-piperidin-4-ylamino)-6-methyl-pyrimidin-2-ylamino]-methyl}-[1,2,3]triazol-1-yl)-propyl]-[3-(<i>tert</i>-butoxycarbonyl-cyclohexyl-amino)-propyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>5</b>)</h4><div class="NLM_p last">A solution of compound <b>4</b> (1.01 g, 3.19 mmol) and linker <b>1</b> (1.74 g, 3.52 mmol) in 1-pentanol (25 mL) was heated at 150 °C for 15 h and then concentrated. The residue thus obtained was purified by flash chromatography on silica gel with MeOH/DCM (1:32) to afford compound <b>5</b> (1.55 g, 63%) as a sticky oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61 (s, 1H), 7.34–7.21 (m, 5H), 5.59 (s, 1H), 4.68 (m, 2H), 4.30 (t, <i>J</i> = 7.2 Hz, 2H), 3.87 (m, 1H), 3.52 (s, 2H), 3.26–2.98 (m, 6H), 2.84 (m, 2H), 2.20 (s, 3H), 2.19–2.04 (m, 6H), 1.98 (m, 2H), 1.80–1.46 (m, 7H), 1.44 (s, 18H), 1.40–1.22 (m, 5H), 1.05 (m, 1H). ESMS <i>m</i>/<i>z</i>: 775.6 (M+1).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> [3-(<i>tert</i>-Butoxycarbonyl-cyclohexyl-amino)-propyl]-[3-(4-{[4-methyl-6-(piperidin-4-ylamino)-pyrimidin-2-ylamino]-methyl}-[1,2,3]triazol-1-yl)-propyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>6</b>)</h4><div class="NLM_p last">A solution of <b>5</b> (1.50 g, 1.94 mmol) and 10% Pd/C (0.15 g) in 2-propanol (30 mL) was stirred under H<sub>2</sub> (1 atm) at 60 °C for 15 h. The resulting mixture was filtered and the filtrate was concentrated to give <b>6</b> (1.22 g, 92%) as a white solid: mp 182.3–182.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82 (s, 1H), 6.20 (s, 1H), 4.70 (s, 2H), 4.41–4.30 (m, 3H), 3.59 (m, 2H), 3.32–2.98 (m, 8H), 2.25 (s, 3H), 2.22–2.00 (m, 6H), 1.82–1.59 (m, 7H), 1.44 (s, 18H), 1.40–1.20 (m, 5H), 1.05 (m, 1H). ESMS <i>m</i>/<i>z</i>: 685.5 (M+1).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-6-methyl-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>7</b>)</h4><div class="NLM_p last">A solution of 1 N HCl/ether (5.13 mL, 5.13 mmol) was added to the solution of <b>6</b> (344 mg, 0.51 mmol) in dichloromethane (6.88 mL). The mixture was stirred at 25 °C for 15 h and concentrated to afford <b>7</b> (300 mg, 95%). <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 5.93 (s, 1H), 4.75 (s, 2H), 4.56 (t, <i>J</i> = 6.9 Hz, 2H), 4.17 (m, 1H), 3.46 (m, 2H), 3.21–3.04 (m, 8H), 2.33 (m, 2H), 2.25 (s, 3H), 2.16–1.99 (m, 6H), 1.87–1.62 (m, 5H), 1.40–1.17 (m, 6H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 162.54, 153.85, 152.27, 145.46, 123.69, 96.56, 57.40, 47.38, 45.27, 44.71, 44.58, 42.60, 41.14, 36.14, 28.73, 27.18, 26.12, 24.36, 23.78, 22.79, 17.66. ESMS <i>m</i>/<i>z</i>: 485.5 (M+1). HPLC purity = 96.92%, <i>t</i><sub>R</sub> = 13.04 min.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>8</b>)</h4><div class="NLM_p last">Following a synthetic procedure similar to that used for compound <b>7</b>, products <b>8</b>–<b>13</b> were prepared in a sequence of four steps using various 2,4-dichloropyrimidine derivatives as starting material. Starting from 2,4-dichloropyrimidine (500 mg, 3.36 mmol), compound <b>8</b> (641 mg) was obtained in 31% yield over four steps. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.06 (s, 1H), 7.56 (d, <i>J</i> = 7.2 Hz, 1H), 6.11 (d, <i>J</i> = 7.2 Hz, 1H), 4.75 (s, 2H), 4.56 (t, <i>J</i> = 6.9 Hz, 2H), 4.19 (m, 1H), 3.47 (m, 2H), 3.22–3.06 (m, 8H), 2.33 (m, 2H), 2.18–1.99 (m, 6H), 1.85–1.59 (m, 5H), 1.40–1.17 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 162.14, 153.36, 145.28, 140.34, 123.73, 98.20, 57.38, 47.39, 45.33, 44.71, 44.58, 42.58, 41.15, 36.11, 28.72, 27.04, 26.14, 24.37, 23.79, 22.80. ESMS <i>m</i>/<i>z</i>: 471.4 (M+1). HPLC purity = 97.42%, <i>t</i><sub>R</sub> = 12.71 min.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-6-ethyl-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>9</b>)</h4><div class="NLM_p last">Starting from 2,4-dichloro-6-ethyl pyrimidine (503 mg, 2.84 mmol), compound <b>9</b> (513 mg) was obtained in 28% yield over four steps. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.04 (s, 1H), 5.96 (s, 1H), 4.77 (s, 2H), 4.57 (t, <i>J</i> = 6.8 Hz, 2H), 4.19 (m, 1H), 3.46 (m, 2H), 3.22–3.08 (m, 8H), 2.56 (q, <i>J</i> = 7.5 Hz, 2H), 2.36 (m, 2H), 2.18–2.00 (m, 6H), 1.88–1.60 (m, 5H), 1.40–1.17 (m, 9H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 162.71, 157.40, 153.92, 145.49, 123.67, 95.12, 57.39, 47.38, 45.32, 44.72, 44.59, 42.60, 41.15, 36.18, 28.73, 27.18, 26.14, 25.10, 24.38, 23.79, 22.81, 10.84. ESMS <i>m</i>/<i>z</i>: 499.5 (M+1). HPLC purity = 97.92%, <i>t</i><sub>R</sub> = 13.17 min.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-6-isopropyl-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>10</b>)</h4><div class="NLM_p last">Starting from 2,4-dichloro-6-isopropyl pyrimidine (505 mg, 2.64 mmol), compound <b>10</b> (453 mg) was obtained in 26% yield over four steps. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 5.94 (s, 1H), 4.75 (s, 2H), 4.55 (t, <i>J</i> = 6.8 Hz, 2H), 4.18 (m, 1H), 3.46 (m, 2H), 3.21–3.06 (m, 8H), 2.79 (m, 1H), 2.34 (m, 2H), 2.18–1.99 (m, 6H), 1.88–1.62 (m, 5H), 1.40–1.17 (m, 12H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 162.84, 161.28, 154.05, 145.65, 123.55, 93.73, 57.39, 47.29, 45.32, 44.72, 44.56, 42.60, 41.12, 36.22, 31.15, 28.73, 27.17, 26.14, 24.36, 23.78, 22.79, 19.68. ESMS <i>m</i>/<i>z</i>: 513.5 (M+1). HPLC purity = 98.68%, <i>t</i><sub>R</sub> = 13.52 min.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-6-methoxy-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Trifluoroacetic Acid Salt (<b>11</b>)</h4><div class="NLM_p last">Starting from 2,4,6-trichloropyrimidine (501 mg, 2.73 mmol), compound <b>11</b> (470 mg) was obtained in 18% yield over five steps. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.89 (s, 1H), 5.25 (s, 1H), 4.53 (s, 2H), 4.36 (t, <i>J</i> = 6.4 Hz, 2H), 3.87 (m, 1H), 3.69 (s, 3H), 3.24 (m, 2H), 2.98–2.81 (m, 8H), 2.12 (m, 2H), 1.83–1.76 (m, 6H), 1.63–1.40 (m, 5H), 1.19–0.86 (m, 6H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 164.36, 162.40 (q, <i>J</i> = 36.1 Hz, CF<sub>3</sub><u class="uu">C</u>O<sub>2</sub>H), 153.35, 144.87, 143.56, 124.40, 116.24 (q, <i>J</i> = 289.8 Hz, <u class="uu">C</u>F<sub>3</sub>CO<sub>2</sub>H), 75.44, 57.59, 56.92, 48.03, 45.88, 44.78, 44.71, 42.71, 41.25, 35.83, 28.86, 27.54, 26.04, 24.50, 23.93, 22.92. ESMS <i>m</i>/<i>z</i>: 501.5 (M+1). HPLC purity = 99.10%, <i>t</i><sub>R</sub> = 13.18 min.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-Chloro-<i>N</i>2-{1-[3-(3-cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-<i>N</i>4-piperidin-4-yl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>12</b>)</h4><div class="NLM_p last">Starting from 2,4,6-trichloropyrimidine (503 mg, 2.74 mmol), compound <b>12</b> (536 mg) was obtained in 30% yield over four steps. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 6.22 (s, 1H), 4.75 (s, 2H), 4.55 (t, <i>J</i> = 6.6 Hz, 2H), 4.17 (m, 1H), 3.45 (m, 2H), 3.21–3.04 (m, 8H), 2.32 (m, 2H), 2.16–2.00 (m, 6H), 1.90–1.60 (m, 5H), 1.41–1.13 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 161.83, 153.92, 144.69, 143.63, 124.00, 97.36, 57.38, 47.58, 45.79, 44.67, 44.58, 42.51, 41.15, 36.26, 28.71, 27.01, 26.05, 24.35, 23.77, 22.80. ESMS <i>m</i>/<i>z</i>: 505.4 (M+1). HPLC purity = 97.20%, <i>t</i><sub>R</sub> = 13.16 min.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> N2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-<i>N</i>4-piperidin-4-yl-6-trifluoromethyl-pyrimidine-2,4-diamine Hydrochloride Salt (<b>13</b>)</h4><div class="NLM_p last">Starting from 2,4-dichloro-6-trifluoromethyl pyrimidine (501 mg, 2.31 mmol), compound <b>3</b> (443 mg) was obtained in 28% yield over four steps. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 6.53 (s, 1H), 4.79 (s, 2H), 4.56 (t, <i>J</i> = 6.6 Hz, 2H), 4.25 (m, 1H), 3.49 (m, 2H), 3.21–3.04 (m, 8H), 2.34 (m, 2H), 2.18–2.00 (m, 6H), 1.86–1.60 (m, 5H), 1.40–1.17 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 161.40, 153.95, 144.88, 139.86 (q, <i>J</i> = 31.5 Hz), 123.77, 118.51 (q, <i>J</i> = 271.5 Hz), 97.63 (q, <i>J</i> = 4.6 Hz), 57.38, 47.41, 46.02, 44.71, 44.58, 42.51, 41.15, 36.49, 28.72, 26.77, 26.13, 24.35, 23.77, 22.80. ESMS <i>m</i>/<i>z</i>: 539.5 (M+1). HPLC purity = 96.61%, <i>t</i><sub>R</sub> = 13.90 min.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>tert</i>-Butoxycarbonyl-{3-[4-(2-{[1-(3-{<i>tert</i>-butoxycarbonyl-[3-(<i>tert</i>-butoxycarbonyl-cyclohexyl-amino)-propyl]-amino}-propyl)-1<i>H</i>-[1,2,3]triazol-4-ylmethyl]-amino}-6-methyl-pyrimidin-4-ylamino)-piperidin-1-yl]-3-oxo-propyl}-amino)-acetic Acid Ethyl Ester (<b>14</b>)</h4><div class="NLM_p last">To a magnetically stirred solution of 3-((<i>tert</i>-butoxycarbonyl)(2-ethoxy-2-oxoethyl)amino)propionic acid (395 mg, 1.44 mmol) in dichloromethane (50 mL) under an atmosphere of nitrogen was added EDCI (210 mg, 1.10 mmol) and HOBt (165 mg, 1.22 mmol) at 25 °C. After the mixture was stirred at 25 °C for 1 h, a solution of <b>6</b> (490 mg, 0.72 mmol) in dichloromethane (2 mL) was added to the mixture in one potion. The reaction mixture was stirred for another 6 h and then poured into water. The resulting mixture was extracted with dichloromethane. The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue thus obtained was purified by flash chromatography on silica gel with MeOH/DCM (1:19) to give <b>14</b> (480 mg, 71%) as sticky oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.62 (s, 1H), 5.63 (s, 1H), 4.65 (s, 2H), 4.41 (m, 1H), 4.29 (t, <i>J</i> = 7.2 Hz, 2H), 4.13 (q, <i>J</i> = 6.8 Hz, 2H), 4.02–3.95 (m, 3H), 3.84 (m, 1H), 3.54 (m, 2H), 3.26–2.97 (m, 7H), 2.76 (m, 1H), 2.62 (m, 2H), 2.17 (s, 3H), 2.15–1.86 (m, 5H), 1.78–1.54 (m, 8H), 1.48–1.20 (m, 35H), 1.03 (m, 1H). ESMS <i>m</i>/<i>z</i>: 942.7 (M+1).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>tert</i>-Butoxycarbonyl-{3-[4-(2-{[1-(3-{<i>tert</i>-butoxycarbonyl-[3-(<i>tert</i>-butoxycarbonyl-cyclohexyl-amino)-propyl]-amino}-propyl)-1<i>H</i>-[1,2,3]triazol-4-ylmethyl]-amino}-6-methyl-pyrimidin-4-ylamino)-piperidin-1-yl]-3-oxo-propyl}-amino)-acetic Acid (<b>15</b>)</h4><div class="NLM_p last">To a solution of <b>14</b> (455 mg, 0.48 mmol) in THF (2.28 mL) under an atmosphere of nitrogen was added a solution of LiOH(aq) (1.37 mL, 1 N). The mixture was stirred at 25 °C for 15 h and then quenched with NH<sub>4</sub>Cl(aq). The aqueous phase was extracted with ethyl acetate. The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue thus obtained was purified by flash chromatography on silica gel with MeOH/DCM (1:9) to give the compound <b>15</b> (435 mg, 99%) as sticky oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (s, 1H), 5.72 (s, 1H), 4.62 (m, 2H), 4.41–4.36 (m, 3H), 4.08 (m, 1H), 3.96 (m, 1H), 3.81 (m, 2H), 3.54 (t, <i>J</i> = 6.8 Hz, 2H), 3.30–3.18 (m, 5H), 3.07 (m, 2H), 2.84 (m, 1H), 2.71 (m, 2H), 2.14 (s, 3H), 2.10 (m, 2H), 2.00–1.60 (m, 11H), 1.56–1.08 (m, 32H), 1.12 (m, 1H). ESMS <i>m</i>/<i>z</i>: 914.6 (M+1).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-acetic Acid Hydrochloride Salt (<b>16</b>)</h4><div class="NLM_p last">A solution of 1 N HCl/ether (7 mL) was added to the solution of <b>15</b> (421 mg, 0.46 mmol) in dichloromethane (14 mL). The mixture was stirred at 25 °C for 15 h and concentrated to afford <b>16</b> (333 mg, 95%). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.01 (s, 1H), 5.89 (s, 1H), 4.73 (m, 2H), 4.56 (t, <i>J</i> = 6.8 Hz, 2H), 4.26 (m, 1H), 4.11 (m, 1H), 4.01 (s, 2H), 3.86 (m, 1H), 3.42 (t, <i>J</i> = 6.0 Hz, 2H), 3.25 (m, 1H), 3.21–3.07 (m, 6H), 2.98 (t, <i>J</i> = 6.0 Hz, 2H), 2.90 (m, 1H), 2.33 (m, 2H), 2.24 (s, 3H), 2.18–2.04 (m, 5H), 1.96–1.78 (m, 4H), 1.67 (m, 1H), 1.51 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 169.57, 169.01, 162.33, 153.85, 151.91, 145.68, 123.48, 96.50, 57.39, 47.61, 47.56, 47.27, 44.72, 44.56, 44.19, 43.76, 41.12, 40.71, 36.25, 30.34, 29.88, 28.74, 28.52, 26.16, 24.35, 23.77, 22.78, 17.62. ESMS <i>m</i>/<i>z</i>: 614.5 (M+1). HPLC purity = 97.45%, <i>t</i><sub>R</sub> = 13.33 min.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-(2-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-2-oxo-ethylamino)-propionic Acid Hydrochloride Salt (<b>17</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (301 mg, 0.44 mmol), compound <b>17</b> (193 mg) was obtained in 58% yield over three steps: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.03 (s, 1H), 5.92 (s, 1H), 4.75 (m, 2H), 4.58 (t, <i>J</i> = 6.8 Hz, 2H), 4.28–4.21 (m, 3H), 4.17 (m, 1H), 3.70 (m, 1H), 3.44 (t, <i>J</i> = 6.4 Hz, 2H), 3.28 (m, 1H), 3.21–3.08 (m, 6H), 2.99 (m, 1H), 2.94 (t, <i>J</i> = 6.4 Hz, 2H), 2.36 (m, 2H), 2.26 (s, 3H), 2.20–2.02 (m, 5H), 1.99–1.78 (m, 4H), 1.68 (m, 1H), 1.55 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 174.03, 163.62, 162.29, 153.79, 151.91, 145.69, 123.47, 96.47, 57.35, 47.79, 47.33, 47.24, 44.69, 44.54, 43.39, 43.19, 41.10, 41.06, 36.23, 30.10, 29.97, 29.67, 28.71, 26.16, 24.34, 23.76, 22.77, 17.61. ESMS <i>m</i>/<i>z</i>: 614.5 (M+1). HPLC purity = 96.71%, <i>t</i><sub>R</sub> = 13.18 min.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (4-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-4-oxo-butylamino)-acetic Acid Hydrochloride Salt (<b>18</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (304 mg, 0.44 mmol), compound <b>18</b> (199 mg) was obtained in 58% yield over three steps: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.99 (s, 1H), 5.89 (s, 1H), 4.73 (m, 2H), 4.56 (t, <i>J</i> = 6.4 Hz, 2H), 4.26 (m, 1H), 4.11 (m, 1H), 3.98 (s, 2H), 3.90 (m, 1H), 3.22 (m, 1H), 3.21–3.08 (m, 8H), 2.88 (m, 1H), 2.63 (t, <i>J</i> = 6.0 Hz, 2H), 2.32 (m, 2H), 2.24 (s, 3H), 2.18–1.98 (m, 7H), 1.97–1.74 (m, 4H), 1.66 (m, 1H), 1.49 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C (75 MHz, D<sub>2</sub>O) δ 172.20, 168.99, 162.29, 153.82, 151.86, 145.65, 123.45, 96.47, 57.36, 47.59, 47.30, 47.28, 46.93, 44.69, 44.54, 44.38, 41.09, 40.81, 36.20, 30.49, 29.99, 29.58, 28.71, 26.13, 24.34, 23.76, 22.77, 21.06, 17.59. ESMS <i>m</i>/<i>z</i>: 628.6 (M+1). HPLC purity = 97.81%, <i>t</i><sub>R</sub> = 13.43 min.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-(3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-propionic Acid Hydrochloride Salt (<b>19</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (302 mg, 0.44 mmol), compound <b>19</b> (184 mg) was obtained in 54% yield over three steps. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.01 (s, 1H), 5.89 (s, 1H), 4.73 (m, 2H), 4.54 (t, <i>J</i> = 6.9 Hz, 2H), 4.25 (m, 1H), 4.11 (m, 1H), 3.86 (m, 1H), 3.42–3.35 (m, 4H), 3.24 (m, 1H), 3.21–3.06 (m, 6H), 2.95 (t, <i>J</i> = 6.0 Hz, 2H), 2.90–2.82 (m, 3H), 2.33 (m, 2H), 2.23 (s, 3H), 2.18–2.01 (m, 5H), 1.97–1.74 (m, 4H), 1.66 (m, 1H), 1.50 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C (75 MHz, D<sub>2</sub>O) δ 174.27, 169.77, 162.30, 153.82, 151.89, 145.62, 123.51, 96.50, 57.38, 47.53, 47.29, 44.71, 44.55, 44.14, 43.74, 42.96, 41.12, 40.69, 36.20, 30.32, 29.88, 29.70, 28.72, 28.26, 26.14, 24.35, 23.77, 22.78, 17.61. ESMS <i>m</i>/<i>z</i>: 628.6 (M+1). HPLC purity = 96.76%, <i>t</i><sub>R</sub> = 13.37 min.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-ethyl-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-acetic Acid Hydrochloride Salt (<b>20</b>)</h4><div class="NLM_p last">Starting from a derivative of compound <b>6</b> (304 mg, 0.43 mmol), compound <b>20</b> (172 mg) was obtained in 51% yield over three steps: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.00 (s, 1H), 5.89 (s, 1H), 4.73 (m, 2H), 4.55 (t, <i>J</i> = 6.8 Hz, 2H), 4.24 (m, 1H), 4.10 (m, 1H), 4.00 (s, 2H), 3.85 (m, 1H), 3.41 (t, <i>J</i> = 6.0 Hz, 2H), 3.24 (m, 1H), 3.21–3.06 (m, 6H), 2.96 (t, <i>J</i> = 6.0 Hz, 2H), 2.88 (m, 1H), 2.52 (q, <i>J</i> = 7.6 Hz, 2H), 2.32 (m, 2H), 2.18–2.00 (m, 5H), 1.95–1.76 (m, 4H), 1.64 (m, 1H), 1.51 (m, 1H), 1.41–1.16 (m, 9H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 169.63, 169.02, 162.56, 157.12, 153.97, 145.71, 123.56, 95.14, 57.44, 47.65, 47.63, 47.34, 44.77, 44.62, 44.22, 43.84, 41.19, 40.75, 36.31, 30.38, 29.92, 28.77, 28.57, 26.19, 25.11, 24.40, 23.82, 22.83, 10.86. ESMS <i>m</i>/<i>z</i>: 628.6 (M+1). HPLC purity = 95.28%, <i>t</i><sub>R</sub> = 13.37 min.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-acetic Acid Hydrochloride Salt (<b>21</b>)</h4><div class="NLM_p last">Starting from a derivative of compound <b>6</b> (303 mg, 0.45 mmol), compound <b>21</b> (191 mg) was obtained in 57% yield over three steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.03 (s, 1H), 7.55 (d, <i>J</i> = 7.2 Hz, 1H), 6.09 (d, <i>J</i> = 7.2 Hz, 1H), 4.76 (m, 2H), 4.58 (t, <i>J</i> = 6.9 Hz, 2H), 4.28 (m, 1H), 4.16 (m, 1H), 3.97 (s, 2H), 3.89 (m, 1H), 3.44 (t, <i>J</i> = 6.0 Hz, 2H), 3.30 (m, 1H), 3.22–3.08 (m, 6H), 3.00 (t, <i>J</i> = 6.0 Hz, 2H), 2.92 (m, 1H), 2.36 (m, 2H), 2.19–2.02 (m, 5H), 1.98–1.78 (m, 4H), 1.68 (m, 1H), 1.55 (m, 1H), 1.41–1.17 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 169.56, 169.17, 161.88, 153.34, 145.54, 140.00, 123.44, 98.14, 57.36, 47.77, 47.59, 47.21, 44.69, 44.54, 44.14, 43.70, 41.10, 40.67, 36.19, 30.19, 29.71, 28.71, 28.52, 26.16, 24.34, 23.76, 22.77. ESMS <i>m</i>/<i>z</i>: 600.5 (M+1). HPLC purity = 97.63%, <i>t</i><sub>R</sub> = 12.99 min.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> [3-(4-{[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-yl]-methylamino}-piperidin-1-yl)-3-oxo-propylamino]-acetic Acid Hydrochloride Salt (<b>22</b>)</h4><div class="NLM_p last">Starting from a derivative of compound <b>6</b> (302 mg, 0.43 mmol), compound <b>22</b> (164 mg) was obtained in 49% yield over three steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 6.15 (s, 1H), 4.75 (s, 2H), 4.60–4.40 (m, 4H), 4.00 (s, 2H), 3.98 (m, 1H), 3.44 (t, <i>J</i> = 6.0 Hz, 2H), 3.22–3.08 (m, 7H), 2.98 (m, 2H), 2.96 (s, 3H), 2.70 (m, 1H), 2.41–2.21 (m, 5H), 2.20–1.98 (m, 5H), 1.97–1.76 (m, 4H), 1.72–1.49 (m, 2H), 1.41–1.16 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 169.57, 169.02, 161.97, 153.34, 152.66, 145.91, 123.40, 94.37, 57.38, 52.95, 47.65, 47.27, 44.83, 44.69, 44.57, 43.76, 41.39, 41.13, 36.43, 30.37, 29.51, 28.72, 28.58, 27.88, 26.19, 24.37, 23.79, 22.80, 18.10. ESMS <i>m</i>/<i>z</i>: 628.6 (M+1). HPLC purity = 95.95%, <i>t</i><sub>R</sub> = 13.51 min.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-5-oxo-pentanoic Acid Hydrochloride Salt (<b>23</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (305 mg, 0.45 mmol), compound <b>23</b> (163 mg) was obtained in 52% yield over three steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.03 (s, 1H), 5.89 (s, 1H), 4.73 (m, 2H), 4.56 (t, <i>J</i> = 6.6 Hz, 2H), 4.23 (m, 1H), 4.08 (m, 1H), 3.92 (m, 1H), 3.24 (m, 1H), 3.20–3.04 (m, 6H), 2.85 (m, 1H), 2.55–2.40 (m, 4H), 2.33 (m, 2H), 2.23 (s, 3H), 2.18–2.02 (m, 5H), 1.93–1.76 (m, 6H), 1.65 (m, 1H), 1.49 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 177.71, 173.46, 162.30, 153.79, 151.91, 145.72, 123.57, 96.52, 57.38, 47.70, 47.36, 44.69, 44.62, 44.57, 41.13, 40.74, 36.19, 32.84, 31.74, 30.64, 30.02, 28.72, 26.13, 24.35, 23.77, 22.78, 20.22, 17.64. ESMS <i>m</i>/<i>z</i>: 599.5 (M+1). HPLC purity = 98.67%, <i>t</i><sub>R</sub> = 12.90 min.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Amino-5-{4-[2-({1-[3-(3-cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-5-oxo-pentanoic Acid Hydrochloride Salt (<b>24</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (302 mg, 0.44 mmol), compound <b>24</b> (179 mg) was obtained in 53% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.04 (s, 1H), 6.01 (s, 1H), 4.74 (m, 2H), 4.56 (t, <i>J</i> = 6.9 Hz, 2H), 4.30 (m, 1H), 4.12–4.00 (m, 2H), 3.92 (m, 1H), 3.25 (m, 1H), 3.21–3.06 (m, 6H), 2.88 (m, 1H), 2.71 (t, <i>J</i> = 6.6 Hz, 2H), 2.34 (m, 2H), 2.26 (s, 3H), 2.23 (m, 2H), 2.18–2.02 (m, 5H), 1.99–1.80 (m, 4H), 1.68 (m, 1H), 1.54 (m, 1H), 1.42–1.18 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 171.68, 171.54, 163.17, 153.16, 152.33, 145.17, 123.66, 96.21, 57.38, 52.14, 47.96, 47.29, 44.69, 44.54, 44.40, 41.10, 40.89, 35.90, 30.69, 30.19, 28.71, 28.45, 26.11, 25.26, 24.34, 23.76, 22.77, 17.68. ESMS <i>m</i>/<i>z</i>: 614.5 (M+1). HPLC purity = 96.21%, <i>t</i><sub>R</sub> = 13.30 min.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> [(3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-methyl]-phosphonic Acid Hydrobromide Salt (<b>25</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (302 mg, 0.44 mmol), compound <b>25</b> (224 mg) was obtained in 57% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 5.88 (s, 1H), 4.73 (m, 2H), 4.56 (t, <i>J</i> = 6.9 Hz, 2H), 4.22 (m, 1H), 4.10 (m, 1H), 3.84 (m, 1H), 3.45 (t, <i>J</i> = 6.3 Hz, 2H), 3.31–3.04 (m, 9H), 2.96 (t, <i>J</i> = 6.3 Hz, 2H), 2.88 (m, 1H), 2.33 (m, 2H), 2.23 (s, 3H), 2.08–2.00 (m, 5H), 1.96–1.70 (m, 4H), 1.65 (m, 1H), 1.51 (m, 1H), 1.41–1.17 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 169.74, 162.30, 153.80, 151.88, 145.60, 123.56, 96.52, 57.35, 47.54, 47.32, 45.27, 44.71, 44.55, 44.20, 42.84, 41.12, 40.67, 36.23, 30.29, 29.83, 28.72, 28.20, 26.14, 24.34, 23.76, 22.77, 17.63. ESMS <i>m</i>/<i>z</i>: 650.6 (M+1). HPLC purity = 97.01%, <i>t</i><sub>R</sub> = 13.26 min.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> [2-(3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-3-oxo-propylamino)-ethyl]-phosphonic Acid Hydrobromide Salt (<b>26</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (300 mg, 0.44 mmol), compound <b>26</b> (214 mg) was obtained in 54% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.03 (s, 1H), 5.90 (s, 1H), 4.75 (m, 2H), 4.58 (t, <i>J</i> = 6.9 Hz, 2H), 4.25 (m, 1H), 4.12 (m, 1H), 3.86 (m, 1H), 3.41–3.30 (m, 4H), 3.24–3.06 (m, 7H), 2.96–2.90 (m, 3H), 2.88 (t, <i>J</i> = 6.6 Hz, 2H), 2.35 (m, 2H), 2.25 (s, 3H), 2.20–2.02 (m, 5H), 1.97–1.74 (m, 4H), 1.65 (m, 1H), 1.52 (m, 1H), 1.41–1.16 (m, 6H). <sup>13</sup>C (75 MHz, D<sub>2</sub>O) δ 169.51, 162.29, 153.79, 151.88, 145.34, 123.86, 96.60, 57.36, 47.54, 47.50, 44.69, 44.57, 44.16, 43.41, 42.75, 41.15, 40.69, 36.14, 30.35, 29.96, 29.88, 28.72, 28.61, 26.10, 24.34, 23.76, 22.78, 17.67. ESMS <i>m</i>/<i>z</i>: 664.6 (M+1). HPLC purity = 96.54%, <i>t</i><sub>R</sub> = 13.48 min.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> N2-{1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-6-methyl-<i>N</i>4-(1-propyl-piperidin-4-yl)-pyrimidine-2,4-diamine Hydrochloride Salt (<b>27</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (301 mg, 0.44 mmol), compound <b>27</b> (176 mg) was obtained in 59% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.01 (s, 1H), 6.01 (s, 0.2H), 5.92 (s, 0.8H), 4.75 (s, 2H), 4.56 (t, <i>J</i> = 6.6 Hz, 2H), 4.28 (m, 0.2H), 4.17 (m, 0.8H), 3.64 (m, 1.6H), 3.46 (m, 0.4H), 3.21–3.04 (m, 10H), 2.33 (m, 2H), 2.26 (s, 3H), 2.18–2.00 (m, 6H), 1.90–1.62 (m, 7H), 1.40–1.17 (m, 6H), 0.99 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 162.59, 153.86, 152.29, 145.72, 123.48, 96.47, 58.35, 57.38, 51.42, 47.19, 45.51, 44.71, 44.54, 41.10, 36.22, 28.72, 28.08, 26.16, 24.34, 23.76, 22.78, 17.62, 17.19, 10.05. ESMS <i>m</i>/<i>z</i>: 527.5 (M+1). HPLC purity = 98.68%, <i>t</i><sub>R</sub> = 13.52 min.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-propionitrile Trifluoroacetic Acid Salt (<b>28</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (303 mg, 0.44 mmol), compound <b>28</b> (260 mg) was obtained in 59% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 7.94 (s, 1H), 5.92 (s, 0.24H), 5.82 (s, 0.76H), 4.67 (s, 2H), 4.47 (t, <i>J</i> = 7.2 Hz, 2H), 4.20 (m, 0.24H), 4.09 (m, 0.76H), 3.63 (m, 1.52H), 3.57–3.46 (m, 2.48H), 3.17–3.02 (m, 10H), 2.25 (m, 2H), 2.16 (s, 3H), 2.14–1.96 (m, 6H), 1.80–1.58 (m, 5H), 1.34–1.02 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 162.52, 162.42 (q, <i>J</i> = 35.5 Hz, CF<sub>3</sub><u class="uu">C</u>O<sub>2</sub>H), 153.75, 152.29, 145.27, 123.71, 117.30, 116.00 (q, <i>J</i> = 289.7 Hz, <u class="uu">C</u>F<sub>3</sub>CO<sub>2</sub>H), 96.49, 57.28, 51.76, 51.32, 47.41, 45.10, 44.55, 44.42, 40.96, 35.88, 28.61, 27.74, 27.42, 25.91, 24.23, 23.67, 22.66, 17.45. ESMS <i>m</i>/<i>z</i>: 538.5 (M+1). HPLC purity = 97.34%, <i>t</i><sub>R</sub> = 13.52 min.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-propionamide Hydrochloride Salt (<b>29</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (301 mg, 0.44 mmol), compound <b>29</b> (181 mg) was obtained in 59% yield over two steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 6.02 (s, 0.22H), 5.93 (s, 0.78H), 4.76 (m, 2H), 4.57 (t, <i>J</i> = 6.9 Hz, 2H), 4.25 (m, 0.22H), 4.19 (m, 0.78H), 3.68 (m, 1.56H), 3.56–3.46 (m, 2.44H), 3.23–3.10 (m, 8H), 2.86 (t, <i>J</i> = 6.6 Hz, 2H), 2.35 (m, 2H), 2.27 (s, 3H), 2.20–12.03 (m, 6H), 1.90–1.62 (m, 5H), 1.42–1.18 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 174.06, 162.62, 153.88, 152.35, 145.71, 123.51, 96.50, 57.39, 52.45, 51.76, 47.21, 45.35, 44.74, 44.55, 41.12, 36.22, 29.04, 28.72, 28.03, 26.16, 24.35, 23.77, 22.78, 17.64. ESMS <i>m</i>/<i>z</i>: 556.5 (M+1). HPLC purity = 96.01%, <i>t</i><sub>R</sub> = 13.25 min.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-propionic Acid Hydrochloride Salt (<b>30</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (299 mg, 0.44 mmol), compound <b>30</b> (188 mg) was obtained in 61% yield over two steps: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.01 (s, 1H), 6.01 (s, 0.22H), 5.91 (s, 0.78H), 4.75 (s, 2H), 4.55 (t, <i>J</i> = 6.8 Hz, 2H), 4.24 (m, 0.22H), 4.18 (m, 0.78H), 3.66 (m, 1.56H), 3.55–3.46 (m, 2.44H), 3.23–3.08 (m, 8H), 2.94 (t, <i>J</i> = 6.8 Hz, 2H), 2.33 (m, 2H), 2.25 (s, 3H), 2.18–2.02 (m, 6H), 1.90–1.62 (m, 5H), 1.42–1.17 (m, 6H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 173.69, 162.62, 153.86, 152.33, 145.71, 123.51, 96.50, 57.39, 52.09, 51.87, 47.22, 45.35, 44.74, 44.55, 41.12, 36.23, 28.72, 28.66, 27.99, 26.16, 24.35, 23.77, 22.80, 17.64. ESMS <i>m</i>/<i>z</i>: 557.5 (M+1). HPLC purity = 95.58%, <i>t</i><sub>R</sub> = 13.07 min.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-pentanoic Acid Hydrochloride Salt (<b>31</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (298 mg, 0.44 mmol), compound <b>31</b> (160 mg) was obtained in 50% yield over three steps: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.00 (s, 1H), 6.02 (s, 0.23H), 5.93 (s, 0.77H), 4.76 (s, 2H), 4.56 (t, <i>J</i> = 6.4 Hz, 2H), 4.25 (m, 0.23H), 4.19 (m, 0.77H), 3.65 (m, 1.54H), 3.48 (m, 0.46H), 3.30–3.06 (m, 10H), 2.49 (t, <i>J</i> = 6.4 Hz, 2H), 2.35 (m, 2H), 2.27 (s, 3H), 2.20–2.03 (m, 6H), 1.95–1.64 (m, 9H), 1.42–1.17 (m, 6H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 177.92, 162.57, 153.84, 152.28, 145.61, 123.47, 96.46, 57.36, 56.32, 51.49, 47.18, 45.46, 44.71, 44.53, 41.09, 36.21, 32.83, 28.70, 28.06, 26.14, 24.33, 23.76, 22.91, 22.78, 21.09, 17.59. ESMS <i>m</i>/<i>z</i>: 585.5 (M+1). HPLC purity = 98.30%, <i>t</i><sub>R</sub> = 13.28 min.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-{4-[2-({1-[3-(3-Cyclohexylamino-propylamino)-propyl]-1<i>H</i>-[1,2,3]triazol-4-ylmethyl}-amino)-6-methyl-pyrimidin-4-ylamino]-piperidin-1-yl}-heptanoic Acid Hydrochloride Salt (<b>32</b>)</h4><div class="NLM_p last">Starting from compound <b>6</b> (302 mg, 0.44 mmol), compound <b>32</b> (153 mg) was obtained in 47% yield over three steps: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 8.02 (s, 1H), 6.03 (s, 0.2H), 5.93 (s, 0.8H), 4.76 (s, 2H), 4.57 (t, <i>J</i> = 6.3 Hz, 2H), 4.24 (m, 0.2H), 4.18 (m, 0.8H), 3.65 (m, 1.6H), 3.48 (m, 0.4H), 3.30–3.02 (m, 10H), 2.45 (t, <i>J</i> = 6.9 Hz, 2H), 2.37 (m, 2H), 2.26 (s, 3H), 2.20–2.00 (m, 6H), 1.97–1.60 (m, 9H), 1.50–1.13 (m, 8H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 178.61, 162.59, 153.86, 152.32, 145.74, 123.53, 96.50, 57.38, 56.61, 51.47, 47.22, 45.51, 44.72, 44.55, 41.12, 36.23, 33.30, 28.72, 28.1, 26.16, 25.10, 24.35, 23.77, 23.55, 23.19, 22.78, 17.64. ESMS <i>m</i>/<i>z</i>: 599.6 (M+1). HPLC purity = 97.55%, <i>t</i><sub>R</sub> = 13.42 min.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Animals</h3><div class="NLM_p last">Eight- to ten-week-old male C57BL/6 mice were used in the study of stem/progenitor cell counting. Male Sprague–Dawley rats (weighing approximately 200–250 g) were used in the study of AKI. All animals were purchased from National Laboratory Animals Center (Taipei, Taiwan, R.O.C.). The Institutional Animal Care and Use Committee (IACUC) of National Health Research Institutes (NHRI) approved all experimental protocols.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Establishment of Human CXCR4 Stable Cell Line and Membrane Purification</h3><div class="NLM_p last">The hCXCR4 cDNA was subcloned into pIRES2-EGFP vector (Clontech Laboratories, Inc., Mountain View, CA). Transfected HEK-293 cells stably expressed hCXCR4 (HEK-293 CXCR4) were selected by EGFP and 1 mg/mL G418 sulfate. The selected clone was maintained in DMEM supplemented with 10% fetal bovine serum and 0.5 mg/mL G418 sulfate with 5% CO<sub>2</sub> at 37 °C in the humidified incubator. For membrane purification, cells were homogenized in ice-cold buffer A (50 mM Tris-HCl, pH 7.4, 5 mM MgCl<sub>2</sub>, 2.5 mM EDTA, 10% sucrose) with freshly prepared 1 mM PMSF. The homogenate was centrifuged at 3500<i>g</i> for 15 min at 4 °C. The pellet was removed and the supernatant then was centrifuged at 43000<i>g</i> for additional 30 min at 4 °C. The final pellet was resuspended in buffer A and stored at −80 °C.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Radioligand Binding Assay</h3><div class="NLM_p last">An amount of 2–4 μg of purified membrane with CXCR4 was incubated with 0.16 nM [<sup>125</sup>I]CXCL12 and compounds of interest in the incubation buffer (50 mM HEPES-NaOH, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 0.5% BSA) The nonspecific binding was defined in the presence of 50 μM AMD3100 (Plerixafor). The reaction mixtures were incubated for 1.5 h at 30 °C and then were transferred to a 96-well GF/B filter plate (Millipore Corp., Billerica, MA, USA). The reaction mixtures were terminated by maniford filtration and washed with ice-cold wash buffer (50 mM HEPES-NaOH, pH 7.4, 100 mM NaCl) for four times. The radioactivity bound to the filter was measured by Topcount (PerkinElmer Inc., Waltham, MA, USA). IC<sub>50</sub> values were determined by the concentration of compounds required to inhibit 50% of the specific binding of [<sup>125</sup>I]SDF-1 and calculated by nonlinear regression (GraphPad software, San Diego, CA, USA).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Chemotaxis Assay</h3><div class="NLM_p last">CCRF-CEM (T-cell acute lymphoblastic leukemia) cells were suspended in RPMI 1640 containing 10% FBS and then preincubated with indicated concentrations of compounds for 10 min at 37 °C. The assay was performed in Millicell Hanging Cell Culture Inserts (pore size 5 μm; 24-well plate; Millipore, Bedford, MA, USA). Compounds containing 10 nM CXCL12 were plated in the lower chambers of inserts, and cells with compounds were plated in the upper chambers of inserts at a density of 2.5 × 10<sup>5</sup> cells/well. After 2.5 h incubation at 37 °C, cells in both chambers of inserts were measured by flow cytometer (Guava Technologies, Hayward, CA, USA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Flow Cytometry Analysis for Stem/Progenitor Cell Counting</h3><div class="NLM_p last">C57BL/6 male mice were treated with potential CXCR4 antagonist individually by subcutaneous injection, and then blood samples containing mobilized stem/progenitor cells were collected 2 h later. After labeled with specific antibodies, including APC-conjugated anti-CXCR4 (clone 2B11; eBioscience), FITC-conjugated anti-CD34 (clone RAM34; eBioscience), PE-conjugated anti-CD133 (clone 13A4; eBioscience) and anti-VEGFR2 (clone Avsa12a1; eBioscience), anti-Sca-1 (clone D7; eBioscience), cells were washed, characterized and quantified by flow cytometer (Guava Technologies, Hayward, CA, USA). Each data point included at least 60 000 events for analysis of different cell types.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Efficacy Analyzed by Colony-Forming Assay</h3><div class="NLM_p last">C57BL/6 male mice were treated with 100 μg/kg G-CSF for 5 consecutive days by SC injection. The mice were treated with indicated concentrations of compounds <b>1</b> or <b>16</b> individually on day 5 by SC injection, and then blood samples containing mobilized stem cells were collected 2 h later. The heparinized blood sample was collected and peripheral blood mononuclear cells (PBMCs) were isolated and cultured in methylcellulose medium (MethoCult GF M3434). CFU-GM colonies were counted after 10–14 days of incubation under an inverted microscope. The aggregate of more than 50 cells was recorded as a colony.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Plasma Pharmacokinetics in Mice</h3><div class="NLM_p last">Male C57BL/6, each weighing 23.4–25.4 g, were quarantined for 1 week before treatment. Compounds <b>1</b> and <b>16</b>, dissolved in 100% saline, were individually given to mice (n = 3) subcutaneously (6 mg/kg; nonfasted mice). Blood samples were collected via the cardiac puncture at defined time points, 0 (immediately before dosing), 0.03, 0.08, 0.25, 1, 1.5, 2, and 4 h after dosing, and then stored at −80 °C. The volume of the dosing solution given was 100 μL for each mouse. The plasma samples were analyzed by liquid chromatography–tandem mass spectrometry (LC–MS/MS) and data were calculated by a standard noncompartmental method using the Kinetica software program (InnaPhase, USA).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Acute Toxicology Study</h3><div class="NLM_p last">C57BL/6 or ICR male mice were subcutaneously treated with test compounds (<i>n</i> = 3/group) from a low to high dose to determine maximum tolerated dose (MTD) based on zero mortality (<i>n</i> = 3, 0/3).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Docking Analysis with the CXCR4 Crystal Structure</h3><div class="NLM_p last">Binding interactions between the CXCR4 crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS">4RWS</a>) and compound <b>16</b> were illustrated through docking and molecular dynamics (MD) simulations. For the docking calculation, the mutated residues (L125W, D187C, and T240P) have been restored to original ones. Through conformational analysis of compound <b>16</b>, the best pose was chosen for further MD simulations. After 20 ns simulations, the complex structure in an equilibrium and stable state was as shown in <a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. All calculations were performed by means of Discovery Studio 2017 software (BIOVIA, Inc., San Diego, CA). The docking analysis was conducted using the DS/LigandFit program with the CHARMm force field.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The number of docking poses was set as 100 with default parameters.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Molecular Dynamics Simulation of Compound <b>16</b></h3><div class="NLM_p last">The molecular dynamics (MD) simulations were carried out using GROMACS v5.1.2 to refine the docked conformation.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The topology of docked ligand <b>16</b> was generated by PRODRG serve.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The force field for the whole system was GROMOS 43a1.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The protein–ligand complex was restrained in a box of cubic shape whose edges were placed at 1 nm from the complex and SPC/E water model was performed. The system was electrically neutralized by adding 5 NA<sup>+</sup> ion. The energy minimization was performed using steepest descent and conjugate gradient algorithms to converge the system up to 10 kJ mol<sup>–1</sup> nm<sup>–1</sup>. After the above short energy minimization step, the system was subjected to NVT (300 K) and NPT (1 bar) equilibration with 100 ps running, and LINCS algorithm was used to constrain the hydrogen bond lengths.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The time step was kept 2 fs for the simulation. The cutoff distance of 10 Å was used for all short-range nonbonded interactions and 12 Å Fourier grid spacing in PME method for long-range electrostatics. Finally, the hydrogen bond constraints of the protein–ligand complex were removed and performed to a 20 ns MD simulation.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Statistical Analysis</h3><div class="NLM_p last">Apart from chemotaxis assay, which is presented as mean ± standard deviation (SD), other values are expressed as mean ± standard error of the mean (SEM). The results were analyzed by Student’s <i>t</i>-test. For all comparisons between groups, <i>p</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01322">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01322" class="ext-link">10.1021/acs.jmedchem.7b01322</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Compound <b>16</b>’s off-target and patch-clamp assays by Eurofins Panlabs Taiwan, Ltd.; counter screening against 12 chemokine receptors by DiscoverX Corporation, Fremont, CA; synthetic protocols of linkers and their characterization data; <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative compounds <b>7</b>–<b>10</b> and <b>16</b>–<b>21</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Binding model of <b>16</b> in CXCR4 receptor (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings of all target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf">jm7b01322_si_001.pdf (5.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_002.pdb">jm7b01322_si_002.pdb (363.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_003.csv">jm7b01322_si_003.csv (1.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01322" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kak-Shan Shia</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9560-2466" title="Orcid link">http://orcid.org/0000-0001-9560-2466</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#137860607b7a72537d7b617a3d7c61743d6764"><span class="__cf_email__" data-cfemail="127961617a7b73527c7a607b3c7d60753c6665">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chien-Huang Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jen-Shin Song</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsuan-Hao Kuan</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Szu-Huei Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Chen Chou</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiing-Jyh Jan</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lun K. Tsou</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1593-5226" title="Orcid link">http://orcid.org/0000-0002-1593-5226</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Yu Ke</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiung-Tong Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai-Chia Yeh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sing-Yi Wang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teng-Kuang Yeh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen-Tso Tseng</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen-Lung Huang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mine-Hsine Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Po-Chu Kuo</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chia-Jui Lee</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology
and Pharmaceutical Research, National Health
Research Institutes, Miaoli
County 35053, Taiwan, R.O.C.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.-H.W., J.-S.S., and H.-H.K. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Authors will release the atomic coordinates and experimental data upon article publication.</p></div></li></ul></div><div class="ack" id="ACK-d7e3404-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the National Health Research Institutes and Ministry of Science and Technology of the Republic of China (MOST 101-2325-B-400-016) for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> Abbreviations Used</h2><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">G protein-coupled CXC chemokine receptor 4</p></td></tr><tr><td class="NLM_term">SDF-1</td><td class="NLM_def"><p class="first last">stromal-cell-derived factor-1</p></td></tr><tr><td class="NLM_term">G-CSF</td><td class="NLM_def"><p class="first last">granulocyte colony-stimulating factor</p></td></tr><tr><td class="NLM_term">HSCs</td><td class="NLM_def"><p class="first last">hematopoietic stem cells</p></td></tr><tr><td class="NLM_term">EPCs</td><td class="NLM_def"><p class="first last">endothelial progenitor cells</p></td></tr><tr><td class="NLM_term">MSCs</td><td class="NLM_def"><p class="first last">mesenchymal stem cells</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">SC</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">ESMS</td><td class="NLM_def"><p class="first last">electrospray mass spectra</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26548" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26548" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lipfert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odemis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boltze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engele, J.</span><span> </span><span class="NLM_article-title">CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia</span> <span class="citation_source-journal">Neuropathol. Appl. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1111/nan.12015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1111%2Fnan.12015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23289420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaqs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=667-680&author=J.+Lipfertauthor=V.+Odemisauthor=D.+C.+Wagnerauthor=J.+Boltzeauthor=J.+Engele&title=CXCR4+and+CXCR7+form+a+functional+receptor+unit+for+SDF-1%2FCXCL12+in+primary+rodent+microglia&doi=10.1111%2Fnan.12015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia</span></div><div class="casAuthors">Lipfert, J.; Oedemis, V.; Wagner, D.-C.; Boltze, J.; Engele, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-680</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Microglial cells have been originally identified as a target for the CXC chemokine, SDF-1, by their expression of CXCR4.  More recently, it has been recognized that SDF-1 addnl. binds to CXCR7, which depending on the cell type acts as either a nonclassical, a classical or a scavenger chemokine receptor.  Here, we asked whether primary microglial cells addnl. express CXCR7 and if so how this chemokine receptor functions in this cell type.  Methods : CXCR4 and CXCR7 expression was analyzed in cultured rat microglia and in the brain of animals with permanent occlusion of the middle cerebral artery (MCAO) by either Western blotting, RT-PCR, flow cytometry and/or immunocytochem.  The function of CXCR4 and CXCR7 was assessed in the presence of selective antagonists.  Results : Cultured primary rat microglia expressed CXCR4 and CXCR7 to similar levels.  Treatment with SDF-1 resulted in the activation of Erk1/2 and Akt signalling.  Erk1/2 and Akt signalling were required for subsequent SDF-1-dependent promotion of microglial proliferation.  In contrast, Erk1/2 signalling was sufficient for SDF-1-induced migration of microglial cells.  Both SDF-1-dependent signalling and the resulting effects on microglial proliferation and migration were abrogated following pharmacol. inactivation of either CXCR4 or CXCR7.  Moreover, treatment of cultured microglia with lipopolysaccharide resulted in the coordinated up-regulation of CXCR4 and CXCR7 expression.  Likewise, reactive microglia accumulating in the area adjacent to the lesion core in MCAO rats expressed both CXCR4 and CXCR7.  Conclusions : CXCR4 and CXCR7 form a functional receptor unit in microglial cells, which is up-regulated during activation of microglia both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqh2TASsK3rVg90H21EOLACvtfcHk0lhQlAhCdUqaZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaqs7jL&md5=677a8a35771e279d15fc5a3d9a5aa75d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fnan.12015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnan.12015%26sid%3Dliteratum%253Aachs%26aulast%3DLipfert%26aufirst%3DJ.%26aulast%3DOdemis%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DD.%2BC.%26aulast%3DBoltze%26aufirst%3DJ.%26aulast%3DEngele%26aufirst%3DJ.%26atitle%3DCXCR4%2520and%2520CXCR7%2520form%2520a%2520functional%2520receptor%2520unit%2520for%2520SDF-1%252FCXCL12%2520in%2520primary%2520rodent%2520microglia%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2013%26volume%3D39%26spage%3D667%26epage%3D680%26doi%3D10.1111%2Fnan.12015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Robin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katakowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopp, M.</span><span> </span><span class="NLM_article-title">Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1038/sj.jcbfm.9600172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fsj.jcbfm.9600172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15959456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFamtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=125-134&author=A.+M.+Robinauthor=Z.+G.+Zhangauthor=L.+Wangauthor=R.+L.+Zhangauthor=M.+Katakowskiauthor=L.+Zhangauthor=Y.+Wangauthor=C.+Zhangauthor=M.+Chopp&title=Stromal+cell-derived+factor+1alpha+mediates+neural+progenitor+cell+motility+after+focal+cerebral+ischemia&doi=10.1038%2Fsj.jcbfm.9600172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal cell-derived factor 1α mediates neural progenitor cell motility after focal cerebral ischemia</span></div><div class="casAuthors">Robin, Adam M.; Zhang, Zheng G.; Wang, Lei; Zhang, Rui L.; Katakowski, Mark; Zhang, Li; Wang, Ying; Zhang, Chunling; Chopp, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the adult rodent, stroke induces an increase in endogenous neural progenitor cell (NPC) proliferation in the subventricular zone (SVZ) and neuroblasts migrate towards the ischemic boundary.  We investigated the role of stromal cell-derived factor 1α (SDF-1α) in mediating NPC migration after stroke.  We found that cultured NPCs harvested from the normal adult SVZ, when they were overlaid onto stroke brain slices, exhibited significantly (P<0.01) increased migration (67.2±25.2 μm) compared with the migration on normal brain slices (29.5±29.5 μm).  Immunohistochem. showed that CXCR 4, a receptor of SDF-1α, is expressed in the NPCs and migrating neuroblasts in stroke brain.  Blocking SDF-1α by a neutralizing antibody against CXCR 4 significantly attenuated stroke-enhanced NPC migration.  ELISA anal. revealed that SDF-1α levels significantly increased (P<0.01) in the stroke hemisphere (43.6±6.5 pg/mg) when compared with the normal brain (25.2±1.9 pg/mg).  Blind-well chamber assays showed that SDF-1α enhanced NPC migration in a dose-dependent manner with max. migration at a dose of 500 ng/mL.  In addn., SDF-1α induced directionally selective migration.  These findings show that SDF-1α generated in the stroke hemisphere may guide NPC migration towards the ischemic boundary via binding to its receptor CXCR 4 in the NPC.  Thus, our data indicate that SDF-1α/CXCR 4 is important for mediating specific migration of NPCs to the site of ischemic damaged neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgFmbYnyho7Vg90H21EOLACvtfcHk0likrOyOY2kmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFamtw%253D%253D&md5=c4ed98368f7c9c4ceaf0aaaa8bb08917</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600172%26sid%3Dliteratum%253Aachs%26aulast%3DRobin%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%2BG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%2BL.%26aulast%3DKatakowski%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DStromal%2520cell-derived%2520factor%25201alpha%2520mediates%2520neural%2520progenitor%2520cell%2520motility%2520after%2520focal%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2006%26volume%3D26%26spage%3D125%26epage%3D134%26doi%3D10.1038%2Fsj.jcbfm.9600172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Stumm, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culmsee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieglstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, S.</span><span> </span><span class="NLM_article-title">A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=12122049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFOjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=5865-5878&author=R.+K.+Stummauthor=J.+Rummelauthor=V.+Junkerauthor=C.+Culmseeauthor=M.+Pfeifferauthor=J.+Krieglsteinauthor=V.+Holltauthor=S.+Schulz&title=A+dual+role+for+the+SDF-1%2FCXCR4+chemokine+receptor+system+in+adult+brain%3A+isoform-selective+regulation+of+SDF-1+expression+modulates+CXCR4-dependent+neuronal+plasticity+and+cerebral+leukocyte+recruitment+after+focal+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia</span></div><div class="casAuthors">Stumm, Ralf K.; Rummel, Jutta; Junker, Vera; Culmsee, Carsten; Pfeiffer, Manuela; Krieglstein, Josef; Hollt, Volker; Schulz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5865-5878</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The chemoattractant stromal cell-derived factor-1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4) are key modulators of immune function.  In the developing brain, SDF-1 is crucial for neuronal guidance; however, cerebral functions of SDF-1/CXCR4 in adulthood are unclear.  Here, the authors examine the cellular expression of SDF-1 isoforms and CXCR4 in the brain of mice receiving systemic lipopolysaccharide (LPS) or permanent focal cerebral ischemia.  CXCR4 mRNA was constitutively expressed in cortical and hippocampal neurons and ependymal cells.  Hippocampal neurons targeted the CXCR4 receptor to their somatodendritic and axonal compartments.  In cortex and hippocampus, CXCR4-expressing neurons exhibited an overlapping distribution with neurons expressing SDF-1 transcripts.  Although neurons synthesized SDF-1α mRNA, the SDF-1β isoform was selectively expressed by endothelial cells of cerebral microvessels.  LPS stimulation dramatically decreased endothelial SDF-1β mRNA expression throughout the forebrain but did not affect neuronal SDF-1α.  After focal cerebral ischemia, SDF-1β expression was selectively increased in endothelial cells of penumbral blood vessels and decreased in endothelial cells of nonlesioned brain areas.  In the penumbra, SDF-1β upregulation was assocd. with a concomitant infiltration of CXCR4-expressing peripheral blood cells, including macrophages.  Neuronal SDF-1α was transiently downregulated and neuronal CXCR4 was transiently upregulated in the nonlesioned cerebral cortex in response to ischemia.  Although endothelial SDF-1β may control cerebral infiltration of CXCR4-carrying leukocytes during cerebral ischemia, the neuronal SDF-1α/CXCR4 system may contribute to ischemia-induced neuronal plasticity.  Thus, the isoform-specific regulation of SDF-1 expression modulates neurotransmission and cerebral infiltration via distinct CXCR4-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqWhaJ6yOafbVg90H21EOLACvtfcHk0likrOyOY2kmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFOjsL8%253D&md5=9a4f7ca7c1e693fb2147f9ab28d24d25</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStumm%26aufirst%3DR.%2BK.%26aulast%3DRummel%26aufirst%3DJ.%26aulast%3DJunker%26aufirst%3DV.%26aulast%3DCulmsee%26aufirst%3DC.%26aulast%3DPfeiffer%26aufirst%3DM.%26aulast%3DKrieglstein%26aufirst%3DJ.%26aulast%3DHollt%26aufirst%3DV.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DA%2520dual%2520role%2520for%2520the%2520SDF-1%252FCXCR4%2520chemokine%2520receptor%2520system%2520in%2520adult%2520brain%253A%2520isoform-selective%2520regulation%2520of%2520SDF-1%2520expression%2520modulates%2520CXCR4-dependent%2520neuronal%2520plasticity%2520and%2520cerebral%2520leukocyte%2520recruitment%2520after%2520focal%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D5865%26epage%3D5878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tran, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banisadr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">500</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1002/cne.21229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fcne.21229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=17183554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFantb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=500&publication_year=2007&pages=1007-1033&author=P.+B.+Tranauthor=G.+Banisadrauthor=D.+Renauthor=A.+Chennauthor=R.+J.+Miller&title=Chemokine+receptor+expression+by+neural+progenitor+cells+in+neurogenic+regions+of+mouse+brain&doi=10.1002%2Fcne.21229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain</span></div><div class="casAuthors">Tran, Phuong B.; Banisadr, Ghazal; Ren, Dongjun; Chenn, Anjen; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">500</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1007-1033</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We previously demonstrated that chemokine receptors are expressed by neural progenitors grown as cultured neurospheres.  To examine the significance of these findings for neural progenitor function in vivo, we investigated whether chemokine receptors were expressed by cells having the characteristics of neural progenitors in neurogenic regions of the postnatal brain.  Using in situ hybridization we demonstrated the expression of CCR1, CCR2, CCR5, CXCR3, and CXCR4 chemokine receptors by cells in the dentate gyrus (DG), subventricular zone of the lateral ventricle, and olfactory bulb.  The pattern of expression for all of these receptors was similar, including regions where neural progenitors normally reside.  In addn., we attempted to colocalize chemokine receptors with markers for neural progenitors.  In order to do this we used nestin-EGFP and TLX-LacZ transgenic mice, as well as labeling for Ki67, a marker for dividing cells.  In all three areas of the brain we demonstrated colocalization of chemokine receptors with these three markers in populations of cells.  Expression of chemokine receptors by neural progenitors was further confirmed using CXCR4-EGFP BAC transgenic mice.  Expression of CXCR4 in the DG included cells that expressed nestin and GFAP as well as cells that appeared to be immature granule neurons expressing PSA-NCAM, calretinin, and Prox-1.  CXCR4-expressing cells in the DG were found in close proximity to immature granule neurons that expressed the chemokine SDF-1/CXCL12.  Cells expressing CXCR4 frequently coexpressed CCR2 receptors.  These data support the hypothesis that chemokine receptors are important in regulating the migration of progenitor cells in postnatal brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTgw6WBPqdH7Vg90H21EOLACvtfcHk0likrOyOY2kmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFantb8%253D&md5=44539569ced589214fb1f615ff613c5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fcne.21229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.21229%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BB.%26aulast%3DBanisadr%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DChenn%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DChemokine%2520receptor%2520expression%2520by%2520neural%2520progenitor%2520cells%2520in%2520neurogenic%2520regions%2520of%2520mouse%2520brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2007%26volume%3D500%26spage%3D1007%26epage%3D1033%26doi%3D10.1002%2Fcne.21229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2007.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.pneurobio.2007.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18177992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=116-131&author=M.+Liauthor=R.+M.+Ransohoff&title=Multiple+roles+of+chemokine+CXCL12+in+the+central+nervous+system%3A+a+migration+from+immunology+to+neurobiology&doi=10.1016%2Fj.pneurobio.2007.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology</span></div><div class="casAuthors">Li, Meizhang; Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-131</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chemotactic cytokines (chemokines) have been traditionally defined as small (10-14 kDa) secreted leukocyte chemoattractants.  However, chemokines and their cognate receptors are constitutively expressed in the central nervous system (CNS) where immune activities are under stringent control.  Why and how the CNS uses the chemokine system to carry out its complex physiol. functions has intrigued neurobiologists.  Here, we focus on chemokine CXCL12 and its receptor CXCR4 that have been widely characterized in peripheral tissues and delineate their main functions in the CNS.  Extensive evidence supports CXCL12 as a key regulator for early development of the CNS.  CXCR4 signaling is required for the migration of neuronal precursors, axon guidance/pathfinding and maintenance of neural progenitor cells (NPCs).  In the mature CNS, CXCL12 modulates neurotransmission, neurotoxicity and neuroglial interactions.  Thus, chemokines represent an inherent system that helps establish and maintain CNS homeostasis.  In addn., growing evidence implicates altered expression of CXCL12 and CXCR4 in the pathogenesis of CNS disorders such as HIV-assocd. encephalopathy, brain tumor, stroke and multiple sclerosis (MS), making them the plausible targets for future pharmacol. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMPBWjvsSTWrVg90H21EOLACvtfcHk0liPk1cRSwiseg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKgt7k%253D&md5=fbbfe9903660e4faf741d522fff638a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DMultiple%2520roles%2520of%2520chemokine%2520CXCL12%2520in%2520the%2520central%2520nervous%2520system%253A%2520a%2520migration%2520from%2520immunology%2520to%2520neurobiology%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D116%26epage%3D131%26doi%3D10.1016%2Fj.pneurobio.2007.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollet, O.</span><span> </span><span class="NLM_article-title">How do stem cells find their way home?</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span><span class="refDoi"> DOI: 10.1182/blood-2005-04-1417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2005-04-1417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15890683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWksLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1901-1910&author=T.+Lapidotauthor=A.+Darauthor=O.+Kollet&title=How+do+stem+cells+find+their+way+home%3F&doi=10.1182%2Fblood-2005-04-1417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">How do stem cells find their way home?</span></div><div class="casAuthors">Lapidot, Tsvee; Dar, Ayelet; Kollet, Orit</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1901-1910</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  The migration of hematopoietic stem cells through the blood, across the endothelial vasculature to different organs and to their bone marrow (BM) niches, requires active navigation, a process termed homing.  Homing is a rapid process and is the 1st and essential step in clin. stem cell transplantation.  Similarly, homing is required for seeding of the fetal BM by hematopoietic progenitors during development.  Homing has physiol. roles in adult BM homeostasis, which are amplified during stress-induced recruitment of leukocytes from the BM reservoir and during stem cell mobilization, as part of host defense and repair.  Homing is thought to be a coordinated, multistep process, which involves signaling by stromal-derived factor 1 (SDF-1) and stem cell factor (SCF), activation of lymphocyte function-assocd. antigen 1 (LFA-1), very late antigen 4/5 (VLA-4/5) and CD44, cytoskeleton rearrangement, membrane type 1 (MT1)-matrix metalloproteinase (MMP) activation, and secretion of MMP2/9.  Rolling and firm adhesion of progenitors to endothelial cells in small marrow sinusoids under blood flow is followed by trans-endothelial migration across the phys. endothelium/extracellular matrix (ECM) barrier.  The stem cells finalize their homing uniquely, by selective access and anchorage to their specialized niches in the extravascular space of the endosteum region and in periarterial sites.  Here, the authors focus on mechanisms and key regulators of human stem cell homing to the BM in exptl. animal models and clin. transplantation protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFxIQwuU-IrVg90H21EOLACvtfcHk0liPk1cRSwiseg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWksLzJ&md5=a7b6f8ed7a24d58a1c459348892c256e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-04-1417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-04-1417%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DDar%26aufirst%3DA.%26aulast%3DKollet%26aufirst%3DO.%26atitle%3DHow%2520do%2520stem%2520cells%2520find%2520their%2520way%2520home%253F%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1901%26epage%3D1910%26doi%3D10.1182%2Fblood-2005-04-1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pitchford, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, S. M.</span><span> </span><span class="NLM_article-title">Differential mobilization of subsets of progenitor cells from the bone marrow</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.stem.2008.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.stem.2008.10.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=62-72&author=S.+C.+Pitchfordauthor=R.+C.+Furzeauthor=C.+P.+Jonesauthor=A.+M.+Wengnerauthor=S.+M.+Rankin&title=Differential+mobilization+of+subsets+of+progenitor+cells+from+the+bone+marrow&doi=10.1016%2Fj.stem.2008.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2008.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2008.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DPitchford%26aufirst%3DS.%2BC.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DJones%26aufirst%3DC.%2BP.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DRankin%26aufirst%3DS.%2BM.%26atitle%3DDifferential%2520mobilization%2520of%2520subsets%2520of%2520progenitor%2520cells%2520from%2520the%2520bone%2520marrow%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2009%26volume%3D4%26spage%3D62%26epage%3D72%26doi%3D10.1016%2Fj.stem.2008.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span> </span><span class="NLM_article-title">SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion</span> <span class="citation_source-journal">Protein Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1007/s13238-011-1097-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1007%2Fs13238-011-1097-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=22058039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=845-854&author=X.+Liuauthor=B.+Duanauthor=Z.+Chengauthor=X.+Jiaauthor=L.+Maoauthor=H.+Fuauthor=Y.+Cheauthor=L.+Ouauthor=L.+Liuauthor=D.+Kong&title=SDF-1%2FCXCR4+axis+modulates+bone+marrow+mesenchymal+stem+cell+apoptosis%2C+migration+and+cytokine+secretion&doi=10.1007%2Fs13238-011-1097-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion</span></div><div class="casAuthors">Liu, Xiaolei; Duan, Biyan; Cheng, Zhaokang; Jia, Xiaohua; Mao, Lina; Fu, Hao; Che, Yongzhe; Ou, Lailiang; Liu, Lin; Kong, Deling</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-854</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">Bone marrow mesenchymal stem cells (MSCs) are considered as a promising cell source to treat the acute myocardial infarction.  However, over 90% of the stem cells usually die in the first three days of transplantation.  Survival potential, migration ability and paracrine capacity have been considered as the most important three factors for cell transplantation in the ischemic cardiac treatment.  We hypothesized that stromal-derived factor-1 (SDF-1)/CXCR4 axis plays a crit. role in the regulation of these processes.  In this study, apoptosis was induced by exposure of MSCs to H2O2 for 2 h.  After re-oxygenation, the SDF-1 pretreated MSCs demonstrated a significant increase in survival and proliferation.  SDF-1 pretreatment also enhanced the migration and increased the secretion of pro-survival and angiogenic cytokines including basic fibroblast growth factor and vascular endothelial growth factor.  Western blot and RT-PCR demonstrated that SDF-1 pretreatment significantly activated the pro-survival Akt and Erk signaling pathways and up-regulated Bcl-2/Bax ratio.  These protective effects were partially inhibited by AMD3100, an antagonist of CXCR4.We conclude that the SDF-1/CXCR4 axis is crit. for MSC survival, migration and cytokine secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRx2hHwUPKjLVg90H21EOLACvtfcHk0liPk1cRSwiseg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgt7jI&md5=a250f614022586b2e3b0046cb49adc27</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13238-011-1097-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-011-1097-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDuan%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DD.%26atitle%3DSDF-1%252FCXCR4%2520axis%2520modulates%2520bone%2520marrow%2520mesenchymal%2520stem%2520cell%2520apoptosis%252C%2520migration%2520and%2520cytokine%2520secretion%26jtitle%3DProtein%2520Cell%26date%3D2011%26volume%3D2%26spage%3D845%26epage%3D854%26doi%3D10.1007%2Fs13238-011-1097-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">For recent reviews, see:</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Harnessing CXCR4 Antagonists in Stem Cell Mobilization, HIV Infection, Ischemic Diseases and Oncology</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1002/med.21464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fmed.21464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=28768055" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+K.+Tsouauthor=Y.+H.+Huangauthor=J.+S.+Songauthor=Y.+Y.+Keauthor=J.+K.+Huangauthor=K.+S.+Shia&title=Harnessing+CXCR4+Antagonists+in+Stem+Cell+Mobilization%2C+HIV+Infection%2C+Ischemic+Diseases+and+Oncology&doi=10.1002%2Fmed.21464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fmed.21464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21464%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DHarnessing%2520CXCR4%2520Antagonists%2520in%2520Stem%2520Cell%2520Mobilization%252C%2520HIV%2520Infection%252C%2520Ischemic%2520Diseases%2520and%2520Oncology%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2017%26doi%3D10.1002%2Fmed.21464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1021/jm200568c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200568c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=977-994&author=W.+T.+Choiauthor=S.+Duggineniauthor=Y.+Xuauthor=Z.+Huangauthor=J.+An&title=Drug+discovery+research+targeting+the+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm200568c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)</span></div><div class="casAuthors">Choi, Won-Tak; Duggineni, Srinivas; Xu, Yan; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">977-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The CXC chemokine receptor 4 (CXCR4) is an attractive target for therapeutic intervention because of its involvement in the pathogenesis of a wide range of infectious, inflammatory, and other diseases.  There has been intensive biol., chem., and pharmaceutical research to understand the mol. mechanisms of chemokine-receptor interactions and the modulation of chemokine-receptor functions.  The ultimate goal is to translate these discoveries into novel treatment strategies for clin. applications.  This review describes and discusses some of the recent advances in medicinal chem. and drug discovery that involve CXCR4, which is implicated in human immunodeficiency virus (HIV)-1 infection, normal hematopoietic and neural stem cell migration, cancer-stromal cell interaction, solid tumors, and inflammation and autoimmune diseases such as rheumatoid arthritis and allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvqHX-IPaxrVg90H21EOLACvtfcHk0lhJZfvhluR2RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF&md5=c996a29f564ca4197139f4802dcbe061</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm200568c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200568c%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520research%2520targeting%2520the%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D977%26epage%3D994%26doi%3D10.1021%2Fjm200568c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Fiorina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayegh, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdi, R.</span><span> </span><span class="NLM_article-title">Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.4049/jimmunol.1000799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4049%2Fjimmunol.1000799" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=121-131&author=P.+Fiorinaauthor=M.+Jurewiczauthor=A.+Verganiauthor=A.+Petrelliauthor=M.+Carvelloauthor=F.+D%E2%80%99Addioauthor=J.+G.+Godwinauthor=K.+Lawauthor=E.+Wuauthor=Z.+Tianauthor=G.+Thomaauthor=J.+Kovarikauthor=S.+La+Rosaauthor=C.+Capellaauthor=S.+Rodigauthor=H.+G.+Zerwesauthor=M.+H.+Sayeghauthor=R.+Abdi&title=Targeting+the+CXCR4-CXCL12+axis+mobilizes+autologous+hematopoietic+stem+cells+and+prolongs+islet+allograft+survival+via+programmed+death+ligand+1&doi=10.4049%2Fjimmunol.1000799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000799%26sid%3Dliteratum%253Aachs%26aulast%3DFiorina%26aufirst%3DP.%26aulast%3DJurewicz%26aufirst%3DM.%26aulast%3DVergani%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DA.%26aulast%3DCarvello%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Addio%26aufirst%3DF.%26aulast%3DGodwin%26aufirst%3DJ.%2BG.%26aulast%3DLaw%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DCapella%26aufirst%3DC.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26aulast%3DSayegh%26aufirst%3DM.%2BH.%26aulast%3DAbdi%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520CXCR4-CXCL12%2520axis%2520mobilizes%2520autologous%2520hematopoietic%2520stem%2520cells%2520and%2520prolongs%2520islet%2520allograft%2520survival%2520via%2520programmed%2520death%2520ligand%25201%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D121%26epage%3D131%26doi%3D10.4049%2Fjimmunol.1000799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ben Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorina, P.</span><span> </span><span class="NLM_article-title">CXCR4 antagonism overcomes diabetic stem cell mobilopathy</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2016.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.atherosclerosis.2016.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2016&pages=512-513&author=M.+Ben+Nasrauthor=P.+Fiorina&title=CXCR4+antagonism+overcomes+diabetic+stem+cell+mobilopathy&doi=10.1016%2Fj.atherosclerosis.2016.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2016.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2016.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DBen%2BNasr%26aufirst%3DM.%26aulast%3DFiorina%26aufirst%3DP.%26atitle%3DCXCR4%2520antagonism%2520overcomes%2520diabetic%2520stem%2520cell%2520mobilopathy%26jtitle%3DAtherosclerosis%26date%3D2016%26volume%3D251%26spage%3D512%26epage%3D513%26doi%3D10.1016%2Fj.atherosclerosis.2016.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gulick, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalezari, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clumeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfeiler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felstead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, H.</span><span> </span><span class="NLM_article-title">Maraviroc for previously treated patients with R5 HIV-1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1056/NEJMoa0803152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1056%2FNEJMoa0803152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18832244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=1429-1441&author=R.+M.+Gulickauthor=J.+Lalezariauthor=J.+Goodrichauthor=N.+Clumeckauthor=E.+DeJesusauthor=A.+Horbanauthor=J.+Nadlerauthor=B.+Clotetauthor=A.+Karlssonauthor=M.+Wohlfeilerauthor=J.+B.+Montanaauthor=M.+McHaleauthor=J.+Sullivanauthor=C.+Ridgwayauthor=S.+Felsteadauthor=M.+W.+Dunneauthor=E.+van+der+Rystauthor=H.+Mayer&title=Maraviroc+for+previously+treated+patients+with+R5+HIV-1+infection&doi=10.1056%2FNEJMoa0803152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc for previously treated patients with R5 HIV-1 infection</span></div><div class="casAuthors">Gulick, Roy M.; Lalezari, Jacob; Goodrich, James; Clumeck, Nathan; DeJesus, Edwin; Horban, Andrzej; Nadler, Jeffrey; Clotet, Bonaventura; Karlsson, Anders; Wohlfeiler, Michael; Montana, John B.; McHale, Mary; Sullivan, John; Ridgway, Caroline; Felstead, Steve; Dunne, Michael W.; van der Ryst, Elna; Mayer, Howard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1429-1441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">CC chemokine receptor 5 antagonists are a new class of antiretroviral agents.  We conducted two double-blind, placebo-controlled, phase 3 studies - Maraviroc vs. Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 - with patients who had R5 human immunodeficiency virus type 1 (HIV-1) only.  They had been treated with or had resistance to three antiretroviral-drug classes and had HIV-1 RNA levels of more than 5000 copies per mL.  The patients were randomly assigned to one of three antiretroviral regimens consisting of maraviroc once daily, maraviroc twice daily, or placebo, each of which included optimized background therapy (OBT) based on treatment history and drug-resistance testing.  Safety and efficacy were assessed after 48 wk.  A total of 1049 patients received the randomly assigned study drug; the mean baseline HIV-1 RNA level was 72,400 copies per mL, and the median CD4 cell count was 169 per cubic millimeter.  At 48 wk, in both studies, the mean change in HIV-1 RNA from baseline was greater with maraviroc than with placebo: - 1.66 and - 1.82 log10 copies per mL with the once-daily and twice-daily regimens, resp., vs. -0.80 with placebo in MOTIVATE 1, and - 1.72 and - 1.87 log, copies per mL, resp., vs. - 0.76 with placebo in MOTIVATE 2.  More patients receiving maraviroc once or twice daily had HIV-1 RNA levels of less than 50 copies per mL (42% and 47%, resp., vs. 16% in the placebo group in MOTIVATE 1; 45% in both maraviroc groups vs. 18% in MOTIVATE 2; P < 0.001 for both comparisons in each study).  The change from baseline in CD4 counts was also greater with maraviroc once or twice daily than with placebo (increases of 113 and 122 per cubic millimeter, resp., vs. 54 in MOTIVATE 1; increases of 122 and 128 per cubic millimeter, resp., vs. 69 in MOTIVATE 2; P < 0.001 for both comparisons in each study).  Frequencies of adverse events were similar among the groups.  Maraviroc, as compared with placebo, resulted in significantly greater suppression of HIV-1 and greater increases in CD4 cell counts at 48 wk in previously treated patients with R5 HIV-1 who were receiving OBT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKE-CWXtz37Vg90H21EOLACvtfcHk0ljRVq9vKGbcfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOktLbM&md5=ffac432390f2fedd9d3c6ba1d925e40e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0803152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0803152%26sid%3Dliteratum%253Aachs%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DLalezari%26aufirst%3DJ.%26aulast%3DGoodrich%26aufirst%3DJ.%26aulast%3DClumeck%26aufirst%3DN.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DHorban%26aufirst%3DA.%26aulast%3DNadler%26aufirst%3DJ.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DWohlfeiler%26aufirst%3DM.%26aulast%3DMontana%26aufirst%3DJ.%2BB.%26aulast%3DMcHale%26aufirst%3DM.%26aulast%3DSullivan%26aufirst%3DJ.%26aulast%3DRidgway%26aufirst%3DC.%26aulast%3DFelstead%26aufirst%3DS.%26aulast%3DDunne%26aufirst%3DM.%2BW.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26aulast%3DMayer%26aufirst%3DH.%26atitle%3DMaraviroc%2520for%2520previously%2520treated%2520patients%2520with%2520R5%2520HIV-1%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D1429%26epage%3D1441%26doi%3D10.1056%2FNEJMoa0803152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span> </span><span class="NLM_article-title">Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4920</span><span class="refDoi"> DOI: 10.1128/JVI.80.10.4909-4920.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1128%2FJVI.80.10.4909-4920.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=16641282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=4909-4920&author=M.+Westbyauthor=M.+Lewisauthor=J.+Whitcombauthor=M.+Youleauthor=A.+L.+Pozniakauthor=I.+T.+Jamesauthor=T.+M.+Jenkinsauthor=M.+Perrosauthor=E.+van+der+Ryst&title=Emergence+of+CXCR4-using+human+immunodeficiency+virus+type+1+%28HIV-1%29+variants+in+a+minority+of+HIV-1-infected+patients+following+treatment+with+the+CCR5+antagonist+maraviroc+is+from+a+pretreatment+CXCR4-using+virus+reservoir&doi=10.1128%2FJVI.80.10.4909-4920.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir</span></div><div class="casAuthors">Westby, Mike; Lewis, Marilyn; Whitcomb, Jeannette; Youle, Mike; Pozniak, Anton L.; James, Ian T.; Jenkins, Tim M.; Perros, Manos; van der Ryst, Elna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4909-4920</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antagonists of the human immunodeficiency virus type 1 (HIV-1) coreceptor, CCR5, are being developed as the first anti-HIV agents acting on a host cell target.  We monitored the coreceptor tropism of circulating virus, screened at baseline for coreceptor tropism, in 64 HIV-1-infected patients who received maraviroc (MVC, UK-427,857) as monotherapy for 10 days.  Sixty-two patients harbored CCR5-tropic virus at baseline and had a posttreatment phenotype result.  Circulating virus remained CCR5 tropic in 60/62 patients, 51 of whom experienced an HIV RNA redn. from baseline of > 1 log10 copies/mL, indicating that CXCR4-using variants were not rapidly selected despite CCR5-specific drug pressure.  In two patients, viral load declined during treatment and CXCR4-using virus was detected at day 11.  No pretreatment factor predicted the emergence of CXCR4-tropic virus during maraviroc therapy in these two patients.  Phylogenetic anal. of envelope (Env) clones from pre- and posttreatment time points indicated that the CXCR4-using variants probably emerged by outgrowth of a pretreatment CXCR4-using reservoir, rather than via coreceptor switch of a CCR5-tropic clone under selection pressure from maraviroc.  Phylogenetic anal. was also performed on Env clones from a third patient harboring CXCR4-using virus prior to treatment.  This patient was enrolled due to a sample labeling error.  Although this patient experienced no overall redn. in viral load in response to treatment, the CCR5-tropic components of the circulating virus did appear to be suppressed while receiving maraviroc as monotherapy.  Importantly, in all three patients, circulating virus reverted to predominantly CCR5 tropic following cessation of maraviroc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCJASNGx6_gbVg90H21EOLACvtfcHk0ljRVq9vKGbcfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslChtLc%253D&md5=43a23a5e8481d63ee4742c561843d4d2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.80.10.4909-4920.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.80.10.4909-4920.2006%26sid%3Dliteratum%253Aachs%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DWhitcomb%26aufirst%3DJ.%26aulast%3DYoule%26aufirst%3DM.%26aulast%3DPozniak%26aufirst%3DA.%2BL.%26aulast%3DJames%26aufirst%3DI.%2BT.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26atitle%3DEmergence%2520of%2520CXCR4-using%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520variants%2520in%2520a%2520minority%2520of%2520HIV-1-infected%2520patients%2520following%2520treatment%2520with%2520the%2520CCR5%2520antagonist%2520maraviroc%2520is%2520from%2520a%2520pretreatment%2520CXCR4-using%2520virus%2520reservoir%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D4909%26epage%3D4920%26doi%3D10.1128%2FJVI.80.10.4909-4920.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hendrix, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glesby, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flexner, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1097/01.qai.0000137371.80695.ef</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2F01.qai.0000137371.80695.ef" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15385732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslels7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1253-1262&author=C.+W.+Hendrixauthor=A.+C.+Collierauthor=M.+M.+Ledermanauthor=D.+Scholsauthor=R.+B.+Pollardauthor=S.+Brownauthor=J.+B.+Jacksonauthor=R.+W.+Coombsauthor=M.+J.+Glesbyauthor=C.+W.+Flexnerauthor=G.+J.+Bridgerauthor=K.+Badelauthor=R.+T.+MacFarlandauthor=G.+W.+Hensonauthor=G.+Calandra&title=Safety%2C+pharmacokinetics%2C+and+antiviral+activity+of+AMD3100%2C+a+selective+CXCR4+receptor+inhibitor%2C+in+HIV-1+infection&doi=10.1097%2F01.qai.0000137371.80695.ef"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection</span></div><div class="casAuthors">Hendrix, Craig W.; Collier, Ann C.; Lederman, Michael M.; Schols, Dominique; Pollard, Richard B.; Brown, Stephen; Brooks Jackson, J.; Coombs, Robert W.; Glesby, Marshall J.; Flexner, Charles W.; Bridger, Gary J.; Badel, Karin; MacFarland, Ronald T.; Henson, Geoffrey W.; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1253-1262</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">AMD3100 is a CXCR4 receptor inhibitor with anti-HIV-1 activity in vitro.  We tested the safety, pharmacokinetics, and antiviral effect of AMD3100 administered for 10 days by continuous i.v. infusion in an open-label dose escalation study from 2.5 to 160 μg/kg/h.  Forty HIV-infected patients with an HIV RNA level >5000 copies/mL on stable antiretroviral (ARV) regimens or off therapy were enrolled.  Syncytium-inducing (SI) phenotype in an MT-2 cell assay was required in higher dose cohorts.  Most subjects were black (55%), male (98%), and off ARV therapy.  HIV phenotype was SI (30%), non-SI (45%), or not tested (25%).  One patient (5 μg/kg/h) had serious and possibly drug-related thrombocytopenia.  Two patients (40 and 160 μg/kg/h) had unexpected, although not serious, premature ventricular contractions.  Most patients in the 80- and 160-μg/kg/h cohorts had paresthesias.  Steady-state blood concn. and area under the concn.-time curve were dose proportional across all dose levels; the median terminal elimination half-life was 8.6 h (range: 8.1-11.1 h).  Leukocytosis was obsd. in all patients, with an estd. max. effect of 3.4 times baseline (95% confidence interval: 2.9-3.9).  Only 1 patient, the patient whose virus was confirmed to use purely CXCR4 and who also received the highest dose (160 μg/kg/h), had a significant 0.9-log10 copies/mL HIV RNA drop at day 11.  Overall, however, the av. change in viral load across all patients was +0.03 log10 HIV RNA.  Given these results, AMD3100 is not being further developed for ARV therapy, but development continues for stem cell mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_cEHxd_seH7Vg90H21EOLACvtfcHk0ljRVq9vKGbcfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslels7k%253D&md5=1685124ead6f082a144b60641bf5c604</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F01.qai.0000137371.80695.ef&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.qai.0000137371.80695.ef%26sid%3Dliteratum%253Aachs%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DLederman%26aufirst%3DM.%2BM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DPollard%26aufirst%3DR.%2BB.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%2BB.%26aulast%3DCoombs%26aufirst%3DR.%2BW.%26aulast%3DGlesby%26aufirst%3DM.%2BJ.%26aulast%3DFlexner%26aufirst%3DC.%2BW.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%2BT.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520and%2520antiviral%2520activity%2520of%2520AMD3100%252C%2520a%2520selective%2520CXCR4%2520receptor%2520inhibitor%252C%2520in%2520HIV-1%2520infection%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2004%26volume%3D37%26spage%3D1253%26epage%3D1262%26doi%3D10.1097%2F01.qai.0000137371.80695.ef" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nyunt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macfarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Effect of AMD070, an oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181627566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2FQAI.0b013e3181627566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18362694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=559-565&author=M.+M.+Nyuntauthor=S.+Beckerauthor=R.+T.+Macfarlandauthor=P.+Cheeauthor=R.+Scarboroughauthor=S.+Evertsauthor=G.+B.+Calandraauthor=C.+W.+Hendrix&title=Pharmacokinetic+Effect+of+AMD070%2C+an+oral+CXCR4+antagonist%2C+on+CYP3A4+and+CYP2D6+substrates+midazolam+and+dextromethorphan+in+healthy+volunteers&doi=10.1097%2FQAI.0b013e3181627566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span></div><div class="casAuthors">Nyunt, Myaing M.; Becker, Stephen; MacFarland, Ron T.; Chee, Priscilla; Scarborough, Robert; Everts, Stephanie; Calandra, Gary B.; Hendrix, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Many antiretroviral drugs used in HIV care involve complex drug metab. by CYP3A4 and CYP2D6 enzymes, and drug interactions are problematic clin.  AMD070, a novel entry inhibitor, is an inhibitor of X4-tropic HIV virus.  In vitro data suggested that it is a CYP3A4 substrate and may inhibit CYP2D6 and CYP3A4.  Twelve healthy subjects were given a single oral dose of 5 mg of midazolam and 30 mg of dextromethorphan on day 1 and 9, and 200 mg of AMD070 twice daily on days 2 through 9 (inclusive).  Pharmacokinetic parameters of midazolam and dextromethorphan were assessed alone and in the presence of AMD070.  The mean AUC0-24 and Cmax of dextromethorphan increased 2.86-fold (2.20 to 5.10, 90% confidence interval [CI]) and 2.52-fold (1.99 to 4.24, 90% CI), resp., in the presence of AMD070.  Plasma AUC0-12 of midazolam increased 1.33-fold (1.15 to 1.61, 90% CI) without change in Cmax.  The half-life did not change for both drugs, but significant, parallel decrease in apparent oral clearance and vol. of distribution was obsd.  The data support an alteration in bioavailability due to an AMD070-mediated inhibition of presystemic metab., though an intestinal P-glycoprotein effect could also be contributing.  Interactions between AMD070 with CYP3A4 and, esp., 2D6 substrates of clin. importance in HIV care should be further explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMlBnTo8oO7Vg90H21EOLACvtfcHk0ljPg5mXAivPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D&md5=bfea110729b08f0c25d7219e971b209d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181627566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181627566%26sid%3Dliteratum%253Aachs%26aulast%3DNyunt%26aufirst%3DM.%2BM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DMacfarland%26aufirst%3DR.%2BT.%26aulast%3DChee%26aufirst%3DP.%26aulast%3DScarborough%26aufirst%3DR.%26aulast%3DEverts%26aufirst%3DS.%26aulast%3DCalandra%26aufirst%3DG.%2BB.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DPharmacokinetic%2520Effect%2520of%2520AMD070%252C%2520an%2520oral%2520CXCR4%2520antagonist%252C%2520on%2520CYP3A4%2520and%2520CYP2D6%2520substrates%2520midazolam%2520and%2520dextromethorphan%2520in%2520healthy%2520volunteers%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2008%26volume%3D47%26spage%3D559%26epage%3D565%26doi%3D10.1097%2FQAI.0b013e3181627566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Moyle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1086/597097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1086%2F597097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19193109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=798-805&author=G.+Moyleauthor=E.+DeJesusauthor=M.+Boffitoauthor=R.+S.+Wongauthor=C.+Gibneyauthor=K.+Badelauthor=R.+MacFarlandauthor=G.+Calandraauthor=G.+Bridgerauthor=S.+Becker&title=Proof+of+activity+with+AMD11070%2C+an+orally+bioavailable+inhibitor+of+CXCR4-tropic+HIV+type+1&doi=10.1086%2F597097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span></div><div class="casAuthors">Moyle, Graeme; De Jesus, Edwin; Boffito, Marta; Wong, Rebecca S.; Gibney, Colleen; Badel, Karin; MacFarland, Ron; Calandra, Gary; Bridger, Gary; Becker, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">798-805</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The X4 Antagonist Concept Trial investigates the safety and antiviral activity of AMD11070, a potent inhibitor of X4-tropic human immunodeficiency virus (HIV) in vitro in HIV-infected patients harboring X4-tropic virus.  Methods: Patients enrolled in the study had an X4 virus population ≥2000 relative luminescence units (rlu; by the Monogram Trofile Assay) and an HIV-1 RNA level ≥5000 copies/mL.  Patients received AMD11070 mono-therapy for 10 days.  Coreceptor tropism, plasma HIV-1 RNA level, and CD4 cell count were measured at study entry, on day 5, and on day 10.  Daily predose and serial samples on the last day of treatment were obtained for detn. of plasma AMD11070 concn.  Results: Ten patients were given AMD11070 monotherapy (200 mg to 8 patients and 100 mg to 2 patients) twice daily for 10 days.  The median baseline CD4 cell count was 160 cells/mm3, and the median HIV-1 RNA level was 91,447 copies/mL.  Four of 9 evaluable patients achieved a redn. in X4 virus population of ≥1 - log10 rlu.  The median change in X4 virus population at the end of treatment was -0.22 log10 rlu (range, -1.90 to 0.23 log10 rlu).  Three of 4 patients who responded to therapy showed a tropism shift from dual- or mixed-tropic viruses to exclusively R5 virus by day 10.  There were no drug-related serious adverse events, adverse events of greater than grade 2, or lab. abnormalities.  Conclusion: These results demonstrate the activity of AMD11070, the first oral CXCR4 antagonist, against X4-tropic HIV-1.  The drug was well tolerated, with no serious safety concerns.  AMD11070 is on clin. hold because of histol. changes to the liver obsd. in long-term animal studies; addnl. preclin. safety assessments are pending.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiMCeVyzm_ZLVg90H21EOLACvtfcHk0ljPg5mXAivPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D&md5=e6406e781295be3e9a05e7d142048010</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F597097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597097%26sid%3Dliteratum%253Aachs%26aulast%3DMoyle%26aufirst%3DG.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DBoffito%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DR.%2BS.%26aulast%3DGibney%26aufirst%3DC.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DProof%2520of%2520activity%2520with%2520AMD11070%252C%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520CXCR4-tropic%2520HIV%2520type%25201%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D798%26epage%3D805%26doi%3D10.1086%2F597097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1128/AAC.01727-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1128%2FAAC.01727-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2940-2948&author=T.+Murakamiauthor=S.+Kumakuraauthor=T.+Yamazakiauthor=R.+Tanakaauthor=M.+Hamatakeauthor=K.+Okumaauthor=W.+Huangauthor=J.+Tomaauthor=J.+Komanoauthor=M.+Yanakaauthor=Y.+Tanakaauthor=N.+Yamamoto&title=The+novel+CXCR4+antagonist+KRH-3955+is+an+orally+bioavailable+and+extremely+potent+inhibitor+of+human+immunodeficiency+virus+type+1+infection%3A+comparative+studies+with+AMD3100&doi=10.1128%2FAAC.01727-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1128%2FAAC.01727-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01727-08%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DToma%26aufirst%3DJ.%26aulast%3DKomano%26aufirst%3DJ.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520KRH-3955%2520is%2520an%2520orally%2520bioavailable%2520and%2520extremely%2520potent%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%253A%2520comparative%2520studies%2520with%2520AMD3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D2940%26epage%3D2948%26doi%3D10.1128%2FAAC.01727-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlshøj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8141</span><span class="NLM_x">–</span> <span class="NLM_lpage">8153</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8141-8153&author=Z.+G.+Zachariassenauthor=S.+Karlsh%C3%B8jauthor=B.+E.+Haugauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Probing+the+molecular+interactions+between+CXC+chemokine+receptor+4+%28CXCR4%29+and+an+arginine-based+tripeptidomimetic+antagonist+%28KRH-1636%29&doi=10.1021%2Facs.jmedchem.5b00987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00987%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DKarlsh%25C3%25B8j%26aufirst%3DS.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520molecular%2520interactions%2520between%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%2520and%2520an%2520arginine-based%2520tripeptidomimetic%2520antagonist%2520%2528KRH-1636%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8141%26epage%3D8153%26doi%3D10.1021%2Facs.jmedchem.5b00987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Damme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1084/jem.186.8.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1084%2Fjem.186.8.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=9334378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVelu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1997&pages=1383-1388&author=D.+Scholsauthor=S.+Struyfauthor=J.+Van+Dammeauthor=J.+A.+Est%C3%A9author=G.+Hensonauthor=E.+De+Clercq&title=Inhibition+of+T-tropic+HIV+strains+by+selective+antagonization+of+the+chemokine+receptor+CXCR4&doi=10.1084%2Fjem.186.8.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4</span></div><div class="casAuthors">Schols, Dominique; Struyf, Sofie; Van Damme, Jo; Este, Jose A.; Henson, Geoffrey; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Bicyclams are a novel class of antiviral compds. that are highly potent and selective inhibitors of the replication of HIV-1 and HIV-2.  Surprisingly, however, when the prototype compd. AMD3100 was tested against M-tropic virus strains such as BaL, ADA, JR-CSF, and SF-162 in human peripheral blood mononuclear cells, the compd. was completely inactive.  Because of the specific and potent inhibitory effect of AMD3100 on T-tropic viruses, but not M-tropic viruses, it was verified that AMD3100 interacts with the CXC-chemokine receptor CXCR4, the main coreceptor used by T-tropic viruses.  AMD3100 dose dependently inhibited the binding of a specific CXCR4 monoclonal antibody to SUP-T1 cells as measured by flow cytometry.  It did not inhibit the binding of the biotinylated CC-chemokine macrophage inflammatory protein (MIP) α1 or MIP-1β, ligands for the chemokine receptor CCR5 (the main coreceptor for M-tropic viruses).  In addn., AMD3100 completely blocked (a) the Ca2+ flux at 100 ng/mL in lymphocytic SUP-T1 and monocytic THP-1 cells, and (b) the chemotactic responses of THP-1 cells induced by stromal cell-derived factor 1α, the natural ligand for CXCR4.  Finally, AMD3100 had no effect on the Ca2+ flux induced by the CC-chemokines MIP-1α, regulated on activation normal T cell expressed and secreted (RANTES; also a ligand for CCR5), or monocyte chemoattractant protein 3 (a ligand for CCR1 and CCR2b), nor was it able to induce Ca2+ fluxes by itself.  The bicyclams are, to our knowledge, the first low mol. wt. anti-HIV agents shown to act as potent and selective CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ5dssLvsuLrVg90H21EOLACvtfcHk0lh8sSxT5jHLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVelu7s%253D&md5=1d0dce8df250d0723de73cf83c98d92a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1084%2Fjem.186.8.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.186.8.1383%26sid%3Dliteratum%253Aachs%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%2BA.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520T-tropic%2520HIV%2520strains%2520by%2520selective%2520antagonization%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1997%26volume%3D186%26spage%3D1383%26epage%3D1388%26doi%3D10.1084%2Fjem.186.8.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span><span class="refDoi"> DOI: 10.1021/jm501772w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501772w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1452-1465&author=C.+H.+Wuauthor=C.+J.+Wangauthor=C.+P.+Changauthor=Y.+C.+Chengauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=Y.+Y.+Keauthor=J.+Maauthor=Y.+C.+Wongauthor=T.+C.+Hsiehauthor=Y.+C.+Tienauthor=E.+A.+Gullenauthor=C.+F.+Loauthor=C.+Y.+Chengauthor=Y.+W.+Liuauthor=A.+A.+Sadaniauthor=C.+H.+Tsaiauthor=H.+P.+Hsiehauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Function-oriented+development+of+CXCR4+antagonists+as+selective+human+immunodeficiency+virus+%28HIV%29-1+entry+inhibitors&doi=10.1021%2Fjm501772w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501772w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501772w%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DTien%26aufirst%3DY.%2BC.%26aulast%3DGullen%26aufirst%3DE.%2BA.%26aulast%3DLo%26aufirst%3DC.%2BF.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DFunction-oriented%2520development%2520of%2520CXCR4%2520antagonists%2520as%2520selective%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520entry%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1452%26epage%3D1465%26doi%3D10.1021%2Fjm501772w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G. Q.</span><span> </span><span class="NLM_article-title">SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1195</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.11.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.brainres.2007.11.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18206136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVehur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1195&publication_year=2008&pages=104-112&author=Y.+Wangauthor=Y.+Dengauthor=G.+Q.+Zhou&title=SDF-1alpha%2FCXCR4-mediated+migration+of+systemically+transplanted+bone+marrow+stromal+cells+towards+ischemic+brain+lesion+in+a+rat+model&doi=10.1016%2Fj.brainres.2007.11.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model</span></div><div class="casAuthors">Wang, Ye; Deng, Yubin; Zhou, Guang-Qian</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) can promote functional recovery of brain after stroke with the mechanism regulating the BMSCs migration to ischemic penumbra poorly understood.  Interaction between stromal cell-derived factor-1α (SDF-1α) and its cognate receptor CXCR4 is crucial for homing and migration of multiple stem cell types.  Their potential role in mediating BMSC migration in ischemic brain has not been demonstrated.  In this study, ischemic brain lesion model was created in rats by permanent middle cerebral artery occlusion and green fluorescent protein (GFP)-labeled BMSCs were i.v. injected.  Immunohistochem. staining showed that BMSCs were able to enter the route from olfactory areas to cortex of the rat brain.  Significant recovery of modified Neurol. Severity Score was obsd. at days 14 and 28.  Interestingly, the SDF-1α mRNA and protein were predominantly localized in the ischemic penumbral, peaked by 3-7 days and retained at least 14 days post-transplantation.  On the other hand, the CXCR4 expression by BMSCs was elevated under hypoxia.  The pre-treatment with the CXCR4-specific antagonist AMD3100 significantly prevented the migration of BMSCs to the injured brain.  Taken together, these observations indicate that systemically administered BMSCs can migrate to the ischemic lesion of brain along with the olfactory-thalamus and hippocampus-cortex route.  The interaction of locally produced SDF-1α and CXCR4 expressed on the BMSC surface plays an important role in the migration of transplanted cells, suggesting that it might be a potential approach to modulate the expression of the two mols. in order to further facilitate the therapeutic effects using BMSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo68kYwzFR_pLVg90H21EOLACvtfcHk0lh8sSxT5jHLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVehur4%253D&md5=6eddc731fda277696b1bdd8005faf34d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.11.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.11.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DG.%2BQ.%26atitle%3DSDF-1alpha%252FCXCR4-mediated%2520migration%2520of%2520systemically%2520transplanted%2520bone%2520marrow%2520stromal%2520cells%2520towards%2520ischemic%2520brain%2520lesion%2520in%2520a%2520rat%2520model%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1195%26spage%3D104%26epage%3D112%26doi%3D10.1016%2Fj.brainres.2007.11.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Borlongan, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span> </span><span class="NLM_article-title">Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3615</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span><span class="refDoi"> DOI: 10.1097/00001756-199811160-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2F00001756-199811160-00012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=3615-3621&author=C.+V.+Borlonganauthor=H.+Hidaauthor=H.+Nishino&title=Early+assessment+of+motor+dysfunctions+aids+in+successful+occlusion+of+the+middle+cerebral+artery&doi=10.1097%2F00001756-199811160-00012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2F00001756-199811160-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199811160-00012%26sid%3Dliteratum%253Aachs%26aulast%3DBorlongan%26aufirst%3DC.%2BV.%26aulast%3DHida%26aufirst%3DH.%26aulast%3DNishino%26aufirst%3DH.%26atitle%3DEarly%2520assessment%2520of%2520motor%2520dysfunctions%2520aids%2520in%2520successful%2520occlusion%2520of%2520the%2520middle%2520cerebral%2520artery%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D3615%26epage%3D3621%26doi%3D10.1097%2F00001756-199811160-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wu, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain</span> <span class="citation_source-journal">Cell Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.3727/096368916X693563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.3727%2F096368916X693563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=27938478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252Fislanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=571-583&author=K.+J.+Wuauthor=S.+J.+Yuauthor=K.+S.+Shiaauthor=C.+H.+Wuauthor=J.+S.+Songauthor=H.+H.+Kuanauthor=K.+C.+Yehauthor=C.+T.+Chenauthor=E.+Baeauthor=Y.+Wang&title=A+novel+CXCR4+antagonist+CX549+induces+neuroprotection+in+stroke+brain&doi=10.3727%2F096368916X693563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain</span></div><div class="casAuthors">Wu Kuo-Jen; Yu Seong-Jin; Shia Kak-Shan; Wu Chien-Huang; Song Jen-Shin; Kuan Hsuan-Hao; Yeh Kai-Chia; Chen Chiung-Tong; Bae Eunkyune; Wang Yun</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-583</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12.  Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs).  The purpose of this study was to characterize the neuroprotective and neurotrophic effect of a novel CXCR4 antagonist CX549.  We demonstrated that CX549 had a higher affinity for CXCR4 and was more potent than AMD3100 to inhibit CXCL12-mediated chemotaxis in culture.  CX549 effectively reduced the activation of microglia and improved neuronal survival after injury in neuron/microglia cocultures.  Early poststroke treatment with CX549 significantly improved behavioral function, reduced brain infarction, and suppressed the expression of inflammatory markers.  Compared to AMD3100, CX549 has a higher affinity for CXCR4, is more efficient to mobilize HSCs for transplantation, and induces behavioral improvement.  Our data support that CX549 is a potent anti-inflammatory agent, is neuroprotective against ischemic brain injury, and may have clinical implications for the treatment of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnCtEAI5yEH7xanA7vODO6fW6udTcc2eZR9FZL2wEAU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252Fislanug%253D%253D&md5=6ca127a837546015e43af88e73a228e7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3727%2F096368916X693563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368916X693563%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BJ.%26aulast%3DYu%26aufirst%3DS.%2BJ.%26aulast%3DShia%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DKuan%26aufirst%3DH.%2BH.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DBae%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520novel%2520CXCR4%2520antagonist%2520CX549%2520induces%2520neuroprotection%2520in%2520stroke%2520brain%26jtitle%3DCell%2520Transplant.%26date%3D2017%26volume%3D26%26spage%3D571%26epage%3D583%26doi%3D10.3727%2F096368916X693563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Stem cell mobilizers targeting chemokine receptor CXCR4: renoprotective application in acute kidney injury</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span><span class="refDoi"> DOI: 10.1021/jm501769r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501769r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2315-2325&author=C.+H.+Wuauthor=J.+S.+Songauthor=K.+H.+Changauthor=J.+J.+Janauthor=C.+T.+Chenauthor=M.+C.+Chouauthor=K.+C.+Yehauthor=Y.+C.+Wongauthor=C.+T.+Tsengauthor=S.+H.+Wuauthor=C.+F.+Yehauthor=C.+Y.+Huangauthor=M.+H.+Wangauthor=A.+A.+Sadaniauthor=C.+P.+Changauthor=C.+Y.+Chengauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Stem+cell+mobilizers+targeting+chemokine+receptor+CXCR4%3A+renoprotective+application+in+acute+kidney+injury&doi=10.1021%2Fjm501769r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501769r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501769r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DChang%26aufirst%3DK.%2BH.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DC.%2BF.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DStem%2520cell%2520mobilizers%2520targeting%2520chemokine%2520receptor%2520CXCR4%253A%2520renoprotective%2520application%2520in%2520acute%2520kidney%2520injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2315%26epage%3D2325%26doi%3D10.1021%2Fjm501769r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction</span> <span class="citation_source-journal">Acta Biochim. Biophys. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1093/abbs/gmt045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1093%2Fabbs%2Fgmt045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23676772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCqtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=561-569&author=Y.+Luoauthor=X.+Zhaoauthor=X.+Zhouauthor=W.+Jiauthor=L.+Zhangauthor=T.+Luoauthor=H.+Liuauthor=T.+Huangauthor=T.+Jiangauthor=Y.+Li&title=Short-term+intermittent+administration+of+CXCR4+antagonist+AMD3100+facilitates+myocardial+repair+in+experimental+myocardial+infarction&doi=10.1093%2Fabbs%2Fgmt045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction</span></div><div class="casAuthors">Luo, Yuechen; Zhao, Xiaoning; Zhou, Xin; Ji, Wenjie; Zhang, Ling; Luo, Tao; Liu, Hongmei; Huang, Tigang; Jiang, Tiemin; Li, Yuming</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-569</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">ABBS Editorial Office</span>)
        </div><div class="casAbstract">The binding of the stromal cell-derived factor-1α (SDF-1α) to the cysteine (C)-X-C motif chemokine receptor 4 (CXCR4) has emerged as a key signal for stem and progenitor cells trafficking to the circulation from the bone marrow.  Our aim was to investigate the role of daily intermittent administration of AMD3100 (a specific reversible CXCR4 receptor antagonist) during the healing process after myocardial infarction (MI).  Wistar rats were subjected to MI and AMD3100 was injected i.p. after surgery.  SDF-1α mRNA expression was measured by real-time polymerase chain reaction.  Histol. changes were analyzed with immunofluorescence, Masson's trichrome staining, and wheat germ agglutinin.  The no. of leukocytes in peripheral blood was measured by complete blood cell count anal.  The activities of matrix metalloproteinase-2/9 (MMP-2/9) were detd. by gelatin zymog.  The expression level of SDF-1α mRNA in the infarcted tissue was enhanced rapidly (6 h), peaked at 24 h, and then declined to the normal level at 7 days post-MI.  AMD3100 further enhanced the increase of SDF-1α in infarct area.  Increased leukocytes were obsd. in AMD3100-treated groups.  The mobilization of c-kit+ stem/progenitor cells and enhanced neovascularization were augmented by AMD3100.  Addnl., AMD3100 improved ventricular remodeling, which was revealed by the decrease of infarct size, viable cardiomyocyte cross-sectional area and left ventricle (LV) expansion index, and the increase of LV free wall thickness.  The activities of MMP-2/9 were up-regulated by AMD3100.  In conclusion, short-term intermittent administration of AMD3100 could accelerate the wound healing process in exptl. MI and be a potential therapy for the treatment of MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWz-hKs4KALVg90H21EOLACvtfcHk0lgwnk8aIHVw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCqtbzE&md5=979289b153c95436267a39197ebece3d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmt045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmt045%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DShort-term%2520intermittent%2520administration%2520of%2520CXCR4%2520antagonist%2520AMD3100%2520facilitates%2520myocardial%2520repair%2520in%2520experimental%2520myocardial%2520infarction%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2013%26volume%3D45%26spage%3D561%26epage%3D569%26doi%3D10.1093%2Fabbs%2Fgmt045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hsu, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, W. Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span> </span><span class="NLM_article-title">CXCR4 antagonist TG-0054 mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction</span> <span class="citation_source-journal">Cell Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span><span class="refDoi"> DOI: 10.3727/096368914X681739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.3727%2F096368914X681739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=24823505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BC2cjis1Wrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1313-1328&author=W.+T.+Hsuauthor=H.+Y.+Juiauthor=Y.+H.+Huangauthor=M.+Y.+M.+Suauthor=Y.+W.+Wuauthor=W.+Y.+I.+Tsengauthor=M.+C.+Hsuauthor=B.+L.+Chiangauthor=K.+K.+Wuauthor=C.+M.+Lee&title=CXCR4+antagonist+TG-0054+mobilizes+mesenchymal+stem+cells%2C+attenuates+inflammation%2C+and+preserves+cardiac+systolic+function+in+a+porcine+model+of+myocardial+infarction&doi=10.3727%2F096368914X681739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction</span></div><div class="casAuthors">Hsu Wan-Tseng; Jui Hsiang-Yiang; Huang Ying-Huey; Su Mao-Yuan M; Wu Yen-Wen; Tseng Wen-Yih I; Hsu Ming-Chu; Chiang Bor-Luen; Wu Kenneth K; Lee Chii-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1313-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Interaction between chemokine stromal cell-derived factor 1 and the CXC chemokine receptor 4 (CXCR4) governs the sequestration and mobilization of bone marrow stem cells.  We investigated the therapeutic potential of TG-0054, a novel CXCR4 antagonist, in attenuating cardiac dysfunction after myocardial infarction (MI).  In miniature pigs (minipigs), TG-0054 mobilized CD34(+)CXCR4(+), CD133(+)CXCR4(+), and CD271(+)CXCR4(+) cells into peripheral circulation.  After isolation and expansion, TG-0054-mobilized CD271(+) cells were proved to be mesenchymal stem cells (designated CD271-MSCs) since they had trilineage differentiation potential, surface markers of MSCs, and immunosuppressive effects on allogeneic lymphocyte proliferation.  MI was induced in 22 minipigs using balloon occlusion of the left anterior descending coronary artery, followed by intravenous injections of 2.85 mg/kg of TG-0054 or saline at 3 days and 7 days post-MI.  Serial MRI analyses revealed that TG-0054 treatment prevented left ventricular (LV) dysfunction at 12 weeks after MI (change of LV ejection fraction from baseline, -1.0 ± 6.2% in the TG-0054 group versus -7.9 ± 5.8% in the controls).  The preserved cardiac function was accompanied by a significant decrease in the myocardial expression of TNF-α, IL-1β, and IL-6 at 7 days post-MI.  Moreover, the plasma levels of TNF-α, IL-1β, and IL-6 were persistently suppressed by the TG-0054 treatment.  Infusion of TG-0054-mobilized CD271-MSCs reduced both myocardial and plasma cytokine levels in a pattern, which is temporally correlated with TG-0054 treatment.  This study demonstrated that TG-0054 improves the impaired LV contractility following MI, at least in part, by mobilizing MSCs to attenuate the postinfarction inflammation.  This insight may facilitate exploring novel stem cell-based therapy for treating post-MI heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2k2Eehew6CZVVjGoY74BafW6udTcc2ea6amYAxnejrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjis1Wrsg%253D%253D&md5=9ca3bb72605ae483dc4bf532c3c63bda</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3727%2F096368914X681739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368914X681739%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DW.%2BT.%26aulast%3DJui%26aufirst%3DH.%2BY.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DSu%26aufirst%3DM.%2BY.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DTseng%26aufirst%3DW.%2BY.%2BI.%26aulast%3DHsu%26aufirst%3DM.%2BC.%26aulast%3DChiang%26aufirst%3DB.%2BL.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DLee%26aufirst%3DC.%2BM.%26atitle%3DCXCR4%2520antagonist%2520TG-0054%2520mobilizes%2520mesenchymal%2520stem%2520cells%252C%2520attenuates%2520inflammation%252C%2520and%2520preserves%2520cardiac%2520systolic%2520function%2520in%2520a%2520porcine%2520model%2520of%2520myocardial%2520infarction%26jtitle%3DCell%2520Transplant.%26date%3D2015%26volume%3D24%26spage%3D1313%26epage%3D1328%26doi%3D10.3727%2F096368914X681739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Silencing of CXCR4 blocks breast cancer metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=967-971&author=Z.+Liangauthor=Y.+Yoonauthor=J.+Votawauthor=M.+M.+Goodmanauthor=L.+Williamsauthor=H.+Shim&title=Silencing+of+CXCR4+blocks+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DVotaw%26aufirst%3DJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSilencing%2520of%2520CXCR4%2520blocks%2520breast%2520cancer%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyverman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauwers, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span> </span><span class="NLM_article-title">Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axisand myeloid differentiation antigen-positive myeloid cell infiltration in mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span><span class="refDoi"> DOI: 10.1002/hep.26790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fhep.26790" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=1435-1447&author=Y.+Chenauthor=Y.+Huangauthor=T.+Reibergerauthor=A.+M.+Duyvermanauthor=P.+Huangauthor=R.+Samuelauthor=L.+Hiddinghauthor=S.+Robergeauthor=C.+Koppelauthor=G.+Y.+Lauwersauthor=A.+X.+Zhuauthor=R.+K.+Jainauthor=D.+G.+Duda&title=Differential+effects+of+sorafenib+on+liver+versus+tumor+fibrosis+mediated+by+stromal-derived+factor+1+alpha%2FC-X-C+receptor+type+4+axisand+myeloid+differentiation+antigen-positive+myeloid+cell+infiltration+in+mice&doi=10.1002%2Fhep.26790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhep.26790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26790%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DReiberger%26aufirst%3DT.%26aulast%3DDuyverman%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DSamuel%26aufirst%3DR.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DRoberge%26aufirst%3DS.%26aulast%3DKoppel%26aufirst%3DC.%26aulast%3DLauwers%26aufirst%3DG.%2BY.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26atitle%3DDifferential%2520effects%2520of%2520sorafenib%2520on%2520liver%2520versus%2520tumor%2520fibrosis%2520mediated%2520by%2520stromal-derived%2520factor%25201%2520alpha%252FC-X-C%2520receptor%2520type%25204%2520axisand%2520myeloid%2520differentiation%2520antigen-positive%2520myeloid%2520cell%2520infiltration%2520in%2520mice%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D1435%26epage%3D1447%26doi%3D10.1002%2Fhep.26790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Matthys, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4692</span><span class="refDoi"> DOI: 10.4049/jimmunol.167.8.4686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4049%2Fjimmunol.167.8.4686" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2001&pages=4686-4692&author=P.+Matthysauthor=S.+Hatseauthor=K.+Vermeireauthor=A.+Wuytsauthor=G.+Bridgerauthor=G.+W.+Hensonauthor=E.+De+Clercqauthor=A.+Billiauauthor=D.+Schols&title=AMD3100%2C+a+potent+and+specific+antagonist+of+the+stromal+cell-derived+factor-1+chemokine+receptor+CXCR4%2C+inhibits+autoimmune+joint+inflammation+in+IFN-gamma+receptor-deficient+mice&doi=10.4049%2Fjimmunol.167.8.4686"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.167.8.4686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.167.8.4686%26sid%3Dliteratum%253Aachs%26aulast%3DMatthys%26aufirst%3DP.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBilliau%26aufirst%3DA.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DAMD3100%252C%2520a%2520potent%2520and%2520specific%2520antagonist%2520of%2520the%2520stromal%2520cell-derived%2520factor-1%2520chemokine%2520receptor%2520CXCR4%252C%2520inhibits%2520autoimmune%2520joint%2520inflammation%2520in%2520IFN-gamma%2520receptor-deficient%2520mice%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D167%26spage%3D4686%26epage%3D4692%26doi%3D10.4049%2Fjimmunol.167.8.4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Walter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Maten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antunes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieloch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruscher, K.</span><span> </span><span class="NLM_article-title">Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="refDoi"> DOI: 10.1186/s12974-014-0232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1186%2Fs12974-014-0232-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25881123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=24&author=H.+L.+Walterauthor=G.+van+der+Matenauthor=A.+R.+Antunesauthor=T.+Wielochauthor=K.+Ruscher&title=Treatment+with+AMD3100+attenuates+the+microglial+response+and+improves+outcome+after+experimental+stroke&doi=10.1186%2Fs12974-014-0232-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke</span></div><div class="casAuthors">Walter, Helene L.; van der Maten, Gerlinde; Antunes, Ana Rita; Wieloch, Tadeusz; Ruscher, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24/1-24/15</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recovery of lost neurol. function after stroke is limited and dependent on multiple mechanisms including inflammatory processes.  Selective pharmacol. modulation of inflammation might be a promising approach to improve stroke outcome.  Methods: We used 1,1'-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] (AMD3100), an antagonist to the C-X-C chemokine receptor type 4 (CXCR4) and potential allosteric agonist to CXCR7, administered to mice twice daily from day 2 after induction of photothrombosis (PT).  In addn. to functional outcome, the dynamics of post-stroke microglia response were monitored in vivo by 2-photon-laser-microscopy in heterozygous transgenic CX3CR1-green fluorescent protein (GFP) mice (CX3CR1GFP/+) and complemented with analyses for fractalkine (FKN) and pro-inflammatory cytokines.  Results: We found a significantly enhanced recovery and modified microglia activation without affecting infarct size in mice treated with AMD3100 after PT.  AMD3100 treatment significantly reduced the no. of microglia in the peri-infarct area accompanied by stabilization of soma size and ramified cell morphol.  Within the ischemic infarct core of AMD3100 treated wild-type mice we obtained significantly reduced levels of the endogenous CX3CR1 ligand FKN and the pro-inflammatory cytokines interleukin (IL)-1β and IL-6.  Interestingly, in CX3CR1-deficient mice (homozygous transgenic CX3CR1-GFP mice) subjected to PT, the levels of FKN were significantly lower compared to their wild-type littermates.  Moreover, AMD3100 treatment did not induce any relevant changes of cytokine levels in CX3CR1 deficient mice.  Conclusion: After AMD3100 treatment, attenuation of microglia activation contributes to enhanced recovery of lost neurol. function in exptl. stroke possibly due to a depression of FKN levels in the brain.  We further hypothesize that this mechanism is dependent on a functional receptor CX3CR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0GO6F5fRGa7Vg90H21EOLACvtfcHk0liN_Y4pMHWyng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFKgtbk%253D&md5=41bac65af539956f3973140bcf41a5a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12974-014-0232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-014-0232-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DH.%2BL.%26aulast%3Dvan%2Bder%2BMaten%26aufirst%3DG.%26aulast%3DAntunes%26aufirst%3DA.%2BR.%26aulast%3DWieloch%26aufirst%3DT.%26aulast%3DRuscher%26aufirst%3DK.%26atitle%3DTreatment%2520with%2520AMD3100%2520attenuates%2520the%2520microglial%2520response%2520and%2520improves%2520outcome%2520after%2520experimental%2520stroke%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2015%26volume%3D12%26spage%3D24%26doi%3D10.1186%2Fs12974-014-0232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ruscher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issazadeh-Navikas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieloch, T.</span><span> </span><span class="NLM_article-title">Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span><span class="refDoi"> DOI: 10.1038/jcbfm.2013.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fjcbfm.2013.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23632969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1225-1234&author=K.+Ruscherauthor=E.+Kuricauthor=Y.+Liuauthor=H.+L.+Walterauthor=S.+Issazadeh-Navikasauthor=E.+Englundauthor=T.+Wieloch&title=Inhibition+of+CXCL12+signaling+attenuates+the+postischemic+immune+response+and+improves+functional+recovery+after+stroke&doi=10.1038%2Fjcbfm.2013.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke</span></div><div class="casAuthors">Ruscher, Karsten; Kuric, Enida; Liu, Yawei; Walter, Helene L.; Issazadeh-Navikas, Shohreh; Englund, Elisabet; Wieloch, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1225-1234</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After stroke, brain inflammation in the ischemic hemisphere hampers brain tissue reorganization and functional recovery.  Housing rats in an enriched environment (EE) dramatically improves recovery of lost neurol. functions after exptl. stroke.  We show here that rats housed in EE after stroke induced by permanent occlusion of the middle cerebral artery (pMCAO), showed attenuated levels of proinflammatory cytokines in the ischemic core and the surrounding peri-infarct area, including a significant redn. in the stroke-induced chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor-1 (CXCL12).  To mimic beneficial effects of EE, we studied the impact of inhibiting CXCL12 action on functional recovery after transient MCAO (tMCAO).  Rats treated with the specific CXCL12 receptor antagonist 1-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl-1,4,8,11-tetrazacyclo-tetradecan (AMD3100) showed improved recovery compared with saline-treated rats after tMCAO, without a concomitant redn. in infarct size.  This was accompanied by a redn. of infiltrating immune cells in the ischemic hemisphere, particularly cluster of differentiation 3-pos. (CD3+) and CD3+/CD4+ T cells.  Spleen atrophy and delayed death of splenocytes, induced by tMCAO, was prevented by AMD3100 treatment.  We conclude that immoderate excessive activation of the CXCL12 pathway after stroke contributes to depression of neurol. function after stroke and that CXCR4 antagonism is beneficial for the recovery after stroke.  Journal of Cerebral Blood Flow & Metab. (2013) 33, 1225-1234; doi:10.1038/jcbfm.2013.71; published online 1 May 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqRrtyTj6sbVg90H21EOLACvtfcHk0liN_Y4pMHWyng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wks7%252FL&md5=11b70a3f3d63f130d92f8bfc7cfa620f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2013.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2013.71%26sid%3Dliteratum%253Aachs%26aulast%3DRuscher%26aufirst%3DK.%26aulast%3DKuric%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWalter%26aufirst%3DH.%2BL.%26aulast%3DIssazadeh-Navikas%26aufirst%3DS.%26aulast%3DEnglund%26aufirst%3DE.%26aulast%3DWieloch%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520CXCL12%2520signaling%2520attenuates%2520the%2520postischemic%2520immune%2520response%2520and%2520improves%2520functional%2520recovery%2520after%2520stroke%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2013%26volume%3D33%26spage%3D1225%26epage%3D1234%26doi%3D10.1038%2Fjcbfm.2013.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1161/STROKEAHA.112.670299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1161%2FSTROKEAHA.112.670299" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=190-197&author=J.+Huangauthor=Y.+Liauthor=Y.+Tangauthor=G.+Tangauthor=G.+Y.+Yangauthor=Y.+Wang&title=CXCR4+antagonist+AMD3100+protects+blood-brain+barrier+integrity+and+reduces+inflammatory+response+after+focal+ischemia+in+mice&doi=10.1161%2FSTROKEAHA.112.670299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.112.670299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.112.670299%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCXCR4%2520antagonist%2520AMD3100%2520protects%2520blood-brain%2520barrier%2520integrity%2520and%2520reduces%2520inflammatory%2520response%2520after%2520focal%2520ischemia%2520in%2520mice%26jtitle%3DStroke%26date%3D2013%26volume%3D44%26spage%3D190%26epage%3D197%26doi%3D10.1161%2FSTROKEAHA.112.670299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Jujo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tongers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamide, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Losordo, D. W.</span><span> </span><span class="NLM_article-title">CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.112.099242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1161%2FCIRCULATIONAHA.112.099242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23204107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs1yrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=63-73&author=K.+Jujoauthor=M.+Iiauthor=H.+Sekiguchiauthor=E.+Klyachkoauthor=S.+Misenerauthor=T.+Tanakaauthor=J.+Tongersauthor=J.+Roncalliauthor=M.+A.+Renaultauthor=T.+Thorneauthor=A.+Itoauthor=T.+Clarkeauthor=C.+Kamideauthor=Y.+Tsurumiauthor=N.+Hagiwaraauthor=G.+Qinauthor=M.+Asahiauthor=D.+W.+Losordo&title=CXC-chemokine+receptor+4+antagonist+AMD3100+promotes+cardiac+functional+recovery+after+ischemia%2Freperfusion+injury+via+endothelial+nitric+oxide+synthase-dependent+mechanism&doi=10.1161%2FCIRCULATIONAHA.112.099242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CXC-Chemokine Receptor 4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia/Reperfusion Injury via Endothelial Nitric Oxide Synthase-Dependent Mechanism</span></div><div class="casAuthors">Jujo, Kentaro; Ii, Masaaki; Sekiguchi, Haruki; Klyachko, Ekaterina; Misener, Sol; Tanaka, Toshikazu; Tongers, Joern; Roncalli, Jerome; Renault, Marie-Ange; Thorne, Tina; Ito, Aiko; Clarke, Trevor; Kamide, Christine; Tsurumi, Yukio; Hagiwara, Nobuhisa; Qin, Gangjian; Asahi, Michio; Losordo, Douglas W.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: CXC-chemokine receptor 4 (CXCR4) regulates the retention of stem/progenitor cells in the bone marrow (BM), and the CXCR4 antagonist AMD3100 improves recovery from coronary ligation injury by mobilizing stem/progenitor cells from the BM to the peripheral blood.  Thus, we investigated whether AMD3100 also improves recovery from ischemia/reperfusion injury, which more closely mimics myocardial infarction in patients, because blood flow is only temporarily obstructed.  METHODS AND RESULTS-: Mice were treated with single s.c. injections of AMD3100 (5 mg/kg) or saline after ischemia/reperfusion injury.  Three days later, histol. measurements of the ratio of infarct area to area at risk were smaller in AMD3100-treated mice than in mice administered saline, and echocardiog. measurements of left ventricular function were greater in the AMD3100-treated mice at week 4.  CXCR4 cells were mobilized for just 1 day in both groups, but the mobilization of sca1/flk1 cells endured for 7 days in AMD3100-treated mice compared with just 1 day in the saline-treated mice.  AMD3100 upregulated BM levels of endothelial nitric oxide synthase (eNOS) and 2 targets of eNOS signaling, matrix metalloproteinase-9 and sol. Kit ligand.  Furthermore, the loss of BM eNOS expression abolished the benefit of AMD3100 on sca1/flk1 cell mobilization without altering the mobilization of CXCR4 cells, and the cardioprotective effects of AMD3100 were retained in eNOS-knockout mice that had been transplanted with BM from wild-type mice but not in wild-type mice with eNOS-knockout BM.  CONCLUSIONS-: AMD3100 prolongs BM progenitor mobilization and improves recovery from ischemia/reperfusion injury, and these benefits appear to occur through a previously unidentified link between AMD3100 and BM eNOS expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraGLZvBeNX_7Vg90H21EOLACvtfcHk0liZeOagLkc7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs1yrtA%253D%253D&md5=0fde58ae9ce4757f0a01772246b4f1a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.112.099242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.112.099242%26sid%3Dliteratum%253Aachs%26aulast%3DJujo%26aufirst%3DK.%26aulast%3DIi%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DH.%26aulast%3DKlyachko%26aufirst%3DE.%26aulast%3DMisener%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTongers%26aufirst%3DJ.%26aulast%3DRoncalli%26aufirst%3DJ.%26aulast%3DRenault%26aufirst%3DM.%2BA.%26aulast%3DThorne%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DT.%26aulast%3DKamide%26aufirst%3DC.%26aulast%3DTsurumi%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DN.%26aulast%3DQin%26aufirst%3DG.%26aulast%3DAsahi%26aufirst%3DM.%26aulast%3DLosordo%26aufirst%3DD.%2BW.%26atitle%3DCXC-chemokine%2520receptor%25204%2520antagonist%2520AMD3100%2520promotes%2520cardiac%2520functional%2520recovery%2520after%2520ischemia%252Freperfusion%2520injury%2520via%2520endothelial%2520nitric%2520oxide%2520synthase-dependent%2520mechanism%26jtitle%3DCirculation%26date%3D2013%26volume%3D127%26spage%3D63%26epage%3D73%26doi%3D10.1161%2FCIRCULATIONAHA.112.099242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Liles, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broxmeyer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hangoc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, D. C.</span><span> </span><span class="NLM_article-title">Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1182/blood-2003-02-0663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2003-02-0663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=12855591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotF2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=2728-2730&author=W.+C.+Lilesauthor=H.+E.+Broxmeyerauthor=E.+Rodgerauthor=B.+Woodauthor=K.+H%C3%BCbelauthor=S.+Cooperauthor=G.+Hangocauthor=G.+J.+Bridgerauthor=G.+W.+Hensonauthor=G.+Calandraauthor=D.+C.+Dale&title=Mobilization+of+hematopoietic+progenitor+cells+in+healthy+volunteers+by+AMD3100%2C+a+CXCR4+antagonist&doi=10.1182%2Fblood-2003-02-0663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist</span></div><div class="casAuthors">Liles, W. Conrad; Broxmeyer, Hal E.; Rodger, Elin; Wood, Brent; Huebel, Kai; Cooper, Scott; Hangoc, Giao; Bridger, Gary J.; Henson, Geoffrey W.; Calandra, Gary; Dale, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2728-2730</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Stromal cell-derived factor 1 (SDF1/CXCL12) and its cognate receptor, CXCR4, play key regulatory roles in CD34+ cell trafficking.  We investigated whether AMD3100, a selective CXCR4 antagonist, could mobilize hematopoietic progenitor cells from marrow to peripheral blood in healthy human volunteers.  Initially, 10 persons each received a single dose of AMD3100 (80 μg/kg s.c.), which induced rapid, generalized leukocytosis assocd. with an increase in peripheral blood CD34+ cells, representing pluripotent hematopoietic progenitors by in vitro colony-forming unit assays, from 3.8 ± 0.5/μL to 20.7 ± 3.5/μL at 6 h.  Subsequent dose-response studies showed a max. increase in circulating CD34+ cells from 2.6 ± 0.3/μL to 40.4 ± 3.4/μL at 9 h after 240 μg/kg AMD3100.  Serial administration of AMD3100 (80 μg/kg/d for 3 days) resulted in consistent, reversible increases in peripheral blood CD34+ cells.  AMD3100 was well tolerated and caused only mild, transient toxicity.  These findings suggest potential clin. application of AMD3100 for CD34+ cell mobilization and collection for hematopoietic stem cell transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTITlBQQs3EbVg90H21EOLACvtfcHk0liZeOagLkc7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotF2ntb8%253D&md5=c0a000f9ac7f12cf85f4bd086f205240</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-02-0663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-02-0663%26sid%3Dliteratum%253Aachs%26aulast%3DLiles%26aufirst%3DW.%2BC.%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26aulast%3DRodger%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DB.%26aulast%3DH%25C3%25BCbel%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DS.%26aulast%3DHangoc%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DDale%26aufirst%3DD.%2BC.%26atitle%3DMobilization%2520of%2520hematopoietic%2520progenitor%2520cells%2520in%2520healthy%2520volunteers%2520by%2520AMD3100%252C%2520a%2520CXCR4%2520antagonist%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D2728%26epage%3D2730%26doi%3D10.1182%2Fblood-2003-02-0663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolwell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nademanee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span><span class="refDoi"> DOI: 10.1200/JCO.2008.20.7209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1200%2FJCO.2008.20.7209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19720922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4767-4773&author=J.+F.+DiPersioauthor=I.+N.+Micallefauthor=P.+J.+Stiffauthor=B.+J.+Bolwellauthor=R.+T.+Maziarzauthor=E.+Jacobsenauthor=A.+Nademaneeauthor=J.+McCartyauthor=G.+Bridgerauthor=G.+Calandra&title=Phase+III+prospective+randomized+double-blind+placebo-controlled+trial+of+plerixafor+plus+granulocyte+colony-stimulating+factor+compared+with+placebo+plus+granulocyte+colony-stimulating+factor+for+autologous+stem-cell+mobilization+and+transplantation+for+patients+with+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2008.20.7209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">DiPersio, John F.; Micallef, Ivana N.; Stiff, Patrick J.; Bolwell, Brian J.; Maziarz, Richard T.; Jacobsen, Eric; Nademanee, Auayporn; McCarty, John; Bridger, Gary; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4767-4773</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This study evaluates the safety and efficacy of plerixafor (AMD3100), a CXCR4 antagonist, in mobilizing hematopoietic stem cells for autologous stem-cell transplantation in non-Hodgkin's lymphoma (NHL) patients.  Patients and Methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study.  Patients with non-Hodgkin's lymphoma requiring an autologous hematopoietic stem-cell transplantation in first or second complete or partial remission were eligible.  Patients received granulocyte colony-stimulating factor (G-CSF; 10 μg/kg) s.c. daily for up to 8 days.  Beginning on evening of day 4 and continuing daily for up to 4 days, patients received either plerixafor (240 μg/kg) or placebo s.c.  Starting on day 5, patients began daily apheresis for up to 4 days or until ≥ 5 × 106 CD34+ cells/kg were collected.  The primary end point was the percentage of patients who collected ≥ 5 × 106 CD34+ cells/kg in 4 or fewer apheresis days.  Results: This report presents all data for all patients (n = 298) through 12 mo follow-up.  Eighty-nine (59%) of 150 patients in the plerixafor group and 29 (20%) of 148 patients in the placebo group met the primary end point (P < .001).  One hundred thirty-five patients (90%) in plerixafor group and 82 patients (55%) in placebo group underwent transplantation after initial mobilization.  Median time to engraftment was similar in both groups.  The most common plerixafor-assocd. adverse events were GI disorders and injection site reactions.  Conclusion: Plerixafor and G-CSF were well tolerated and resulted in a significantly higher proportion of patients with non-Hodgkin's lymphoma achieving the optimal CD34+ cell target for transplantation in fewer apheresis days, compared with G-CSF alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYjfnL3AIfbbVg90H21EOLACvtfcHk0lg72tP85l3NvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI&md5=b2e30e8f1372875267ca61af49ee96cd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.20.7209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.20.7209%26sid%3Dliteratum%253Aachs%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DMicallef%26aufirst%3DI.%2BN.%26aulast%3DStiff%26aufirst%3DP.%2BJ.%26aulast%3DBolwell%26aufirst%3DB.%2BJ.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DJacobsen%26aufirst%3DE.%26aulast%3DNademanee%26aufirst%3DA.%26aulast%3DMcCarty%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DPhase%2520III%2520prospective%2520randomized%2520double-blind%2520placebo-controlled%2520trial%2520of%2520plerixafor%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520compared%2520with%2520placebo%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520for%2520autologous%2520stem-cell%2520mobilization%2520and%2520transplantation%2520for%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D4767%26epage%3D4773%26doi%3D10.1200%2FJCO.2008.20.7209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stiff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalhaes-Silverman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Territo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Treatment with plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient</span> <span class="citation_source-journal">Biol. Blood Marrow Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1016/j.bbmt.2008.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bbmt.2008.11.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=249-256&author=P.+Stiffauthor=I.+Micallefauthor=P.+McCarthyauthor=M.+Magalhaes-Silvermanauthor=D.+Weisdorfauthor=M.+Territoauthor=K.+Badelauthor=G.+Calandra&title=Treatment+with+plerixafor+in+non-Hodgkin%E2%80%99s+lymphoma+and+multiple+myeloma+patients+to+increase+the+number+of+peripheral+blood+stem+cells+when+given+a+mobilizing+regimen+of+G-CSF%3A+implications+for+the+heavily+pretreated+patient&doi=10.1016%2Fj.bbmt.2008.11.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbmt.2008.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbmt.2008.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DStiff%26aufirst%3DP.%26aulast%3DMicallef%26aufirst%3DI.%26aulast%3DMcCarthy%26aufirst%3DP.%26aulast%3DMagalhaes-Silverman%26aufirst%3DM.%26aulast%3DWeisdorf%26aufirst%3DD.%26aulast%3DTerrito%26aufirst%3DM.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DTreatment%2520with%2520plerixafor%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520multiple%2520myeloma%2520patients%2520to%2520increase%2520the%2520number%2520of%2520peripheral%2520blood%2520stem%2520cells%2520when%2520given%2520a%2520mobilizing%2520regimen%2520of%2520G-CSF%253A%2520implications%2520for%2520the%2520heavily%2520pretreated%2520patient%26jtitle%3DBiol.%2520Blood%2520Marrow%2520Transplant.%26date%3D2009%26volume%3D15%26spage%3D249%26epage%3D256%26doi%3D10.1016%2Fj.bbmt.2008.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">MacKenzie, A. R.; Valsecchi, M. E.; Flomenberg, N.</span><span> </span><span class="NLM_article-title">The Current Role of Plerixafor in Stem Cell Mobilization for Hematopoietic Stem Cell Transplantation</span>. In  <span class="citation_source-book">Novel Developments in Stem Cell Mobilization</span>; <span class="NLM_contrib-group">Fruehauf, S.; Zeller, W. J.; Calandra, G.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1007%2F978-1-4614-1960-0_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=103-131&author=A.+R.+MacKenzie&author=M.+E.+Valsecchi&author=N.+Flomenbergauthor=S.+Fruehauf&author=W.+J.+Zeller&author=G.+Calandra&title=Novel+Developments+in+Stem+Cell+Mobilization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1960-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1960-0_7%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Current%2520Role%2520of%2520Plerixafor%2520in%2520Stem%2520Cell%2520Mobilization%2520for%2520Hematopoietic%2520Stem%2520Cell%2520Transplantation%26btitle%3DNovel%2520Developments%2520in%2520Stem%2520Cell%2520Mobilization%26aulast%3DFruehauf%26aufirst%3DS.%26pub%3DSpringer%26date%3D2012%26spage%3D103%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flomenberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesole, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesveld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPersio, J. F.</span><span> </span><span class="NLM_article-title">Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1102</span><span class="refDoi"> DOI: 10.1200/JCO.2004.07.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1200%2FJCO.2004.07.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15020611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlCku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=1095-1102&author=S.+M.+Devineauthor=N.+Flomenbergauthor=D.+H.+Vesoleauthor=J.+Liesveldauthor=D.+Weisdorfauthor=K.+Badelauthor=G.+Calandraauthor=J.+F.+DiPersio&title=Rapid+mobilization+of+CD34%2B+cells+following+administration+of+the+CXCR4+antagonist+AMD3100+to+patients+with+multiple+myeloma+and+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2004.07.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma</span></div><div class="casAuthors">Devine, Steven M.; Flomenberg, Neal; Vesole, David H.; Liesveld, Jane; Weisdorf, Daniel; Badel, Karin; Calandra, Gary; DiPersio, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1102</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Interactions between the chemokine receptor CXCR4 and its ligand stromal derived factor-1 regulate hematopoietic stem-cell trafficking.  AMD3100 is a CXCR4 antagonist that induces rapid mobilization of CD34+ cells in healthy volunteers.  We performed a phase I study assessing the safety and clin. effects of AMD3100 in patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL).  Thirteen patients (MM, n = 7; NHL, n = 6) received AMD3100 at a dose of either 160 μg/kg (n = 6) or 240 μg/kg (n = 7).  WBC and peripheral blood (PB) CD34+ cell counts were analyzed at 4 and 6 h following injection.  AMD3100 caused a rapid and statistically significant increase in the total WBC and PB CD34+ counts at both 4 and 6 h following a single injection.  The abs. CD34+ cell count increased from a baseline of 2.6 ± 0.7/μL (mean ± SE) to 15.6 ± 3.9/μL and 16.2 ± 4.3/μL at 4 h (P = .002) and 6 h after injection (P = .003), resp.  The abs. CD34+ cell counts obsd. at 4 and 6 h following AMD3100 were higher in the 240 μg/kg group (19.3 ± 6.9/μL and 20.4 ± 7.6/μL, resp.) compared with the 160 μg/kg group (11.3 ± 2.7/μL and 11.3 ± 2.5/μL, resp.).  The drug was well tolerated and only grade 1 toxicities were encountered.  AMD3100 appears to be a safe and effective agent for the rapid mobilization of CD34+ cells in patients who have received prior chemotherapy.  Further studies in combination with granulocyte colony-stimuating factor in patients with lymphoid malignancies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-jRtcaX8crVg90H21EOLACvtfcHk0lg72tP85l3NvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlCku7s%253D&md5=0c452ac05ac8153370ba3c265154e311</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.07.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.07.131%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DFlomenberg%26aufirst%3DN.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26aulast%3DLiesveld%26aufirst%3DJ.%26aulast%3DWeisdorf%26aufirst%3DD.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26atitle%3DRapid%2520mobilization%2520of%2520CD34%252B%2520cells%2520following%2520administration%2520of%2520the%2520CXCR4%2520antagonist%2520AMD3100%2520to%2520patients%2520with%2520multiple%2520myeloma%2520and%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D1095%26epage%3D1102%26doi%3D10.1200%2FJCO.2004.07.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirthlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J. A.</span><span> </span><span class="NLM_article-title">Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor</span> <span class="citation_source-journal">Biol. Blood Marrow Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.bbmt.2006.12.445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bbmt.2006.12.445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=398-411&author=D.+A.+Hessauthor=J.+Bondeauthor=T.+P.+Craftauthor=L.+Wirthlinauthor=S.+Hohmauthor=R.+Laheyauthor=L.+M.+Todtauthor=J.+F.+Dipersioauthor=S.+M.+Devineauthor=J.+A.+Nolta&title=Human+progenitor+cells+rapidly+mobilized+by+AMD3100+repopulate+NOD%2FSCID+mice+with+increased+frequency+in+comparison+to+cells+from+the+same+donor+mobilized+by+granulocyte+colony+stimulating+factor&doi=10.1016%2Fj.bbmt.2006.12.445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbmt.2006.12.445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbmt.2006.12.445%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DD.%2BA.%26aulast%3DBonde%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DT.%2BP.%26aulast%3DWirthlin%26aufirst%3DL.%26aulast%3DHohm%26aufirst%3DS.%26aulast%3DLahey%26aufirst%3DR.%26aulast%3DTodt%26aufirst%3DL.%2BM.%26aulast%3DDipersio%26aufirst%3DJ.%2BF.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DNolta%26aufirst%3DJ.%2BA.%26atitle%3DHuman%2520progenitor%2520cells%2520rapidly%2520mobilized%2520by%2520AMD3100%2520repopulate%2520NOD%252FSCID%2520mice%2520with%2520increased%2520frequency%2520in%2520comparison%2520to%2520cells%2520from%2520the%2520same%2520donor%2520mobilized%2520by%2520granulocyte%2520colony%2520stimulating%2520factor%26jtitle%3DBiol.%2520Blood%2520Marrow%2520Transplant.%26date%3D2007%26volume%3D13%26spage%3D398%26epage%3D411%26doi%3D10.1016%2Fj.bbmt.2006.12.445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Larochelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krouse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hematti, P.</span><span> </span><span class="NLM_article-title">AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3772</span><span class="NLM_x">–</span> <span class="NLM_lpage">3778</span><span class="refDoi"> DOI: 10.1182/blood-2005-09-3592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2005-09-3592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=3772-3778&author=A.+Larochelleauthor=A.+Krouseauthor=M.+Metzgerauthor=D.+Orlicauthor=R.+E.+Donahueauthor=S.+Frickerauthor=G.+Bridgerauthor=C.+E.+Dunbarauthor=P.+Hematti&title=AMD3100+mobilizes+hematopoietic+stem+cells+with+long-term+repopulating+capacity+in+nonhuman+primates&doi=10.1182%2Fblood-2005-09-3592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-09-3592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-09-3592%26sid%3Dliteratum%253Aachs%26aulast%3DLarochelle%26aufirst%3DA.%26aulast%3DKrouse%26aufirst%3DA.%26aulast%3DMetzger%26aufirst%3DM.%26aulast%3DOrlic%26aufirst%3DD.%26aulast%3DDonahue%26aufirst%3DR.%2BE.%26aulast%3DFricker%26aufirst%3DS.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDunbar%26aufirst%3DC.%2BE.%26aulast%3DHematti%26aufirst%3DP.%26atitle%3DAMD3100%2520mobilizes%2520hematopoietic%2520stem%2520cells%2520with%2520long-term%2520repopulating%2520capacity%2520in%2520nonhuman%2520primates%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D3772%26epage%3D3778%26doi%3D10.1182%2Fblood-2005-09-3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlebak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chataway, J.</span><span> </span><span class="NLM_article-title">Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span><span class="refDoi"> DOI: 10.5966/sctm.2013-0178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.5966%2Fsctm.2013-0178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25107583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=1322-1330&author=S.+Banerjeeauthor=P.+Bentleyauthor=M.+Hamadyauthor=S.+Marleyauthor=J.+Davisauthor=A.+Shlebakauthor=J.+Nichollsauthor=D.+A.+Williamsonauthor=S.+L.+Jensenauthor=M.+Gordonauthor=N.+Habibauthor=J.+Chataway&title=Intra-arterial+immunoselected+CD34%2B+stem+cells+for+acute+ischemic+stroke&doi=10.5966%2Fsctm.2013-0178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke</span></div><div class="casAuthors">Banerjee, Soma; Bentley, Paul; Hamady, Mohammad; Marley, Stephen; Davis, John; Shlebak, Abdul; Nicholls, Joanna; Williamson, Deborah A.; Jensen, Steen L.; Gordon, Myrtle; Habib, Nagy; Chataway, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1322-1330</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Treatment with CD34+ hematopoietic stem/progenitor cells has been shown to improve functional recovery in nonhuman models of ischemic stroke via promotion of angiogenesis and neurogenesis.  We aimed to det. the safety and feasibility of treatment with CD34+ cells delivered intra-arterially in patients with acute ischemic stroke.  This was the first study in human subjects.  We performed a prospective, nonrandomized, open-label, phase I study of autologous, immunoselected CD34+ stem/progenitor cell therapy in patients presenting within 7 days of onset with severe anterior circulation ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≥8).  CD34+ cells were collected from the bone marrow of the subjects before being delivered by catheter angiog. into the ipsilesional middle cerebral artery.  Eighty-two patients with severe anterior circulation ischemic stroke were screened, of whom five proceeded to treatment.  The common reasons for exclusion were age >80 years (n = 19); medical instability (n = 17), and significant carotid stenosis (n = 13).  The procedure was well tolerated in all patients, and no significant treatment-related adverse effects occurred.  All patients showed improvements in clin. functional scores (Modified Rankin Score and NIHSS score) and redns. in lesion vol. during a 6-mo follow-up period.  Autologous CD34+ selected stem/progenitor cell therapy delivered intra-arterially into the infarct territory can be achieved safely in patients with acute ischemic stroke.  Future studies that address eligibility criteria, dosage, delivery site, and timing and that use surrogate imaging markers of outcome are desirable before larger scale clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNQ_3BiralLVg90H21EOLACvtfcHk0lhiEW2MBwjyzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFKitg%253D%253D&md5=b7f157cb9fc1314869bf6e185fa0cfab</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2013-0178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2013-0178%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBentley%26aufirst%3DP.%26aulast%3DHamady%26aufirst%3DM.%26aulast%3DMarley%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DShlebak%26aufirst%3DA.%26aulast%3DNicholls%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BA.%26aulast%3DJensen%26aufirst%3DS.%2BL.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DHabib%26aufirst%3DN.%26aulast%3DChataway%26aufirst%3DJ.%26atitle%3DIntra-arterial%2520immunoselected%2520CD34%252B%2520stem%2520cells%2520for%2520acute%2520ischemic%2520stroke%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2014%26volume%3D3%26spage%3D1322%26epage%3D1330%26doi%3D10.5966%2Fsctm.2013-0178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ichiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama-Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano-Kurosaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4190</span><span class="refDoi"> DOI: 10.1073/pnas.0630420100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1073%2Fpnas.0630420100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4185-4190&author=K.+Ichiyamaauthor=S.+Yokoyama-Kumakuraauthor=Y.+Tanakaauthor=R.+Tanakaauthor=K.+Hiroseauthor=K.+Bannaiauthor=T.+Edamatsuauthor=M.+Yanakaauthor=Y.+Niitaniauthor=N.+Miyano-Kurosakiauthor=H.+Takakuauthor=Y.+Koyanagiauthor=N.+Yamamoto&title=A+duodenally+absorbable+CXC+chemokine+receptor+4+antagonist%2C+KRH-1636%2C+exhibits+a+potent+and+selective+anti-HIV-1+activity&doi=10.1073%2Fpnas.0630420100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630420100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630420100%26sid%3Dliteratum%253Aachs%26aulast%3DIchiyama%26aufirst%3DK.%26aulast%3DYokoyama-Kumakura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DBannai%26aufirst%3DK.%26aulast%3DEdamatsu%26aufirst%3DT.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DNiitani%26aufirst%3DY.%26aulast%3DMiyano-Kurosaki%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520duodenally%2520absorbable%2520CXC%2520chemokine%2520receptor%25204%2520antagonist%252C%2520KRH-1636%252C%2520exhibits%2520a%2520potent%2520and%2520selective%2520anti-HIV-1%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4185%26epage%3D4190%26doi%3D10.1073%2Fpnas.0630420100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3280</span><span class="NLM_x">–</span> <span class="NLM_lpage">3289</span><span class="refDoi"> DOI: 10.1021/jm050009h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050009h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3280-3289&author=H.+Tamamuraauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=S.+Oishiauthor=A.+Esakaauthor=J.+O.+Trentauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=S.+C.+Peiperauthor=A.+Otakaauthor=N.+Fujii&title=Identification+of+novel+low+molecular+weight+CXCR4+antagonists+by+structural+tuning+of+cyclic+tetrapeptide+scaffolds&doi=10.1021%2Fjm050009h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm050009h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050009h%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520novel%2520low%2520molecular%2520weight%2520CXCR4%2520antagonists%2520by%2520structural%2520tuning%2520of%2520cyclic%2520tetrapeptide%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3280%26epage%3D3289%26doi%3D10.1021%2Fjm050009h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1021/jm0607350</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607350" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=192-198&author=S.+Uedaauthor=S.+Oishiauthor=Z.+X.+Wangauthor=T.+Arakiauthor=H.+Tamamuraauthor=J.+Cluzeauauthor=H.+Ohnoauthor=S.+Kusanoauthor=H.+Nakashimaauthor=J.+O.+Trentauthor=S.+C.+Peiperauthor=N.+Fujii&title=Structure-activity+relationships+of+cyclic+peptide-based+chemokine+receptor+CXCR4+antagonists%3A+disclosing+the+importance+of+side-chain+and+backbone+functionalities&doi=10.1021%2Fjm0607350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1021%2Fjm0607350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607350%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationships%2520of%2520cyclic%2520peptide-based%2520chemokine%2520receptor%2520CXCR4%2520antagonists%253A%2520disclosing%2520the%2520importance%2520of%2520side-chain%2520and%2520backbone%2520functionalities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D192%26epage%3D198%26doi%3D10.1021%2Fjm0607350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Introduction of functional groups into peptides via N-alkylation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span><span class="refDoi"> DOI: 10.1021/ol800654n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800654n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFyku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2015-2018&author=O.+Demmerauthor=I.+Dijkgraafauthor=M.+Schotteliusauthor=H.+J.+Westerauthor=H.+Kessler&title=Introduction+of+functional+groups+into+peptides+via+N-alkylation&doi=10.1021%2Fol800654n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40dR"><div class="casContent"><span class="casTitleNuber">40d</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of Functional Groups into Peptides via N-Alkylation</span></div><div class="casAuthors">Demmer, O.; Dijkgraaf, I.; Schottelius, M.; Wester, H.-J.; Kessler, H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-2018</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An optimized protocol for the mild and selective Fukuyama-Mitsunobu reaction was used for mono- and di-N-alkylation on solid support.  Thereby, nonfunctionalized aliph. and arom. residues are quickly introduced into transiently protected, primary amines of a linear peptide.  N-Alkylation can also be used to implement alkyl chains carrying (protected) functionalities suited for subsequent modification.  Applicability of this method is demonstrated by various N-alkylated analogs of a cyclic CXCR4 receptor antagonist originally developed by Fujii et al.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGxHNtia_dvbVg90H21EOLACvtfcHk0ljVN9kLt1jKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFyku74%253D&md5=4778b2a183db741daf53aa25e6ab9d7c</span></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=10.1021%2Fol800654n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800654n%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DDijkgraaf%26aufirst%3DI.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DIntroduction%2520of%2520functional%2520groups%2520into%2520peptides%2520via%2520N-alkylation%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2015%26epage%3D2018%26doi%3D10.1021%2Fol800654n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span> </span><span class="NLM_article-title">Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.+G.+Zerwes&title=Orally+bioavailable+isothioureas+block+function+of+the+chemokine+receptor+CXCR4+in+vitro+and+in+vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40e&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26atitle%3DOrally%2520bioavailable%2520isothioureas%2520block%2520function%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossniklaus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8556</span><span class="NLM_x">–</span> <span class="NLM_lpage">8568</span><span class="refDoi"> DOI: 10.1021/jm100786g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100786g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8556-8568&author=A.+Zhuauthor=W.+Zhanauthor=Z.+Liangauthor=Y.+Yoonauthor=H.+Yangauthor=H.+E.+Grossniklausauthor=J.+Xuauthor=M.+Rojasauthor=M.+Lockwoodauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=H.+Shim&title=Dipyrimidine+amines%3A+a+novel+class+of+chemokine+receptor+type+4+antagonists+with+high+specificity&doi=10.1021%2Fjm100786g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40fR"><div class="casContent"><span class="casTitleNuber">40f</span><div class="casTitle"><span class="NLM_cas:atitle">Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity</span></div><div class="casAuthors">Zhu, Aizhi; Zhan, Weiqiang; Liang, Zhongxing; Yoon, Younghyoun; Yang, Hua; Grossniklaus, Hans E.; Xu, Jianguo; Rojas, Mauricio; Lockwood, Mark; Snyder, James P.; Liotta, Dennis C.; Shim, Hyunsuk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8556-8568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The C-X-C chemokine receptor type 4 (CXCR4)/stromal cell derived factor-1 (SDF-1 or CXCL12) interaction and the resulting cell signaling cascade play a key role in metastasis and inflammation.  On the basis of a previously published CXCR4 antagonist (WZ811), a series of novel nonpeptidic anti-CXCR4 small mols. have been designed and synthesized to improve potency.  Following a structure-activity profile, more advanced compds. in the N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine series were discovered and shown to possess higher CXCR4 binding potential and specificity.  I [R = (2-morpholinoethyl)amino] is the lead compd. and exhibits subnanomolar potency in three in vitro assays including competitive binding, Matrigel invasion, and Gαi cyclic adenosine monophosphate (cAMP) modulation signaling.  Furthermore, I [R = (2-morpholinoethyl)amino] displays promising effects by interfering with CXCR4 function in three mouse models: paw inflammation, Matrigel plug angiogenesis, and uveal melanoma micrometastasis.  These data demonstrate that dipyrimidine amines are unique CXCR4 antagonists with high potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNKsIjSnIYrVg90H21EOLACvtfcHk0lgH5gRUZ88Oaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7jL&md5=cfc72c23b3eb5675f9f2c2c1a43e2961</span></div><a href="/servlet/linkout?suffix=cit40f&amp;dbid=16384&amp;doi=10.1021%2Fjm100786g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100786g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGrossniklaus%26aufirst%3DH.%2BE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DRojas%26aufirst%3DM.%26aulast%3DLockwood%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DDipyrimidine%2520amines%253A%2520a%2520novel%2520class%2520of%2520chemokine%2520receptor%2520type%25204%2520antagonists%2520with%2520high%2520specificity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8556%26epage%3D8568%26doi%3D10.1021%2Fjm100786g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3026</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.03.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20443225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3026-3030&author=J.+F.+Millerauthor=K.+S.+Gudmundssonauthor=L.+D.+Richardsonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Synthesis+and+SAR+of+novel+isoquinoline+CXCR4+antagonists+with+potent+anti-HIV+activity&doi=10.1016%2Fj.bmcl.2010.03.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40gR"><div class="casContent"><span class="casTitleNuber">40g</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span></div><div class="casAuthors">Miller, John F.; Gudmundsson, Kristjan S.; Richardson, Leah D'Aurora; Jenkinson, Stephen; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3026-3030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using AMD070, I, as a starting point for structural modification, a novel series of isoquinoline CXCR4 antagonists was developed, e.g., II.  A structure-activity scan of alternate lower heterocycles led to the 3-isoquinolinyl moiety as an attractive replacement for benzimidazole.  Side chain optimization in the isoquinoline series led to a no. of compds. with low nanomolar anti-HIV activities and promising rat PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKb6n6z51MXbVg90H21EOLACvtfcHk0lgH5gRUZ88Oaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D&md5=4b929a2e6843cb3b8ea5fbb9eba4a865</span></div><a href="/servlet/linkout?suffix=cit40g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.118%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DRichardson%26aufirst%3DL.%2BD.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520isoquinoline%2520CXCR4%2520antagonists%2520with%2520potent%2520anti-HIV%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3026%26epage%3D3030%26doi%3D10.1016%2Fj.bmcl.2010.03.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Catalano, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svolto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span> </span><span class="NLM_article-title">Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2186</span><span class="NLM_x">–</span> <span class="NLM_lpage">2190</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20194023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2186-2190&author=J.+G.+Catalanoauthor=K.+S.+Gudmundssonauthor=A.+Svoltoauthor=S.+D.+Boggsauthor=J.+F.+Millerauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelanauthor=D.+J.+Minickauthor=D.+P.+Phelpsauthor=S.+Jenkinson&title=Synthesis+of+a+novel+tricyclic+1%2C2%2C3%2C4%2C4a%2C5%2C6%2C10b-octahydro-1%2C10-phenanthroline+ring+system+and+CXCR4+antagonists+with+potent+activity+against+HIV-1&doi=10.1016%2Fj.bmcl.2010.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40hR"><div class="casContent"><span class="casTitleNuber">40h</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1</span></div><div class="casAuthors">Catalano, John G.; Gudmundsson, Kristjan S.; Svolto, Angilique; Boggs, Sharon D.; Miller, John F.; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat; Minick, Doug J.; Phelps, Dean P.; Jenkinson, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2186-2190</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stereorandom and diastereoselective syntheses of a novel 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system are described.  Derivs. of all four diastereomers were prepd. and isolated in >98% ee.  The pure enantiomers were compared in order to det. the preferred abs. and relative configuration required for optimal anti-HIV activity.  Anti-HIV potency and pharmacokinetic properties of the newly synthesized tricyclic octahydrophenanthroline inhibitors, e.g., I, are presented and comparisons are made to previously reported bicyclic (8S)-N-methyl-5,6,7,8-tetrahydro-8-quinolinamine analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPwCJZdIKPobVg90H21EOLACvtfcHk0lhvBhbyeqIIwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmt74%253D&md5=851402ecf131353d85062e3551a2e82d</span></div><a href="/servlet/linkout?suffix=cit40h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DJ.%2BG.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DSvolto%26aufirst%3DA.%26aulast%3DBoggs%26aufirst%3DS.%2BD.%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DPhelps%26aufirst%3DD.%2BP.%26aulast%3DJenkinson%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520tricyclic%25201%252C2%252C3%252C4%252C4a%252C5%252C6%252C10b-octahydro-1%252C10-phenanthroline%2520ring%2520system%2520and%2520CXCR4%2520antagonists%2520with%2520potent%2520activity%2520against%2520HIV-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2186%26epage%3D2190%26doi%3D10.1016%2Fj.bmcl.2010.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2125</span><span class="NLM_x">–</span> <span class="NLM_lpage">2128</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.02.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2125-2128&author=J.+F.+Millerauthor=E.+M.+Turnerauthor=K.+S.+Gudmundssonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Novel+N-substituted+benzimidazole+CXCR4+antagonists+as+potential+anti-HIV+agents&doi=10.1016%2Fj.bmcl.2010.02.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.053%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DNovel%2520N-substituted%2520benzimidazole%2520CXCR4%2520antagonists%2520as%2520potential%2520anti-HIV%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2125%26epage%3D2128%26doi%3D10.1016%2Fj.bmcl.2010.02.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skupinska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fluri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=262-266&author=R.+Skerljauthor=G.+Bridgerauthor=E.+McEachernauthor=C.+Harwigauthor=C.+Smithauthor=T.+Wilsonauthor=D.+Vealeauthor=H.+Yeeauthor=J.+Crawfordauthor=K.+Skupinskaauthor=R.+Wauthyauthor=W.+Yangauthor=Y.+Zhuauthor=D.+Boguckiauthor=M.+Di+Fluriauthor=J.+Langilleauthor=D.+Huskensauthor=E.+De+Clercqauthor=D.+Schols&title=Synthesis+and+SAR+of+novel+CXCR4+antagonists+that+are+potent+inhibitors+of+T+tropic+%28X4%29+HIV-1+replication&doi=10.1016%2Fj.bmcl.2010.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40j&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DMcEachern%26aufirst%3DE.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DYee%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DJ.%26aulast%3DSkupinska%26aufirst%3DK.%26aulast%3DWauthy%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DDi%2BFluri%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520CXCR4%2520antagonists%2520that%2520are%2520potent%2520inhibitors%2520of%2520T%2520tropic%2520%2528X4%2529%2520HIV-1%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D262%26epage%3D266%26doi%3D10.1016%2Fj.bmcl.2010.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Discovery of novel stem cell mobilizers that target the CXCR4 receptor</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1002/cmdc.201100525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fcmdc.201100525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=209-212&author=C.+H.+Wuauthor=C.+P.+Changauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=S.+H.+Wuauthor=K.+C.+Yehauthor=Y.+C.+Wongauthor=C.+J.+Hsiehauthor=C.+T.+Chenauthor=T.+T.+Kaoauthor=S.+Y.+Wuauthor=C.+F.+Yehauthor=C.+T.+Tsengauthor=Y.+S.+Chaoauthor=K.+S.+Shia&title=Discovery+of+novel+stem+cell+mobilizers+that+target+the+CXCR4+receptor&doi=10.1002%2Fcmdc.201100525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40k&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100525%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DKao%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DYeh%26aufirst%3DC.%2BF.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520novel%2520stem%2520cell%2520mobilizers%2520that%2520target%2520the%2520CXCR4%2520receptor%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D209%26epage%3D212%26doi%3D10.1002%2Fcmdc.201100525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40lR"><div class="casContent"><span class="casTitleNuber">40l</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0liGCg_HJzXwZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit40l&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Mooring, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4</span> <span class="citation_source-journal">Heterocycl. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1515/hc-2014-0041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1515%2Fhc-2014-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25620839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=149-153&author=S.+R.+Mooringauthor=T.+Gainesauthor=Z.+Liangauthor=H.+Shim&title=Synthesis+of+pyridine+derivatives+as+potential+antagonists+of+chemokine+receptor+type+4&doi=10.1515%2Fhc-2014-0041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40mR"><div class="casContent"><span class="casTitleNuber">40m</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4</span></div><div class="casAuthors">Mooring, Suazette Reid; Gaines, Theresa; Liang, Zhongxing; Shim, Hyunsuk</div><div class="citationInfo"><span class="NLM_cas:title">Heterocyclic Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-153</span>CODEN:
                <span class="NLM_cas:coden">HCOMEX</span>;
        ISSN:<span class="NLM_cas:issn">0793-0283</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A series of pyridine derivs. were synthesized as potential inhibitors of chemokine receptor type 4.  This chemokine receptor has been linked to various disease pathways including HIV-1 proliferation, autoimmune disorders, inflammatory diseases, and cancer metastasis.  The compds. were tested for activity using an affinity binding assay and an assay that tests the ability to inhibit cell invasion.  Two hit compds. (2b and 2j) have been identified for further evaluation that inhibit cell invasion by at least 50% and have an effective concn. of less than 100 nm in the binding affinity assay.  The structures of the synthesized compds. were confirmed by spectral data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqguOyRBdcZ8LVg90H21EOLACvtfcHk0liGCg_HJzXwZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCns7Y%253D&md5=e45659a568fb379d8b775a464b57ead1</span></div><a href="/servlet/linkout?suffix=cit40m&amp;dbid=16384&amp;doi=10.1515%2Fhc-2014-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhc-2014-0041%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520pyridine%2520derivatives%2520as%2520potential%2520antagonists%2520of%2520chemokine%2520receptor%2520type%25204%26jtitle%3DHeterocycl.%2520Commun.%26date%3D2014%26volume%3D20%26spage%3D149%26epage%3D153%26doi%3D10.1515%2Fhc-2014-0041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4769</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmc.2014.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4759-4769&author=Z.+G.+Zachariassenauthor=S.+Thieleauthor=E.+A.+Bergauthor=P.+Rasmussenauthor=T.+Fossenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8author=B.+E.+Haug&title=Design%2C+synthesis%2C+and+biological+evaluation+of+scaffold-based+tripeptidomimetic+antagonists+for+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1016%2Fj.bmc.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DE.%2BA.%26aulast%3DRasmussen%26aufirst%3DP.%26aulast%3DFossen%26aufirst%3DT.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520scaffold-based%2520tripeptidomimetic%2520antagonists%2520for%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4759%26epage%3D4769%26doi%3D10.1016%2Fj.bmc.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Nomura, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span> </span><span class="NLM_article-title">Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">–</span> <span class="NLM_lpage">8739</span><span class="refDoi"> DOI: 10.1039/C5OB00891C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1039%2FC5OB00891C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=26186480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=8734-8739&author=W.+Nomuraauthor=T.+Kosekiauthor=N.+Ohashiauthor=T.+Mizuguchiauthor=H.+Tamamura&title=Trivalent+ligands+for+CXCR4+bearing+polyproline+linkers+show+specific+recognition+for+cells+with+increased+CXCR4+expression&doi=10.1039%2FC5OB00891C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40oR"><div class="casContent"><span class="casTitleNuber">40o</span><div class="casTitle"><span class="NLM_cas:atitle">Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression</span></div><div class="casAuthors">Nomura, Wataru; Koseki, Taisuke; Ohashi, Nami; Mizuguchi, Takaaki; Tamamura, Hirokazu</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8734-8739</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The assembly status of G protein-coupled receptors (GPCR) on the cell surface is of interest because the multimerization of GPCR could play pivotal roles in cellular functions.  A bivalent ligand with polyproline linkers for CXCR4 has been shown to serve as a "mol. ruler" as a result of the rigid structure of polyproline helixes.  To expand the utility of the ligands with rigid linkers and explore the possible multimeric forms of GPCR, trivalent ligands with polyproline helixes were newly designed and synthesized.  The binding affinities of the trivalent ligands for CXCR4 suggested that the ligands recognize the dimeric form of CXCR4 on the cell surface.  The fluorescence imaging and anal. by flow cytometry revealed that the ligand with 9 proline linkers binds to CXCR4 with remarkable specificity.  The results of the present study suggest that the ligand design with rigid linkers is useful in the multimeric form, but the design of trivalent ligands requires different strategic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8j0uYj20niLVg90H21EOLACvtfcHk0lhwWSyKOqLtdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgtbnP&md5=2013c734cffb4870b0a0abca749cfa3d</span></div><a href="/servlet/linkout?suffix=cit40o&amp;dbid=16384&amp;doi=10.1039%2FC5OB00891C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00891C%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DW.%26aulast%3DKoseki%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DMizuguchi%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26atitle%3DTrivalent%2520ligands%2520for%2520CXCR4%2520bearing%2520polyproline%2520linkers%2520show%2520specific%2520recognition%2520for%2520cells%2520with%2520increased%2520CXCR4%2520expression%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D8734%26epage%3D8739%26doi%3D10.1039%2FC5OB00891C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Curreli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scacalossi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span> </span><span class="NLM_article-title">Structure-based design of a small molecule CD4-antagonist with broad spectrum anti-HIV-1 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6909</span><span class="NLM_x">–</span> <span class="NLM_lpage">6927</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40p&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6909-6927&author=F.+Curreliauthor=Y.+D.+Kwonauthor=H.+Zhangauthor=D.+Scacalossiauthor=D.+S.+Belovauthor=A.+A.+Tikhonovauthor=I.+A.+Andreevauthor=A.+Altieriauthor=A.+V.+Kurkinauthor=P.+D.+Kwongauthor=A.+K.+Debnath&title=Structure-based+design+of+a+small+molecule+CD4-antagonist+with+broad+spectrum+anti-HIV-1+activity&doi=10.1021%2Facs.jmedchem.5b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40pR"><div class="casContent"><span class="casTitleNuber">40p</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity</span></div><div class="casAuthors">Curreli, Francesca; Kwon, Young Do; Zhang, Hongtao; Scacalossi, Daniel; Belov, Dmitry S.; Tikhonov, Artur A.; Andreev, Ivan A.; Altieri, Andrea; Kurkin, Alexander V.; Kwong, Peter D.; Debnath, Asim K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6909-6927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Earlier the authors reported the discovery and design of NBD-556 and their analogs which demonstrated their potential as HIV-1 entry inhibitors.  However, progress in developing these inhibitors has been stymied by their CD4-agonist properties, an unfavorable trait for use as drug.  Here, the authors demonstrate the successful conversion of a full CD4-agonist (NBD-556) through a partial CD4-agonist (NBD-09027), to a full CD4-antagonist I (NBD-11021) by structure-based modification of the crit. oxalamide mid-region, previously thought to be intolerant of modification.  I showed unprecedented neutralization breath for this class of inhibitors, with pan-neutralization against a panel of 56 Env-pseudotyped HIV-1 representing diverse subtypes of clin. isolates (IC50 as low as 270 nM).  The cocrystal structure of NBD-11021 complexed to a monomeric HIV-1 gp120 core revealed its detail binding characteristics.  The study is expected to provide a framework for further development of NBD series as HIV-1 entry inhibitors for clin. application against AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZjeIlR_smLVg90H21EOLACvtfcHk0lhwWSyKOqLtdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK&md5=db75d8df02d72d932b75596bec6fc1fc</span></div><a href="/servlet/linkout?suffix=cit40p&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00709%26sid%3Dliteratum%253Aachs%26aulast%3DCurreli%26aufirst%3DF.%26aulast%3DKwon%26aufirst%3DY.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DScacalossi%26aufirst%3DD.%26aulast%3DBelov%26aufirst%3DD.%2BS.%26aulast%3DTikhonov%26aufirst%3DA.%2BA.%26aulast%3DAndreev%26aufirst%3DI.%2BA.%26aulast%3DAltieri%26aufirst%3DA.%26aulast%3DKurkin%26aufirst%3DA.%2BV.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520a%2520small%2520molecule%2520CD4-antagonist%2520with%2520broad%2520spectrum%2520anti-HIV-1%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6909%26epage%3D6927%26doi%3D10.1021%2Facs.jmedchem.5b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Zhan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span><span class="refDoi"> DOI: 10.1111/jcmm.12536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1111%2Fjcmm.12536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25753200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOktL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1614-1623&author=Y.+Zhanauthor=H.+Zhangauthor=J.+Liauthor=Y.+Zhangauthor=J.+Zhangauthor=L.+He&title=A+novel+biphenyl+urea+derivate+inhibits+the+invasion+of+breast+cancer+through+the+modulation+of+CXCR4&doi=10.1111%2Fjcmm.12536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40qR"><div class="casContent"><span class="casTitleNuber">40q</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4</span></div><div class="casAuthors">Zhan, Yingzhuan; Zhang, Han; Li, Jing; Zhang, Yanmin; Zhang, Jie; He, Langchong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1614-1623</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The increased migration and invasion of breast carcinoma cells are key events in the development of metastasis to the lymph nodes and distant organs.  CXCR4, the receptor for stromal-derived factor-1, is reportedly involved in breast carcinogenesis and invasion.  In this study, we investigated a novel biphenyl urea derivate, TPD7 for its ability to affect CXCR4 expression as well as function in breast cancer cells.  We demonstrated that TPD7 inhibited the breast cancer proliferation and down-regulated the CXCR4 expression on breast cancer cells both over-expressing and low-expressing HER2, an oncogene known to induce the chemokine receptor.  Treatments with pharmacol. proteasome inhibitors partial suppressed TPD7-induced decrease in CXCR4 expression.  Real-time PCR anal. revealed that down-regulation of CXCR4 by TPD7 also occurred at the translational level.  Inhibition of CXCR4 expression by TPD7 further correlated with the suppression of SDF-1α-induced migration and invasion in breast tumor cells, knockdown of CXCR4 attenuated TPD7-inhibitory effects.  In addn., TPD7 treatment significantly suppressed matrix metalloproteinase (MMP)-2 and MMP-9 expression, the downstream targets of CXCR4, perhaps via inactivation of the ERK signaling pathway.  Overall, our results showed that TPD7 exerted its anti-invasive effect through the down-regulation of CXCR4 expression and thus had the potential for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouO5qfgyfU37Vg90H21EOLACvtfcHk0lig-tKzuX5ZBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOktL3E&md5=95e2f4cb4e6b097d71a534ed1a3b052d</span></div><a href="/servlet/linkout?suffix=cit40q&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12536%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DA%2520novel%2520biphenyl%2520urea%2520derivate%2520inhibits%2520the%2520invasion%2520of%2520breast%2520cancer%2520through%2520the%2520modulation%2520of%2520CXCR4%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2015%26volume%3D19%26spage%3D1614%26epage%3D1623%26doi%3D10.1111%2Fjcmm.12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.4155/fmc.15.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4155%2Ffmc.15.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=26144264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1261-1283&author=J.+V%C3%A5ben%C3%B8author=B.+E.+Haugauthor=M.+M.+Rosenkilde&title=Progress+toward+rationally+designed+small-molecule+peptide+and+peptidomimetic+CXCR4+antagonists&doi=10.4155%2Ffmc.15.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40rR"><div class="casContent"><span class="casTitleNuber">40r</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span></div><div class="casAuthors">Vabeno, Jon; Haug, Bengt Erik; Rosenkilde, Mette M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1283</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Over the last 5 years, X-ray structures of CXCR4 in complex with three different ligands (the small-mol. antagonist IT1t, the polypeptide antagonist CVX15 and the viral chemokine antagonist vMIP-II) have been released.  In addn. to the inherent scientific value of these specific X-ray structures, they provide a reliable structural foundation for studies of the mol. interactions between CXCR4 and its key peptide ligands (CXCL12 and HIV-1 gp120), and serve as valuable templates for further development of small-mol. CXCR4 antagonists with therapeutic potential.  We here review recent computational studies of the mol. interactions between CXCR4 and its peptide ligands - based on the X-ray structures of CXCR4 - and the current status of small-mol. peptide and peptidomimetic CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocFGE-iw60gbVg90H21EOLACvtfcHk0lig-tKzuX5ZBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN&md5=217b88bf8ca537e333adffeaff189576</span></div><a href="/servlet/linkout?suffix=cit40r&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.64%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DProgress%2520toward%2520rationally%2520designed%2520small-molecule%2520peptide%2520and%2520peptidomimetic%2520CXCR4%2520antagonists%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1261%26epage%3D1283%26doi%3D10.4155%2Ffmc.15.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of novel N-aryl piperazine CXCR4 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40s&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4950-4955&author=H.+Zhaoauthor=A.+R.+Prosserauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+novel+N-aryl+piperazine+CXCR4+antagonists&doi=10.1016%2Fj.bmcl.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40s&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520N-aryl%2520piperazine%2520CXCR4%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4950%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Pyrazolo-piperidines exhibit dual inhibition of CCR5/CXCR4 HIV entry and reverse transcriptase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=753-757&author=B.+D.+Coxauthor=A.+R.+Prosserauthor=Y.+Sunauthor=Z.+Liauthor=S.+Leeauthor=M.+B.+Huangauthor=V.+C.+Bondauthor=J.+P.+Snyderauthor=M.+Krystalauthor=L.+J.+Wilsonauthor=D.+C.+Liotta&title=Pyrazolo-piperidines+exhibit+dual+inhibition+of+CCR5%2FCXCR4+HIV+entry+and+reverse+transcriptase&doi=10.1021%2Facsmedchemlett.5b00036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40t&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00036%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%2BB.%26aulast%3DBond%26aufirst%3DV.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DPyrazolo-piperidines%2520exhibit%2520dual%2520inhibition%2520of%2520CCR5%252FCXCR4%2520HIV%2520entry%2520and%2520reverse%2520transcriptase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D753%26epage%3D757%26doi%3D10.1021%2Facsmedchemlett.5b00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platanias, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiltz, G. E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30155</span><span class="refDoi"> DOI: 10.1038/srep30155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fsrep30155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=27456816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1yqsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30155&author=R.+K.+Mishraauthor=A.+K.+Shumauthor=L.+C.+Plataniasauthor=R.+J.+Millerauthor=G.+E.+Schiltz&title=Discovery+and+characterization+of+novel+small-molecule+CXCR4+receptor+agonists+and+antagonists&doi=10.1038%2Fsrep30155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40uR"><div class="casContent"><span class="casTitleNuber">40u</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists</span></div><div class="casAuthors">Mishra, Rama K.; Shum, Andrew K.; Platanias, Leonidas C.; Miller, Richard J.; Schiltz, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30155</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The chemokine CXCL12 (SDF-1) and its cognate receptor CXCR4 are involved in a large no. of physiol. processes including HIV-1 infectivity, inflammation, tumorigenesis, stem cell migration, and autoimmune diseases.  While previous efforts have identified a no. of CXCR4 antagonists, there have been no small mol. agonists reported.  Herein, we describe the identification of a novel series of CXCR4 modulators, including the first small mols. to display agonist behavior against this receptor, using a combination of structure- and ligand-based virtual screening.  These agonists produce robust calcium mobilization in human melanoma cell lines which can be blocked by the CXCR4-selective antagonist AMD3100.  We also demonstrate the ability of these new agonists to induce receptor internalization, ERK activation, and chemotaxis, all hallmarks of CXCR4 activation.  Our results describe a new series of biol. relevant small mols. that will enable further study of the CXCR4 receptor and may contribute to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiMOfle4R1B7Vg90H21EOLACvtfcHk0ljgFk10LPJBMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1yqsr7L&md5=4304791d8f288abea5006a28fd871542</span></div><a href="/servlet/linkout?suffix=cit40u&amp;dbid=16384&amp;doi=10.1038%2Fsrep30155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30155%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DShum%26aufirst%3DA.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26aulast%3DSchiltz%26aufirst%3DG.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520novel%2520small-molecule%2520CXCR4%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D30155%26doi%3D10.1038%2Fsrep30155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Puig de la Bellacasa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planesas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batllori, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span> </span><span class="NLM_article-title">Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1039/C5OB02419F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40v&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1039%2FC5OB02419F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=1455-1472&author=R.+Puig+de+la+Bellacasaauthor=A.+Gibertauthor=J.+M.+Planesasauthor=L.+Ros-Blancoauthor=X.+Batlloriauthor=R.+Bad%C3%ADaauthor=B.+Clotetauthor=J.+Est%C3%A9author=J.+Teixid%C3%B3author=J.+I.+Borrell&title=Nitrogen+positional+scanning+in+tetramines+active+against+HIV-1+as+potential+CXCR4+inhibitors&doi=10.1039%2FC5OB02419F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40v&amp;dbid=16384&amp;doi=10.1039%2FC5OB02419F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB02419F%26sid%3Dliteratum%253Aachs%26aulast%3DPuig%2Bde%2Bla%2BBellacasa%26aufirst%3DR.%26aulast%3DGibert%26aufirst%3DA.%26aulast%3DPlanesas%26aufirst%3DJ.%2BM.%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DBatllori%26aufirst%3DX.%26aulast%3DBad%25C3%25ADa%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26atitle%3DNitrogen%2520positional%2520scanning%2520in%2520tetramines%2520active%2520against%2520HIV-1%2520as%2520potential%2520CXCR4%2520inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D1455%26epage%3D1472%26doi%3D10.1039%2FC5OB02419F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooring, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Symmetrical bis-tertiary amines as novel CXCR4 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40w&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.ejmech.2016.04.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=340-350&author=R.+Baiauthor=Z.+Liangauthor=Y.+Yoonauthor=S.+Liuauthor=T.+Gainesauthor=Y.+Oumauthor=Q.+Shiauthor=S.+R.+Mooringauthor=H.+Shim&title=Symmetrical+bis-tertiary+amines+as+novel+CXCR4+inhibitors&doi=10.1016%2Fj.ejmech.2016.04.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40w&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DOum%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSymmetrical%2520bis-tertiary%2520amines%2520as%2520novel%2520CXCR4%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D340%26epage%3D350%26doi%3D10.1016%2Fj.ejmech.2016.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooring, S. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5052</span><span class="NLM_x">–</span> <span class="NLM_lpage">5060</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40x&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmc.2016.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5052-5060&author=T.+Gainesauthor=D.+Campauthor=R.+Baiauthor=Z.+Liangauthor=Y.+Yoonauthor=H.+Shimauthor=S.+R.+Mooring&title=Synthesis+and+evaluation+of+2%2C5+and+2%2C6+pyridine-based+CXCR4+inhibitors&doi=10.1016%2Fj.bmc.2016.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DCamp%26aufirst%3DD.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DMooring%26aufirst%3DS.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25202%252C5%2520and%25202%252C6%2520pyridine-based%2520CXCR4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5052%26epage%3D5060%26doi%3D10.1016%2Fj.bmc.2016.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+T.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+GPCR+with+small-molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0liEiahhQT6t9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520GPCR%2520with%2520small-molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0liEiahhQT6t9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure-based studies of chemokine receptors</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1016/j.sbi.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.sbi.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23706951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=539-546&author=L.+Zhuauthor=Q.+Zhaoauthor=B.+Wu&title=Structure-based+studies+of+chemokine+receptors&doi=10.1016%2Fj.sbi.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based studies of chemokine receptors</span></div><div class="casAuthors">Zhu, Lan; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-546</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemokine receptors, which belong to the G protein-coupled receptor (GPCR) family of proteins, are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  Recently detd. structures of chemokine receptor CXCR4 reveal unique structural features, and offer templates for homol. modeling of other chemokine receptors, which deepen our understanding in ligand-binding modes and signal transduction mechanisms.  Dimerization, another intriguing issue for GPCR research, is also reviewed based on all published GPCR structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_pW0eZucXLVg90H21EOLACvtfcHk0liRe-LbXcun3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cisbo%253D&md5=bfd2e532ade8e17a68fd7a9a1fe7be2d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure-based%2520studies%2520of%2520chemokine%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26spage%3D539%26epage%3D546%26doi%3D10.1016%2Fj.sbi.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Shia, K. S.; Jan, J. J.; Tsou, L. K.; Chen, C. T.; Chao, Y. S.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds and Use Thereof</span>. U.S. Patent 0,083,369, March 24,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+S.+Shia&author=J.+J.+Jan&author=L.+K.+Tsou&author=C.+T.+Chen&author=Y.+S.+Chao&title=Heterocyclic+Compounds+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DHeterocyclic%2520Compounds%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, K.</span><span> </span><span class="NLM_article-title">CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1182/blood.V97.2.419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood.V97.2.419" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2001&pages=419-425&author=S.+Matsuokaauthor=Y.+Ebiharaauthor=M.+Xuauthor=T.+Ishiiauthor=D.+Sugiyamaauthor=H.+Yoshinoauthor=T.+Uedaauthor=A.+Manabeauthor=R.+Tanakaauthor=Y.+Ikedaauthor=T.+Nakahataauthor=K.+Tsuji&title=CD34+expression+on+long-term+repopulating+hematopoietic+stem+cells+changes+during+developmental+stages&doi=10.1182%2Fblood.V97.2.419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1182%2Fblood.V97.2.419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V97.2.419%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DEbihara%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DSugiyama%26aufirst%3DD.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DManabe%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DK.%26atitle%3DCD34%2520expression%2520on%2520long-term%2520repopulating%2520hematopoietic%2520stem%2520cells%2520changes%2520during%2520developmental%2520stages%26jtitle%3DBlood%26date%3D2001%26volume%3D97%26spage%3D419%26epage%3D425%26doi%3D10.1182%2Fblood.V97.2.419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mende, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waskow, C.</span><span> </span><span class="NLM_article-title">CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5582</span><span class="NLM_x">–</span> <span class="NLM_lpage">5587</span><span class="refDoi"> DOI: 10.1073/pnas.1215438110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1073%2Fpnas.1215438110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5582-5587&author=K.+Arndtauthor=T.+Grinenkoauthor=N.+Mendeauthor=D.+Reichertauthor=M.+Portzauthor=T.+Ripichauthor=P.+Carmelietauthor=D.+Corbeilauthor=C.+Waskow&title=CD133+is+a+modifier+of+hematopoietic+progenitor+frequencies+but+is+dispensable+for+the+maintenance+of+mouse+hematopoietic+stem+cells&doi=10.1073%2Fpnas.1215438110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1215438110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1215438110%26sid%3Dliteratum%253Aachs%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGrinenko%26aufirst%3DT.%26aulast%3DMende%26aufirst%3DN.%26aulast%3DReichert%26aufirst%3DD.%26aulast%3DPortz%26aufirst%3DM.%26aulast%3DRipich%26aufirst%3DT.%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DCorbeil%26aufirst%3DD.%26aulast%3DWaskow%26aufirst%3DC.%26atitle%3DCD133%2520is%2520a%2520modifier%2520of%2520hematopoietic%2520progenitor%2520frequencies%2520but%2520is%2520dispensable%2520for%2520the%2520maintenance%2520of%2520mouse%2520hematopoietic%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5582%26epage%3D5587%26doi%3D10.1073%2Fpnas.1215438110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span> </span><span class="NLM_article-title">Granulocyte colony-stimulating factor reduces hyperoxia-induced alveolarization inhibition by increasing angiogenic factors</span> <span class="citation_source-journal">Neonatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1159/000335285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1159%2F000335285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=278-284&author=H.+J.+Leeauthor=C.+W.+Choiauthor=E.+K.+Kimauthor=H.+S.+Kimauthor=B.+I.+Kimauthor=J.+H.+Choi&title=Granulocyte+colony-stimulating+factor+reduces+hyperoxia-induced+alveolarization+inhibition+by+increasing+angiogenic+factors&doi=10.1159%2F000335285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1159%2F000335285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000335285%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DE.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BI.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26atitle%3DGranulocyte%2520colony-stimulating%2520factor%2520reduces%2520hyperoxia-induced%2520alveolarization%2520inhibition%2520by%2520increasing%2520angiogenic%2520factors%26jtitle%3DNeonatology%26date%3D2012%26volume%3D101%26spage%3D278%26epage%3D284%26doi%3D10.1159%2F000335285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Westvik, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimiento, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancher, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westvik, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishibe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, O. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, A.</span><span> </span><span class="NLM_article-title">Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis</span> <span class="citation_source-journal">J. Vasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1016/j.jvs.2008.08.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.jvs.2008.08.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19028053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ktlygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=464-473&author=T.+S.+Westvikauthor=T.+N.+Fitzgeraldauthor=A.+Mutoauthor=S.+P.+Maloneyauthor=J.+M.+Pimientoauthor=T.+T.+Fancherauthor=D.+Magriauthor=H.+H.+Westvikauthor=T.+Nishibeauthor=O.+C.+Velazquezauthor=A.+Dardik&title=Limb+ischemia+after+iliac+ligation+in+aged+mice+stimulates+angiogenesis+without+arteriogenesis&doi=10.1016%2Fj.jvs.2008.08.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis</span></div><div class="casAuthors">Westvik Tormod S; Fitzgerald Tamara N; Muto Akihito; Maloney Stephen P; Pimiento Jose M; Fancher Tiffany T; Magri Dania; Westvik Hilde H; Nishibe Toshiya; Velazquez Omaida C; Dardik Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">464-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Older patients are thought to tolerate acute ischemia more poorly than younger patients.  Since aging may depress both angiogenesis and arteriogenesis, we determined the effects of age on both angiogenesis and arteriogenesis in a model of severe acute limb ischemia.  METHODS:  Young adult (3-months-old) and aged (18-months-old) C57BL/6 mice underwent right common iliac artery and vein ligation and transection.  Data were collected on days 0, 7, and 14.  Perfusion was measured with a laser Doppler scan and compared to the contralateral limb.  Functional deficits were evaluated with the Tarlov scale.  Capillary density and endothelial progenitor cell (EPC) number were determined by direct counting lectin-positive/alpha-actin-negative cells and VEGFR2/CXCR4 dually-positive cells, respectively; angiography was performed to directly assess arteriogenesis.  RESULTS:  Young adult and aged mice had a similar degree of decreased perfusion after iliac ligation (young, n = 15: 20.4 +/- 1.9%, vs aged, n = 20: 19.6 +/- 1.3%; P = .72, analysis of variance [ANOVA]); however, young mice recovered faster and to a greater degree than aged mice (day 7, 35 +/- 6% vs 17 +/- 4%, P = .046; day 14, 60 +/- 5% vs 27 +/- 7%, P = .0014).  Aged mice had worse functional recovery by day 14 compared to young mice (2.3 +/- 0.3 vs 4.3 +/- 0.4; P = .0021).  Aged mice had increased capillary density (day 7, 12.9 +/- 4.4 vs 2.8 +/- 0.3 capillaries/hpf; P = .02) and increased number of EPC incorporated into the ischemic muscle (day 7, 8.1 +/- 0.9 vs 2.5 +/- 1.9 cells; P = .007) compared to young mice, but diminished numbers of collateral vessels to the ischemic limb (1 vs 9; P = .01), as seen on angiography.  CONCLUSION:  After severe hind limb ischemia, aged animals become ischemic to a similar degree as young animals, but aged animals have significantly impaired arteriogenesis and functional recovery compared to younger animals.  These results suggest that strategies to stimulate arteriogenesis may complement those that increase angiogenesis, and may result in improved relief of ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwnNQH8CZfT5PlX7E30qdzfW6udTcc2eYZ7NGpvHbNw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ktlygsw%253D%253D&md5=e80b356904efe023da0b865a3a76335e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2008.08.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2008.08.077%26sid%3Dliteratum%253Aachs%26aulast%3DWestvik%26aufirst%3DT.%2BS.%26aulast%3DFitzgerald%26aufirst%3DT.%2BN.%26aulast%3DMuto%26aufirst%3DA.%26aulast%3DMaloney%26aufirst%3DS.%2BP.%26aulast%3DPimiento%26aufirst%3DJ.%2BM.%26aulast%3DFancher%26aufirst%3DT.%2BT.%26aulast%3DMagri%26aufirst%3DD.%26aulast%3DWestvik%26aufirst%3DH.%2BH.%26aulast%3DNishibe%26aufirst%3DT.%26aulast%3DVelazquez%26aufirst%3DO.%2BC.%26aulast%3DDardik%26aufirst%3DA.%26atitle%3DLimb%2520ischemia%2520after%2520iliac%2520ligation%2520in%2520aged%2520mice%2520stimulates%2520angiogenesis%2520without%2520arteriogenesis%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2009%26volume%3D49%26spage%3D464%26epage%3D473%26doi%3D10.1016%2Fj.jvs.2008.08.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Broxmeyer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orschell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapp, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hangoc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plett, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liles, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham-Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srour, E. F.</span><span> </span><span class="NLM_article-title">Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1318</span><span class="refDoi"> DOI: 10.1084/jem.20041385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1084%2Fjem.20041385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15837815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Citbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2005&pages=1307-1318&author=H.+E.+Broxmeyerauthor=C.+M.+Orschellauthor=D.+W.+Clappauthor=G.+Hangocauthor=S.+Cooperauthor=P.+A.+Plettauthor=W.+C.+Lilesauthor=X.+Liauthor=B.+Graham-Evansauthor=T.+B.+Campbellauthor=G.+Calandraauthor=G.+Bridgerauthor=D.+C.+Daleauthor=E.+F.+Srour&title=Rapid+mobilization+of+murine+and+human+hematopoietic+stem+and+progenitor+cells+with+AMD3100%2C+a+CXCR4+antagonist&doi=10.1084%2Fjem.20041385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist</span></div><div class="casAuthors">Broxmeyer, Hal E.; Orschell, Christie M.; Clapp, D. Wade; Hangoc, Giao; Cooper, Scott; Plett, P. Artur; Liles, W. Conrad; Li, Xiaxin; Graham-Evans, Barbara; Campbell, Timothy B.; Calandra, Gary; Bridger, Gary; Dale, David C.; Srour, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1307-1318</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Improving approaches for hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) mobilization is clin. important because increased nos. of these cells are needed for enhanced transplantation.  Chemokine stromal cell derived factor-1 (also known as CXCL12) is believed to be involved in retention of HSCs and HPCs in bone marrow.  AMD3100, a selective antagonist of CXCL12 that binds to its receptor, CXCR4, was evaluated in murine and human systems for mobilizing capacity, alone and in combination with granulocyte colony-stimulating factor (G-CSF).  AMD3100 induced rapid mobilization of mouse and human HPCs and synergistically augmented G-CSF-induced mobilization of HPCs.  AMD3100 also mobilized murine long-term repopulating (LTR) cells that engrafted primary and secondary lethally-irradiated mice, and human CD34+ cells that can repopulate nonobese diabetic-severe combined immunodeficiency (SCID) mice.  AMD3100 synergized with G-CSF to mobilize murine LTR cells and human SCID repopulating cells (SRCs).  Human CD34+ cells isolated after treatment with G-CSF plus AMD3100 expressed a phenotype that was characteristic of highly engrafting mouse HSCs.  Synergy of AMD3100 and G-CSF in mobilization was due to enhanced nos. and perhaps other characteristics of the mobilized cells.  These results support the hypothesis that the CXCL12-CXCR4 axis is involved in marrow retention of HSCs and HPCs, and demonstrate the clin. potential of AMD3100 for HSC mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDUgOByTJX07Vg90H21EOLACvtfcHk0lhCDDkiF1aYDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Citbo%253D&md5=e5942dc81a7687a8b7c10f9542cbf29d</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1084%2Fjem.20041385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20041385%26sid%3Dliteratum%253Aachs%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26aulast%3DOrschell%26aufirst%3DC.%2BM.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DHangoc%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DS.%26aulast%3DPlett%26aufirst%3DP.%2BA.%26aulast%3DLiles%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGraham-Evans%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DT.%2BB.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDale%26aufirst%3DD.%2BC.%26aulast%3DSrour%26aufirst%3DE.%2BF.%26atitle%3DRapid%2520mobilization%2520of%2520murine%2520and%2520human%2520hematopoietic%2520stem%2520and%2520progenitor%2520cells%2520with%2520AMD3100%252C%2520a%2520CXCR4%2520antagonist%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D201%26spage%3D1307%26epage%3D1318%26doi%3D10.1084%2Fjem.20041385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, B.</span><span> </span><span class="NLM_article-title">AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1097/FJC.0b013e3180587e4d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2FFJC.0b013e3180587e4d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=61-67&author=Y.+Yinauthor=L.+Huangauthor=X.+Zhaoauthor=Y.+Fangauthor=S.+Yuauthor=J.+Zhaoauthor=B.+Cui&title=AMD3100+mobilizes+endothelial+progenitor+cells+in+mice%2C+but+inhibits+its+biological+functions+by+blocking+an+autocrine%2Fparacrine+regulatory+loop+of+stromal+cell+derived+factor-1+in+vitro&doi=10.1097%2FFJC.0b013e3180587e4d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1097%2FFJC.0b013e3180587e4d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0b013e3180587e4d%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DB.%26atitle%3DAMD3100%2520mobilizes%2520endothelial%2520progenitor%2520cells%2520in%2520mice%252C%2520but%2520inhibits%2520its%2520biological%2520functions%2520by%2520blocking%2520an%2520autocrine%252Fparacrine%2520regulatory%2520loop%2520of%2520stromal%2520cell%2520derived%2520factor-1%2520in%2520vitro%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D61%26epage%3D67%26doi%3D10.1097%2FFJC.0b013e3180587e4d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ward, P. A.</span><span> </span><span class="NLM_article-title">Leukotaxis and leukotactic disorders. A review</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=4611227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaE2MXhtlKqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1974&pages=520-538&author=P.+A.+Ward&title=Leukotaxis+and+leukotactic+disorders.+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotaxis and leukotactic disorders.  Review</span></div><div class="casAuthors">Ward, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">520-38</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">A review with 97 refs. of methodologies of measuring leukotoxis; leukotactic factors for neutrophils, eosinophils, basophils, monocytes, and lymphocytes; interaction of chemotactic factors with leukocytes; and leukotactic defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROznA65Fo1rVg90H21EOLACvtfcHk0lggT7JuksBriQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtlKqtr8%253D&md5=afa57721325c26f422fd597db86ec8e4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BA.%26atitle%3DLeukotaxis%2520and%2520leukotactic%2520disorders.%2520A%2520review%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1974%26volume%3D77%26spage%3D520%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span> </span><span class="NLM_article-title">The pharmacology and toxicology of plerixafor</span> (NDA: 022311, p  <span class="NLM_fpage">43</span>), <a href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_PharmR.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_PharmR.pdf</a> (accessed Dec 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+pharmacology+and+toxicology+of+plerixafor+%28NDA%3A+022311%2C+p+43%29%2C+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2008%2F022311s000_PharmR.pdf+%28accessed+Dec+15%2C+2008%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520pharmacology%2520and%2520toxicology%2520of%2520plerixafor%26spage%3D43%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lggT7JuksBriQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boresch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodoscek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazaridis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovchinnikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: the biomolecular simulation program</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span><span class="refDoi"> DOI: 10.1002/jcc.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fjcc.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19444816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Ciu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1545-1614&author=B.+R.+Brooksauthor=C.+L.+Brooksauthor=A.+D.+Mackerellauthor=L.+Nilssonauthor=R.+J.+Petrellaauthor=B.+Rouxauthor=Y.+Wonauthor=G.+Archontisauthor=C.+Bartelsauthor=S.+Boreschauthor=A.+Caflischauthor=L.+Cavesauthor=Q.+Cuiauthor=A.+R.+Dinnerauthor=M.+Feigauthor=S.+Fischerauthor=J.+Gaoauthor=M.+Hodoscekauthor=W.+Imauthor=K.+Kuczeraauthor=T.+Lazaridisauthor=J.+Maauthor=V.+Ovchinnikovauthor=E.+Paciauthor=R.+W.+Pastorauthor=C.+B.+Postauthor=J.+Z.+Puauthor=M.+Schaeferauthor=B.+Tidorauthor=R.+M.+Venableauthor=H.+L.+Woodcockauthor=X.+Wuauthor=W.+Yangauthor=D.+M.+Yorkauthor=M.+Karplus&title=CHARMM%3A+the+biomolecular+simulation+program&doi=10.1002%2Fjcc.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM: The biomolecular simulation program</span></div><div class="casAuthors">Brooks, B. R.; Brooks, C. L., III; Mackerell, A. D., Jr.; Nilsson, L.; Petrella, R. J.; Roux, B.; Won, Y.; Archontis, G.; Bartels, C.; Boresch, S.; Caflisch, A.; Caves, L.; Cui, Q.; Dinner, A. R.; Feig, M.; Fischer, S.; Gao, J.; Hodoscek, M.; Im, W.; Kuczera, K.; Lazaridis, T.; Ma, J.; Ovchinnikov, V.; Paci, E.; Pastor, R. W.; Post, C. B.; Pu, J. Z.; Schaefer, M.; Tidor, B.; Venable, R. M.; Woodcock, H. L.; Wu, X.; Yang, W.; York, D. M.; Karplus, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1545-1614</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  CHARMM (Chem. at HARvard Mol. Mechanics) is a highly versatile and widely used mol. simulation program.  It has been developed over the last three decades with a primary focus on mols. of biol. interest, including proteins, peptides, lipids, nucleic acids, carbohydrates, and small mol. ligands, as they occur in soln., crystals, and membrane environments.  For the study of such systems, the program provides a large suite of computational tools that include numerous conformational and path sampling methods, free energy estimators, mol. minimization, dynamics, and anal. techniques, and model-building capabilities.  The CHARMM program is applicable to problems involving a much broader class of many-particle systems.  Calcns. with CHARMM can be performed using a no. of different energy functions and models, from mixed quantum mech.-mol. mech. force fields, to all-atom classical potential energy functions with explicit solvent and various boundary conditions, to implicit solvent and membrane models.  The program has been ported to numerous platforms in both serial and parallel architectures.  This article provides an overview of the program as it exists today with an emphasis on developments since the publication of the original CHARMM article in 1983.  © 2009 Wiley Periodicals, Inc. J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOXZCtNIqoCbVg90H21EOLACvtfcHk0lhSUvEL3bP7WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Ciu70%253D&md5=2c6a2be869362d7131f5aea8411c1552</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21287%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPetrella%26aufirst%3DR.%2BJ.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DWon%26aufirst%3DY.%26aulast%3DArchontis%26aufirst%3DG.%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DBoresch%26aufirst%3DS.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DCaves%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DDinner%26aufirst%3DA.%2BR.%26aulast%3DFeig%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHodoscek%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DKuczera%26aufirst%3DK.%26aulast%3DLazaridis%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DOvchinnikov%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DPost%26aufirst%3DC.%2BB.%26aulast%3DPu%26aufirst%3DJ.%2BZ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DVenable%26aufirst%3DR.%2BM.%26aulast%3DWoodcock%26aufirst%3DH.%2BL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYork%26aufirst%3DD.%2BM.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520the%2520biomolecular%2520simulation%2520program%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D1545%26epage%3D1614%26doi%3D10.1002%2Fjcc.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderspoel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandrunen, R.</span><span> </span><span class="NLM_article-title">GROMACS: a message-passing parallel molecular-dynamics implementation</span> <span class="citation_source-journal">Comput. Phys. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/0010-4655(95)00042-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+Vanderspoelauthor=R.+Vandrunen&title=GROMACS%3A+a+message-passing+parallel+molecular-dynamics+implementation&doi=10.1016%2F0010-4655%2895%2900042-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1b7c6974767a78685b78737e7635696e7c357577">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0lhSUvEL3bP7WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DVanderspoel%26aufirst%3DD.%26aulast%3DVandrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520a%2520message-passing%2520parallel%2520molecular-dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56%26doi%3D10.1016%2F0010-4655%2895%2900042-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eZH-5uTw1gAHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Chiu, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, E.</span><span> </span><span class="NLM_article-title">An improved united atom force field for simulation of mixed lipid bilayers</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2748</span><span class="NLM_x">–</span> <span class="NLM_lpage">2763</span><span class="refDoi"> DOI: 10.1021/jp807056c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp807056c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=2748-2763&author=S.+W.+Chiuauthor=S.+A.+Panditauthor=H.+L.+Scottauthor=E.+Jakobsson&title=An+improved+united+atom+force+field+for+simulation+of+mixed+lipid+bilayers&doi=10.1021%2Fjp807056c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved United Atom Force Field for Simulation of Mixed Lipid Bilayers</span></div><div class="casAuthors">Chiu, See-Wing; Pandit, Sagar A.; Scott, H. L.; Jakobsson, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2748-2763</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce a new force field (43A1-S3) for simulation of membranes by the Gromacs simulation package.  Construction of the force fields is by std. methods of electronic structure computations for bond parameters and charge distribution and sp. vol.s and heats of vaporization for small-mol. components of the larger lipid mols. for van der Waals parameters.  Some parameters from the earlier 43A1 force field are found to be correct in the context of these calcns., while others are modified.  The validity of the force fields is demonstrated by correct replication of X-ray form factors and NMR order parameters over a wide range of membrane compns. in semi-isotropic NTP 1 atm simulations.  43-A1-S3 compares favorably with other force fields used in conjunction with the Gromacs simulation package with respect to the breadth of phenomena that it accurately reproduces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPmuQBx7de7Vg90H21EOLACvtfcHk0lj_8h3Xn72XDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltro%253D&md5=c881cacab451368c125262e4b9dd0e01</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjp807056c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp807056c%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.%2BW.%26aulast%3DPandit%26aufirst%3DS.%2BA.%26aulast%3DScott%26aufirst%3DH.%2BL.%26aulast%3DJakobsson%26aufirst%3DE.%26atitle%3DAn%2520improved%2520united%2520atom%2520force%2520field%2520for%2520simulation%2520of%2520mixed%2520lipid%2520bilayers%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2009%26volume%3D113%26spage%3D2748%26epage%3D2763%26doi%3D10.1021%2Fjp807056c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraaije, J. G. E. M.</span><span> </span><span class="NLM_article-title">LINCS: a linear constraint solver for molecular simulations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=1463-1472&author=B.+Hessauthor=H.+Bekkerauthor=H.+J.+C.+Berendsenauthor=J.+G.+E.+M.+Fraaije&title=LINCS%3A+a+linear+constraint+solver+for+molecular+simulations&doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">LINCS: a linear constraint solver for molecular simulations</span></div><div class="casAuthors">Hess, Berk; Bekker, Henk; Berendsen, Herman J. C.; Fraaije, Johannes G. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1463-1472</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">We present a new LINear Constraint Solver (LINCS) for mol. simulations with bond constraints using the enzyme lysozyme and a 32-residue peptide as test systems.  The algorithm is inherently stable, as the constraints themselves are reset instead of derivs. of the constraints, thereby eliminating drift.  Although the derivation of the algorithm is presented in terms of matrixes, no matrix matrix multiplications are needed and only the nonzero matrix elements have to be stored, making the method useful for very large mols.  At the same accuracy, the LINCS algorithm is 3-4 times faster than the SHAKE algorithm.  Parallelization of the algorithm is straightforward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6h4pdV0Nx7Vg90H21EOLACvtfcHk0liKdLxrF-4i6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D&md5=890f8af0d2ca1f65aa93db5a3a0bacf2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199709%252918%253A12%253C1463%253A%253AAID-JCC4%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DBekker%26aufirst%3DH.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DFraaije%26aufirst%3DJ.%2BG.%2BE.%2BM.%26atitle%3DLINCS%253A%2520a%2520linear%2520constraint%2520solver%2520for%2520molecular%2520simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D1463%26epage%3D1472%26doi%3D10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b','cit40c','cit40d','cit40e','cit40f','cit40g','cit40h','cit40i','cit40j','cit40k','cit40l','cit40m','cit40n','cit40o','cit40p','cit40q','cit40r','cit40s','cit40t','cit40u','cit40v','cit40w','cit40x'],'ref41':['cit41a','cit41b'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengxin  Luo</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Guixian  Wu</span>, <span class="hlFld-ContribAuthor ">Xiangtao  Huang</span>, <span class="hlFld-ContribAuthor ">Yali  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanni  Ma</span>, <span class="hlFld-ContribAuthor ">Mingling  Xie</span>, <span class="hlFld-ContribAuthor ">Yanni  Sun</span>, <span class="hlFld-ContribAuthor ">Yarui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Qiuyue  Song</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Hou</span>, <span class="hlFld-ContribAuthor ">Xi  Li</span>, <span class="hlFld-ContribAuthor ">Shuangnian  Xu</span>, <span class="hlFld-ContribAuthor ">Jieping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies. </span><span class="cited-content_cbyCitation_journal-name">Stem Cell Research & Therapy</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13287-021-02379-6" title="DOI URL">https://doi.org/10.1186/s13287-021-02379-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13287-021-02379-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13287-021-02379-6%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cell%2520Research%2520%2526%2520Therapy%26atitle%3DComparison%252Bof%252Bthe%252Befficacy%252Bof%252Bhematopoietic%252Bstem%252Bcell%252Bmobilization%252Bregimens%25253A%252Ba%252Bsystematic%252Breview%252Band%252Bnetwork%252Bmeta-analysis%252Bof%252Bpreclinical%252Bstudies%26aulast%3DLuo%26aufirst%3DChengxin%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Chih-Chun  Chang</span>, <span class="hlFld-ContribAuthor ">Chien-Huang  Wu</span>, <span class="hlFld-ContribAuthor ">Trinh Kieu  Dinh</span>, <span class="hlFld-ContribAuthor ">Jiing-Jyh  Jan</span>, <span class="hlFld-ContribAuthor ">Kuan-Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Ming-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Ting-Yun  Shiue</span>, <span class="hlFld-ContribAuthor ">Kai-Chia  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Yen-Nhi Ngoc  Ta</span>, <span class="hlFld-ContribAuthor ">Chia-Jui  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Kai  Huang</span>, <span class="hlFld-ContribAuthor ">Yun-Chieh  Sung</span>, <span class="hlFld-ContribAuthor ">Kak-Shan  Shia</span>, <span class="hlFld-ContribAuthor ">Yunching  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (13)
                                     , e2015433118. <a href="https://doi.org/10.1073/pnas.2015433118" title="DOI URL">https://doi.org/10.1073/pnas.2015433118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2015433118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2015433118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DA%252Bhighly%252Bselective%252Band%252Bpotent%252BCXCR4%252Bantagonist%252Bfor%252Bhepatocellular%252Bcarcinoma%252Btreatment%26aulast%3DSong%26aufirst%3DJen-Shin%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D13%26spage%3De2015433118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10165-4" title="DOI URL">https://doi.org/10.1007/s11030-020-10165-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10165-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DClassification%252Bmodels%252Band%252BSAR%252Banalysis%252Bon%252BCysLT1%252Breceptor%252Bantagonists%252Busing%252Bmachine%252Blearning%252Balgorithms%26aulast%3DWang%26aufirst%3DHongzhao%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Na  Shen</span>, <span class="hlFld-ContribAuthor ">Wantong  Song</span>, <span class="hlFld-ContribAuthor ">Haiyang  Yu</span>, <span class="hlFld-ContribAuthor ">Kazuo  Sakurai</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Tang</span>, <span class="hlFld-ContribAuthor ">Gao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2019,</strong> <em>7 </em>
                                    (12)
                                     , 5283-5291. <a href="https://doi.org/10.1039/C9BM01418G" title="DOI URL">https://doi.org/10.1039/C9BM01418G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9BM01418G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9BM01418G%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DCombretastatin%252BA4%252Bnanodrug%252Bcombined%252Bplerixafor%252Bfor%252Binhibiting%252Btumor%252Bgrowth%252Band%252Bmetastasis%252Bsimultaneously%26aulast%3DJiang%26aufirst%3DJian%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D12%26spage%3D5283%26epage%3D5291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Chemistry and Chemotherapy</span><span> <strong>2019,</strong> <em>27 </em>, 204020661982938. <a href="https://doi.org/10.1177/2040206619829382" title="DOI URL">https://doi.org/10.1177/2040206619829382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040206619829382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040206619829382%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Chemistry%2520and%2520Chemotherapy%26atitle%3DMozobil%2525C2%2525AE%252B%252528Plerixafor%25252C%252BAMD3100%252529%25252C%252B10%252Byears%252Bafter%252Bits%252Bapproval%252Bby%252Bthe%252BUS%252BFood%252Band%252BDrug%252BAdministration%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2019%26date%3D2019%26volume%3D27%26spage%3D204020661982938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Small-Molecule CXCR4 Antagonists with Anti-HIV-1 Activity</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Representative Compound <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-amino-1-benzyl-piperidine, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C to rt, 16 h, 62%; (b) linker <b>1</b>, 1-pentanol, 140 °C, 5 h, 63%; (c) Pd/C (10%), 2-propanol, 60 °C, 16 h, 92%; (d) 1 N HCl in diethyl ether, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 95%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of <i>N</i>-Boc-Protected Linker <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzyl chloroformate, K<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O = 1/2, 5 °C to rt, 15 h, 95%; (b) 3-azido-propanol, CuSO<sub>4</sub>, (+) sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, K<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O = 4/1, rt, 15 h, 83%; (c) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C to rt, 15 h, 90%; (d) propane-1,3-diamine, THF, 65 °C, 15 h; (e) cyclohexanone, MeOH, 60 °C, 6 h then NaBH<sub>4</sub>, 5 °C, 1 h; (f) Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 15 h, 43% over three steps; (g) H<sub>2</sub>, Pd/C, 2-propanol, 60 °C, 15 h, 93%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Representative Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-((<i>tert</i>-butoxycarbonyl)(2-ethoxy-2-oxoethyl)amino)propionic acid, EDCI, HOBt, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 71%; (b) LiOH, THF/H<sub>2</sub>O, rt, 16 h, 99%; (c) 1 N HCl in diethyl ether, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 95%.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CXCL12-induced chemotaxis assay was conducted for compound <b>16</b>. Data were collected from three independent experiments and represent the mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CXCR4<sup>+</sup> cells were analyzed by flow cytometry. The blood samples containing mobilized CXCR4<sup>+</sup> stem cells were collected from C57BL/6 mice and measured by flow cytometry at a time point of 2 h after SC injection with indicated concentrations of compound <b>16</b>. Data represent the mean ± SEM (<i>n</i> = 3 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05 and **<i>p</i> < 0.01 between control and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Double staining analysis by flow cytometry. (A) CXCR4<sup>+</sup>CD34<sup>+</sup> cells, (B) CXCR4<sup>+</sup>CD133<sup>+</sup> cells, (C) CXCR4<sup>+</sup>VEGFR2<sup>+</sup> cells, and (D) VEGFR2<sup>+</sup>Sca-1<sup>+</sup> cells. The blood samples were collected from C57BL/6 mice and measured by flow cytometry at a time point of 2 h after SC injection of compound <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg) at the maximal response dose. Data represent the mean ± SEM (<i>n</i> = 3 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 between control and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> efficacy comparison in colony-forming assay. C57BL/6 male mice were treated with G-CSF (100 μg/kg) daily for 4 consecutive days by SC injection. On day 5, G-CSF (100 μg/kg) in combination with <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg) was given, respectively. The heparinized blood samples containing mobilized stem cells were collected 2 h after SC administration, and then peripheral blood mononuclear cells (PBMCs) were isolated and cultured for CFU-GM colony-forming assay. Data represent the mean ± SEM with 8–12 mice per group. Statistical analysis was performed by <i>t</i> test: ***<i>p</i> < 0.001 between control (G-CSF alone) and the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>In vivo</i> efficacy comparison in WBC mobilization. The blood samples containing mobilized white blood cells were collected from C57BL/6 mice and analyzed for (A) total white blood cells, (B) neutrophils, (C) lymphocytes, and (D) monocytes at a time point of 2 h after SC injection with compound <b>1</b> (6 mg/kg) or <b>16</b> (35 mg/kg). Data represent the mean ± SEM (<i>n</i> = 5 per group). Statistical analysis was performed by <i>t</i> test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 between the indicated test group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking compound <b>16</b> (orange) to the CXCR4 crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS">4RWS</a>) after 20 ns of MD simulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/medium/jm-2017-01322d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>16</b> (orange) is assumed to occupy both major and minor subpockets displayed with a pink (CVX15) and green (IT1t) surface field.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01322/20180201/images/large/jm-2017-01322d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01322&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lipfert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odemis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boltze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engele, J.</span><span> </span><span class="NLM_article-title">CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia</span> <span class="citation_source-journal">Neuropathol. Appl. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1111/nan.12015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1111%2Fnan.12015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23289420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaqs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=667-680&author=J.+Lipfertauthor=V.+Odemisauthor=D.+C.+Wagnerauthor=J.+Boltzeauthor=J.+Engele&title=CXCR4+and+CXCR7+form+a+functional+receptor+unit+for+SDF-1%2FCXCL12+in+primary+rodent+microglia&doi=10.1111%2Fnan.12015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia</span></div><div class="casAuthors">Lipfert, J.; Oedemis, V.; Wagner, D.-C.; Boltze, J.; Engele, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-680</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Microglial cells have been originally identified as a target for the CXC chemokine, SDF-1, by their expression of CXCR4.  More recently, it has been recognized that SDF-1 addnl. binds to CXCR7, which depending on the cell type acts as either a nonclassical, a classical or a scavenger chemokine receptor.  Here, we asked whether primary microglial cells addnl. express CXCR7 and if so how this chemokine receptor functions in this cell type.  Methods : CXCR4 and CXCR7 expression was analyzed in cultured rat microglia and in the brain of animals with permanent occlusion of the middle cerebral artery (MCAO) by either Western blotting, RT-PCR, flow cytometry and/or immunocytochem.  The function of CXCR4 and CXCR7 was assessed in the presence of selective antagonists.  Results : Cultured primary rat microglia expressed CXCR4 and CXCR7 to similar levels.  Treatment with SDF-1 resulted in the activation of Erk1/2 and Akt signalling.  Erk1/2 and Akt signalling were required for subsequent SDF-1-dependent promotion of microglial proliferation.  In contrast, Erk1/2 signalling was sufficient for SDF-1-induced migration of microglial cells.  Both SDF-1-dependent signalling and the resulting effects on microglial proliferation and migration were abrogated following pharmacol. inactivation of either CXCR4 or CXCR7.  Moreover, treatment of cultured microglia with lipopolysaccharide resulted in the coordinated up-regulation of CXCR4 and CXCR7 expression.  Likewise, reactive microglia accumulating in the area adjacent to the lesion core in MCAO rats expressed both CXCR4 and CXCR7.  Conclusions : CXCR4 and CXCR7 form a functional receptor unit in microglial cells, which is up-regulated during activation of microglia both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqh2TASsK3rVg90H21EOLACvtfcHk0libA9zp_aIm_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaqs7jL&md5=677a8a35771e279d15fc5a3d9a5aa75d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fnan.12015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnan.12015%26sid%3Dliteratum%253Aachs%26aulast%3DLipfert%26aufirst%3DJ.%26aulast%3DOdemis%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DD.%2BC.%26aulast%3DBoltze%26aufirst%3DJ.%26aulast%3DEngele%26aufirst%3DJ.%26atitle%3DCXCR4%2520and%2520CXCR7%2520form%2520a%2520functional%2520receptor%2520unit%2520for%2520SDF-1%252FCXCL12%2520in%2520primary%2520rodent%2520microglia%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2013%26volume%3D39%26spage%3D667%26epage%3D680%26doi%3D10.1111%2Fnan.12015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Robin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katakowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopp, M.</span><span> </span><span class="NLM_article-title">Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1038/sj.jcbfm.9600172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fsj.jcbfm.9600172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15959456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFamtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=125-134&author=A.+M.+Robinauthor=Z.+G.+Zhangauthor=L.+Wangauthor=R.+L.+Zhangauthor=M.+Katakowskiauthor=L.+Zhangauthor=Y.+Wangauthor=C.+Zhangauthor=M.+Chopp&title=Stromal+cell-derived+factor+1alpha+mediates+neural+progenitor+cell+motility+after+focal+cerebral+ischemia&doi=10.1038%2Fsj.jcbfm.9600172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal cell-derived factor 1α mediates neural progenitor cell motility after focal cerebral ischemia</span></div><div class="casAuthors">Robin, Adam M.; Zhang, Zheng G.; Wang, Lei; Zhang, Rui L.; Katakowski, Mark; Zhang, Li; Wang, Ying; Zhang, Chunling; Chopp, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the adult rodent, stroke induces an increase in endogenous neural progenitor cell (NPC) proliferation in the subventricular zone (SVZ) and neuroblasts migrate towards the ischemic boundary.  We investigated the role of stromal cell-derived factor 1α (SDF-1α) in mediating NPC migration after stroke.  We found that cultured NPCs harvested from the normal adult SVZ, when they were overlaid onto stroke brain slices, exhibited significantly (P<0.01) increased migration (67.2±25.2 μm) compared with the migration on normal brain slices (29.5±29.5 μm).  Immunohistochem. showed that CXCR 4, a receptor of SDF-1α, is expressed in the NPCs and migrating neuroblasts in stroke brain.  Blocking SDF-1α by a neutralizing antibody against CXCR 4 significantly attenuated stroke-enhanced NPC migration.  ELISA anal. revealed that SDF-1α levels significantly increased (P<0.01) in the stroke hemisphere (43.6±6.5 pg/mg) when compared with the normal brain (25.2±1.9 pg/mg).  Blind-well chamber assays showed that SDF-1α enhanced NPC migration in a dose-dependent manner with max. migration at a dose of 500 ng/mL.  In addn., SDF-1α induced directionally selective migration.  These findings show that SDF-1α generated in the stroke hemisphere may guide NPC migration towards the ischemic boundary via binding to its receptor CXCR 4 in the NPC.  Thus, our data indicate that SDF-1α/CXCR 4 is important for mediating specific migration of NPCs to the site of ischemic damaged neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgFmbYnyho7Vg90H21EOLACvtfcHk0libA9zp_aIm_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFamtw%253D%253D&md5=c4ed98368f7c9c4ceaf0aaaa8bb08917</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600172%26sid%3Dliteratum%253Aachs%26aulast%3DRobin%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%2BG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%2BL.%26aulast%3DKatakowski%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DStromal%2520cell-derived%2520factor%25201alpha%2520mediates%2520neural%2520progenitor%2520cell%2520motility%2520after%2520focal%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2006%26volume%3D26%26spage%3D125%26epage%3D134%26doi%3D10.1038%2Fsj.jcbfm.9600172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Stumm, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culmsee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieglstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, S.</span><span> </span><span class="NLM_article-title">A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=12122049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFOjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=5865-5878&author=R.+K.+Stummauthor=J.+Rummelauthor=V.+Junkerauthor=C.+Culmseeauthor=M.+Pfeifferauthor=J.+Krieglsteinauthor=V.+Holltauthor=S.+Schulz&title=A+dual+role+for+the+SDF-1%2FCXCR4+chemokine+receptor+system+in+adult+brain%3A+isoform-selective+regulation+of+SDF-1+expression+modulates+CXCR4-dependent+neuronal+plasticity+and+cerebral+leukocyte+recruitment+after+focal+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia</span></div><div class="casAuthors">Stumm, Ralf K.; Rummel, Jutta; Junker, Vera; Culmsee, Carsten; Pfeiffer, Manuela; Krieglstein, Josef; Hollt, Volker; Schulz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5865-5878</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The chemoattractant stromal cell-derived factor-1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4) are key modulators of immune function.  In the developing brain, SDF-1 is crucial for neuronal guidance; however, cerebral functions of SDF-1/CXCR4 in adulthood are unclear.  Here, the authors examine the cellular expression of SDF-1 isoforms and CXCR4 in the brain of mice receiving systemic lipopolysaccharide (LPS) or permanent focal cerebral ischemia.  CXCR4 mRNA was constitutively expressed in cortical and hippocampal neurons and ependymal cells.  Hippocampal neurons targeted the CXCR4 receptor to their somatodendritic and axonal compartments.  In cortex and hippocampus, CXCR4-expressing neurons exhibited an overlapping distribution with neurons expressing SDF-1 transcripts.  Although neurons synthesized SDF-1α mRNA, the SDF-1β isoform was selectively expressed by endothelial cells of cerebral microvessels.  LPS stimulation dramatically decreased endothelial SDF-1β mRNA expression throughout the forebrain but did not affect neuronal SDF-1α.  After focal cerebral ischemia, SDF-1β expression was selectively increased in endothelial cells of penumbral blood vessels and decreased in endothelial cells of nonlesioned brain areas.  In the penumbra, SDF-1β upregulation was assocd. with a concomitant infiltration of CXCR4-expressing peripheral blood cells, including macrophages.  Neuronal SDF-1α was transiently downregulated and neuronal CXCR4 was transiently upregulated in the nonlesioned cerebral cortex in response to ischemia.  Although endothelial SDF-1β may control cerebral infiltration of CXCR4-carrying leukocytes during cerebral ischemia, the neuronal SDF-1α/CXCR4 system may contribute to ischemia-induced neuronal plasticity.  Thus, the isoform-specific regulation of SDF-1 expression modulates neurotransmission and cerebral infiltration via distinct CXCR4-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqWhaJ6yOafbVg90H21EOLACvtfcHk0libA9zp_aIm_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFOjsL8%253D&md5=9a4f7ca7c1e693fb2147f9ab28d24d25</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStumm%26aufirst%3DR.%2BK.%26aulast%3DRummel%26aufirst%3DJ.%26aulast%3DJunker%26aufirst%3DV.%26aulast%3DCulmsee%26aufirst%3DC.%26aulast%3DPfeiffer%26aufirst%3DM.%26aulast%3DKrieglstein%26aufirst%3DJ.%26aulast%3DHollt%26aufirst%3DV.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DA%2520dual%2520role%2520for%2520the%2520SDF-1%252FCXCR4%2520chemokine%2520receptor%2520system%2520in%2520adult%2520brain%253A%2520isoform-selective%2520regulation%2520of%2520SDF-1%2520expression%2520modulates%2520CXCR4-dependent%2520neuronal%2520plasticity%2520and%2520cerebral%2520leukocyte%2520recruitment%2520after%2520focal%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D5865%26epage%3D5878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tran, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banisadr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">500</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1002/cne.21229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fcne.21229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=17183554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFantb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=500&publication_year=2007&pages=1007-1033&author=P.+B.+Tranauthor=G.+Banisadrauthor=D.+Renauthor=A.+Chennauthor=R.+J.+Miller&title=Chemokine+receptor+expression+by+neural+progenitor+cells+in+neurogenic+regions+of+mouse+brain&doi=10.1002%2Fcne.21229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain</span></div><div class="casAuthors">Tran, Phuong B.; Banisadr, Ghazal; Ren, Dongjun; Chenn, Anjen; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">500</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1007-1033</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We previously demonstrated that chemokine receptors are expressed by neural progenitors grown as cultured neurospheres.  To examine the significance of these findings for neural progenitor function in vivo, we investigated whether chemokine receptors were expressed by cells having the characteristics of neural progenitors in neurogenic regions of the postnatal brain.  Using in situ hybridization we demonstrated the expression of CCR1, CCR2, CCR5, CXCR3, and CXCR4 chemokine receptors by cells in the dentate gyrus (DG), subventricular zone of the lateral ventricle, and olfactory bulb.  The pattern of expression for all of these receptors was similar, including regions where neural progenitors normally reside.  In addn., we attempted to colocalize chemokine receptors with markers for neural progenitors.  In order to do this we used nestin-EGFP and TLX-LacZ transgenic mice, as well as labeling for Ki67, a marker for dividing cells.  In all three areas of the brain we demonstrated colocalization of chemokine receptors with these three markers in populations of cells.  Expression of chemokine receptors by neural progenitors was further confirmed using CXCR4-EGFP BAC transgenic mice.  Expression of CXCR4 in the DG included cells that expressed nestin and GFAP as well as cells that appeared to be immature granule neurons expressing PSA-NCAM, calretinin, and Prox-1.  CXCR4-expressing cells in the DG were found in close proximity to immature granule neurons that expressed the chemokine SDF-1/CXCL12.  Cells expressing CXCR4 frequently coexpressed CCR2 receptors.  These data support the hypothesis that chemokine receptors are important in regulating the migration of progenitor cells in postnatal brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTgw6WBPqdH7Vg90H21EOLACvtfcHk0ljhxNwKxUyfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFantb8%253D&md5=44539569ced589214fb1f615ff613c5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fcne.21229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.21229%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BB.%26aulast%3DBanisadr%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DChenn%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DChemokine%2520receptor%2520expression%2520by%2520neural%2520progenitor%2520cells%2520in%2520neurogenic%2520regions%2520of%2520mouse%2520brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2007%26volume%3D500%26spage%3D1007%26epage%3D1033%26doi%3D10.1002%2Fcne.21229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2007.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.pneurobio.2007.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18177992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=116-131&author=M.+Liauthor=R.+M.+Ransohoff&title=Multiple+roles+of+chemokine+CXCL12+in+the+central+nervous+system%3A+a+migration+from+immunology+to+neurobiology&doi=10.1016%2Fj.pneurobio.2007.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology</span></div><div class="casAuthors">Li, Meizhang; Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-131</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chemotactic cytokines (chemokines) have been traditionally defined as small (10-14 kDa) secreted leukocyte chemoattractants.  However, chemokines and their cognate receptors are constitutively expressed in the central nervous system (CNS) where immune activities are under stringent control.  Why and how the CNS uses the chemokine system to carry out its complex physiol. functions has intrigued neurobiologists.  Here, we focus on chemokine CXCL12 and its receptor CXCR4 that have been widely characterized in peripheral tissues and delineate their main functions in the CNS.  Extensive evidence supports CXCL12 as a key regulator for early development of the CNS.  CXCR4 signaling is required for the migration of neuronal precursors, axon guidance/pathfinding and maintenance of neural progenitor cells (NPCs).  In the mature CNS, CXCL12 modulates neurotransmission, neurotoxicity and neuroglial interactions.  Thus, chemokines represent an inherent system that helps establish and maintain CNS homeostasis.  In addn., growing evidence implicates altered expression of CXCL12 and CXCR4 in the pathogenesis of CNS disorders such as HIV-assocd. encephalopathy, brain tumor, stroke and multiple sclerosis (MS), making them the plausible targets for future pharmacol. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMPBWjvsSTWrVg90H21EOLACvtfcHk0ljhxNwKxUyfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKgt7k%253D&md5=fbbfe9903660e4faf741d522fff638a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DMultiple%2520roles%2520of%2520chemokine%2520CXCL12%2520in%2520the%2520central%2520nervous%2520system%253A%2520a%2520migration%2520from%2520immunology%2520to%2520neurobiology%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D116%26epage%3D131%26doi%3D10.1016%2Fj.pneurobio.2007.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollet, O.</span><span> </span><span class="NLM_article-title">How do stem cells find their way home?</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span><span class="refDoi"> DOI: 10.1182/blood-2005-04-1417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2005-04-1417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15890683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWksLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1901-1910&author=T.+Lapidotauthor=A.+Darauthor=O.+Kollet&title=How+do+stem+cells+find+their+way+home%3F&doi=10.1182%2Fblood-2005-04-1417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">How do stem cells find their way home?</span></div><div class="casAuthors">Lapidot, Tsvee; Dar, Ayelet; Kollet, Orit</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1901-1910</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  The migration of hematopoietic stem cells through the blood, across the endothelial vasculature to different organs and to their bone marrow (BM) niches, requires active navigation, a process termed homing.  Homing is a rapid process and is the 1st and essential step in clin. stem cell transplantation.  Similarly, homing is required for seeding of the fetal BM by hematopoietic progenitors during development.  Homing has physiol. roles in adult BM homeostasis, which are amplified during stress-induced recruitment of leukocytes from the BM reservoir and during stem cell mobilization, as part of host defense and repair.  Homing is thought to be a coordinated, multistep process, which involves signaling by stromal-derived factor 1 (SDF-1) and stem cell factor (SCF), activation of lymphocyte function-assocd. antigen 1 (LFA-1), very late antigen 4/5 (VLA-4/5) and CD44, cytoskeleton rearrangement, membrane type 1 (MT1)-matrix metalloproteinase (MMP) activation, and secretion of MMP2/9.  Rolling and firm adhesion of progenitors to endothelial cells in small marrow sinusoids under blood flow is followed by trans-endothelial migration across the phys. endothelium/extracellular matrix (ECM) barrier.  The stem cells finalize their homing uniquely, by selective access and anchorage to their specialized niches in the extravascular space of the endosteum region and in periarterial sites.  Here, the authors focus on mechanisms and key regulators of human stem cell homing to the BM in exptl. animal models and clin. transplantation protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFxIQwuU-IrVg90H21EOLACvtfcHk0ljhxNwKxUyfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWksLzJ&md5=a7b6f8ed7a24d58a1c459348892c256e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-04-1417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-04-1417%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DDar%26aufirst%3DA.%26aulast%3DKollet%26aufirst%3DO.%26atitle%3DHow%2520do%2520stem%2520cells%2520find%2520their%2520way%2520home%253F%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1901%26epage%3D1910%26doi%3D10.1182%2Fblood-2005-04-1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pitchford, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, S. M.</span><span> </span><span class="NLM_article-title">Differential mobilization of subsets of progenitor cells from the bone marrow</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.stem.2008.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.stem.2008.10.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=62-72&author=S.+C.+Pitchfordauthor=R.+C.+Furzeauthor=C.+P.+Jonesauthor=A.+M.+Wengnerauthor=S.+M.+Rankin&title=Differential+mobilization+of+subsets+of+progenitor+cells+from+the+bone+marrow&doi=10.1016%2Fj.stem.2008.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2008.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2008.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DPitchford%26aufirst%3DS.%2BC.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DJones%26aufirst%3DC.%2BP.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DRankin%26aufirst%3DS.%2BM.%26atitle%3DDifferential%2520mobilization%2520of%2520subsets%2520of%2520progenitor%2520cells%2520from%2520the%2520bone%2520marrow%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2009%26volume%3D4%26spage%3D62%26epage%3D72%26doi%3D10.1016%2Fj.stem.2008.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span> </span><span class="NLM_article-title">SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion</span> <span class="citation_source-journal">Protein Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1007/s13238-011-1097-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1007%2Fs13238-011-1097-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=22058039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=845-854&author=X.+Liuauthor=B.+Duanauthor=Z.+Chengauthor=X.+Jiaauthor=L.+Maoauthor=H.+Fuauthor=Y.+Cheauthor=L.+Ouauthor=L.+Liuauthor=D.+Kong&title=SDF-1%2FCXCR4+axis+modulates+bone+marrow+mesenchymal+stem+cell+apoptosis%2C+migration+and+cytokine+secretion&doi=10.1007%2Fs13238-011-1097-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion</span></div><div class="casAuthors">Liu, Xiaolei; Duan, Biyan; Cheng, Zhaokang; Jia, Xiaohua; Mao, Lina; Fu, Hao; Che, Yongzhe; Ou, Lailiang; Liu, Lin; Kong, Deling</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-854</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">Bone marrow mesenchymal stem cells (MSCs) are considered as a promising cell source to treat the acute myocardial infarction.  However, over 90% of the stem cells usually die in the first three days of transplantation.  Survival potential, migration ability and paracrine capacity have been considered as the most important three factors for cell transplantation in the ischemic cardiac treatment.  We hypothesized that stromal-derived factor-1 (SDF-1)/CXCR4 axis plays a crit. role in the regulation of these processes.  In this study, apoptosis was induced by exposure of MSCs to H2O2 for 2 h.  After re-oxygenation, the SDF-1 pretreated MSCs demonstrated a significant increase in survival and proliferation.  SDF-1 pretreatment also enhanced the migration and increased the secretion of pro-survival and angiogenic cytokines including basic fibroblast growth factor and vascular endothelial growth factor.  Western blot and RT-PCR demonstrated that SDF-1 pretreatment significantly activated the pro-survival Akt and Erk signaling pathways and up-regulated Bcl-2/Bax ratio.  These protective effects were partially inhibited by AMD3100, an antagonist of CXCR4.We conclude that the SDF-1/CXCR4 axis is crit. for MSC survival, migration and cytokine secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRx2hHwUPKjLVg90H21EOLACvtfcHk0ljLNWIYXDM9LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgt7jI&md5=a250f614022586b2e3b0046cb49adc27</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13238-011-1097-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-011-1097-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDuan%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DD.%26atitle%3DSDF-1%252FCXCR4%2520axis%2520modulates%2520bone%2520marrow%2520mesenchymal%2520stem%2520cell%2520apoptosis%252C%2520migration%2520and%2520cytokine%2520secretion%26jtitle%3DProtein%2520Cell%26date%3D2011%26volume%3D2%26spage%3D845%26epage%3D854%26doi%3D10.1007%2Fs13238-011-1097-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">For recent reviews, see:</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Harnessing CXCR4 Antagonists in Stem Cell Mobilization, HIV Infection, Ischemic Diseases and Oncology</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1002/med.21464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fmed.21464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=28768055" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+K.+Tsouauthor=Y.+H.+Huangauthor=J.+S.+Songauthor=Y.+Y.+Keauthor=J.+K.+Huangauthor=K.+S.+Shia&title=Harnessing+CXCR4+Antagonists+in+Stem+Cell+Mobilization%2C+HIV+Infection%2C+Ischemic+Diseases+and+Oncology&doi=10.1002%2Fmed.21464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2Fmed.21464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21464%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DHarnessing%2520CXCR4%2520Antagonists%2520in%2520Stem%2520Cell%2520Mobilization%252C%2520HIV%2520Infection%252C%2520Ischemic%2520Diseases%2520and%2520Oncology%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2017%26doi%3D10.1002%2Fmed.21464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1021/jm200568c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200568c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=977-994&author=W.+T.+Choiauthor=S.+Duggineniauthor=Y.+Xuauthor=Z.+Huangauthor=J.+An&title=Drug+discovery+research+targeting+the+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm200568c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)</span></div><div class="casAuthors">Choi, Won-Tak; Duggineni, Srinivas; Xu, Yan; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">977-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The CXC chemokine receptor 4 (CXCR4) is an attractive target for therapeutic intervention because of its involvement in the pathogenesis of a wide range of infectious, inflammatory, and other diseases.  There has been intensive biol., chem., and pharmaceutical research to understand the mol. mechanisms of chemokine-receptor interactions and the modulation of chemokine-receptor functions.  The ultimate goal is to translate these discoveries into novel treatment strategies for clin. applications.  This review describes and discusses some of the recent advances in medicinal chem. and drug discovery that involve CXCR4, which is implicated in human immunodeficiency virus (HIV)-1 infection, normal hematopoietic and neural stem cell migration, cancer-stromal cell interaction, solid tumors, and inflammation and autoimmune diseases such as rheumatoid arthritis and allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvqHX-IPaxrVg90H21EOLACvtfcHk0ljLNWIYXDM9LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF&md5=c996a29f564ca4197139f4802dcbe061</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm200568c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200568c%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520research%2520targeting%2520the%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D977%26epage%3D994%26doi%3D10.1021%2Fjm200568c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Fiorina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godwin, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayegh, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdi, R.</span><span> </span><span class="NLM_article-title">Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.4049/jimmunol.1000799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4049%2Fjimmunol.1000799" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=121-131&author=P.+Fiorinaauthor=M.+Jurewiczauthor=A.+Verganiauthor=A.+Petrelliauthor=M.+Carvelloauthor=F.+D%E2%80%99Addioauthor=J.+G.+Godwinauthor=K.+Lawauthor=E.+Wuauthor=Z.+Tianauthor=G.+Thomaauthor=J.+Kovarikauthor=S.+La+Rosaauthor=C.+Capellaauthor=S.+Rodigauthor=H.+G.+Zerwesauthor=M.+H.+Sayeghauthor=R.+Abdi&title=Targeting+the+CXCR4-CXCL12+axis+mobilizes+autologous+hematopoietic+stem+cells+and+prolongs+islet+allograft+survival+via+programmed+death+ligand+1&doi=10.4049%2Fjimmunol.1000799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000799%26sid%3Dliteratum%253Aachs%26aulast%3DFiorina%26aufirst%3DP.%26aulast%3DJurewicz%26aufirst%3DM.%26aulast%3DVergani%26aufirst%3DA.%26aulast%3DPetrelli%26aufirst%3DA.%26aulast%3DCarvello%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Addio%26aufirst%3DF.%26aulast%3DGodwin%26aufirst%3DJ.%2BG.%26aulast%3DLaw%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DCapella%26aufirst%3DC.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26aulast%3DSayegh%26aufirst%3DM.%2BH.%26aulast%3DAbdi%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520CXCR4-CXCL12%2520axis%2520mobilizes%2520autologous%2520hematopoietic%2520stem%2520cells%2520and%2520prolongs%2520islet%2520allograft%2520survival%2520via%2520programmed%2520death%2520ligand%25201%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D121%26epage%3D131%26doi%3D10.4049%2Fjimmunol.1000799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ben Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorina, P.</span><span> </span><span class="NLM_article-title">CXCR4 antagonism overcomes diabetic stem cell mobilopathy</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2016.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.atherosclerosis.2016.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2016&pages=512-513&author=M.+Ben+Nasrauthor=P.+Fiorina&title=CXCR4+antagonism+overcomes+diabetic+stem+cell+mobilopathy&doi=10.1016%2Fj.atherosclerosis.2016.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2016.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2016.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DBen%2BNasr%26aufirst%3DM.%26aulast%3DFiorina%26aufirst%3DP.%26atitle%3DCXCR4%2520antagonism%2520overcomes%2520diabetic%2520stem%2520cell%2520mobilopathy%26jtitle%3DAtherosclerosis%26date%3D2016%26volume%3D251%26spage%3D512%26epage%3D513%26doi%3D10.1016%2Fj.atherosclerosis.2016.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gulick, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalezari, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clumeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfeiler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felstead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, H.</span><span> </span><span class="NLM_article-title">Maraviroc for previously treated patients with R5 HIV-1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1056/NEJMoa0803152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1056%2FNEJMoa0803152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18832244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=1429-1441&author=R.+M.+Gulickauthor=J.+Lalezariauthor=J.+Goodrichauthor=N.+Clumeckauthor=E.+DeJesusauthor=A.+Horbanauthor=J.+Nadlerauthor=B.+Clotetauthor=A.+Karlssonauthor=M.+Wohlfeilerauthor=J.+B.+Montanaauthor=M.+McHaleauthor=J.+Sullivanauthor=C.+Ridgwayauthor=S.+Felsteadauthor=M.+W.+Dunneauthor=E.+van+der+Rystauthor=H.+Mayer&title=Maraviroc+for+previously+treated+patients+with+R5+HIV-1+infection&doi=10.1056%2FNEJMoa0803152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc for previously treated patients with R5 HIV-1 infection</span></div><div class="casAuthors">Gulick, Roy M.; Lalezari, Jacob; Goodrich, James; Clumeck, Nathan; DeJesus, Edwin; Horban, Andrzej; Nadler, Jeffrey; Clotet, Bonaventura; Karlsson, Anders; Wohlfeiler, Michael; Montana, John B.; McHale, Mary; Sullivan, John; Ridgway, Caroline; Felstead, Steve; Dunne, Michael W.; van der Ryst, Elna; Mayer, Howard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1429-1441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">CC chemokine receptor 5 antagonists are a new class of antiretroviral agents.  We conducted two double-blind, placebo-controlled, phase 3 studies - Maraviroc vs. Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 - with patients who had R5 human immunodeficiency virus type 1 (HIV-1) only.  They had been treated with or had resistance to three antiretroviral-drug classes and had HIV-1 RNA levels of more than 5000 copies per mL.  The patients were randomly assigned to one of three antiretroviral regimens consisting of maraviroc once daily, maraviroc twice daily, or placebo, each of which included optimized background therapy (OBT) based on treatment history and drug-resistance testing.  Safety and efficacy were assessed after 48 wk.  A total of 1049 patients received the randomly assigned study drug; the mean baseline HIV-1 RNA level was 72,400 copies per mL, and the median CD4 cell count was 169 per cubic millimeter.  At 48 wk, in both studies, the mean change in HIV-1 RNA from baseline was greater with maraviroc than with placebo: - 1.66 and - 1.82 log10 copies per mL with the once-daily and twice-daily regimens, resp., vs. -0.80 with placebo in MOTIVATE 1, and - 1.72 and - 1.87 log, copies per mL, resp., vs. - 0.76 with placebo in MOTIVATE 2.  More patients receiving maraviroc once or twice daily had HIV-1 RNA levels of less than 50 copies per mL (42% and 47%, resp., vs. 16% in the placebo group in MOTIVATE 1; 45% in both maraviroc groups vs. 18% in MOTIVATE 2; P < 0.001 for both comparisons in each study).  The change from baseline in CD4 counts was also greater with maraviroc once or twice daily than with placebo (increases of 113 and 122 per cubic millimeter, resp., vs. 54 in MOTIVATE 1; increases of 122 and 128 per cubic millimeter, resp., vs. 69 in MOTIVATE 2; P < 0.001 for both comparisons in each study).  Frequencies of adverse events were similar among the groups.  Maraviroc, as compared with placebo, resulted in significantly greater suppression of HIV-1 and greater increases in CD4 cell counts at 48 wk in previously treated patients with R5 HIV-1 who were receiving OBT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKE-CWXtz37Vg90H21EOLACvtfcHk0licQ6QhSEaTFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOktLbM&md5=ffac432390f2fedd9d3c6ba1d925e40e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0803152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0803152%26sid%3Dliteratum%253Aachs%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DLalezari%26aufirst%3DJ.%26aulast%3DGoodrich%26aufirst%3DJ.%26aulast%3DClumeck%26aufirst%3DN.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DHorban%26aufirst%3DA.%26aulast%3DNadler%26aufirst%3DJ.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DWohlfeiler%26aufirst%3DM.%26aulast%3DMontana%26aufirst%3DJ.%2BB.%26aulast%3DMcHale%26aufirst%3DM.%26aulast%3DSullivan%26aufirst%3DJ.%26aulast%3DRidgway%26aufirst%3DC.%26aulast%3DFelstead%26aufirst%3DS.%26aulast%3DDunne%26aufirst%3DM.%2BW.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26aulast%3DMayer%26aufirst%3DH.%26atitle%3DMaraviroc%2520for%2520previously%2520treated%2520patients%2520with%2520R5%2520HIV-1%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D1429%26epage%3D1441%26doi%3D10.1056%2FNEJMoa0803152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozniak, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ryst, E.</span><span> </span><span class="NLM_article-title">Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4920</span><span class="refDoi"> DOI: 10.1128/JVI.80.10.4909-4920.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1128%2FJVI.80.10.4909-4920.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=16641282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=4909-4920&author=M.+Westbyauthor=M.+Lewisauthor=J.+Whitcombauthor=M.+Youleauthor=A.+L.+Pozniakauthor=I.+T.+Jamesauthor=T.+M.+Jenkinsauthor=M.+Perrosauthor=E.+van+der+Ryst&title=Emergence+of+CXCR4-using+human+immunodeficiency+virus+type+1+%28HIV-1%29+variants+in+a+minority+of+HIV-1-infected+patients+following+treatment+with+the+CCR5+antagonist+maraviroc+is+from+a+pretreatment+CXCR4-using+virus+reservoir&doi=10.1128%2FJVI.80.10.4909-4920.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir</span></div><div class="casAuthors">Westby, Mike; Lewis, Marilyn; Whitcomb, Jeannette; Youle, Mike; Pozniak, Anton L.; James, Ian T.; Jenkins, Tim M.; Perros, Manos; van der Ryst, Elna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4909-4920</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antagonists of the human immunodeficiency virus type 1 (HIV-1) coreceptor, CCR5, are being developed as the first anti-HIV agents acting on a host cell target.  We monitored the coreceptor tropism of circulating virus, screened at baseline for coreceptor tropism, in 64 HIV-1-infected patients who received maraviroc (MVC, UK-427,857) as monotherapy for 10 days.  Sixty-two patients harbored CCR5-tropic virus at baseline and had a posttreatment phenotype result.  Circulating virus remained CCR5 tropic in 60/62 patients, 51 of whom experienced an HIV RNA redn. from baseline of > 1 log10 copies/mL, indicating that CXCR4-using variants were not rapidly selected despite CCR5-specific drug pressure.  In two patients, viral load declined during treatment and CXCR4-using virus was detected at day 11.  No pretreatment factor predicted the emergence of CXCR4-tropic virus during maraviroc therapy in these two patients.  Phylogenetic anal. of envelope (Env) clones from pre- and posttreatment time points indicated that the CXCR4-using variants probably emerged by outgrowth of a pretreatment CXCR4-using reservoir, rather than via coreceptor switch of a CCR5-tropic clone under selection pressure from maraviroc.  Phylogenetic anal. was also performed on Env clones from a third patient harboring CXCR4-using virus prior to treatment.  This patient was enrolled due to a sample labeling error.  Although this patient experienced no overall redn. in viral load in response to treatment, the CCR5-tropic components of the circulating virus did appear to be suppressed while receiving maraviroc as monotherapy.  Importantly, in all three patients, circulating virus reverted to predominantly CCR5 tropic following cessation of maraviroc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCJASNGx6_gbVg90H21EOLACvtfcHk0ljkwqoEZDyt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslChtLc%253D&md5=43a23a5e8481d63ee4742c561843d4d2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.80.10.4909-4920.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.80.10.4909-4920.2006%26sid%3Dliteratum%253Aachs%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DWhitcomb%26aufirst%3DJ.%26aulast%3DYoule%26aufirst%3DM.%26aulast%3DPozniak%26aufirst%3DA.%2BL.%26aulast%3DJames%26aufirst%3DI.%2BT.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BRyst%26aufirst%3DE.%26atitle%3DEmergence%2520of%2520CXCR4-using%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520variants%2520in%2520a%2520minority%2520of%2520HIV-1-infected%2520patients%2520following%2520treatment%2520with%2520the%2520CCR5%2520antagonist%2520maraviroc%2520is%2520from%2520a%2520pretreatment%2520CXCR4-using%2520virus%2520reservoir%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D4909%26epage%3D4920%26doi%3D10.1128%2FJVI.80.10.4909-4920.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hendrix, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glesby, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flexner, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1097/01.qai.0000137371.80695.ef</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2F01.qai.0000137371.80695.ef" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15385732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslels7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1253-1262&author=C.+W.+Hendrixauthor=A.+C.+Collierauthor=M.+M.+Ledermanauthor=D.+Scholsauthor=R.+B.+Pollardauthor=S.+Brownauthor=J.+B.+Jacksonauthor=R.+W.+Coombsauthor=M.+J.+Glesbyauthor=C.+W.+Flexnerauthor=G.+J.+Bridgerauthor=K.+Badelauthor=R.+T.+MacFarlandauthor=G.+W.+Hensonauthor=G.+Calandra&title=Safety%2C+pharmacokinetics%2C+and+antiviral+activity+of+AMD3100%2C+a+selective+CXCR4+receptor+inhibitor%2C+in+HIV-1+infection&doi=10.1097%2F01.qai.0000137371.80695.ef"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection</span></div><div class="casAuthors">Hendrix, Craig W.; Collier, Ann C.; Lederman, Michael M.; Schols, Dominique; Pollard, Richard B.; Brown, Stephen; Brooks Jackson, J.; Coombs, Robert W.; Glesby, Marshall J.; Flexner, Charles W.; Bridger, Gary J.; Badel, Karin; MacFarland, Ronald T.; Henson, Geoffrey W.; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1253-1262</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">AMD3100 is a CXCR4 receptor inhibitor with anti-HIV-1 activity in vitro.  We tested the safety, pharmacokinetics, and antiviral effect of AMD3100 administered for 10 days by continuous i.v. infusion in an open-label dose escalation study from 2.5 to 160 μg/kg/h.  Forty HIV-infected patients with an HIV RNA level >5000 copies/mL on stable antiretroviral (ARV) regimens or off therapy were enrolled.  Syncytium-inducing (SI) phenotype in an MT-2 cell assay was required in higher dose cohorts.  Most subjects were black (55%), male (98%), and off ARV therapy.  HIV phenotype was SI (30%), non-SI (45%), or not tested (25%).  One patient (5 μg/kg/h) had serious and possibly drug-related thrombocytopenia.  Two patients (40 and 160 μg/kg/h) had unexpected, although not serious, premature ventricular contractions.  Most patients in the 80- and 160-μg/kg/h cohorts had paresthesias.  Steady-state blood concn. and area under the concn.-time curve were dose proportional across all dose levels; the median terminal elimination half-life was 8.6 h (range: 8.1-11.1 h).  Leukocytosis was obsd. in all patients, with an estd. max. effect of 3.4 times baseline (95% confidence interval: 2.9-3.9).  Only 1 patient, the patient whose virus was confirmed to use purely CXCR4 and who also received the highest dose (160 μg/kg/h), had a significant 0.9-log10 copies/mL HIV RNA drop at day 11.  Overall, however, the av. change in viral load across all patients was +0.03 log10 HIV RNA.  Given these results, AMD3100 is not being further developed for ARV therapy, but development continues for stem cell mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_cEHxd_seH7Vg90H21EOLACvtfcHk0ljkwqoEZDyt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslels7k%253D&md5=1685124ead6f082a144b60641bf5c604</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F01.qai.0000137371.80695.ef&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.qai.0000137371.80695.ef%26sid%3Dliteratum%253Aachs%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DLederman%26aufirst%3DM.%2BM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DPollard%26aufirst%3DR.%2BB.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%2BB.%26aulast%3DCoombs%26aufirst%3DR.%2BW.%26aulast%3DGlesby%26aufirst%3DM.%2BJ.%26aulast%3DFlexner%26aufirst%3DC.%2BW.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%2BT.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DSafety%252C%2520pharmacokinetics%252C%2520and%2520antiviral%2520activity%2520of%2520AMD3100%252C%2520a%2520selective%2520CXCR4%2520receptor%2520inhibitor%252C%2520in%2520HIV-1%2520infection%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2004%26volume%3D37%26spage%3D1253%26epage%3D1262%26doi%3D10.1097%2F01.qai.0000137371.80695.ef" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nyunt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macfarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Effect of AMD070, an oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181627566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2FQAI.0b013e3181627566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18362694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=559-565&author=M.+M.+Nyuntauthor=S.+Beckerauthor=R.+T.+Macfarlandauthor=P.+Cheeauthor=R.+Scarboroughauthor=S.+Evertsauthor=G.+B.+Calandraauthor=C.+W.+Hendrix&title=Pharmacokinetic+Effect+of+AMD070%2C+an+oral+CXCR4+antagonist%2C+on+CYP3A4+and+CYP2D6+substrates+midazolam+and+dextromethorphan+in+healthy+volunteers&doi=10.1097%2FQAI.0b013e3181627566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span></div><div class="casAuthors">Nyunt, Myaing M.; Becker, Stephen; MacFarland, Ron T.; Chee, Priscilla; Scarborough, Robert; Everts, Stephanie; Calandra, Gary B.; Hendrix, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Many antiretroviral drugs used in HIV care involve complex drug metab. by CYP3A4 and CYP2D6 enzymes, and drug interactions are problematic clin.  AMD070, a novel entry inhibitor, is an inhibitor of X4-tropic HIV virus.  In vitro data suggested that it is a CYP3A4 substrate and may inhibit CYP2D6 and CYP3A4.  Twelve healthy subjects were given a single oral dose of 5 mg of midazolam and 30 mg of dextromethorphan on day 1 and 9, and 200 mg of AMD070 twice daily on days 2 through 9 (inclusive).  Pharmacokinetic parameters of midazolam and dextromethorphan were assessed alone and in the presence of AMD070.  The mean AUC0-24 and Cmax of dextromethorphan increased 2.86-fold (2.20 to 5.10, 90% confidence interval [CI]) and 2.52-fold (1.99 to 4.24, 90% CI), resp., in the presence of AMD070.  Plasma AUC0-12 of midazolam increased 1.33-fold (1.15 to 1.61, 90% CI) without change in Cmax.  The half-life did not change for both drugs, but significant, parallel decrease in apparent oral clearance and vol. of distribution was obsd.  The data support an alteration in bioavailability due to an AMD070-mediated inhibition of presystemic metab., though an intestinal P-glycoprotein effect could also be contributing.  Interactions between AMD070 with CYP3A4 and, esp., 2D6 substrates of clin. importance in HIV care should be further explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMlBnTo8oO7Vg90H21EOLACvtfcHk0ljkwqoEZDyt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D&md5=bfea110729b08f0c25d7219e971b209d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181627566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181627566%26sid%3Dliteratum%253Aachs%26aulast%3DNyunt%26aufirst%3DM.%2BM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DMacfarland%26aufirst%3DR.%2BT.%26aulast%3DChee%26aufirst%3DP.%26aulast%3DScarborough%26aufirst%3DR.%26aulast%3DEverts%26aufirst%3DS.%26aulast%3DCalandra%26aufirst%3DG.%2BB.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DPharmacokinetic%2520Effect%2520of%2520AMD070%252C%2520an%2520oral%2520CXCR4%2520antagonist%252C%2520on%2520CYP3A4%2520and%2520CYP2D6%2520substrates%2520midazolam%2520and%2520dextromethorphan%2520in%2520healthy%2520volunteers%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2008%26volume%3D47%26spage%3D559%26epage%3D565%26doi%3D10.1097%2FQAI.0b013e3181627566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Moyle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1086/597097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1086%2F597097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19193109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=798-805&author=G.+Moyleauthor=E.+DeJesusauthor=M.+Boffitoauthor=R.+S.+Wongauthor=C.+Gibneyauthor=K.+Badelauthor=R.+MacFarlandauthor=G.+Calandraauthor=G.+Bridgerauthor=S.+Becker&title=Proof+of+activity+with+AMD11070%2C+an+orally+bioavailable+inhibitor+of+CXCR4-tropic+HIV+type+1&doi=10.1086%2F597097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span></div><div class="casAuthors">Moyle, Graeme; De Jesus, Edwin; Boffito, Marta; Wong, Rebecca S.; Gibney, Colleen; Badel, Karin; MacFarland, Ron; Calandra, Gary; Bridger, Gary; Becker, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">798-805</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The X4 Antagonist Concept Trial investigates the safety and antiviral activity of AMD11070, a potent inhibitor of X4-tropic human immunodeficiency virus (HIV) in vitro in HIV-infected patients harboring X4-tropic virus.  Methods: Patients enrolled in the study had an X4 virus population ≥2000 relative luminescence units (rlu; by the Monogram Trofile Assay) and an HIV-1 RNA level ≥5000 copies/mL.  Patients received AMD11070 mono-therapy for 10 days.  Coreceptor tropism, plasma HIV-1 RNA level, and CD4 cell count were measured at study entry, on day 5, and on day 10.  Daily predose and serial samples on the last day of treatment were obtained for detn. of plasma AMD11070 concn.  Results: Ten patients were given AMD11070 monotherapy (200 mg to 8 patients and 100 mg to 2 patients) twice daily for 10 days.  The median baseline CD4 cell count was 160 cells/mm3, and the median HIV-1 RNA level was 91,447 copies/mL.  Four of 9 evaluable patients achieved a redn. in X4 virus population of ≥1 - log10 rlu.  The median change in X4 virus population at the end of treatment was -0.22 log10 rlu (range, -1.90 to 0.23 log10 rlu).  Three of 4 patients who responded to therapy showed a tropism shift from dual- or mixed-tropic viruses to exclusively R5 virus by day 10.  There were no drug-related serious adverse events, adverse events of greater than grade 2, or lab. abnormalities.  Conclusion: These results demonstrate the activity of AMD11070, the first oral CXCR4 antagonist, against X4-tropic HIV-1.  The drug was well tolerated, with no serious safety concerns.  AMD11070 is on clin. hold because of histol. changes to the liver obsd. in long-term animal studies; addnl. preclin. safety assessments are pending.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiMCeVyzm_ZLVg90H21EOLACvtfcHk0liIaXlWExiOjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D&md5=e6406e781295be3e9a05e7d142048010</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F597097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597097%26sid%3Dliteratum%253Aachs%26aulast%3DMoyle%26aufirst%3DG.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DBoffito%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DR.%2BS.%26aulast%3DGibney%26aufirst%3DC.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DProof%2520of%2520activity%2520with%2520AMD11070%252C%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520CXCR4-tropic%2520HIV%2520type%25201%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D798%26epage%3D805%26doi%3D10.1086%2F597097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1128/AAC.01727-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1128%2FAAC.01727-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2940-2948&author=T.+Murakamiauthor=S.+Kumakuraauthor=T.+Yamazakiauthor=R.+Tanakaauthor=M.+Hamatakeauthor=K.+Okumaauthor=W.+Huangauthor=J.+Tomaauthor=J.+Komanoauthor=M.+Yanakaauthor=Y.+Tanakaauthor=N.+Yamamoto&title=The+novel+CXCR4+antagonist+KRH-3955+is+an+orally+bioavailable+and+extremely+potent+inhibitor+of+human+immunodeficiency+virus+type+1+infection%3A+comparative+studies+with+AMD3100&doi=10.1128%2FAAC.01727-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1128%2FAAC.01727-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01727-08%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DToma%26aufirst%3DJ.%26aulast%3DKomano%26aufirst%3DJ.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520KRH-3955%2520is%2520an%2520orally%2520bioavailable%2520and%2520extremely%2520potent%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%253A%2520comparative%2520studies%2520with%2520AMD3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D2940%26epage%3D2948%26doi%3D10.1128%2FAAC.01727-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlshøj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8141</span><span class="NLM_x">–</span> <span class="NLM_lpage">8153</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8141-8153&author=Z.+G.+Zachariassenauthor=S.+Karlsh%C3%B8jauthor=B.+E.+Haugauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Probing+the+molecular+interactions+between+CXC+chemokine+receptor+4+%28CXCR4%29+and+an+arginine-based+tripeptidomimetic+antagonist+%28KRH-1636%29&doi=10.1021%2Facs.jmedchem.5b00987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00987%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DKarlsh%25C3%25B8j%26aufirst%3DS.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520molecular%2520interactions%2520between%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%2520and%2520an%2520arginine-based%2520tripeptidomimetic%2520antagonist%2520%2528KRH-1636%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8141%26epage%3D8153%26doi%3D10.1021%2Facs.jmedchem.5b00987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Damme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1084/jem.186.8.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1084%2Fjem.186.8.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=9334378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVelu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1997&pages=1383-1388&author=D.+Scholsauthor=S.+Struyfauthor=J.+Van+Dammeauthor=J.+A.+Est%C3%A9author=G.+Hensonauthor=E.+De+Clercq&title=Inhibition+of+T-tropic+HIV+strains+by+selective+antagonization+of+the+chemokine+receptor+CXCR4&doi=10.1084%2Fjem.186.8.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4</span></div><div class="casAuthors">Schols, Dominique; Struyf, Sofie; Van Damme, Jo; Este, Jose A.; Henson, Geoffrey; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1383-1388</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Bicyclams are a novel class of antiviral compds. that are highly potent and selective inhibitors of the replication of HIV-1 and HIV-2.  Surprisingly, however, when the prototype compd. AMD3100 was tested against M-tropic virus strains such as BaL, ADA, JR-CSF, and SF-162 in human peripheral blood mononuclear cells, the compd. was completely inactive.  Because of the specific and potent inhibitory effect of AMD3100 on T-tropic viruses, but not M-tropic viruses, it was verified that AMD3100 interacts with the CXC-chemokine receptor CXCR4, the main coreceptor used by T-tropic viruses.  AMD3100 dose dependently inhibited the binding of a specific CXCR4 monoclonal antibody to SUP-T1 cells as measured by flow cytometry.  It did not inhibit the binding of the biotinylated CC-chemokine macrophage inflammatory protein (MIP) α1 or MIP-1β, ligands for the chemokine receptor CCR5 (the main coreceptor for M-tropic viruses).  In addn., AMD3100 completely blocked (a) the Ca2+ flux at 100 ng/mL in lymphocytic SUP-T1 and monocytic THP-1 cells, and (b) the chemotactic responses of THP-1 cells induced by stromal cell-derived factor 1α, the natural ligand for CXCR4.  Finally, AMD3100 had no effect on the Ca2+ flux induced by the CC-chemokines MIP-1α, regulated on activation normal T cell expressed and secreted (RANTES; also a ligand for CCR5), or monocyte chemoattractant protein 3 (a ligand for CCR1 and CCR2b), nor was it able to induce Ca2+ fluxes by itself.  The bicyclams are, to our knowledge, the first low mol. wt. anti-HIV agents shown to act as potent and selective CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ5dssLvsuLrVg90H21EOLACvtfcHk0ljpk8HYwOkMJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVelu7s%253D&md5=1d0dce8df250d0723de73cf83c98d92a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1084%2Fjem.186.8.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.186.8.1383%26sid%3Dliteratum%253Aachs%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%2BA.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520T-tropic%2520HIV%2520strains%2520by%2520selective%2520antagonization%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1997%26volume%3D186%26spage%3D1383%26epage%3D1388%26doi%3D10.1084%2Fjem.186.8.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span><span class="refDoi"> DOI: 10.1021/jm501772w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501772w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1452-1465&author=C.+H.+Wuauthor=C.+J.+Wangauthor=C.+P.+Changauthor=Y.+C.+Chengauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=Y.+Y.+Keauthor=J.+Maauthor=Y.+C.+Wongauthor=T.+C.+Hsiehauthor=Y.+C.+Tienauthor=E.+A.+Gullenauthor=C.+F.+Loauthor=C.+Y.+Chengauthor=Y.+W.+Liuauthor=A.+A.+Sadaniauthor=C.+H.+Tsaiauthor=H.+P.+Hsiehauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Function-oriented+development+of+CXCR4+antagonists+as+selective+human+immunodeficiency+virus+%28HIV%29-1+entry+inhibitors&doi=10.1021%2Fjm501772w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501772w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501772w%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DTien%26aufirst%3DY.%2BC.%26aulast%3DGullen%26aufirst%3DE.%2BA.%26aulast%3DLo%26aufirst%3DC.%2BF.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DFunction-oriented%2520development%2520of%2520CXCR4%2520antagonists%2520as%2520selective%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520entry%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1452%26epage%3D1465%26doi%3D10.1021%2Fjm501772w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G. Q.</span><span> </span><span class="NLM_article-title">SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1195</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.brainres.2007.11.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.brainres.2007.11.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=18206136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVehur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1195&publication_year=2008&pages=104-112&author=Y.+Wangauthor=Y.+Dengauthor=G.+Q.+Zhou&title=SDF-1alpha%2FCXCR4-mediated+migration+of+systemically+transplanted+bone+marrow+stromal+cells+towards+ischemic+brain+lesion+in+a+rat+model&doi=10.1016%2Fj.brainres.2007.11.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model</span></div><div class="casAuthors">Wang, Ye; Deng, Yubin; Zhou, Guang-Qian</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) can promote functional recovery of brain after stroke with the mechanism regulating the BMSCs migration to ischemic penumbra poorly understood.  Interaction between stromal cell-derived factor-1α (SDF-1α) and its cognate receptor CXCR4 is crucial for homing and migration of multiple stem cell types.  Their potential role in mediating BMSC migration in ischemic brain has not been demonstrated.  In this study, ischemic brain lesion model was created in rats by permanent middle cerebral artery occlusion and green fluorescent protein (GFP)-labeled BMSCs were i.v. injected.  Immunohistochem. staining showed that BMSCs were able to enter the route from olfactory areas to cortex of the rat brain.  Significant recovery of modified Neurol. Severity Score was obsd. at days 14 and 28.  Interestingly, the SDF-1α mRNA and protein were predominantly localized in the ischemic penumbral, peaked by 3-7 days and retained at least 14 days post-transplantation.  On the other hand, the CXCR4 expression by BMSCs was elevated under hypoxia.  The pre-treatment with the CXCR4-specific antagonist AMD3100 significantly prevented the migration of BMSCs to the injured brain.  Taken together, these observations indicate that systemically administered BMSCs can migrate to the ischemic lesion of brain along with the olfactory-thalamus and hippocampus-cortex route.  The interaction of locally produced SDF-1α and CXCR4 expressed on the BMSC surface plays an important role in the migration of transplanted cells, suggesting that it might be a potential approach to modulate the expression of the two mols. in order to further facilitate the therapeutic effects using BMSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo68kYwzFR_pLVg90H21EOLACvtfcHk0ljpk8HYwOkMJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVehur4%253D&md5=6eddc731fda277696b1bdd8005faf34d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.11.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.11.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DG.%2BQ.%26atitle%3DSDF-1alpha%252FCXCR4-mediated%2520migration%2520of%2520systemically%2520transplanted%2520bone%2520marrow%2520stromal%2520cells%2520towards%2520ischemic%2520brain%2520lesion%2520in%2520a%2520rat%2520model%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1195%26spage%3D104%26epage%3D112%26doi%3D10.1016%2Fj.brainres.2007.11.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Borlongan, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, H.</span><span> </span><span class="NLM_article-title">Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3615</span><span class="NLM_x">–</span> <span class="NLM_lpage">3621</span><span class="refDoi"> DOI: 10.1097/00001756-199811160-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2F00001756-199811160-00012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=3615-3621&author=C.+V.+Borlonganauthor=H.+Hidaauthor=H.+Nishino&title=Early+assessment+of+motor+dysfunctions+aids+in+successful+occlusion+of+the+middle+cerebral+artery&doi=10.1097%2F00001756-199811160-00012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2F00001756-199811160-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199811160-00012%26sid%3Dliteratum%253Aachs%26aulast%3DBorlongan%26aufirst%3DC.%2BV.%26aulast%3DHida%26aufirst%3DH.%26aulast%3DNishino%26aufirst%3DH.%26atitle%3DEarly%2520assessment%2520of%2520motor%2520dysfunctions%2520aids%2520in%2520successful%2520occlusion%2520of%2520the%2520middle%2520cerebral%2520artery%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D3615%26epage%3D3621%26doi%3D10.1097%2F00001756-199811160-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wu, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain</span> <span class="citation_source-journal">Cell Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.3727/096368916X693563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.3727%2F096368916X693563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=27938478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252Fislanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=571-583&author=K.+J.+Wuauthor=S.+J.+Yuauthor=K.+S.+Shiaauthor=C.+H.+Wuauthor=J.+S.+Songauthor=H.+H.+Kuanauthor=K.+C.+Yehauthor=C.+T.+Chenauthor=E.+Baeauthor=Y.+Wang&title=A+novel+CXCR4+antagonist+CX549+induces+neuroprotection+in+stroke+brain&doi=10.3727%2F096368916X693563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain</span></div><div class="casAuthors">Wu Kuo-Jen; Yu Seong-Jin; Shia Kak-Shan; Wu Chien-Huang; Song Jen-Shin; Kuan Hsuan-Hao; Yeh Kai-Chia; Chen Chiung-Tong; Bae Eunkyune; Wang Yun</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-583</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12.  Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs).  The purpose of this study was to characterize the neuroprotective and neurotrophic effect of a novel CXCR4 antagonist CX549.  We demonstrated that CX549 had a higher affinity for CXCR4 and was more potent than AMD3100 to inhibit CXCL12-mediated chemotaxis in culture.  CX549 effectively reduced the activation of microglia and improved neuronal survival after injury in neuron/microglia cocultures.  Early poststroke treatment with CX549 significantly improved behavioral function, reduced brain infarction, and suppressed the expression of inflammatory markers.  Compared to AMD3100, CX549 has a higher affinity for CXCR4, is more efficient to mobilize HSCs for transplantation, and induces behavioral improvement.  Our data support that CX549 is a potent anti-inflammatory agent, is neuroprotective against ischemic brain injury, and may have clinical implications for the treatment of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnCtEAI5yEH7xanA7vODO6fW6udTcc2eZaWYxHdrmfgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252Fislanug%253D%253D&md5=6ca127a837546015e43af88e73a228e7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3727%2F096368916X693563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368916X693563%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%2BJ.%26aulast%3DYu%26aufirst%3DS.%2BJ.%26aulast%3DShia%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DKuan%26aufirst%3DH.%2BH.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DBae%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520novel%2520CXCR4%2520antagonist%2520CX549%2520induces%2520neuroprotection%2520in%2520stroke%2520brain%26jtitle%3DCell%2520Transplant.%26date%3D2017%26volume%3D26%26spage%3D571%26epage%3D583%26doi%3D10.3727%2F096368916X693563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Stem cell mobilizers targeting chemokine receptor CXCR4: renoprotective application in acute kidney injury</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span><span class="refDoi"> DOI: 10.1021/jm501769r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501769r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2315-2325&author=C.+H.+Wuauthor=J.+S.+Songauthor=K.+H.+Changauthor=J.+J.+Janauthor=C.+T.+Chenauthor=M.+C.+Chouauthor=K.+C.+Yehauthor=Y.+C.+Wongauthor=C.+T.+Tsengauthor=S.+H.+Wuauthor=C.+F.+Yehauthor=C.+Y.+Huangauthor=M.+H.+Wangauthor=A.+A.+Sadaniauthor=C.+P.+Changauthor=C.+Y.+Chengauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Stem+cell+mobilizers+targeting+chemokine+receptor+CXCR4%3A+renoprotective+application+in+acute+kidney+injury&doi=10.1021%2Fjm501769r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501769r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501769r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DChang%26aufirst%3DK.%2BH.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DC.%2BF.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DStem%2520cell%2520mobilizers%2520targeting%2520chemokine%2520receptor%2520CXCR4%253A%2520renoprotective%2520application%2520in%2520acute%2520kidney%2520injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2315%26epage%3D2325%26doi%3D10.1021%2Fjm501769r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction</span> <span class="citation_source-journal">Acta Biochim. Biophys. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1093/abbs/gmt045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1093%2Fabbs%2Fgmt045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23676772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCqtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=561-569&author=Y.+Luoauthor=X.+Zhaoauthor=X.+Zhouauthor=W.+Jiauthor=L.+Zhangauthor=T.+Luoauthor=H.+Liuauthor=T.+Huangauthor=T.+Jiangauthor=Y.+Li&title=Short-term+intermittent+administration+of+CXCR4+antagonist+AMD3100+facilitates+myocardial+repair+in+experimental+myocardial+infarction&doi=10.1093%2Fabbs%2Fgmt045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction</span></div><div class="casAuthors">Luo, Yuechen; Zhao, Xiaoning; Zhou, Xin; Ji, Wenjie; Zhang, Ling; Luo, Tao; Liu, Hongmei; Huang, Tigang; Jiang, Tiemin; Li, Yuming</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-569</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">ABBS Editorial Office</span>)
        </div><div class="casAbstract">The binding of the stromal cell-derived factor-1α (SDF-1α) to the cysteine (C)-X-C motif chemokine receptor 4 (CXCR4) has emerged as a key signal for stem and progenitor cells trafficking to the circulation from the bone marrow.  Our aim was to investigate the role of daily intermittent administration of AMD3100 (a specific reversible CXCR4 receptor antagonist) during the healing process after myocardial infarction (MI).  Wistar rats were subjected to MI and AMD3100 was injected i.p. after surgery.  SDF-1α mRNA expression was measured by real-time polymerase chain reaction.  Histol. changes were analyzed with immunofluorescence, Masson's trichrome staining, and wheat germ agglutinin.  The no. of leukocytes in peripheral blood was measured by complete blood cell count anal.  The activities of matrix metalloproteinase-2/9 (MMP-2/9) were detd. by gelatin zymog.  The expression level of SDF-1α mRNA in the infarcted tissue was enhanced rapidly (6 h), peaked at 24 h, and then declined to the normal level at 7 days post-MI.  AMD3100 further enhanced the increase of SDF-1α in infarct area.  Increased leukocytes were obsd. in AMD3100-treated groups.  The mobilization of c-kit+ stem/progenitor cells and enhanced neovascularization were augmented by AMD3100.  Addnl., AMD3100 improved ventricular remodeling, which was revealed by the decrease of infarct size, viable cardiomyocyte cross-sectional area and left ventricle (LV) expansion index, and the increase of LV free wall thickness.  The activities of MMP-2/9 were up-regulated by AMD3100.  In conclusion, short-term intermittent administration of AMD3100 could accelerate the wound healing process in exptl. MI and be a potential therapy for the treatment of MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWz-hKs4KALVg90H21EOLACvtfcHk0liHy3VgDcZg2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCqtbzE&md5=979289b153c95436267a39197ebece3d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmt045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmt045%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DShort-term%2520intermittent%2520administration%2520of%2520CXCR4%2520antagonist%2520AMD3100%2520facilitates%2520myocardial%2520repair%2520in%2520experimental%2520myocardial%2520infarction%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2013%26volume%3D45%26spage%3D561%26epage%3D569%26doi%3D10.1093%2Fabbs%2Fgmt045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hsu, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, W. Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span> </span><span class="NLM_article-title">CXCR4 antagonist TG-0054 mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction</span> <span class="citation_source-journal">Cell Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span><span class="refDoi"> DOI: 10.3727/096368914X681739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.3727%2F096368914X681739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=24823505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BC2cjis1Wrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1313-1328&author=W.+T.+Hsuauthor=H.+Y.+Juiauthor=Y.+H.+Huangauthor=M.+Y.+M.+Suauthor=Y.+W.+Wuauthor=W.+Y.+I.+Tsengauthor=M.+C.+Hsuauthor=B.+L.+Chiangauthor=K.+K.+Wuauthor=C.+M.+Lee&title=CXCR4+antagonist+TG-0054+mobilizes+mesenchymal+stem+cells%2C+attenuates+inflammation%2C+and+preserves+cardiac+systolic+function+in+a+porcine+model+of+myocardial+infarction&doi=10.3727%2F096368914X681739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction</span></div><div class="casAuthors">Hsu Wan-Tseng; Jui Hsiang-Yiang; Huang Ying-Huey; Su Mao-Yuan M; Wu Yen-Wen; Tseng Wen-Yih I; Hsu Ming-Chu; Chiang Bor-Luen; Wu Kenneth K; Lee Chii-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1313-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Interaction between chemokine stromal cell-derived factor 1 and the CXC chemokine receptor 4 (CXCR4) governs the sequestration and mobilization of bone marrow stem cells.  We investigated the therapeutic potential of TG-0054, a novel CXCR4 antagonist, in attenuating cardiac dysfunction after myocardial infarction (MI).  In miniature pigs (minipigs), TG-0054 mobilized CD34(+)CXCR4(+), CD133(+)CXCR4(+), and CD271(+)CXCR4(+) cells into peripheral circulation.  After isolation and expansion, TG-0054-mobilized CD271(+) cells were proved to be mesenchymal stem cells (designated CD271-MSCs) since they had trilineage differentiation potential, surface markers of MSCs, and immunosuppressive effects on allogeneic lymphocyte proliferation.  MI was induced in 22 minipigs using balloon occlusion of the left anterior descending coronary artery, followed by intravenous injections of 2.85 mg/kg of TG-0054 or saline at 3 days and 7 days post-MI.  Serial MRI analyses revealed that TG-0054 treatment prevented left ventricular (LV) dysfunction at 12 weeks after MI (change of LV ejection fraction from baseline, -1.0 ± 6.2% in the TG-0054 group versus -7.9 ± 5.8% in the controls).  The preserved cardiac function was accompanied by a significant decrease in the myocardial expression of TNF-α, IL-1β, and IL-6 at 7 days post-MI.  Moreover, the plasma levels of TNF-α, IL-1β, and IL-6 were persistently suppressed by the TG-0054 treatment.  Infusion of TG-0054-mobilized CD271-MSCs reduced both myocardial and plasma cytokine levels in a pattern, which is temporally correlated with TG-0054 treatment.  This study demonstrated that TG-0054 improves the impaired LV contractility following MI, at least in part, by mobilizing MSCs to attenuate the postinfarction inflammation.  This insight may facilitate exploring novel stem cell-based therapy for treating post-MI heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2k2Eehew6CZVVjGoY74BafW6udTcc2eYN7ZGlUtcg8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjis1Wrsg%253D%253D&md5=9ca3bb72605ae483dc4bf532c3c63bda</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3727%2F096368914X681739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368914X681739%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DW.%2BT.%26aulast%3DJui%26aufirst%3DH.%2BY.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DSu%26aufirst%3DM.%2BY.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DTseng%26aufirst%3DW.%2BY.%2BI.%26aulast%3DHsu%26aufirst%3DM.%2BC.%26aulast%3DChiang%26aufirst%3DB.%2BL.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DLee%26aufirst%3DC.%2BM.%26atitle%3DCXCR4%2520antagonist%2520TG-0054%2520mobilizes%2520mesenchymal%2520stem%2520cells%252C%2520attenuates%2520inflammation%252C%2520and%2520preserves%2520cardiac%2520systolic%2520function%2520in%2520a%2520porcine%2520model%2520of%2520myocardial%2520infarction%26jtitle%3DCell%2520Transplant.%26date%3D2015%26volume%3D24%26spage%3D1313%26epage%3D1328%26doi%3D10.3727%2F096368914X681739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Silencing of CXCR4 blocks breast cancer metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=967-971&author=Z.+Liangauthor=Y.+Yoonauthor=J.+Votawauthor=M.+M.+Goodmanauthor=L.+Williamsauthor=H.+Shim&title=Silencing+of+CXCR4+blocks+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DVotaw%26aufirst%3DJ.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSilencing%2520of%2520CXCR4%2520blocks%2520breast%2520cancer%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyverman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiddingh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauwers, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span> </span><span class="NLM_article-title">Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axisand myeloid differentiation antigen-positive myeloid cell infiltration in mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span><span class="refDoi"> DOI: 10.1002/hep.26790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fhep.26790" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=1435-1447&author=Y.+Chenauthor=Y.+Huangauthor=T.+Reibergerauthor=A.+M.+Duyvermanauthor=P.+Huangauthor=R.+Samuelauthor=L.+Hiddinghauthor=S.+Robergeauthor=C.+Koppelauthor=G.+Y.+Lauwersauthor=A.+X.+Zhuauthor=R.+K.+Jainauthor=D.+G.+Duda&title=Differential+effects+of+sorafenib+on+liver+versus+tumor+fibrosis+mediated+by+stromal-derived+factor+1+alpha%2FC-X-C+receptor+type+4+axisand+myeloid+differentiation+antigen-positive+myeloid+cell+infiltration+in+mice&doi=10.1002%2Fhep.26790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhep.26790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26790%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DReiberger%26aufirst%3DT.%26aulast%3DDuyverman%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DSamuel%26aufirst%3DR.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DRoberge%26aufirst%3DS.%26aulast%3DKoppel%26aufirst%3DC.%26aulast%3DLauwers%26aufirst%3DG.%2BY.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26atitle%3DDifferential%2520effects%2520of%2520sorafenib%2520on%2520liver%2520versus%2520tumor%2520fibrosis%2520mediated%2520by%2520stromal-derived%2520factor%25201%2520alpha%252FC-X-C%2520receptor%2520type%25204%2520axisand%2520myeloid%2520differentiation%2520antigen-positive%2520myeloid%2520cell%2520infiltration%2520in%2520mice%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D1435%26epage%3D1447%26doi%3D10.1002%2Fhep.26790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Matthys, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4692</span><span class="refDoi"> DOI: 10.4049/jimmunol.167.8.4686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4049%2Fjimmunol.167.8.4686" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2001&pages=4686-4692&author=P.+Matthysauthor=S.+Hatseauthor=K.+Vermeireauthor=A.+Wuytsauthor=G.+Bridgerauthor=G.+W.+Hensonauthor=E.+De+Clercqauthor=A.+Billiauauthor=D.+Schols&title=AMD3100%2C+a+potent+and+specific+antagonist+of+the+stromal+cell-derived+factor-1+chemokine+receptor+CXCR4%2C+inhibits+autoimmune+joint+inflammation+in+IFN-gamma+receptor-deficient+mice&doi=10.4049%2Fjimmunol.167.8.4686"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.167.8.4686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.167.8.4686%26sid%3Dliteratum%253Aachs%26aulast%3DMatthys%26aufirst%3DP.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBilliau%26aufirst%3DA.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DAMD3100%252C%2520a%2520potent%2520and%2520specific%2520antagonist%2520of%2520the%2520stromal%2520cell-derived%2520factor-1%2520chemokine%2520receptor%2520CXCR4%252C%2520inhibits%2520autoimmune%2520joint%2520inflammation%2520in%2520IFN-gamma%2520receptor-deficient%2520mice%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D167%26spage%3D4686%26epage%3D4692%26doi%3D10.4049%2Fjimmunol.167.8.4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Walter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Maten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antunes, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieloch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruscher, K.</span><span> </span><span class="NLM_article-title">Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="refDoi"> DOI: 10.1186/s12974-014-0232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1186%2Fs12974-014-0232-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25881123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=24&author=H.+L.+Walterauthor=G.+van+der+Matenauthor=A.+R.+Antunesauthor=T.+Wielochauthor=K.+Ruscher&title=Treatment+with+AMD3100+attenuates+the+microglial+response+and+improves+outcome+after+experimental+stroke&doi=10.1186%2Fs12974-014-0232-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke</span></div><div class="casAuthors">Walter, Helene L.; van der Maten, Gerlinde; Antunes, Ana Rita; Wieloch, Tadeusz; Ruscher, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24/1-24/15</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Recovery of lost neurol. function after stroke is limited and dependent on multiple mechanisms including inflammatory processes.  Selective pharmacol. modulation of inflammation might be a promising approach to improve stroke outcome.  Methods: We used 1,1'-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] (AMD3100), an antagonist to the C-X-C chemokine receptor type 4 (CXCR4) and potential allosteric agonist to CXCR7, administered to mice twice daily from day 2 after induction of photothrombosis (PT).  In addn. to functional outcome, the dynamics of post-stroke microglia response were monitored in vivo by 2-photon-laser-microscopy in heterozygous transgenic CX3CR1-green fluorescent protein (GFP) mice (CX3CR1GFP/+) and complemented with analyses for fractalkine (FKN) and pro-inflammatory cytokines.  Results: We found a significantly enhanced recovery and modified microglia activation without affecting infarct size in mice treated with AMD3100 after PT.  AMD3100 treatment significantly reduced the no. of microglia in the peri-infarct area accompanied by stabilization of soma size and ramified cell morphol.  Within the ischemic infarct core of AMD3100 treated wild-type mice we obtained significantly reduced levels of the endogenous CX3CR1 ligand FKN and the pro-inflammatory cytokines interleukin (IL)-1β and IL-6.  Interestingly, in CX3CR1-deficient mice (homozygous transgenic CX3CR1-GFP mice) subjected to PT, the levels of FKN were significantly lower compared to their wild-type littermates.  Moreover, AMD3100 treatment did not induce any relevant changes of cytokine levels in CX3CR1 deficient mice.  Conclusion: After AMD3100 treatment, attenuation of microglia activation contributes to enhanced recovery of lost neurol. function in exptl. stroke possibly due to a depression of FKN levels in the brain.  We further hypothesize that this mechanism is dependent on a functional receptor CX3CR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0GO6F5fRGa7Vg90H21EOLACvtfcHk0li5Z0NbaBZIcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFKgtbk%253D&md5=41bac65af539956f3973140bcf41a5a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12974-014-0232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-014-0232-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DH.%2BL.%26aulast%3Dvan%2Bder%2BMaten%26aufirst%3DG.%26aulast%3DAntunes%26aufirst%3DA.%2BR.%26aulast%3DWieloch%26aufirst%3DT.%26aulast%3DRuscher%26aufirst%3DK.%26atitle%3DTreatment%2520with%2520AMD3100%2520attenuates%2520the%2520microglial%2520response%2520and%2520improves%2520outcome%2520after%2520experimental%2520stroke%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2015%26volume%3D12%26spage%3D24%26doi%3D10.1186%2Fs12974-014-0232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ruscher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issazadeh-Navikas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieloch, T.</span><span> </span><span class="NLM_article-title">Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span><span class="refDoi"> DOI: 10.1038/jcbfm.2013.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fjcbfm.2013.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23632969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1225-1234&author=K.+Ruscherauthor=E.+Kuricauthor=Y.+Liuauthor=H.+L.+Walterauthor=S.+Issazadeh-Navikasauthor=E.+Englundauthor=T.+Wieloch&title=Inhibition+of+CXCL12+signaling+attenuates+the+postischemic+immune+response+and+improves+functional+recovery+after+stroke&doi=10.1038%2Fjcbfm.2013.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke</span></div><div class="casAuthors">Ruscher, Karsten; Kuric, Enida; Liu, Yawei; Walter, Helene L.; Issazadeh-Navikas, Shohreh; Englund, Elisabet; Wieloch, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1225-1234</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After stroke, brain inflammation in the ischemic hemisphere hampers brain tissue reorganization and functional recovery.  Housing rats in an enriched environment (EE) dramatically improves recovery of lost neurol. functions after exptl. stroke.  We show here that rats housed in EE after stroke induced by permanent occlusion of the middle cerebral artery (pMCAO), showed attenuated levels of proinflammatory cytokines in the ischemic core and the surrounding peri-infarct area, including a significant redn. in the stroke-induced chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor-1 (CXCL12).  To mimic beneficial effects of EE, we studied the impact of inhibiting CXCL12 action on functional recovery after transient MCAO (tMCAO).  Rats treated with the specific CXCL12 receptor antagonist 1-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl-1,4,8,11-tetrazacyclo-tetradecan (AMD3100) showed improved recovery compared with saline-treated rats after tMCAO, without a concomitant redn. in infarct size.  This was accompanied by a redn. of infiltrating immune cells in the ischemic hemisphere, particularly cluster of differentiation 3-pos. (CD3+) and CD3+/CD4+ T cells.  Spleen atrophy and delayed death of splenocytes, induced by tMCAO, was prevented by AMD3100 treatment.  We conclude that immoderate excessive activation of the CXCL12 pathway after stroke contributes to depression of neurol. function after stroke and that CXCR4 antagonism is beneficial for the recovery after stroke.  Journal of Cerebral Blood Flow & Metab. (2013) 33, 1225-1234; doi:10.1038/jcbfm.2013.71; published online 1 May 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqRrtyTj6sbVg90H21EOLACvtfcHk0litVx1kVq3Hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wks7%252FL&md5=11b70a3f3d63f130d92f8bfc7cfa620f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2013.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2013.71%26sid%3Dliteratum%253Aachs%26aulast%3DRuscher%26aufirst%3DK.%26aulast%3DKuric%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWalter%26aufirst%3DH.%2BL.%26aulast%3DIssazadeh-Navikas%26aufirst%3DS.%26aulast%3DEnglund%26aufirst%3DE.%26aulast%3DWieloch%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520CXCL12%2520signaling%2520attenuates%2520the%2520postischemic%2520immune%2520response%2520and%2520improves%2520functional%2520recovery%2520after%2520stroke%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2013%26volume%3D33%26spage%3D1225%26epage%3D1234%26doi%3D10.1038%2Fjcbfm.2013.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1161/STROKEAHA.112.670299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1161%2FSTROKEAHA.112.670299" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=190-197&author=J.+Huangauthor=Y.+Liauthor=Y.+Tangauthor=G.+Tangauthor=G.+Y.+Yangauthor=Y.+Wang&title=CXCR4+antagonist+AMD3100+protects+blood-brain+barrier+integrity+and+reduces+inflammatory+response+after+focal+ischemia+in+mice&doi=10.1161%2FSTROKEAHA.112.670299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1161%2FSTROKEAHA.112.670299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FSTROKEAHA.112.670299%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCXCR4%2520antagonist%2520AMD3100%2520protects%2520blood-brain%2520barrier%2520integrity%2520and%2520reduces%2520inflammatory%2520response%2520after%2520focal%2520ischemia%2520in%2520mice%26jtitle%3DStroke%26date%3D2013%26volume%3D44%26spage%3D190%26epage%3D197%26doi%3D10.1161%2FSTROKEAHA.112.670299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Jujo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyachko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tongers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncalli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamide, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Losordo, D. W.</span><span> </span><span class="NLM_article-title">CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.112.099242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1161%2FCIRCULATIONAHA.112.099242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23204107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs1yrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=63-73&author=K.+Jujoauthor=M.+Iiauthor=H.+Sekiguchiauthor=E.+Klyachkoauthor=S.+Misenerauthor=T.+Tanakaauthor=J.+Tongersauthor=J.+Roncalliauthor=M.+A.+Renaultauthor=T.+Thorneauthor=A.+Itoauthor=T.+Clarkeauthor=C.+Kamideauthor=Y.+Tsurumiauthor=N.+Hagiwaraauthor=G.+Qinauthor=M.+Asahiauthor=D.+W.+Losordo&title=CXC-chemokine+receptor+4+antagonist+AMD3100+promotes+cardiac+functional+recovery+after+ischemia%2Freperfusion+injury+via+endothelial+nitric+oxide+synthase-dependent+mechanism&doi=10.1161%2FCIRCULATIONAHA.112.099242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CXC-Chemokine Receptor 4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia/Reperfusion Injury via Endothelial Nitric Oxide Synthase-Dependent Mechanism</span></div><div class="casAuthors">Jujo, Kentaro; Ii, Masaaki; Sekiguchi, Haruki; Klyachko, Ekaterina; Misener, Sol; Tanaka, Toshikazu; Tongers, Joern; Roncalli, Jerome; Renault, Marie-Ange; Thorne, Tina; Ito, Aiko; Clarke, Trevor; Kamide, Christine; Tsurumi, Yukio; Hagiwara, Nobuhisa; Qin, Gangjian; Asahi, Michio; Losordo, Douglas W.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: CXC-chemokine receptor 4 (CXCR4) regulates the retention of stem/progenitor cells in the bone marrow (BM), and the CXCR4 antagonist AMD3100 improves recovery from coronary ligation injury by mobilizing stem/progenitor cells from the BM to the peripheral blood.  Thus, we investigated whether AMD3100 also improves recovery from ischemia/reperfusion injury, which more closely mimics myocardial infarction in patients, because blood flow is only temporarily obstructed.  METHODS AND RESULTS-: Mice were treated with single s.c. injections of AMD3100 (5 mg/kg) or saline after ischemia/reperfusion injury.  Three days later, histol. measurements of the ratio of infarct area to area at risk were smaller in AMD3100-treated mice than in mice administered saline, and echocardiog. measurements of left ventricular function were greater in the AMD3100-treated mice at week 4.  CXCR4 cells were mobilized for just 1 day in both groups, but the mobilization of sca1/flk1 cells endured for 7 days in AMD3100-treated mice compared with just 1 day in the saline-treated mice.  AMD3100 upregulated BM levels of endothelial nitric oxide synthase (eNOS) and 2 targets of eNOS signaling, matrix metalloproteinase-9 and sol. Kit ligand.  Furthermore, the loss of BM eNOS expression abolished the benefit of AMD3100 on sca1/flk1 cell mobilization without altering the mobilization of CXCR4 cells, and the cardioprotective effects of AMD3100 were retained in eNOS-knockout mice that had been transplanted with BM from wild-type mice but not in wild-type mice with eNOS-knockout BM.  CONCLUSIONS-: AMD3100 prolongs BM progenitor mobilization and improves recovery from ischemia/reperfusion injury, and these benefits appear to occur through a previously unidentified link between AMD3100 and BM eNOS expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraGLZvBeNX_7Vg90H21EOLACvtfcHk0litVx1kVq3Hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs1yrtA%253D%253D&md5=0fde58ae9ce4757f0a01772246b4f1a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.112.099242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.112.099242%26sid%3Dliteratum%253Aachs%26aulast%3DJujo%26aufirst%3DK.%26aulast%3DIi%26aufirst%3DM.%26aulast%3DSekiguchi%26aufirst%3DH.%26aulast%3DKlyachko%26aufirst%3DE.%26aulast%3DMisener%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTongers%26aufirst%3DJ.%26aulast%3DRoncalli%26aufirst%3DJ.%26aulast%3DRenault%26aufirst%3DM.%2BA.%26aulast%3DThorne%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DT.%26aulast%3DKamide%26aufirst%3DC.%26aulast%3DTsurumi%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DN.%26aulast%3DQin%26aufirst%3DG.%26aulast%3DAsahi%26aufirst%3DM.%26aulast%3DLosordo%26aufirst%3DD.%2BW.%26atitle%3DCXC-chemokine%2520receptor%25204%2520antagonist%2520AMD3100%2520promotes%2520cardiac%2520functional%2520recovery%2520after%2520ischemia%252Freperfusion%2520injury%2520via%2520endothelial%2520nitric%2520oxide%2520synthase-dependent%2520mechanism%26jtitle%3DCirculation%26date%3D2013%26volume%3D127%26spage%3D63%26epage%3D73%26doi%3D10.1161%2FCIRCULATIONAHA.112.099242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Liles, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broxmeyer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hangoc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, D. C.</span><span> </span><span class="NLM_article-title">Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1182/blood-2003-02-0663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2003-02-0663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=12855591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotF2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=2728-2730&author=W.+C.+Lilesauthor=H.+E.+Broxmeyerauthor=E.+Rodgerauthor=B.+Woodauthor=K.+H%C3%BCbelauthor=S.+Cooperauthor=G.+Hangocauthor=G.+J.+Bridgerauthor=G.+W.+Hensonauthor=G.+Calandraauthor=D.+C.+Dale&title=Mobilization+of+hematopoietic+progenitor+cells+in+healthy+volunteers+by+AMD3100%2C+a+CXCR4+antagonist&doi=10.1182%2Fblood-2003-02-0663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist</span></div><div class="casAuthors">Liles, W. Conrad; Broxmeyer, Hal E.; Rodger, Elin; Wood, Brent; Huebel, Kai; Cooper, Scott; Hangoc, Giao; Bridger, Gary J.; Henson, Geoffrey W.; Calandra, Gary; Dale, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2728-2730</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Stromal cell-derived factor 1 (SDF1/CXCL12) and its cognate receptor, CXCR4, play key regulatory roles in CD34+ cell trafficking.  We investigated whether AMD3100, a selective CXCR4 antagonist, could mobilize hematopoietic progenitor cells from marrow to peripheral blood in healthy human volunteers.  Initially, 10 persons each received a single dose of AMD3100 (80 μg/kg s.c.), which induced rapid, generalized leukocytosis assocd. with an increase in peripheral blood CD34+ cells, representing pluripotent hematopoietic progenitors by in vitro colony-forming unit assays, from 3.8 ± 0.5/μL to 20.7 ± 3.5/μL at 6 h.  Subsequent dose-response studies showed a max. increase in circulating CD34+ cells from 2.6 ± 0.3/μL to 40.4 ± 3.4/μL at 9 h after 240 μg/kg AMD3100.  Serial administration of AMD3100 (80 μg/kg/d for 3 days) resulted in consistent, reversible increases in peripheral blood CD34+ cells.  AMD3100 was well tolerated and caused only mild, transient toxicity.  These findings suggest potential clin. application of AMD3100 for CD34+ cell mobilization and collection for hematopoietic stem cell transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTITlBQQs3EbVg90H21EOLACvtfcHk0ljpTGz4GSt86Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotF2ntb8%253D&md5=c0a000f9ac7f12cf85f4bd086f205240</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-02-0663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-02-0663%26sid%3Dliteratum%253Aachs%26aulast%3DLiles%26aufirst%3DW.%2BC.%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26aulast%3DRodger%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DB.%26aulast%3DH%25C3%25BCbel%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DS.%26aulast%3DHangoc%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DHenson%26aufirst%3DG.%2BW.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DDale%26aufirst%3DD.%2BC.%26atitle%3DMobilization%2520of%2520hematopoietic%2520progenitor%2520cells%2520in%2520healthy%2520volunteers%2520by%2520AMD3100%252C%2520a%2520CXCR4%2520antagonist%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D2728%26epage%3D2730%26doi%3D10.1182%2Fblood-2003-02-0663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolwell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nademanee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span><span class="refDoi"> DOI: 10.1200/JCO.2008.20.7209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1200%2FJCO.2008.20.7209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19720922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4767-4773&author=J.+F.+DiPersioauthor=I.+N.+Micallefauthor=P.+J.+Stiffauthor=B.+J.+Bolwellauthor=R.+T.+Maziarzauthor=E.+Jacobsenauthor=A.+Nademaneeauthor=J.+McCartyauthor=G.+Bridgerauthor=G.+Calandra&title=Phase+III+prospective+randomized+double-blind+placebo-controlled+trial+of+plerixafor+plus+granulocyte+colony-stimulating+factor+compared+with+placebo+plus+granulocyte+colony-stimulating+factor+for+autologous+stem-cell+mobilization+and+transplantation+for+patients+with+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2008.20.7209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">DiPersio, John F.; Micallef, Ivana N.; Stiff, Patrick J.; Bolwell, Brian J.; Maziarz, Richard T.; Jacobsen, Eric; Nademanee, Auayporn; McCarty, John; Bridger, Gary; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4767-4773</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This study evaluates the safety and efficacy of plerixafor (AMD3100), a CXCR4 antagonist, in mobilizing hematopoietic stem cells for autologous stem-cell transplantation in non-Hodgkin's lymphoma (NHL) patients.  Patients and Methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study.  Patients with non-Hodgkin's lymphoma requiring an autologous hematopoietic stem-cell transplantation in first or second complete or partial remission were eligible.  Patients received granulocyte colony-stimulating factor (G-CSF; 10 μg/kg) s.c. daily for up to 8 days.  Beginning on evening of day 4 and continuing daily for up to 4 days, patients received either plerixafor (240 μg/kg) or placebo s.c.  Starting on day 5, patients began daily apheresis for up to 4 days or until ≥ 5 × 106 CD34+ cells/kg were collected.  The primary end point was the percentage of patients who collected ≥ 5 × 106 CD34+ cells/kg in 4 or fewer apheresis days.  Results: This report presents all data for all patients (n = 298) through 12 mo follow-up.  Eighty-nine (59%) of 150 patients in the plerixafor group and 29 (20%) of 148 patients in the placebo group met the primary end point (P < .001).  One hundred thirty-five patients (90%) in plerixafor group and 82 patients (55%) in placebo group underwent transplantation after initial mobilization.  Median time to engraftment was similar in both groups.  The most common plerixafor-assocd. adverse events were GI disorders and injection site reactions.  Conclusion: Plerixafor and G-CSF were well tolerated and resulted in a significantly higher proportion of patients with non-Hodgkin's lymphoma achieving the optimal CD34+ cell target for transplantation in fewer apheresis days, compared with G-CSF alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYjfnL3AIfbbVg90H21EOLACvtfcHk0ljpTGz4GSt86Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI&md5=b2e30e8f1372875267ca61af49ee96cd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.20.7209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.20.7209%26sid%3Dliteratum%253Aachs%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DMicallef%26aufirst%3DI.%2BN.%26aulast%3DStiff%26aufirst%3DP.%2BJ.%26aulast%3DBolwell%26aufirst%3DB.%2BJ.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DJacobsen%26aufirst%3DE.%26aulast%3DNademanee%26aufirst%3DA.%26aulast%3DMcCarty%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DPhase%2520III%2520prospective%2520randomized%2520double-blind%2520placebo-controlled%2520trial%2520of%2520plerixafor%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520compared%2520with%2520placebo%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520for%2520autologous%2520stem-cell%2520mobilization%2520and%2520transplantation%2520for%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D4767%26epage%3D4773%26doi%3D10.1200%2FJCO.2008.20.7209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stiff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalhaes-Silverman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Territo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Treatment with plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient</span> <span class="citation_source-journal">Biol. Blood Marrow Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1016/j.bbmt.2008.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bbmt.2008.11.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=249-256&author=P.+Stiffauthor=I.+Micallefauthor=P.+McCarthyauthor=M.+Magalhaes-Silvermanauthor=D.+Weisdorfauthor=M.+Territoauthor=K.+Badelauthor=G.+Calandra&title=Treatment+with+plerixafor+in+non-Hodgkin%E2%80%99s+lymphoma+and+multiple+myeloma+patients+to+increase+the+number+of+peripheral+blood+stem+cells+when+given+a+mobilizing+regimen+of+G-CSF%3A+implications+for+the+heavily+pretreated+patient&doi=10.1016%2Fj.bbmt.2008.11.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbmt.2008.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbmt.2008.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DStiff%26aufirst%3DP.%26aulast%3DMicallef%26aufirst%3DI.%26aulast%3DMcCarthy%26aufirst%3DP.%26aulast%3DMagalhaes-Silverman%26aufirst%3DM.%26aulast%3DWeisdorf%26aufirst%3DD.%26aulast%3DTerrito%26aufirst%3DM.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DTreatment%2520with%2520plerixafor%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520multiple%2520myeloma%2520patients%2520to%2520increase%2520the%2520number%2520of%2520peripheral%2520blood%2520stem%2520cells%2520when%2520given%2520a%2520mobilizing%2520regimen%2520of%2520G-CSF%253A%2520implications%2520for%2520the%2520heavily%2520pretreated%2520patient%26jtitle%3DBiol.%2520Blood%2520Marrow%2520Transplant.%26date%3D2009%26volume%3D15%26spage%3D249%26epage%3D256%26doi%3D10.1016%2Fj.bbmt.2008.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">MacKenzie, A. R.; Valsecchi, M. E.; Flomenberg, N.</span><span> </span><span class="NLM_article-title">The Current Role of Plerixafor in Stem Cell Mobilization for Hematopoietic Stem Cell Transplantation</span>. In  <span class="citation_source-book">Novel Developments in Stem Cell Mobilization</span>; <span class="NLM_contrib-group">Fruehauf, S.; Zeller, W. J.; Calandra, G.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1007%2F978-1-4614-1960-0_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=103-131&author=A.+R.+MacKenzie&author=M.+E.+Valsecchi&author=N.+Flomenbergauthor=S.+Fruehauf&author=W.+J.+Zeller&author=G.+Calandra&title=Novel+Developments+in+Stem+Cell+Mobilization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1960-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1960-0_7%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DA.%2BR.%26atitle%3DThe%2520Current%2520Role%2520of%2520Plerixafor%2520in%2520Stem%2520Cell%2520Mobilization%2520for%2520Hematopoietic%2520Stem%2520Cell%2520Transplantation%26btitle%3DNovel%2520Developments%2520in%2520Stem%2520Cell%2520Mobilization%26aulast%3DFruehauf%26aufirst%3DS.%26pub%3DSpringer%26date%3D2012%26spage%3D103%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flomenberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesole, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesveld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPersio, J. F.</span><span> </span><span class="NLM_article-title">Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1102</span><span class="refDoi"> DOI: 10.1200/JCO.2004.07.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1200%2FJCO.2004.07.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15020611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlCku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=1095-1102&author=S.+M.+Devineauthor=N.+Flomenbergauthor=D.+H.+Vesoleauthor=J.+Liesveldauthor=D.+Weisdorfauthor=K.+Badelauthor=G.+Calandraauthor=J.+F.+DiPersio&title=Rapid+mobilization+of+CD34%2B+cells+following+administration+of+the+CXCR4+antagonist+AMD3100+to+patients+with+multiple+myeloma+and+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2004.07.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma</span></div><div class="casAuthors">Devine, Steven M.; Flomenberg, Neal; Vesole, David H.; Liesveld, Jane; Weisdorf, Daniel; Badel, Karin; Calandra, Gary; DiPersio, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1102</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Interactions between the chemokine receptor CXCR4 and its ligand stromal derived factor-1 regulate hematopoietic stem-cell trafficking.  AMD3100 is a CXCR4 antagonist that induces rapid mobilization of CD34+ cells in healthy volunteers.  We performed a phase I study assessing the safety and clin. effects of AMD3100 in patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL).  Thirteen patients (MM, n = 7; NHL, n = 6) received AMD3100 at a dose of either 160 μg/kg (n = 6) or 240 μg/kg (n = 7).  WBC and peripheral blood (PB) CD34+ cell counts were analyzed at 4 and 6 h following injection.  AMD3100 caused a rapid and statistically significant increase in the total WBC and PB CD34+ counts at both 4 and 6 h following a single injection.  The abs. CD34+ cell count increased from a baseline of 2.6 ± 0.7/μL (mean ± SE) to 15.6 ± 3.9/μL and 16.2 ± 4.3/μL at 4 h (P = .002) and 6 h after injection (P = .003), resp.  The abs. CD34+ cell counts obsd. at 4 and 6 h following AMD3100 were higher in the 240 μg/kg group (19.3 ± 6.9/μL and 20.4 ± 7.6/μL, resp.) compared with the 160 μg/kg group (11.3 ± 2.7/μL and 11.3 ± 2.5/μL, resp.).  The drug was well tolerated and only grade 1 toxicities were encountered.  AMD3100 appears to be a safe and effective agent for the rapid mobilization of CD34+ cells in patients who have received prior chemotherapy.  Further studies in combination with granulocyte colony-stimuating factor in patients with lymphoid malignancies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-jRtcaX8crVg90H21EOLACvtfcHk0lh56SXCgkB13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlCku7s%253D&md5=0c452ac05ac8153370ba3c265154e311</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.07.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.07.131%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DFlomenberg%26aufirst%3DN.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26aulast%3DLiesveld%26aufirst%3DJ.%26aulast%3DWeisdorf%26aufirst%3DD.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26atitle%3DRapid%2520mobilization%2520of%2520CD34%252B%2520cells%2520following%2520administration%2520of%2520the%2520CXCR4%2520antagonist%2520AMD3100%2520to%2520patients%2520with%2520multiple%2520myeloma%2520and%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D1095%26epage%3D1102%26doi%3D10.1200%2FJCO.2004.07.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirthlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J. A.</span><span> </span><span class="NLM_article-title">Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor</span> <span class="citation_source-journal">Biol. Blood Marrow Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.bbmt.2006.12.445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bbmt.2006.12.445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=398-411&author=D.+A.+Hessauthor=J.+Bondeauthor=T.+P.+Craftauthor=L.+Wirthlinauthor=S.+Hohmauthor=R.+Laheyauthor=L.+M.+Todtauthor=J.+F.+Dipersioauthor=S.+M.+Devineauthor=J.+A.+Nolta&title=Human+progenitor+cells+rapidly+mobilized+by+AMD3100+repopulate+NOD%2FSCID+mice+with+increased+frequency+in+comparison+to+cells+from+the+same+donor+mobilized+by+granulocyte+colony+stimulating+factor&doi=10.1016%2Fj.bbmt.2006.12.445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbmt.2006.12.445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbmt.2006.12.445%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DD.%2BA.%26aulast%3DBonde%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DT.%2BP.%26aulast%3DWirthlin%26aufirst%3DL.%26aulast%3DHohm%26aufirst%3DS.%26aulast%3DLahey%26aufirst%3DR.%26aulast%3DTodt%26aufirst%3DL.%2BM.%26aulast%3DDipersio%26aufirst%3DJ.%2BF.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DNolta%26aufirst%3DJ.%2BA.%26atitle%3DHuman%2520progenitor%2520cells%2520rapidly%2520mobilized%2520by%2520AMD3100%2520repopulate%2520NOD%252FSCID%2520mice%2520with%2520increased%2520frequency%2520in%2520comparison%2520to%2520cells%2520from%2520the%2520same%2520donor%2520mobilized%2520by%2520granulocyte%2520colony%2520stimulating%2520factor%26jtitle%3DBiol.%2520Blood%2520Marrow%2520Transplant.%26date%3D2007%26volume%3D13%26spage%3D398%26epage%3D411%26doi%3D10.1016%2Fj.bbmt.2006.12.445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Larochelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krouse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hematti, P.</span><span> </span><span class="NLM_article-title">AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">3772</span><span class="NLM_x">–</span> <span class="NLM_lpage">3778</span><span class="refDoi"> DOI: 10.1182/blood-2005-09-3592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood-2005-09-3592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=3772-3778&author=A.+Larochelleauthor=A.+Krouseauthor=M.+Metzgerauthor=D.+Orlicauthor=R.+E.+Donahueauthor=S.+Frickerauthor=G.+Bridgerauthor=C.+E.+Dunbarauthor=P.+Hematti&title=AMD3100+mobilizes+hematopoietic+stem+cells+with+long-term+repopulating+capacity+in+nonhuman+primates&doi=10.1182%2Fblood-2005-09-3592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-09-3592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-09-3592%26sid%3Dliteratum%253Aachs%26aulast%3DLarochelle%26aufirst%3DA.%26aulast%3DKrouse%26aufirst%3DA.%26aulast%3DMetzger%26aufirst%3DM.%26aulast%3DOrlic%26aufirst%3DD.%26aulast%3DDonahue%26aufirst%3DR.%2BE.%26aulast%3DFricker%26aufirst%3DS.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDunbar%26aufirst%3DC.%2BE.%26aulast%3DHematti%26aufirst%3DP.%26atitle%3DAMD3100%2520mobilizes%2520hematopoietic%2520stem%2520cells%2520with%2520long-term%2520repopulating%2520capacity%2520in%2520nonhuman%2520primates%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D3772%26epage%3D3778%26doi%3D10.1182%2Fblood-2005-09-3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlebak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chataway, J.</span><span> </span><span class="NLM_article-title">Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span><span class="refDoi"> DOI: 10.5966/sctm.2013-0178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.5966%2Fsctm.2013-0178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25107583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=1322-1330&author=S.+Banerjeeauthor=P.+Bentleyauthor=M.+Hamadyauthor=S.+Marleyauthor=J.+Davisauthor=A.+Shlebakauthor=J.+Nichollsauthor=D.+A.+Williamsonauthor=S.+L.+Jensenauthor=M.+Gordonauthor=N.+Habibauthor=J.+Chataway&title=Intra-arterial+immunoselected+CD34%2B+stem+cells+for+acute+ischemic+stroke&doi=10.5966%2Fsctm.2013-0178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke</span></div><div class="casAuthors">Banerjee, Soma; Bentley, Paul; Hamady, Mohammad; Marley, Stephen; Davis, John; Shlebak, Abdul; Nicholls, Joanna; Williamson, Deborah A.; Jensen, Steen L.; Gordon, Myrtle; Habib, Nagy; Chataway, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1322-1330</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Treatment with CD34+ hematopoietic stem/progenitor cells has been shown to improve functional recovery in nonhuman models of ischemic stroke via promotion of angiogenesis and neurogenesis.  We aimed to det. the safety and feasibility of treatment with CD34+ cells delivered intra-arterially in patients with acute ischemic stroke.  This was the first study in human subjects.  We performed a prospective, nonrandomized, open-label, phase I study of autologous, immunoselected CD34+ stem/progenitor cell therapy in patients presenting within 7 days of onset with severe anterior circulation ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≥8).  CD34+ cells were collected from the bone marrow of the subjects before being delivered by catheter angiog. into the ipsilesional middle cerebral artery.  Eighty-two patients with severe anterior circulation ischemic stroke were screened, of whom five proceeded to treatment.  The common reasons for exclusion were age >80 years (n = 19); medical instability (n = 17), and significant carotid stenosis (n = 13).  The procedure was well tolerated in all patients, and no significant treatment-related adverse effects occurred.  All patients showed improvements in clin. functional scores (Modified Rankin Score and NIHSS score) and redns. in lesion vol. during a 6-mo follow-up period.  Autologous CD34+ selected stem/progenitor cell therapy delivered intra-arterially into the infarct territory can be achieved safely in patients with acute ischemic stroke.  Future studies that address eligibility criteria, dosage, delivery site, and timing and that use surrogate imaging markers of outcome are desirable before larger scale clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNQ_3BiralLVg90H21EOLACvtfcHk0lh56SXCgkB13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFKitg%253D%253D&md5=b7f157cb9fc1314869bf6e185fa0cfab</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2013-0178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2013-0178%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBentley%26aufirst%3DP.%26aulast%3DHamady%26aufirst%3DM.%26aulast%3DMarley%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DShlebak%26aufirst%3DA.%26aulast%3DNicholls%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BA.%26aulast%3DJensen%26aufirst%3DS.%2BL.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DHabib%26aufirst%3DN.%26aulast%3DChataway%26aufirst%3DJ.%26atitle%3DIntra-arterial%2520immunoselected%2520CD34%252B%2520stem%2520cells%2520for%2520acute%2520ischemic%2520stroke%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2014%26volume%3D3%26spage%3D1322%26epage%3D1330%26doi%3D10.5966%2Fsctm.2013-0178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ichiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama-Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano-Kurosaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4190</span><span class="refDoi"> DOI: 10.1073/pnas.0630420100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1073%2Fpnas.0630420100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4185-4190&author=K.+Ichiyamaauthor=S.+Yokoyama-Kumakuraauthor=Y.+Tanakaauthor=R.+Tanakaauthor=K.+Hiroseauthor=K.+Bannaiauthor=T.+Edamatsuauthor=M.+Yanakaauthor=Y.+Niitaniauthor=N.+Miyano-Kurosakiauthor=H.+Takakuauthor=Y.+Koyanagiauthor=N.+Yamamoto&title=A+duodenally+absorbable+CXC+chemokine+receptor+4+antagonist%2C+KRH-1636%2C+exhibits+a+potent+and+selective+anti-HIV-1+activity&doi=10.1073%2Fpnas.0630420100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630420100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630420100%26sid%3Dliteratum%253Aachs%26aulast%3DIchiyama%26aufirst%3DK.%26aulast%3DYokoyama-Kumakura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DBannai%26aufirst%3DK.%26aulast%3DEdamatsu%26aufirst%3DT.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DNiitani%26aufirst%3DY.%26aulast%3DMiyano-Kurosaki%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520duodenally%2520absorbable%2520CXC%2520chemokine%2520receptor%25204%2520antagonist%252C%2520KRH-1636%252C%2520exhibits%2520a%2520potent%2520and%2520selective%2520anti-HIV-1%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4185%26epage%3D4190%26doi%3D10.1073%2Fpnas.0630420100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3280</span><span class="NLM_x">–</span> <span class="NLM_lpage">3289</span><span class="refDoi"> DOI: 10.1021/jm050009h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050009h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3280-3289&author=H.+Tamamuraauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=S.+Oishiauthor=A.+Esakaauthor=J.+O.+Trentauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=S.+C.+Peiperauthor=A.+Otakaauthor=N.+Fujii&title=Identification+of+novel+low+molecular+weight+CXCR4+antagonists+by+structural+tuning+of+cyclic+tetrapeptide+scaffolds&doi=10.1021%2Fjm050009h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm050009h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050009h%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520novel%2520low%2520molecular%2520weight%2520CXCR4%2520antagonists%2520by%2520structural%2520tuning%2520of%2520cyclic%2520tetrapeptide%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3280%26epage%3D3289%26doi%3D10.1021%2Fjm050009h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1021/jm0607350</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607350" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=192-198&author=S.+Uedaauthor=S.+Oishiauthor=Z.+X.+Wangauthor=T.+Arakiauthor=H.+Tamamuraauthor=J.+Cluzeauauthor=H.+Ohnoauthor=S.+Kusanoauthor=H.+Nakashimaauthor=J.+O.+Trentauthor=S.+C.+Peiperauthor=N.+Fujii&title=Structure-activity+relationships+of+cyclic+peptide-based+chemokine+receptor+CXCR4+antagonists%3A+disclosing+the+importance+of+side-chain+and+backbone+functionalities&doi=10.1021%2Fjm0607350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1021%2Fjm0607350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607350%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationships%2520of%2520cyclic%2520peptide-based%2520chemokine%2520receptor%2520CXCR4%2520antagonists%253A%2520disclosing%2520the%2520importance%2520of%2520side-chain%2520and%2520backbone%2520functionalities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D192%26epage%3D198%26doi%3D10.1021%2Fjm0607350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Introduction of functional groups into peptides via N-alkylation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span><span class="refDoi"> DOI: 10.1021/ol800654n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800654n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFyku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2015-2018&author=O.+Demmerauthor=I.+Dijkgraafauthor=M.+Schotteliusauthor=H.+J.+Westerauthor=H.+Kessler&title=Introduction+of+functional+groups+into+peptides+via+N-alkylation&doi=10.1021%2Fol800654n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40dR"><div class="casContent"><span class="casTitleNuber">40d</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of Functional Groups into Peptides via N-Alkylation</span></div><div class="casAuthors">Demmer, O.; Dijkgraaf, I.; Schottelius, M.; Wester, H.-J.; Kessler, H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-2018</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An optimized protocol for the mild and selective Fukuyama-Mitsunobu reaction was used for mono- and di-N-alkylation on solid support.  Thereby, nonfunctionalized aliph. and arom. residues are quickly introduced into transiently protected, primary amines of a linear peptide.  N-Alkylation can also be used to implement alkyl chains carrying (protected) functionalities suited for subsequent modification.  Applicability of this method is demonstrated by various N-alkylated analogs of a cyclic CXCR4 receptor antagonist originally developed by Fujii et al.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGxHNtia_dvbVg90H21EOLACvtfcHk0lgY9oKrGsNrcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFyku74%253D&md5=4778b2a183db741daf53aa25e6ab9d7c</span></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=10.1021%2Fol800654n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800654n%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DDijkgraaf%26aufirst%3DI.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DIntroduction%2520of%2520functional%2520groups%2520into%2520peptides%2520via%2520N-alkylation%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2015%26epage%3D2018%26doi%3D10.1021%2Fol800654n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span> </span><span class="NLM_article-title">Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.+G.+Zerwes&title=Orally+bioavailable+isothioureas+block+function+of+the+chemokine+receptor+CXCR4+in+vitro+and+in+vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40e&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26atitle%3DOrally%2520bioavailable%2520isothioureas%2520block%2520function%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossniklaus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8556</span><span class="NLM_x">–</span> <span class="NLM_lpage">8568</span><span class="refDoi"> DOI: 10.1021/jm100786g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100786g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8556-8568&author=A.+Zhuauthor=W.+Zhanauthor=Z.+Liangauthor=Y.+Yoonauthor=H.+Yangauthor=H.+E.+Grossniklausauthor=J.+Xuauthor=M.+Rojasauthor=M.+Lockwoodauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=H.+Shim&title=Dipyrimidine+amines%3A+a+novel+class+of+chemokine+receptor+type+4+antagonists+with+high+specificity&doi=10.1021%2Fjm100786g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40fR"><div class="casContent"><span class="casTitleNuber">40f</span><div class="casTitle"><span class="NLM_cas:atitle">Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity</span></div><div class="casAuthors">Zhu, Aizhi; Zhan, Weiqiang; Liang, Zhongxing; Yoon, Younghyoun; Yang, Hua; Grossniklaus, Hans E.; Xu, Jianguo; Rojas, Mauricio; Lockwood, Mark; Snyder, James P.; Liotta, Dennis C.; Shim, Hyunsuk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8556-8568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The C-X-C chemokine receptor type 4 (CXCR4)/stromal cell derived factor-1 (SDF-1 or CXCL12) interaction and the resulting cell signaling cascade play a key role in metastasis and inflammation.  On the basis of a previously published CXCR4 antagonist (WZ811), a series of novel nonpeptidic anti-CXCR4 small mols. have been designed and synthesized to improve potency.  Following a structure-activity profile, more advanced compds. in the N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine series were discovered and shown to possess higher CXCR4 binding potential and specificity.  I [R = (2-morpholinoethyl)amino] is the lead compd. and exhibits subnanomolar potency in three in vitro assays including competitive binding, Matrigel invasion, and Gαi cyclic adenosine monophosphate (cAMP) modulation signaling.  Furthermore, I [R = (2-morpholinoethyl)amino] displays promising effects by interfering with CXCR4 function in three mouse models: paw inflammation, Matrigel plug angiogenesis, and uveal melanoma micrometastasis.  These data demonstrate that dipyrimidine amines are unique CXCR4 antagonists with high potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNKsIjSnIYrVg90H21EOLACvtfcHk0lgXYpip2W143A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7jL&md5=cfc72c23b3eb5675f9f2c2c1a43e2961</span></div><a href="/servlet/linkout?suffix=cit40f&amp;dbid=16384&amp;doi=10.1021%2Fjm100786g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100786g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGrossniklaus%26aufirst%3DH.%2BE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DRojas%26aufirst%3DM.%26aulast%3DLockwood%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DDipyrimidine%2520amines%253A%2520a%2520novel%2520class%2520of%2520chemokine%2520receptor%2520type%25204%2520antagonists%2520with%2520high%2520specificity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8556%26epage%3D8568%26doi%3D10.1021%2Fjm100786g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3026</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.03.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20443225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3026-3030&author=J.+F.+Millerauthor=K.+S.+Gudmundssonauthor=L.+D.+Richardsonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Synthesis+and+SAR+of+novel+isoquinoline+CXCR4+antagonists+with+potent+anti-HIV+activity&doi=10.1016%2Fj.bmcl.2010.03.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40gR"><div class="casContent"><span class="casTitleNuber">40g</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span></div><div class="casAuthors">Miller, John F.; Gudmundsson, Kristjan S.; Richardson, Leah D'Aurora; Jenkinson, Stephen; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3026-3030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using AMD070, I, as a starting point for structural modification, a novel series of isoquinoline CXCR4 antagonists was developed, e.g., II.  A structure-activity scan of alternate lower heterocycles led to the 3-isoquinolinyl moiety as an attractive replacement for benzimidazole.  Side chain optimization in the isoquinoline series led to a no. of compds. with low nanomolar anti-HIV activities and promising rat PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKb6n6z51MXbVg90H21EOLACvtfcHk0lgXYpip2W143A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D&md5=4b929a2e6843cb3b8ea5fbb9eba4a865</span></div><a href="/servlet/linkout?suffix=cit40g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.118%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DRichardson%26aufirst%3DL.%2BD.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520isoquinoline%2520CXCR4%2520antagonists%2520with%2520potent%2520anti-HIV%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3026%26epage%3D3030%26doi%3D10.1016%2Fj.bmcl.2010.03.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Catalano, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svolto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span> </span><span class="NLM_article-title">Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2186</span><span class="NLM_x">–</span> <span class="NLM_lpage">2190</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20194023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2186-2190&author=J.+G.+Catalanoauthor=K.+S.+Gudmundssonauthor=A.+Svoltoauthor=S.+D.+Boggsauthor=J.+F.+Millerauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelanauthor=D.+J.+Minickauthor=D.+P.+Phelpsauthor=S.+Jenkinson&title=Synthesis+of+a+novel+tricyclic+1%2C2%2C3%2C4%2C4a%2C5%2C6%2C10b-octahydro-1%2C10-phenanthroline+ring+system+and+CXCR4+antagonists+with+potent+activity+against+HIV-1&doi=10.1016%2Fj.bmcl.2010.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40hR"><div class="casContent"><span class="casTitleNuber">40h</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1</span></div><div class="casAuthors">Catalano, John G.; Gudmundsson, Kristjan S.; Svolto, Angilique; Boggs, Sharon D.; Miller, John F.; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat; Minick, Doug J.; Phelps, Dean P.; Jenkinson, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2186-2190</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stereorandom and diastereoselective syntheses of a novel 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system are described.  Derivs. of all four diastereomers were prepd. and isolated in >98% ee.  The pure enantiomers were compared in order to det. the preferred abs. and relative configuration required for optimal anti-HIV activity.  Anti-HIV potency and pharmacokinetic properties of the newly synthesized tricyclic octahydrophenanthroline inhibitors, e.g., I, are presented and comparisons are made to previously reported bicyclic (8S)-N-methyl-5,6,7,8-tetrahydro-8-quinolinamine analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPwCJZdIKPobVg90H21EOLACvtfcHk0liutP0ChhGmlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmt74%253D&md5=851402ecf131353d85062e3551a2e82d</span></div><a href="/servlet/linkout?suffix=cit40h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DJ.%2BG.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DSvolto%26aufirst%3DA.%26aulast%3DBoggs%26aufirst%3DS.%2BD.%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DPhelps%26aufirst%3DD.%2BP.%26aulast%3DJenkinson%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520novel%2520tricyclic%25201%252C2%252C3%252C4%252C4a%252C5%252C6%252C10b-octahydro-1%252C10-phenanthroline%2520ring%2520system%2520and%2520CXCR4%2520antagonists%2520with%2520potent%2520activity%2520against%2520HIV-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2186%26epage%3D2190%26doi%3D10.1016%2Fj.bmcl.2010.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2125</span><span class="NLM_x">–</span> <span class="NLM_lpage">2128</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.02.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2125-2128&author=J.+F.+Millerauthor=E.+M.+Turnerauthor=K.+S.+Gudmundssonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Novel+N-substituted+benzimidazole+CXCR4+antagonists+as+potential+anti-HIV+agents&doi=10.1016%2Fj.bmcl.2010.02.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.053%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DNovel%2520N-substituted%2520benzimidazole%2520CXCR4%2520antagonists%2520as%2520potential%2520anti-HIV%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2125%26epage%3D2128%26doi%3D10.1016%2Fj.bmcl.2010.02.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skupinska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fluri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2010.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=262-266&author=R.+Skerljauthor=G.+Bridgerauthor=E.+McEachernauthor=C.+Harwigauthor=C.+Smithauthor=T.+Wilsonauthor=D.+Vealeauthor=H.+Yeeauthor=J.+Crawfordauthor=K.+Skupinskaauthor=R.+Wauthyauthor=W.+Yangauthor=Y.+Zhuauthor=D.+Boguckiauthor=M.+Di+Fluriauthor=J.+Langilleauthor=D.+Huskensauthor=E.+De+Clercqauthor=D.+Schols&title=Synthesis+and+SAR+of+novel+CXCR4+antagonists+that+are+potent+inhibitors+of+T+tropic+%28X4%29+HIV-1+replication&doi=10.1016%2Fj.bmcl.2010.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40j&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DMcEachern%26aufirst%3DE.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DYee%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DJ.%26aulast%3DSkupinska%26aufirst%3DK.%26aulast%3DWauthy%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DDi%2BFluri%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520CXCR4%2520antagonists%2520that%2520are%2520potent%2520inhibitors%2520of%2520T%2520tropic%2520%2528X4%2529%2520HIV-1%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D262%26epage%3D266%26doi%3D10.1016%2Fj.bmcl.2010.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Discovery of novel stem cell mobilizers that target the CXCR4 receptor</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1002/cmdc.201100525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fcmdc.201100525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=209-212&author=C.+H.+Wuauthor=C.+P.+Changauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=S.+H.+Wuauthor=K.+C.+Yehauthor=Y.+C.+Wongauthor=C.+J.+Hsiehauthor=C.+T.+Chenauthor=T.+T.+Kaoauthor=S.+Y.+Wuauthor=C.+F.+Yehauthor=C.+T.+Tsengauthor=Y.+S.+Chaoauthor=K.+S.+Shia&title=Discovery+of+novel+stem+cell+mobilizers+that+target+the+CXCR4+receptor&doi=10.1002%2Fcmdc.201100525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40k&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100525%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DK.%2BC.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DKao%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DYeh%26aufirst%3DC.%2BF.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520novel%2520stem%2520cell%2520mobilizers%2520that%2520target%2520the%2520CXCR4%2520receptor%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D209%26epage%3D212%26doi%3D10.1002%2Fcmdc.201100525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40lR"><div class="casContent"><span class="casTitleNuber">40l</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0lh7xN0tr5u6kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit40l&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Mooring, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4</span> <span class="citation_source-journal">Heterocycl. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1515/hc-2014-0041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1515%2Fhc-2014-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25620839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=149-153&author=S.+R.+Mooringauthor=T.+Gainesauthor=Z.+Liangauthor=H.+Shim&title=Synthesis+of+pyridine+derivatives+as+potential+antagonists+of+chemokine+receptor+type+4&doi=10.1515%2Fhc-2014-0041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40mR"><div class="casContent"><span class="casTitleNuber">40m</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4</span></div><div class="casAuthors">Mooring, Suazette Reid; Gaines, Theresa; Liang, Zhongxing; Shim, Hyunsuk</div><div class="citationInfo"><span class="NLM_cas:title">Heterocyclic Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-153</span>CODEN:
                <span class="NLM_cas:coden">HCOMEX</span>;
        ISSN:<span class="NLM_cas:issn">0793-0283</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A series of pyridine derivs. were synthesized as potential inhibitors of chemokine receptor type 4.  This chemokine receptor has been linked to various disease pathways including HIV-1 proliferation, autoimmune disorders, inflammatory diseases, and cancer metastasis.  The compds. were tested for activity using an affinity binding assay and an assay that tests the ability to inhibit cell invasion.  Two hit compds. (2b and 2j) have been identified for further evaluation that inhibit cell invasion by at least 50% and have an effective concn. of less than 100 nm in the binding affinity assay.  The structures of the synthesized compds. were confirmed by spectral data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqguOyRBdcZ8LVg90H21EOLACvtfcHk0lh7xN0tr5u6kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCns7Y%253D&md5=e45659a568fb379d8b775a464b57ead1</span></div><a href="/servlet/linkout?suffix=cit40m&amp;dbid=16384&amp;doi=10.1515%2Fhc-2014-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhc-2014-0041%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520pyridine%2520derivatives%2520as%2520potential%2520antagonists%2520of%2520chemokine%2520receptor%2520type%25204%26jtitle%3DHeterocycl.%2520Commun.%26date%3D2014%26volume%3D20%26spage%3D149%26epage%3D153%26doi%3D10.1515%2Fhc-2014-0041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4769</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmc.2014.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4759-4769&author=Z.+G.+Zachariassenauthor=S.+Thieleauthor=E.+A.+Bergauthor=P.+Rasmussenauthor=T.+Fossenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8author=B.+E.+Haug&title=Design%2C+synthesis%2C+and+biological+evaluation+of+scaffold-based+tripeptidomimetic+antagonists+for+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1016%2Fj.bmc.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DE.%2BA.%26aulast%3DRasmussen%26aufirst%3DP.%26aulast%3DFossen%26aufirst%3DT.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520scaffold-based%2520tripeptidomimetic%2520antagonists%2520for%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4759%26epage%3D4769%26doi%3D10.1016%2Fj.bmc.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Nomura, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span> </span><span class="NLM_article-title">Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">8734</span><span class="NLM_x">–</span> <span class="NLM_lpage">8739</span><span class="refDoi"> DOI: 10.1039/C5OB00891C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1039%2FC5OB00891C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=26186480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40o&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=8734-8739&author=W.+Nomuraauthor=T.+Kosekiauthor=N.+Ohashiauthor=T.+Mizuguchiauthor=H.+Tamamura&title=Trivalent+ligands+for+CXCR4+bearing+polyproline+linkers+show+specific+recognition+for+cells+with+increased+CXCR4+expression&doi=10.1039%2FC5OB00891C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40oR"><div class="casContent"><span class="casTitleNuber">40o</span><div class="casTitle"><span class="NLM_cas:atitle">Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression</span></div><div class="casAuthors">Nomura, Wataru; Koseki, Taisuke; Ohashi, Nami; Mizuguchi, Takaaki; Tamamura, Hirokazu</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8734-8739</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The assembly status of G protein-coupled receptors (GPCR) on the cell surface is of interest because the multimerization of GPCR could play pivotal roles in cellular functions.  A bivalent ligand with polyproline linkers for CXCR4 has been shown to serve as a "mol. ruler" as a result of the rigid structure of polyproline helixes.  To expand the utility of the ligands with rigid linkers and explore the possible multimeric forms of GPCR, trivalent ligands with polyproline helixes were newly designed and synthesized.  The binding affinities of the trivalent ligands for CXCR4 suggested that the ligands recognize the dimeric form of CXCR4 on the cell surface.  The fluorescence imaging and anal. by flow cytometry revealed that the ligand with 9 proline linkers binds to CXCR4 with remarkable specificity.  The results of the present study suggest that the ligand design with rigid linkers is useful in the multimeric form, but the design of trivalent ligands requires different strategic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8j0uYj20niLVg90H21EOLACvtfcHk0lh7xN0tr5u6kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgtbnP&md5=2013c734cffb4870b0a0abca749cfa3d</span></div><a href="/servlet/linkout?suffix=cit40o&amp;dbid=16384&amp;doi=10.1039%2FC5OB00891C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00891C%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DW.%26aulast%3DKoseki%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DMizuguchi%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26atitle%3DTrivalent%2520ligands%2520for%2520CXCR4%2520bearing%2520polyproline%2520linkers%2520show%2520specific%2520recognition%2520for%2520cells%2520with%2520increased%2520CXCR4%2520expression%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D8734%26epage%3D8739%26doi%3D10.1039%2FC5OB00891C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Curreli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scacalossi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span> </span><span class="NLM_article-title">Structure-based design of a small molecule CD4-antagonist with broad spectrum anti-HIV-1 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6909</span><span class="NLM_x">–</span> <span class="NLM_lpage">6927</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40p&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6909-6927&author=F.+Curreliauthor=Y.+D.+Kwonauthor=H.+Zhangauthor=D.+Scacalossiauthor=D.+S.+Belovauthor=A.+A.+Tikhonovauthor=I.+A.+Andreevauthor=A.+Altieriauthor=A.+V.+Kurkinauthor=P.+D.+Kwongauthor=A.+K.+Debnath&title=Structure-based+design+of+a+small+molecule+CD4-antagonist+with+broad+spectrum+anti-HIV-1+activity&doi=10.1021%2Facs.jmedchem.5b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40pR"><div class="casContent"><span class="casTitleNuber">40p</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity</span></div><div class="casAuthors">Curreli, Francesca; Kwon, Young Do; Zhang, Hongtao; Scacalossi, Daniel; Belov, Dmitry S.; Tikhonov, Artur A.; Andreev, Ivan A.; Altieri, Andrea; Kurkin, Alexander V.; Kwong, Peter D.; Debnath, Asim K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6909-6927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Earlier the authors reported the discovery and design of NBD-556 and their analogs which demonstrated their potential as HIV-1 entry inhibitors.  However, progress in developing these inhibitors has been stymied by their CD4-agonist properties, an unfavorable trait for use as drug.  Here, the authors demonstrate the successful conversion of a full CD4-agonist (NBD-556) through a partial CD4-agonist (NBD-09027), to a full CD4-antagonist I (NBD-11021) by structure-based modification of the crit. oxalamide mid-region, previously thought to be intolerant of modification.  I showed unprecedented neutralization breath for this class of inhibitors, with pan-neutralization against a panel of 56 Env-pseudotyped HIV-1 representing diverse subtypes of clin. isolates (IC50 as low as 270 nM).  The cocrystal structure of NBD-11021 complexed to a monomeric HIV-1 gp120 core revealed its detail binding characteristics.  The study is expected to provide a framework for further development of NBD series as HIV-1 entry inhibitors for clin. application against AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZjeIlR_smLVg90H21EOLACvtfcHk0lhBqnyuR69CLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK&md5=db75d8df02d72d932b75596bec6fc1fc</span></div><a href="/servlet/linkout?suffix=cit40p&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00709%26sid%3Dliteratum%253Aachs%26aulast%3DCurreli%26aufirst%3DF.%26aulast%3DKwon%26aufirst%3DY.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DScacalossi%26aufirst%3DD.%26aulast%3DBelov%26aufirst%3DD.%2BS.%26aulast%3DTikhonov%26aufirst%3DA.%2BA.%26aulast%3DAndreev%26aufirst%3DI.%2BA.%26aulast%3DAltieri%26aufirst%3DA.%26aulast%3DKurkin%26aufirst%3DA.%2BV.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520a%2520small%2520molecule%2520CD4-antagonist%2520with%2520broad%2520spectrum%2520anti-HIV-1%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6909%26epage%3D6927%26doi%3D10.1021%2Facs.jmedchem.5b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Zhan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span><span class="refDoi"> DOI: 10.1111/jcmm.12536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1111%2Fjcmm.12536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25753200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40q&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOktL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1614-1623&author=Y.+Zhanauthor=H.+Zhangauthor=J.+Liauthor=Y.+Zhangauthor=J.+Zhangauthor=L.+He&title=A+novel+biphenyl+urea+derivate+inhibits+the+invasion+of+breast+cancer+through+the+modulation+of+CXCR4&doi=10.1111%2Fjcmm.12536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40qR"><div class="casContent"><span class="casTitleNuber">40q</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4</span></div><div class="casAuthors">Zhan, Yingzhuan; Zhang, Han; Li, Jing; Zhang, Yanmin; Zhang, Jie; He, Langchong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1614-1623</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The increased migration and invasion of breast carcinoma cells are key events in the development of metastasis to the lymph nodes and distant organs.  CXCR4, the receptor for stromal-derived factor-1, is reportedly involved in breast carcinogenesis and invasion.  In this study, we investigated a novel biphenyl urea derivate, TPD7 for its ability to affect CXCR4 expression as well as function in breast cancer cells.  We demonstrated that TPD7 inhibited the breast cancer proliferation and down-regulated the CXCR4 expression on breast cancer cells both over-expressing and low-expressing HER2, an oncogene known to induce the chemokine receptor.  Treatments with pharmacol. proteasome inhibitors partial suppressed TPD7-induced decrease in CXCR4 expression.  Real-time PCR anal. revealed that down-regulation of CXCR4 by TPD7 also occurred at the translational level.  Inhibition of CXCR4 expression by TPD7 further correlated with the suppression of SDF-1α-induced migration and invasion in breast tumor cells, knockdown of CXCR4 attenuated TPD7-inhibitory effects.  In addn., TPD7 treatment significantly suppressed matrix metalloproteinase (MMP)-2 and MMP-9 expression, the downstream targets of CXCR4, perhaps via inactivation of the ERK signaling pathway.  Overall, our results showed that TPD7 exerted its anti-invasive effect through the down-regulation of CXCR4 expression and thus had the potential for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouO5qfgyfU37Vg90H21EOLACvtfcHk0lhBqnyuR69CLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOktL3E&md5=95e2f4cb4e6b097d71a534ed1a3b052d</span></div><a href="/servlet/linkout?suffix=cit40q&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12536%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DA%2520novel%2520biphenyl%2520urea%2520derivate%2520inhibits%2520the%2520invasion%2520of%2520breast%2520cancer%2520through%2520the%2520modulation%2520of%2520CXCR4%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2015%26volume%3D19%26spage%3D1614%26epage%3D1623%26doi%3D10.1111%2Fjcmm.12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.4155/fmc.15.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.4155%2Ffmc.15.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=26144264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40r&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1261-1283&author=J.+V%C3%A5ben%C3%B8author=B.+E.+Haugauthor=M.+M.+Rosenkilde&title=Progress+toward+rationally+designed+small-molecule+peptide+and+peptidomimetic+CXCR4+antagonists&doi=10.4155%2Ffmc.15.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40rR"><div class="casContent"><span class="casTitleNuber">40r</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span></div><div class="casAuthors">Vabeno, Jon; Haug, Bengt Erik; Rosenkilde, Mette M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1283</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Over the last 5 years, X-ray structures of CXCR4 in complex with three different ligands (the small-mol. antagonist IT1t, the polypeptide antagonist CVX15 and the viral chemokine antagonist vMIP-II) have been released.  In addn. to the inherent scientific value of these specific X-ray structures, they provide a reliable structural foundation for studies of the mol. interactions between CXCR4 and its key peptide ligands (CXCL12 and HIV-1 gp120), and serve as valuable templates for further development of small-mol. CXCR4 antagonists with therapeutic potential.  We here review recent computational studies of the mol. interactions between CXCR4 and its peptide ligands - based on the X-ray structures of CXCR4 - and the current status of small-mol. peptide and peptidomimetic CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocFGE-iw60gbVg90H21EOLACvtfcHk0ljbukPF8exyaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN&md5=217b88bf8ca537e333adffeaff189576</span></div><a href="/servlet/linkout?suffix=cit40r&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.64%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DProgress%2520toward%2520rationally%2520designed%2520small-molecule%2520peptide%2520and%2520peptidomimetic%2520CXCR4%2520antagonists%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1261%26epage%3D1283%26doi%3D10.4155%2Ffmc.15.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of novel N-aryl piperazine CXCR4 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40s&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmcl.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4950-4955&author=H.+Zhaoauthor=A.+R.+Prosserauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+novel+N-aryl+piperazine+CXCR4+antagonists&doi=10.1016%2Fj.bmcl.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40s&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520N-aryl%2520piperazine%2520CXCR4%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4950%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Pyrazolo-piperidines exhibit dual inhibition of CCR5/CXCR4 HIV entry and reverse transcriptase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=753-757&author=B.+D.+Coxauthor=A.+R.+Prosserauthor=Y.+Sunauthor=Z.+Liauthor=S.+Leeauthor=M.+B.+Huangauthor=V.+C.+Bondauthor=J.+P.+Snyderauthor=M.+Krystalauthor=L.+J.+Wilsonauthor=D.+C.+Liotta&title=Pyrazolo-piperidines+exhibit+dual+inhibition+of+CCR5%2FCXCR4+HIV+entry+and+reverse+transcriptase&doi=10.1021%2Facsmedchemlett.5b00036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40t&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00036%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DM.%2BB.%26aulast%3DBond%26aufirst%3DV.%2BC.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DPyrazolo-piperidines%2520exhibit%2520dual%2520inhibition%2520of%2520CCR5%252FCXCR4%2520HIV%2520entry%2520and%2520reverse%2520transcriptase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D753%26epage%3D757%26doi%3D10.1021%2Facsmedchemlett.5b00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Mishra, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platanias, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiltz, G. E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30155</span><span class="refDoi"> DOI: 10.1038/srep30155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1038%2Fsrep30155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=27456816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1yqsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=30155&author=R.+K.+Mishraauthor=A.+K.+Shumauthor=L.+C.+Plataniasauthor=R.+J.+Millerauthor=G.+E.+Schiltz&title=Discovery+and+characterization+of+novel+small-molecule+CXCR4+receptor+agonists+and+antagonists&doi=10.1038%2Fsrep30155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40uR"><div class="casContent"><span class="casTitleNuber">40u</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists</span></div><div class="casAuthors">Mishra, Rama K.; Shum, Andrew K.; Platanias, Leonidas C.; Miller, Richard J.; Schiltz, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30155</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The chemokine CXCL12 (SDF-1) and its cognate receptor CXCR4 are involved in a large no. of physiol. processes including HIV-1 infectivity, inflammation, tumorigenesis, stem cell migration, and autoimmune diseases.  While previous efforts have identified a no. of CXCR4 antagonists, there have been no small mol. agonists reported.  Herein, we describe the identification of a novel series of CXCR4 modulators, including the first small mols. to display agonist behavior against this receptor, using a combination of structure- and ligand-based virtual screening.  These agonists produce robust calcium mobilization in human melanoma cell lines which can be blocked by the CXCR4-selective antagonist AMD3100.  We also demonstrate the ability of these new agonists to induce receptor internalization, ERK activation, and chemotaxis, all hallmarks of CXCR4 activation.  Our results describe a new series of biol. relevant small mols. that will enable further study of the CXCR4 receptor and may contribute to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiMOfle4R1B7Vg90H21EOLACvtfcHk0ljbukPF8exyaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1yqsr7L&md5=4304791d8f288abea5006a28fd871542</span></div><a href="/servlet/linkout?suffix=cit40u&amp;dbid=16384&amp;doi=10.1038%2Fsrep30155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep30155%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DShum%26aufirst%3DA.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26aulast%3DSchiltz%26aufirst%3DG.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520novel%2520small-molecule%2520CXCR4%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D30155%26doi%3D10.1038%2Fsrep30155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Puig de la Bellacasa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planesas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batllori, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span> </span><span class="NLM_article-title">Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1039/C5OB02419F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40v&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1039%2FC5OB02419F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=1455-1472&author=R.+Puig+de+la+Bellacasaauthor=A.+Gibertauthor=J.+M.+Planesasauthor=L.+Ros-Blancoauthor=X.+Batlloriauthor=R.+Bad%C3%ADaauthor=B.+Clotetauthor=J.+Est%C3%A9author=J.+Teixid%C3%B3author=J.+I.+Borrell&title=Nitrogen+positional+scanning+in+tetramines+active+against+HIV-1+as+potential+CXCR4+inhibitors&doi=10.1039%2FC5OB02419F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40v&amp;dbid=16384&amp;doi=10.1039%2FC5OB02419F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB02419F%26sid%3Dliteratum%253Aachs%26aulast%3DPuig%2Bde%2Bla%2BBellacasa%26aufirst%3DR.%26aulast%3DGibert%26aufirst%3DA.%26aulast%3DPlanesas%26aufirst%3DJ.%2BM.%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DBatllori%26aufirst%3DX.%26aulast%3DBad%25C3%25ADa%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26atitle%3DNitrogen%2520positional%2520scanning%2520in%2520tetramines%2520active%2520against%2520HIV-1%2520as%2520potential%2520CXCR4%2520inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D1455%26epage%3D1472%26doi%3D10.1039%2FC5OB02419F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooring, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span> </span><span class="NLM_article-title">Symmetrical bis-tertiary amines as novel CXCR4 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40w&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.ejmech.2016.04.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=340-350&author=R.+Baiauthor=Z.+Liangauthor=Y.+Yoonauthor=S.+Liuauthor=T.+Gainesauthor=Y.+Oumauthor=Q.+Shiauthor=S.+R.+Mooringauthor=H.+Shim&title=Symmetrical+bis-tertiary+amines+as+novel+CXCR4+inhibitors&doi=10.1016%2Fj.ejmech.2016.04.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40w&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DOum%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DShim%26aufirst%3DH.%26atitle%3DSymmetrical%2520bis-tertiary%2520amines%2520as%2520novel%2520CXCR4%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D340%26epage%3D350%26doi%3D10.1016%2Fj.ejmech.2016.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Gaines, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooring, S. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5052</span><span class="NLM_x">–</span> <span class="NLM_lpage">5060</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40x&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.bmc.2016.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5052-5060&author=T.+Gainesauthor=D.+Campauthor=R.+Baiauthor=Z.+Liangauthor=Y.+Yoonauthor=H.+Shimauthor=S.+R.+Mooring&title=Synthesis+and+evaluation+of+2%2C5+and+2%2C6+pyridine-based+CXCR4+inhibitors&doi=10.1016%2Fj.bmc.2016.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DGaines%26aufirst%3DT.%26aulast%3DCamp%26aufirst%3DD.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DYoon%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DH.%26aulast%3DMooring%26aufirst%3DS.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25202%252C5%2520and%25202%252C6%2520pyridine-based%2520CXCR4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5052%26epage%3D5060%26doi%3D10.1016%2Fj.bmc.2016.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+T.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+GPCR+with+small-molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0liBXn_M_koZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520GPCR%2520with%2520small-molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0liBXn_M_koZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure-based studies of chemokine receptors</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1016/j.sbi.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.sbi.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=23706951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=539-546&author=L.+Zhuauthor=Q.+Zhaoauthor=B.+Wu&title=Structure-based+studies+of+chemokine+receptors&doi=10.1016%2Fj.sbi.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based studies of chemokine receptors</span></div><div class="casAuthors">Zhu, Lan; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-546</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chemokine receptors, which belong to the G protein-coupled receptor (GPCR) family of proteins, are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  Recently detd. structures of chemokine receptor CXCR4 reveal unique structural features, and offer templates for homol. modeling of other chemokine receptors, which deepen our understanding in ligand-binding modes and signal transduction mechanisms.  Dimerization, another intriguing issue for GPCR research, is also reviewed based on all published GPCR structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_pW0eZucXLVg90H21EOLACvtfcHk0lhHXaWxWmBylw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cisbo%253D&md5=bfd2e532ade8e17a68fd7a9a1fe7be2d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure-based%2520studies%2520of%2520chemokine%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26spage%3D539%26epage%3D546%26doi%3D10.1016%2Fj.sbi.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Shia, K. S.; Jan, J. J.; Tsou, L. K.; Chen, C. T.; Chao, Y. S.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds and Use Thereof</span>. U.S. Patent 0,083,369, March 24,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+S.+Shia&author=J.+J.+Jan&author=L.+K.+Tsou&author=C.+T.+Chen&author=Y.+S.+Chao&title=Heterocyclic+Compounds+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DHeterocyclic%2520Compounds%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Matsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, K.</span><span> </span><span class="NLM_article-title">CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1182/blood.V97.2.419</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1182%2Fblood.V97.2.419" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2001&pages=419-425&author=S.+Matsuokaauthor=Y.+Ebiharaauthor=M.+Xuauthor=T.+Ishiiauthor=D.+Sugiyamaauthor=H.+Yoshinoauthor=T.+Uedaauthor=A.+Manabeauthor=R.+Tanakaauthor=Y.+Ikedaauthor=T.+Nakahataauthor=K.+Tsuji&title=CD34+expression+on+long-term+repopulating+hematopoietic+stem+cells+changes+during+developmental+stages&doi=10.1182%2Fblood.V97.2.419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1182%2Fblood.V97.2.419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V97.2.419%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DS.%26aulast%3DEbihara%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DSugiyama%26aufirst%3DD.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DManabe%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DK.%26atitle%3DCD34%2520expression%2520on%2520long-term%2520repopulating%2520hematopoietic%2520stem%2520cells%2520changes%2520during%2520developmental%2520stages%26jtitle%3DBlood%26date%3D2001%26volume%3D97%26spage%3D419%26epage%3D425%26doi%3D10.1182%2Fblood.V97.2.419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mende, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waskow, C.</span><span> </span><span class="NLM_article-title">CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5582</span><span class="NLM_x">–</span> <span class="NLM_lpage">5587</span><span class="refDoi"> DOI: 10.1073/pnas.1215438110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1073%2Fpnas.1215438110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5582-5587&author=K.+Arndtauthor=T.+Grinenkoauthor=N.+Mendeauthor=D.+Reichertauthor=M.+Portzauthor=T.+Ripichauthor=P.+Carmelietauthor=D.+Corbeilauthor=C.+Waskow&title=CD133+is+a+modifier+of+hematopoietic+progenitor+frequencies+but+is+dispensable+for+the+maintenance+of+mouse+hematopoietic+stem+cells&doi=10.1073%2Fpnas.1215438110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1215438110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1215438110%26sid%3Dliteratum%253Aachs%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGrinenko%26aufirst%3DT.%26aulast%3DMende%26aufirst%3DN.%26aulast%3DReichert%26aufirst%3DD.%26aulast%3DPortz%26aufirst%3DM.%26aulast%3DRipich%26aufirst%3DT.%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DCorbeil%26aufirst%3DD.%26aulast%3DWaskow%26aufirst%3DC.%26atitle%3DCD133%2520is%2520a%2520modifier%2520of%2520hematopoietic%2520progenitor%2520frequencies%2520but%2520is%2520dispensable%2520for%2520the%2520maintenance%2520of%2520mouse%2520hematopoietic%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5582%26epage%3D5587%26doi%3D10.1073%2Fpnas.1215438110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span> </span><span class="NLM_article-title">Granulocyte colony-stimulating factor reduces hyperoxia-induced alveolarization inhibition by increasing angiogenic factors</span> <span class="citation_source-journal">Neonatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1159/000335285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1159%2F000335285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=278-284&author=H.+J.+Leeauthor=C.+W.+Choiauthor=E.+K.+Kimauthor=H.+S.+Kimauthor=B.+I.+Kimauthor=J.+H.+Choi&title=Granulocyte+colony-stimulating+factor+reduces+hyperoxia-induced+alveolarization+inhibition+by+increasing+angiogenic+factors&doi=10.1159%2F000335285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1159%2F000335285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000335285%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DE.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BI.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26atitle%3DGranulocyte%2520colony-stimulating%2520factor%2520reduces%2520hyperoxia-induced%2520alveolarization%2520inhibition%2520by%2520increasing%2520angiogenic%2520factors%26jtitle%3DNeonatology%26date%3D2012%26volume%3D101%26spage%3D278%26epage%3D284%26doi%3D10.1159%2F000335285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Westvik, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimiento, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancher, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westvik, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishibe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, O. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, A.</span><span> </span><span class="NLM_article-title">Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis</span> <span class="citation_source-journal">J. Vasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1016/j.jvs.2008.08.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2Fj.jvs.2008.08.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19028053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ktlygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=464-473&author=T.+S.+Westvikauthor=T.+N.+Fitzgeraldauthor=A.+Mutoauthor=S.+P.+Maloneyauthor=J.+M.+Pimientoauthor=T.+T.+Fancherauthor=D.+Magriauthor=H.+H.+Westvikauthor=T.+Nishibeauthor=O.+C.+Velazquezauthor=A.+Dardik&title=Limb+ischemia+after+iliac+ligation+in+aged+mice+stimulates+angiogenesis+without+arteriogenesis&doi=10.1016%2Fj.jvs.2008.08.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis</span></div><div class="casAuthors">Westvik Tormod S; Fitzgerald Tamara N; Muto Akihito; Maloney Stephen P; Pimiento Jose M; Fancher Tiffany T; Magri Dania; Westvik Hilde H; Nishibe Toshiya; Velazquez Omaida C; Dardik Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular surgery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">464-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Older patients are thought to tolerate acute ischemia more poorly than younger patients.  Since aging may depress both angiogenesis and arteriogenesis, we determined the effects of age on both angiogenesis and arteriogenesis in a model of severe acute limb ischemia.  METHODS:  Young adult (3-months-old) and aged (18-months-old) C57BL/6 mice underwent right common iliac artery and vein ligation and transection.  Data were collected on days 0, 7, and 14.  Perfusion was measured with a laser Doppler scan and compared to the contralateral limb.  Functional deficits were evaluated with the Tarlov scale.  Capillary density and endothelial progenitor cell (EPC) number were determined by direct counting lectin-positive/alpha-actin-negative cells and VEGFR2/CXCR4 dually-positive cells, respectively; angiography was performed to directly assess arteriogenesis.  RESULTS:  Young adult and aged mice had a similar degree of decreased perfusion after iliac ligation (young, n = 15: 20.4 +/- 1.9%, vs aged, n = 20: 19.6 +/- 1.3%; P = .72, analysis of variance [ANOVA]); however, young mice recovered faster and to a greater degree than aged mice (day 7, 35 +/- 6% vs 17 +/- 4%, P = .046; day 14, 60 +/- 5% vs 27 +/- 7%, P = .0014).  Aged mice had worse functional recovery by day 14 compared to young mice (2.3 +/- 0.3 vs 4.3 +/- 0.4; P = .0021).  Aged mice had increased capillary density (day 7, 12.9 +/- 4.4 vs 2.8 +/- 0.3 capillaries/hpf; P = .02) and increased number of EPC incorporated into the ischemic muscle (day 7, 8.1 +/- 0.9 vs 2.5 +/- 1.9 cells; P = .007) compared to young mice, but diminished numbers of collateral vessels to the ischemic limb (1 vs 9; P = .01), as seen on angiography.  CONCLUSION:  After severe hind limb ischemia, aged animals become ischemic to a similar degree as young animals, but aged animals have significantly impaired arteriogenesis and functional recovery compared to younger animals.  These results suggest that strategies to stimulate arteriogenesis may complement those that increase angiogenesis, and may result in improved relief of ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwnNQH8CZfT5PlX7E30qdzfW6udTcc2eaoTaP4I0fc67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ktlygsw%253D%253D&md5=e80b356904efe023da0b865a3a76335e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jvs.2008.08.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jvs.2008.08.077%26sid%3Dliteratum%253Aachs%26aulast%3DWestvik%26aufirst%3DT.%2BS.%26aulast%3DFitzgerald%26aufirst%3DT.%2BN.%26aulast%3DMuto%26aufirst%3DA.%26aulast%3DMaloney%26aufirst%3DS.%2BP.%26aulast%3DPimiento%26aufirst%3DJ.%2BM.%26aulast%3DFancher%26aufirst%3DT.%2BT.%26aulast%3DMagri%26aufirst%3DD.%26aulast%3DWestvik%26aufirst%3DH.%2BH.%26aulast%3DNishibe%26aufirst%3DT.%26aulast%3DVelazquez%26aufirst%3DO.%2BC.%26aulast%3DDardik%26aufirst%3DA.%26atitle%3DLimb%2520ischemia%2520after%2520iliac%2520ligation%2520in%2520aged%2520mice%2520stimulates%2520angiogenesis%2520without%2520arteriogenesis%26jtitle%3DJ.%2520Vasc.%2520Surg.%26date%3D2009%26volume%3D49%26spage%3D464%26epage%3D473%26doi%3D10.1016%2Fj.jvs.2008.08.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Broxmeyer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orschell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapp, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hangoc, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plett, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liles, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham-Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srour, E. F.</span><span> </span><span class="NLM_article-title">Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1318</span><span class="refDoi"> DOI: 10.1084/jem.20041385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1084%2Fjem.20041385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15837815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Citbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2005&pages=1307-1318&author=H.+E.+Broxmeyerauthor=C.+M.+Orschellauthor=D.+W.+Clappauthor=G.+Hangocauthor=S.+Cooperauthor=P.+A.+Plettauthor=W.+C.+Lilesauthor=X.+Liauthor=B.+Graham-Evansauthor=T.+B.+Campbellauthor=G.+Calandraauthor=G.+Bridgerauthor=D.+C.+Daleauthor=E.+F.+Srour&title=Rapid+mobilization+of+murine+and+human+hematopoietic+stem+and+progenitor+cells+with+AMD3100%2C+a+CXCR4+antagonist&doi=10.1084%2Fjem.20041385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist</span></div><div class="casAuthors">Broxmeyer, Hal E.; Orschell, Christie M.; Clapp, D. Wade; Hangoc, Giao; Cooper, Scott; Plett, P. Artur; Liles, W. Conrad; Li, Xiaxin; Graham-Evans, Barbara; Campbell, Timothy B.; Calandra, Gary; Bridger, Gary; Dale, David C.; Srour, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1307-1318</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Improving approaches for hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) mobilization is clin. important because increased nos. of these cells are needed for enhanced transplantation.  Chemokine stromal cell derived factor-1 (also known as CXCL12) is believed to be involved in retention of HSCs and HPCs in bone marrow.  AMD3100, a selective antagonist of CXCL12 that binds to its receptor, CXCR4, was evaluated in murine and human systems for mobilizing capacity, alone and in combination with granulocyte colony-stimulating factor (G-CSF).  AMD3100 induced rapid mobilization of mouse and human HPCs and synergistically augmented G-CSF-induced mobilization of HPCs.  AMD3100 also mobilized murine long-term repopulating (LTR) cells that engrafted primary and secondary lethally-irradiated mice, and human CD34+ cells that can repopulate nonobese diabetic-severe combined immunodeficiency (SCID) mice.  AMD3100 synergized with G-CSF to mobilize murine LTR cells and human SCID repopulating cells (SRCs).  Human CD34+ cells isolated after treatment with G-CSF plus AMD3100 expressed a phenotype that was characteristic of highly engrafting mouse HSCs.  Synergy of AMD3100 and G-CSF in mobilization was due to enhanced nos. and perhaps other characteristics of the mobilized cells.  These results support the hypothesis that the CXCL12-CXCR4 axis is involved in marrow retention of HSCs and HPCs, and demonstrate the clin. potential of AMD3100 for HSC mobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDUgOByTJX07Vg90H21EOLACvtfcHk0ljx6L0Eb9ayxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Citbo%253D&md5=e5942dc81a7687a8b7c10f9542cbf29d</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1084%2Fjem.20041385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20041385%26sid%3Dliteratum%253Aachs%26aulast%3DBroxmeyer%26aufirst%3DH.%2BE.%26aulast%3DOrschell%26aufirst%3DC.%2BM.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DHangoc%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DS.%26aulast%3DPlett%26aufirst%3DP.%2BA.%26aulast%3DLiles%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGraham-Evans%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DT.%2BB.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDale%26aufirst%3DD.%2BC.%26aulast%3DSrour%26aufirst%3DE.%2BF.%26atitle%3DRapid%2520mobilization%2520of%2520murine%2520and%2520human%2520hematopoietic%2520stem%2520and%2520progenitor%2520cells%2520with%2520AMD3100%252C%2520a%2520CXCR4%2520antagonist%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D201%26spage%3D1307%26epage%3D1318%26doi%3D10.1084%2Fjem.20041385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, B.</span><span> </span><span class="NLM_article-title">AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1097/FJC.0b013e3180587e4d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1097%2FFJC.0b013e3180587e4d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=61-67&author=Y.+Yinauthor=L.+Huangauthor=X.+Zhaoauthor=Y.+Fangauthor=S.+Yuauthor=J.+Zhaoauthor=B.+Cui&title=AMD3100+mobilizes+endothelial+progenitor+cells+in+mice%2C+but+inhibits+its+biological+functions+by+blocking+an+autocrine%2Fparacrine+regulatory+loop+of+stromal+cell+derived+factor-1+in+vitro&doi=10.1097%2FFJC.0b013e3180587e4d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1097%2FFJC.0b013e3180587e4d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0b013e3180587e4d%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DB.%26atitle%3DAMD3100%2520mobilizes%2520endothelial%2520progenitor%2520cells%2520in%2520mice%252C%2520but%2520inhibits%2520its%2520biological%2520functions%2520by%2520blocking%2520an%2520autocrine%252Fparacrine%2520regulatory%2520loop%2520of%2520stromal%2520cell%2520derived%2520factor-1%2520in%2520vitro%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D61%26epage%3D67%26doi%3D10.1097%2FFJC.0b013e3180587e4d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ward, P. A.</span><span> </span><span class="NLM_article-title">Leukotaxis and leukotactic disorders. A review</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=4611227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaE2MXhtlKqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1974&pages=520-538&author=P.+A.+Ward&title=Leukotaxis+and+leukotactic+disorders.+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Leukotaxis and leukotactic disorders.  Review</span></div><div class="casAuthors">Ward, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">520-38</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">A review with 97 refs. of methodologies of measuring leukotoxis; leukotactic factors for neutrophils, eosinophils, basophils, monocytes, and lymphocytes; interaction of chemotactic factors with leukocytes; and leukotactic defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROznA65Fo1rVg90H21EOLACvtfcHk0lgRWkRiIb6wtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtlKqtr8%253D&md5=afa57721325c26f422fd597db86ec8e4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BA.%26atitle%3DLeukotaxis%2520and%2520leukotactic%2520disorders.%2520A%2520review%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1974%26volume%3D77%26spage%3D520%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span> </span><span class="NLM_article-title">The pharmacology and toxicology of plerixafor</span> (NDA: 022311, p  <span class="NLM_fpage">43</span>), <a href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_PharmR.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022311s000_PharmR.pdf</a> (accessed Dec 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+pharmacology+and+toxicology+of+plerixafor+%28NDA%3A+022311%2C+p+43%29%2C+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2008%2F022311s000_PharmR.pdf+%28accessed+Dec+15%2C+2008%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520pharmacology%2520and%2520toxicology%2520of%2520plerixafor%26spage%3D43%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgRWkRiIb6wtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackerell, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boresch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodoscek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazaridis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovchinnikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">York, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: the biomolecular simulation program</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span><span class="refDoi"> DOI: 10.1002/jcc.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2Fjcc.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=19444816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Ciu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1545-1614&author=B.+R.+Brooksauthor=C.+L.+Brooksauthor=A.+D.+Mackerellauthor=L.+Nilssonauthor=R.+J.+Petrellaauthor=B.+Rouxauthor=Y.+Wonauthor=G.+Archontisauthor=C.+Bartelsauthor=S.+Boreschauthor=A.+Caflischauthor=L.+Cavesauthor=Q.+Cuiauthor=A.+R.+Dinnerauthor=M.+Feigauthor=S.+Fischerauthor=J.+Gaoauthor=M.+Hodoscekauthor=W.+Imauthor=K.+Kuczeraauthor=T.+Lazaridisauthor=J.+Maauthor=V.+Ovchinnikovauthor=E.+Paciauthor=R.+W.+Pastorauthor=C.+B.+Postauthor=J.+Z.+Puauthor=M.+Schaeferauthor=B.+Tidorauthor=R.+M.+Venableauthor=H.+L.+Woodcockauthor=X.+Wuauthor=W.+Yangauthor=D.+M.+Yorkauthor=M.+Karplus&title=CHARMM%3A+the+biomolecular+simulation+program&doi=10.1002%2Fjcc.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM: The biomolecular simulation program</span></div><div class="casAuthors">Brooks, B. R.; Brooks, C. L., III; Mackerell, A. D., Jr.; Nilsson, L.; Petrella, R. J.; Roux, B.; Won, Y.; Archontis, G.; Bartels, C.; Boresch, S.; Caflisch, A.; Caves, L.; Cui, Q.; Dinner, A. R.; Feig, M.; Fischer, S.; Gao, J.; Hodoscek, M.; Im, W.; Kuczera, K.; Lazaridis, T.; Ma, J.; Ovchinnikov, V.; Paci, E.; Pastor, R. W.; Post, C. B.; Pu, J. Z.; Schaefer, M.; Tidor, B.; Venable, R. M.; Woodcock, H. L.; Wu, X.; Yang, W.; York, D. M.; Karplus, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1545-1614</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  CHARMM (Chem. at HARvard Mol. Mechanics) is a highly versatile and widely used mol. simulation program.  It has been developed over the last three decades with a primary focus on mols. of biol. interest, including proteins, peptides, lipids, nucleic acids, carbohydrates, and small mol. ligands, as they occur in soln., crystals, and membrane environments.  For the study of such systems, the program provides a large suite of computational tools that include numerous conformational and path sampling methods, free energy estimators, mol. minimization, dynamics, and anal. techniques, and model-building capabilities.  The CHARMM program is applicable to problems involving a much broader class of many-particle systems.  Calcns. with CHARMM can be performed using a no. of different energy functions and models, from mixed quantum mech.-mol. mech. force fields, to all-atom classical potential energy functions with explicit solvent and various boundary conditions, to implicit solvent and membrane models.  The program has been ported to numerous platforms in both serial and parallel architectures.  This article provides an overview of the program as it exists today with an emphasis on developments since the publication of the original CHARMM article in 1983.  © 2009 Wiley Periodicals, Inc. J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOXZCtNIqoCbVg90H21EOLACvtfcHk0lgRWkRiIb6wtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Ciu70%253D&md5=2c6a2be869362d7131f5aea8411c1552</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21287%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DMackerell%26aufirst%3DA.%2BD.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DPetrella%26aufirst%3DR.%2BJ.%26aulast%3DRoux%26aufirst%3DB.%26aulast%3DWon%26aufirst%3DY.%26aulast%3DArchontis%26aufirst%3DG.%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DBoresch%26aufirst%3DS.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DCaves%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DQ.%26aulast%3DDinner%26aufirst%3DA.%2BR.%26aulast%3DFeig%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHodoscek%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DKuczera%26aufirst%3DK.%26aulast%3DLazaridis%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DOvchinnikov%26aufirst%3DV.%26aulast%3DPaci%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BW.%26aulast%3DPost%26aufirst%3DC.%2BB.%26aulast%3DPu%26aufirst%3DJ.%2BZ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DVenable%26aufirst%3DR.%2BM.%26aulast%3DWoodcock%26aufirst%3DH.%2BL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYork%26aufirst%3DD.%2BM.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520the%2520biomolecular%2520simulation%2520program%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D1545%26epage%3D1614%26doi%3D10.1002%2Fjcc.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderspoel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandrunen, R.</span><span> </span><span class="NLM_article-title">GROMACS: a message-passing parallel molecular-dynamics implementation</span> <span class="citation_source-journal">Comput. Phys. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/0010-4655(95)00042-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+Vanderspoelauthor=R.+Vandrunen&title=GROMACS%3A+a+message-passing+parallel+molecular-dynamics+implementation&doi=10.1016%2F0010-4655%2895%2900042-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d9beabb6b4b8baaa99bab1bcb4f7abacbef7b7b5">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0lgRw9PrmJwVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DVanderspoel%26aufirst%3DD.%26aulast%3DVandrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520a%2520message-passing%2520parallel%2520molecular-dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56%26doi%3D10.1016%2F0010-4655%2895%2900042-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eY9MYSIH46hQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Chiu, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, E.</span><span> </span><span class="NLM_article-title">An improved united atom force field for simulation of mixed lipid bilayers</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2748</span><span class="NLM_x">–</span> <span class="NLM_lpage">2763</span><span class="refDoi"> DOI: 10.1021/jp807056c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp807056c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=2748-2763&author=S.+W.+Chiuauthor=S.+A.+Panditauthor=H.+L.+Scottauthor=E.+Jakobsson&title=An+improved+united+atom+force+field+for+simulation+of+mixed+lipid+bilayers&doi=10.1021%2Fjp807056c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved United Atom Force Field for Simulation of Mixed Lipid Bilayers</span></div><div class="casAuthors">Chiu, See-Wing; Pandit, Sagar A.; Scott, H. L.; Jakobsson, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2748-2763</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce a new force field (43A1-S3) for simulation of membranes by the Gromacs simulation package.  Construction of the force fields is by std. methods of electronic structure computations for bond parameters and charge distribution and sp. vol.s and heats of vaporization for small-mol. components of the larger lipid mols. for van der Waals parameters.  Some parameters from the earlier 43A1 force field are found to be correct in the context of these calcns., while others are modified.  The validity of the force fields is demonstrated by correct replication of X-ray form factors and NMR order parameters over a wide range of membrane compns. in semi-isotropic NTP 1 atm simulations.  43-A1-S3 compares favorably with other force fields used in conjunction with the Gromacs simulation package with respect to the breadth of phenomena that it accurately reproduces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPmuQBx7de7Vg90H21EOLACvtfcHk0lgRw9PrmJwVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltro%253D&md5=c881cacab451368c125262e4b9dd0e01</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjp807056c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp807056c%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.%2BW.%26aulast%3DPandit%26aufirst%3DS.%2BA.%26aulast%3DScott%26aufirst%3DH.%2BL.%26aulast%3DJakobsson%26aufirst%3DE.%26atitle%3DAn%2520improved%2520united%2520atom%2520force%2520field%2520for%2520simulation%2520of%2520mixed%2520lipid%2520bilayers%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2009%26volume%3D113%26spage%3D2748%26epage%3D2763%26doi%3D10.1021%2Fjp807056c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraaije, J. G. E. M.</span><span> </span><span class="NLM_article-title">LINCS: a linear constraint solver for molecular simulations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;key=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=1463-1472&author=B.+Hessauthor=H.+Bekkerauthor=H.+J.+C.+Berendsenauthor=J.+G.+E.+M.+Fraaije&title=LINCS%3A+a+linear+constraint+solver+for+molecular+simulations&doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">LINCS: a linear constraint solver for molecular simulations</span></div><div class="casAuthors">Hess, Berk; Bekker, Henk; Berendsen, Herman J. C.; Fraaije, Johannes G. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1463-1472</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">We present a new LINear Constraint Solver (LINCS) for mol. simulations with bond constraints using the enzyme lysozyme and a 32-residue peptide as test systems.  The algorithm is inherently stable, as the constraints themselves are reset instead of derivs. of the constraints, thereby eliminating drift.  Although the derivation of the algorithm is presented in terms of matrixes, no matrix matrix multiplications are needed and only the nonzero matrix elements have to be stored, making the method useful for very large mols.  At the same accuracy, the LINCS algorithm is 3-4 times faster than the SHAKE algorithm.  Parallelization of the algorithm is straightforward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6h4pdV0Nx7Vg90H21EOLACvtfcHk0lj-gl_-saskdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D&md5=890f8af0d2ca1f65aa93db5a3a0bacf2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199709%252918%253A12%253C1463%253A%253AAID-JCC4%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DBekker%26aufirst%3DH.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DFraaije%26aufirst%3DJ.%2BG.%2BE.%2BM.%26atitle%3DLINCS%253A%2520a%2520linear%2520constraint%2520solver%2520for%2520molecular%2520simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D1463%26epage%3D1472%26doi%3D10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RWS','PDB','4RWS'); return false;">PDB: 4RWS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ODU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ODU','PDB','3ODU'); return false;">PDB: 3ODU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0','PDB','3OE0'); return false;">PDB: 3OE0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01322">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12566"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01322">10.1021/acs.jmedchem.7b01322</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Compound <b>16</b>’s off-target and patch-clamp assays by Eurofins Panlabs Taiwan, Ltd.; counter screening against 12 chemokine receptors by DiscoverX Corporation, Fremont, CA; synthetic protocols of linkers and their characterization data; <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative compounds <b>7</b>–<b>10</b> and <b>16</b>–<b>21</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Binding model of <b>16</b> in CXCR4 receptor (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings of all target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_001.pdf">jm7b01322_si_001.pdf (5.7 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_002.pdb">jm7b01322_si_002.pdb (363.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01322/suppl_file/jm7b01322_si_003.csv">jm7b01322_si_003.csv (1.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01322&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01322%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01322" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a4a200c313d76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
